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Abstract
The World Health Assembly resolution (WHA 50.29) called for the elimination 
of lymphatic filariasis (IF) as a public health problem and set in motion a 
series of global, regional and country activities aimed at the achievement of 
this objective, the guiding principle of Ghana’s programme to eliminate LF. 
The main goal of this study is to determine the impact of mass drug 
administration (MDA) on the prevalence and transmission intensity of LF and 
investigate the suitability of the community directed approach as a vehicle for 
developing an integrated treatment strategy and plan targeting other 
neglected tropical diseases (NTDs) amenable to MDA within the context of 
the health system. To determine the impact of the Ghana Filariasis 
Elimination Programme on LF elimination and on other NTDs amenable to 
MDA and the health system
Ghana has an estimated population of 25 million and is endemic for all the 
diseases targeted with preventive chemotherapy. The country has been 
mapped for all these diseases. The Lymphatic Filariasis Elimination 
Programme, serving as an implementation platform, has made significant 
impacts on the epidemiology, implementation of LF elimination and 
implementation of other NTDs and within overall health system service 
provision. These diseases are LF, onchocerciasis, soil transmitted 
helminthiasis, schistosomiasis and trachoma.
This evaluation has revealed that NTDs are among the most disabling and 
stigmatising conditions with long-term sequelae. The awareness of other 
NTDs amenable to preventive chemotherapy was low compared to LF. 
Microfilaria prevalence and immuno-parasitologic indicators have shown 
significant downward trends in all districts including the five start-up districts 
on the programme. Districts with high prevalence at baseline had difficulty in
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achieving end points after six rounds of MDA. One of the five start-up districts 
demonstrated the possibility this could be achieved after further two years of 
treatment. The number of years required to break LF transmission requires 
reviewing. Operational issues including therapeutic and geographic coverage, 
compliance with MDA, mosquito vector characteristics and drug regimens 
should be considered.
Morbidity control builds the confidence of communities in the programme with 
improvements in the physical, social and economic life of beneficiaries. 
Mobility, self care and ability to undertake activities had improved while pain, 
discomfort, anxiety and depression associated with hydrocoele had reduced 
after hydrocoeiectomy.
Remapping of onchocerciasis has been undertaken, biannual treatments of 
onchocerciasis using ivermectin instituted and declining trends have been 
observed. Schistosomiasis and soil transmitted helminthiasis have been 
mapped and regular treatment instituted. Trachoma elimination is in sight. 
Health systems impacts have been demonstrated at the national, regional, 
district and community levels. International and local partnerships have been 
strengthened.
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Chapter 1
Introduction
Chapter 1: Introduction
1.1: Distribution of Lymphatic Filariasis (LF)
Lymphatic filariasis (LF) or elephantiasis has become a household name in 
many endemic countries. It is a well known disease due to the disfigurement 
that it causes. The disease is found in the tropical and sub-tropical regions of 
Asia, Africa, Western Pacific and limited parts of Central and South America 
(Ottesen et al, 2008; WHO, 2006a).
LF is one of the major public health problems in many tropical countries. It is 
endemic in 83 countries where over 1.2 billion people are at risk of the 
infection (Ottesen et al, 2008; WHO, 2006a). Recent estimates suggest that at 
least 120 million people are infected with LF worldwide and may suffer from 
one form or other of the clinical disease (Ottesen et al, 2008). Some 106 
million individuals are infected with W. bancrofti and 13 million with Brugia 
malayi and Brugia timori (Rao et al, 2006). The number of physical disabilities 
due to lymphoedema, hydrocoele and recurrent infections or to sub-clinical 
abnormalities of lymphatic and renal function is currently estimated at 43 
million, with bancroftian filariasis accounting for almost 40 million of these 
cases (WHO, 2000). About 74 million people who are microfilaraemic and 
asymptomatic may have covert lymphatic and renal pathology. Almost 27 
million men and 16 million men and women are estimated to be affected with 
hydrocoeles and lymphoedema or elephantiasis respectively. Those with 
lymphoedema or elephantiasis have accompanying recurrent episodes of 
acute adenolymphangitis (ADL) presently known as 
dermatolymphangioadenitis (DLA) (WHO, 2001a; Gyapong et al., 2005). 
Finally, another one million individuals are also documented to have 
concealed infections resulting in conditions such as topical pulmonary
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eosinophilia (TPE) (WHO, 2001). There are over 40 million people with LF in 
sub-Saharan Africa with some 400 million being at-risk of the condition.
The public health significance and social and economic costs of the disease 
globally as well as for Africa are obvious (Gyapong et al, 1996; Chu et al, 
2010). The World Bank Report of 1993 estimated the global burden of LF at 
850,000 DALYs lost. This represented 0.23% of the global burden of parasitic 
diseases (World Bank, 1993). Based on more recent knowledge of the 
epidemiology and distribution of the disease, however, this figure is likely to 
be a gross underestimate, especially in the light of new findings relating to 
incidence, duration and severity of acute adenolymphangitis (Gyapong et al, 
1996). The Disability Adjusted Life Years (DALYs) lost due to LF disease is 
now estimated to be 5-8 million DALYs (Hotez et al, 2009).
The vision of the Global Programme to Eliminate Lymphatic Filariasis 
(GPELF) is to achieve elimination of LF by 2020 after ensuring that all 
endemic countries started implementing programmes by 2010. The GPELF 
therefore needed to take stock of its progress towards the achievement of 
these goals. The recent Global Alliance for the Elimination of Lymphatic 
Filariasis (GAELF) meeting in Seoul, South Korea presented an opportunity to 
undertake this assessment of the GPELF as the programme reached a 
halfway point (Addiss, 2010). This assessment followed the World Health 
Organization WHO recommended process towards interruption of 
transmission. This begins with mapping of the distribution of LF to identify 
areas for MDA, followed by a 5-year or more period of delivering MDA using 
the double drug regimen of albendazole and ivermectin or diethylcarbamazine 
(DEC) to identified endemic populations, and a period of surveillance 
culminating finally in determining the end point of MDA and cessation of 
transmission (Addiss, 2010).
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The GPELF has made significant progress since its inception. Among the 83 
originaliy identified endemic countries 10 (12.3%) did not need MDA, about 52 
(64.2%) were undertaking programmes leaving 19 countries which were to 
start implementing MDA. Among the 52 implementing countries 37 had 
completed the minimum of 5 rounds of MDA in some of the implementation 
units (Addiss, 2010). The GAELF was able to annually reach an estimated 
population of about 570 million people with MDA with albendazole and 
ivermectin/DEC, though a total of 1.9 billion treatments were provided to 48 
out of the 83 known LF endemic countries during the period 2000- 
2008(0ttesen et al, 2008). Recent statistics also indicate that there are 
presently 120 million infected individuals from 73 endemic countries with 
1.393 people at-risk of the infection needing MDA (WHO 2012). Some 15 
million people are estimated to have lymphoedema or elephantiasis with 25 
million with urogenital swellings principally scrotal hydrocoeles (WHO, 2012).
Other landmark achievements under the GAELF include protection of an 
estimated number of 22 million people from LF infection and disease with 
economic savings of about $24.2 billion being made (Chu et al, 2010). A 
decline in microfilaraemia prevalence has been demonstrated in 131 sentinel 
sites after five rounds of MDA with 68 sites (63%) showing a 100% reduction 
in prevalence (Addiss, 2010).
Some 27 (33.3%) country morbidity management programmes have 
demonstrated marked reductions in acute attacks in persons living with 
elephantiasis or lymphoedema. Ancillary benefits of LF have also accrued by 
treating or preventing infestation of individuals with intestinal worms, scabies 
and pediculosis (Ottesen et al, 2008) due to the broad anti-parasitic activity of 
albendazole and ivermectin/albendazole (Mohammed et al, 2008).
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In spite of the achievements of the GAELF, many challenges need to be 
addressed. There is a need to improve partnerships, improve financial, 
logistic and human resources and undertake research leading to refined 
implementation strategies. These challenges border on the need to ensure 
that all endemic countries are committed to the programme, the need to 
upscale to full geographic coverage in all implementing countries, 
surmounting the treatment barrier presented in Loa loa co-endemic countries 
(LFSC, 2003; Twum-Danso, 2003) ensuring effective treatment in urban 
areas, strategies for treatment within conflict and post-conflict settings 
(Hopkins A and GAELF 6, 2010), refining post-MDA surveillance guidelines 
and the need for clear and easy to implement procedures and guidelines for 
determining the end points for MDA (Addiss, 2010).
1.2: Distribution, Transmission and Prevention of Lymphatic Filariasis
LF is a disease caused by the adults of W.bancrofti, which causes some 90% 
of the disease, however, other filaria species causing the disease are Brugia 
malayi and Brugia timori. Adult worms live in the lymphatic system of human 
beings. There are no known animal reservoirs of W. bancrofti. The mosquito 
is the only known vector of this parasitic infection and is spread from one 
person to another is through the bites of various genera and species of 
mosquitoes. The mosquito becomes infected when it ingests the microfilaria 
from an infected person’s blood. The mosquito is also able to pass on these 
parasites when it bites another individual following a cycle of development. 
This happens when the mosquito bites another non-infected person and the 
infective larvae pass through the skin of the other non-infected person and 
migrate to the lymphatic vessels. They grow into the adult macrofilariae within 
the lymphatic vessels where they are estimated to live for as long as 7-10 
years (Hawking, 1967). During this period the adult worms mate, and female 
macrofilariae produce millions of microscopic larvae called microfilariae, which
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are released into the blood stream of the affected individual. Once these 
microfilariae appear in the blood, a mosquito that bites this person is capable 
of picking up the microfilariae for transmission to yet another person. The 
parasites within the lymphatic system cause the pathology, which results in 
chronic gross disfigurement. W.bancrofti microfilariae exhibit nocturnal 
periodicity and appear in the blood stream at night and they are thus available 
for ingestion and transmission by night biting mosquitoes. During the daytime 
they accumulate in the small vessels of the lungs, and hence there are few in 
the peripheral blood. This phase is adapted to allow the microfilariae to enjoy 
favourable physiological conditions provided by the increase in oxygen 
tension in the lungs, referred to as the ‘oxygen barrier’. Microfilariae pass 
through the lungs by night but accumulate there by day (Hawking, 1967). The 
nocturnal periodicity exhibited by W. bancrofti facilitates transmission when 
the night biting vectors the rural Anopheles or urban Culex is available to 
ingest the microfilaria parasites (Pichon et al, 2004). This circadian cycle is 
observed in the tropics and sub-tropics while diurnal sub-periodicity is 
associated with the vector Aedes mosquito in urban settings.
LF is known to be a leading cause of permanent and long-term disability 
worldwide. Pain, disfigurement and sexual disability are recognised features 
of the disease (Gyapong et al, 1996; WHO, 1998) as well as the inability to 
work due to disability, which has negative economic impacts on their families 
and communities (Perera et al., 2007). An individual needs multiple mosquito 
bites over many months or even years to acquire active clinical LF (Centers 
for Disease Control and Prevention (CDC), 2012). This risk of infection with 
LF is greatest for people who live in the tropical and sub-tropical areas where 
the infection is common (CDC, 2012). An infection can be demonstrated in the 
blood of an infected person even when they have no symptoms and signs of 
the disease and these people are unaware that they have this infection (CDC, 
2012). This could continue until the death of the adult worm. The disease is
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rarely known to be life threatening or a direct cause of mortality. However, the 
infection can cause permanent damage to the lymphatic system and kidneys 
leading to the collection of lymph fluid in the arms, breasts, legs and also 
genital area in men. This swelling is referred to as lymphoedema resulting in 
limb swelling up to several times the normal size of the leg, arm or genital 
area. The function of the lymphatic system in fighting bacterial infections is 
compromised leading to bacterial infections in the skin and lymphatic system. 
These cause hardening and thickening of the skin called elephantiasis (WHO, 
2001a; 2001b).
Common conditions associated with the disease are poor sanitation and rapid 
growth of communities in the tropical and subtropical areas of the world. In 
these areas the disease is common since mosquito breeding sites are easy to 
find leading to more people becoming infected. Giving anti-filarial medicines to 
the entire at risk communities will reduce the microfilaria levels and hence 
reduce the risk of transmission. Controlling the mosquito breeding sites and 
avoiding the mosquito bites between dusk and dawn helps to prevent 
transmission and hence the disease. It is therefore recommended that people, 
who live in endemic areas sleep under mosquito nets, take the yearly dose of 
anti-filarial medicines to kill microfilaria circulating in the blood and even some 
adult worms (http://www.dpd.cdc.gov/dpdx/HTML/Filariasis.htm>(last
accessed 28 April 2012). Application of in-door residual spraying as has been 
starte in certain parts of Ghana under the Presidents Malaria Initiative (PMI) 
should have the added advantage of aiding elimination of LF disease. Early 
studies in the Solomon Islands clearly showed that anti malarial measures- 
indoor residual spraying eliminated transmission (Bockarie et al, 2009).
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1.3: Global Burden and Programme to Eliminate Lymphatic Filariasis
The GPELF had its beginning with an inauguration at the Royal Society of 
Tropical Medicine and Hygiene in London in January 2000. In May 2000 the 
first meeting of the GAELF was held in Spain. These initial activities became 
possible after several years of research into LF but limited efforts had been 
made to control this disease with the exception of some implementation 
activities in countries such as China, Korea, Sri Lanka and Thailand. With 83 
countries regarded as endemic for LF at the time, national plans of action to 
eliminate LF by 23 endemic countries were drawn up leading to the 
successful initiation of programme implementation activities in 12 of these 
countries resulting in the treatment of about 3 million people (WHO, 2000). In 
Africa the total population at-risk of LF is estimated to be 408,429,756 in 39 
countries, 18 of which are currently under MDA. Among these 18 countries 10 
of them have completed 5 rounds of MDA implementation activities (WHO, 
2010 a, b).
The initiative to eliminate filariasis was informed by decades of scientific 
research and investigations early control programmes in China, Costa Rica, 
Suriname and other countries whose experiences lead the International Task 
Force for Disease Eradication (ITFDE) in 1993 to suggest that LF was an 
“eradicable disease” (Centers for Disease Control and Prevention, 1998). 
During the past 13 years Ghana as a country and the focus of this thesis has 
greatly benefited from this global initiative. During this period Ghana has 
undertaken mapping resulting in an endemic map and developed a strategic 
plan of action, established baseline information and undertaken follow-up 
surveys in selected sentinel sites which have helped with monitoring in all the 
endemic regions, and is presently involved in designing an exit plan to help 
determine the end points of mass drug distribution in areas which have 
completed a minimum of 6 rounds of distribution. Some districts, in which the
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Ghana programme has undertaken continuous microfilaria prevalence and 
density monitoring have shown significant reduction in microfilaria prevalence 
and densities to the expected low levels while others, remain a challenge. 
Also the programme has had striking impacts on the health system. It 
provided the platform for implementing other NTD programmes that rely on 
mass chemotherapy as a strategy.
The World Health Report of 1995 described LF as the second leading cause 
of permanent and long term disability (WHO, 1995). This was followed up in 
the World Health Report of 2000 where it was again said to be the second 
leading cause of lost ‘disability adjusted life years (DALY’s) (WHO 2000). The 
research findings of the 1980s and 1990s led to the declaration that LF was a 
potentially eradicable disease and also provided the impetus for the World 
Health Assembly Resolution 50.29 in 1997. This resolution had the support of 
the Ministries of Health of the endemic countries and other organizations such 
as the Arab Fund for Economic and Social Development, the World Bank and 
the United States CDC among others (WHO, 2000).
The 50th World Health Assembly resolution in 1997 (WHA 50.29) called on 
member states to work towards the elimination of LF as a public health 
problem by 2020 (WHO,2011a). Scientific knowledge, human, material and 
financial resources have been harnessed to see to realise this challenging 
goal. The WHA resolution sought to cover all endemic countries with 
elimination programmes by 2010 and aim a gradual reduction and ultimately 
interruption of transmission by 2020 (WHO, 2011a).
The two main strategies adopted were
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(a) Interruption of transmission through MDA with annual single dose two- 
drug regimen to entire at risk populations for at least 5 years, and 
(WHO, 2006 a; WHO 2006b)
(b) Alleviation of disability through morbidity management of clinical cases 
(WHO 2007 a, b)
A major factor in the momentum to launch the GPELF was the commitment of 
SmithKIineBeecham now GlaxoSmithKline in 1998 to donate albendazole 
worldwide. Merck & Co Inc., pledged to donate ivermectin in all African 
countries co-endemic for onchocerciasis and LF for as long as it was required. 
A Memorandum of Understanding was signed between the Chief Executives 
of these companies with the Director-General of the WHO. This brought on 
board other major international organisations that pledged further funding to 
help realise the goals of this noble objective. A broad coalition of partners 
resulted after several other organisations joined the partnership, which was 
made up of some 27 organisations and national Ministries of hHealth of LF 
endemic countries (WHO, 2000). With interim monitoring guidelines, the 
programme was successful in treating 200,000 people from 4 endemic 
countries with the start-up programme (WHO, 2000). Governments of 
endemic countries have borne about 80% of implementation costs the GPELF 
was able to reach about half of the total global at-risk population (WHO, 
2006).
1.4 Interruption of transmission
In the WHO 2001 LF report, to interrupt transmission of LF was defined as 
“reduction in the disease incidence to close to zero as a result of deliberate 
efforts requiring continued and coordinated activities" (WHO, 2001a, WHO, 
2001b). This meant that the entire at-risk population had to be covered by 
MDA over sufficient time long enough to bring about this desired effect of
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interrupting transmission. The drugs that were recommended were DEC 
(6mg/kg) and albendazole (400mg) or ivermectin (150ug/kg) and albendazole 
(400mg). In areas co-endemic for LF and onchocerciasis, DEC -fortified 
cooking salt daily over a period of 6-12 months is another option that is 
available to endemic countries (Gyapong et al, 2005; Bockarie et al, 2009).
1.5 Lymphatic Filariasis in Ghana
The serious health and socioeconomic impacts of LF disease in Ghana has 
raised the public health awareness of the disease in Ghana (Gyapong et al., 
1996). There have been various attempts to describe LF in Ghana over the 
years. In a study conducted through rapid community diagnosis of LF, key 
informants interviewed ranked scrotal swellings second and elephantiasis fifth 
among common conditions in adults in parts of rural Ghana (Gyapong et al., 
1996). This study established a high correlation between rapid LF at the 
community level. Routine reporting at health facilities estimated hydrocoele 
surgeries to be among the commonest surgeries carried out in district level 
health facilities surveyed followed by hernias. District assembly members 
were able to provide reliable estimates of numbers of people with 
elephantiasis, which could be corroborated with data from the district health 
management team (DHMT). Data on hydrocoeles were largely 
underestimated because reports focused on cases of gross scrotal 
enlargements. Reports from teachers interviewed also gave estimates close 
to figures from the DHMT and similar to that by the district assembly 
members. Teachers reported a history of acute adenolymphangitis (ADL) 
among some of their class children. Adult males over 20 years had 
prevalence of hydrocoeles ranging from 4.1% and 19.8% (Gyapong et al., 
1996). More than 50% of those examined had hydrocoeles with sizes bigger 
than a tennis ball. A marked correlation between the prevalence of
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hydrocoeles among males and the community microfilaria prevalence was 
established (Gyapong et al., 1996).
Surveys undertaken in Ghana also assessed the prevalence of hydrocoeles 
as a rapid diagnostic index for LF and established that it is possible to obtain 
a reliable and valid estimate of the community burden of LF using the 
prevalence of hydrocoeles as a diagnostic index. This study documented a 
positive and significant association between filarial disease prevalence and 
infection prevalence and intensity at the community level in Ghana (Gyapong 
et al, 1998). This was done by establishing the correlation between the 
prevalence of disease status associated with LF such as ADL, elephantiasis 
and hydrocoeles and microfilaraemia at the community level. The prevalence 
of the disease, especially hydrocoeles in Ghana was used to identify 
communities at-risk and predict the intensity of the infection without 
recommending its use in the monitoring of control programmes since 
prevalence and intensity of infection was not likely to be reflected in 
immediate reduction in disease prevalence (Gyapong et al, 1998).
Further studies described the epidemiology of LF in Ghana and established 
that the disease was a significant public health problem in Ghana (Gyapong et 
al, 1993, Gyapong et al, 1994, Gyapong et al, 1996) especially in northern 
regions and the coastal savanna requiring the design and implementation of a 
control programme. Another survey identified LF in 41 communities of north 
east Ghana. Several levels of the disease were identified in these hyper­
endemic areas with two government-introduced rice irrigation projects. In 
these areas it was discovered that failure to control LF made patients avoid 
hospitals and neglect the disease, by both the sufferers and medical 
personnel (Flunter, 1992). The prevalence in the northern guinea savanna 
was greater than in southern coastal savannah while the middle forest belt 
was relatively free. For this study the national microfilaraemia was 3.0% and
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regional levels varied from zero in Brong Ahafo and Greater Accra regions to 
20.0% in Upper West region. Infection was found to be present in 8 of the 10 
regions of Ghana. The study also demonstrated an increase in 
microfilaraemia and other clinical disease manifestations such as acute 
adenolymphagitis, elephantiasis of the leg, hydrocoeles and lymphoedema of 
the breast with age. Males were also found to have higher microfilaraemia 
intensities than females (Gyapong et al, 1996).
Ghana was one of the countries in which the use of the grid sampling method 
was used for the rapid assessment of the geographic distribution of 
bancroftian filariasis. The study recommended the 50x50-km grid method as 
being adequate for this rapid determination of the prevalence of LF. The 
antigen detection test using the immunochromatographic cards (ICT) method 
was also found to be a better diagnostic test than the use of clinical 
examination for hydrocoeles or night blood films. Filarial antigen tests have 
been found to be more sensitive than parasitological tests, and are a species- 
specific filarial diagnostic test for \N. bancrofti (Weil et al, 1997). This study 
therefore recommended that for rapid mapping of filariasis in Africa, the use of 
the 50-km sample grid, rapid assessment procedure (RAP) for antigenaemia 
in sample villages and spatial analysis to plot prevalence contours (Gyapong 
et al, 2001) should be the method to employ.
This mapping of LF disease in Ghana laid the groundwork for the 
commencement of a country elimination programme with the availability of 
tools and strategies including donated ivermectin and albendazole and the 
community-directed treatment approach for MDA for the control of 
onchocerciasis and LF in co-endemic areas. Wuchereria bancrofti is the 
causative agent of LF disease, and the female Anopheles mosquito the 
vector. Since the inception of the programme Ghana has gone through a 
national administrative re-demarcation of its district boundaries twice. The
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number of administrative districts in the country has changed from 110 to 138 
and presently stands at 170 and with it, the number of LF endemic districts 
has also changed from 49 to 61 and now stands at 74. The total at risk 
population is, however, still projected at about 10 million of Ghana’s total 
population of 24 million. Prevalence of the overt forms of the disease is 
between 0 - 4% for elephantiasis and 0 - 35% for hydrocoeles (Gyapong et 
al, 1998).
Ghana has completed the mapping of LF and completed 9 rounds of 
implementation activities during which time the programme pursued and 
completed a gradual scale up plan. These activities include planning and 
implementing mass drug distribution and morbidity control. It was estimated 
that the disease will be eliminated in Ghana by 2010 (Ghana Health Service, 
2000), however, evidence presently available to the programme suggests 
otherwise. With this task are major implementation issues that require to be 
addressed. Significant among these are the ability to monitor the processes 
and impact of the programme on various health outcome and output 
indicators including coverage and microfilarial prevalence and intensity. 
Effective but essential monitoring will help determine the possible endpoint of 
programme implementation. During this period, the LF Elimination 
Programme has been merged with the Onchocerciasis Control Programme, 
and then later integrated with the Schistosomiasis and Soil Transmitted 
Helminths Control Programme. All these implementation activities are being 
undertaken under one programme management. Many aspects of the 
Trachoma Elimination Programme have also been integrated with the LF, 
onchocerciasis, schistosomiasis and soil transmitted helminths control.
Ghana operates the Primary Health Care System with emphasis on 
preventive services and basic clinical care at the health centre level. The 
Ghana Health Service is the main implementing body of the Primary Health
Care System, with assistance from organizations and non-governmental 
groups working in health. Administratively, the Ghana Health Service is 
organized at 3 levels, the national, regional and district levels. Preventive 
Health Services are provided and coordinated by the Public Health Division of 
the Ghana Health Services. Disease control programme implementation is 
under this division but operates through the regions, district, sub-district to the 
communities; (Government of Ghana, 2006).
1.6 Ghana Filariasis Elimination Programme
The burden of LF in Ghana has been documented extensively culminating in 
the countrywide mapping of the condition in 2000 in addition to three other 
West African countries (Burkina Faso, Togo and Benin) (Gyapong et al, 
2002). Before the 1990’s surveys conducted by scientists and hospital record 
data had helped to establish Ghana as being endemic for LF (Figures 1.1 and 
1.2). Clinical reports had indicated that elephantiasis of the leg and 
hydrocoeles were common in northern areas and along the coastal belt west 
from Accra to the border with Cote d’Ivoire (unpublished reports). The Gold 
Coast Medical Report of 1937 had also indicated that filariasis was prevalent 
in the northern part of the country. Several other publications provide 
information on the endemicity of LF in Ghana (Hunter, 1992; Dunyo et al, 
1996; Gyapong et al, 1996a). Manifestations of LF in the form of elephantiasis 
and hydrocoeles with manifestations of ADLmanaged with antibiotics and 
analgesics have all been reported earlier, though the cause was never 
confirmed as being of infective origin or as a result podoconiosis (Davey et al, 
2007).
Several studies were carried out, particularly in the 1990’s confirmed the 
endemicity of LF in Ghana and prepared the ground for the Programme for 
the Elimination of Lymphatic Filariasis (PELF) in Ghana (Figure 1.1). Among
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these are studies undertaken in northern Ghana and as part of the Vitamin A 
Supplementation Trials Survival Studies (Gyapong et al, 1993) in which 
12.6% of compounds visited had at least one resident within the compound 
with visible or reported elephantiasis of the leg (Gyapong et al, 1993). There 
were also observations of cases of elephantiasis in market places and 
medical reports of hydrocoelectomies forming about 20% of all surgical cases 
undertaken within district hospitals (Gyapong et al, 1995). Other surveys 
conducted demonstrated 41.1% microfilaraemia with W.bancrofti, 3.6% 
prevalence of elephantiasis and 30.8% of males with hydrocoeles (Gyapong 
et al, 1993) (Figures 1. and 1.2). Another survey revealed microfilaraemia 
prevalence of 32.4%, geometric mean density of 794 mf/ml for infected 
persons, elephantiasis prevalence of 4.6% of the study population and 32.2% 
of males with hydrocoeles (Gyapong el al, 1994). In the Western region 
studies showed microfilaraemia prevalence of about 10% in 15 sampled 
villages, elephantiasis prevalence of 5.2% and a hydrocoele prevalence of 
17% among males (Ghana Health Services, 1999). Further parasitological 
studies also established the endemicity of filariasis along the coast of Ghana 
(Dunyo et al, 1996). The extent of distribution of the disease in the Ahanta 
West district of the Western Region was also carried out using rapid 
assessment methods which confirmed that the district had widespread LF 
disease (Hunter, 1992; Gyapong et al, 1996a).
Finally, a national prevalence survey was conducted to determine the 
prevalence and distribution of LF in Ghana (Ghana Health Service, 1999). A 
high prevalence of microfilaraemia and disease was demonstrated through 
these surveys. The disease was found to be of a much higher prevalence in 
the northern savanna areas (microfilaraemia prevalence between 20-40%) 
and the coastal savanna areas (10-20%) of Ghana. The forest belt within the 
central part of Ghana was relatively free of the disease. The survey also 
showed significant variations between regions and also within regions. These
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surveys confirmed that LF was a major public health problem in Ghana 
especially in the northern and southern coastal savannah and required the 
design and implementation of a control programme (Gyapong et al, 1996b).
In Ghana, filariasis has been shown to have grave socio-economic effects 
associated with social stigma with its severe debilitating effects on sufferers 
(Gyapong et al, 1996). Armed with the results of the national mapping 
exercise a national strategic plan of implementation was put in place for the 
elimination of LF from Ghana.
1.7 Neglected Tropical Diseases and Integrated Control
The Neglected Tropical Diseases (NTDs) are a group of disease conditions 
common in the tropics and sub-tropics that have been described as “ancient 
afflictions that have burdened humanity for centuries” (Hotez et al, 2006). 
These NTDs tend to be common infections that affect the poorest of the 
world's populations causing chronic disability and disfigurement in these 
middle and low income countries worldwide (Hotez et al, 2007; Hotez, 2008; 
Hotez et al, 2009). They are also “poverty-promoting and are associated with 
stigma” (Hotez et al, 2006). They are found in rural areas even in these low- 
income countries (Hotez et al, 2006). In these areas the most at-risk people 
are children and women of child bearing age (Hotez et al., 2009). They reduce 
agricultural productivity eventually depriving these already vulnerable groups 
of good health and economic well-being. The cycle of poverty is what results 
for these populations estimated at 1.4 billion globally (Hotez et al, 2009).
The NTDs are parasitic, bacterial or viral diseases often spread by insects 
and other vectors such as mosquitoes, black flies tsetse flies and snails and 
associated with poor living conditions and lack of clean water and sanitation 
(WHO, 2010a). Contamination of certain environments by these agents such
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as soil contaminated with the eggs of worms, poor living standards, poor 
conditions of hygiene which are common in settings of extreme poverty, urban 
slums and areas of conflict or civil unrest (Hopkins A, GAELF 6, 2010; Hotez 
et al,2010) largely support and contribute to the transmission these diseases.
These diseases cause severe disability and life-long medical impairments. 
Their close linkage with poverty cause them to geographically overlap and 
cluster in areas where there is lack of potable water, poor personal hygiene, 
poor sanitation, poor housing and where the vectors that transmit these 
diseases are usually abundant.
The list of NTDs currently stands at about 17 according to the WHO and these 
include
1. Dengue
2. Rabies
3. Trachoma
4. Mycobacterium ulcerans infection (Buruli ulcer disease)
5. Endemic treponematoses
6. Leprosy (Hansen disease)
7. Chagas disease (American trypanosomiasis)
8. Human African trypanosomiasis
9. Leishmaniasis
10. Cysticercosis
H.Dracunculiasis (guinea-worm disease)
12. Echinococcosis
13. Foodborne trematode infections
14. Lymphatic filariasis
15. Onchocerciasis (river blindness)
16. Schistosomiasis (bilharziasis)
17. Soil transmitted helminthiasis
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The burden of NTDs is enormous. On their own NTDs contribute to poverty 
particularly in sub-Saharan Africa (Molyneux et al, 2005). About 90% of the 
burden of disease due to the NTDs can be found in Africa with those having 
the highest intensity and prevalence being schistosomiasis, LF, 
onchocerciasis, soil transmitted helminthiasis, trachoma among others 
(Molyneux et al, 2005). NTDs contribute to an estimated 500,000 deaths 
annually with a DALYs equivalent of about a quarter of the disease burden for 
HIV/AIDS, and about 50% for malaria (Hotez et al, 2006). Reasons assigned 
for their neglect are many but among them is the fact that policy makers and 
public health officials have focused their efforts at the control of the “big three 
diseases (HIV/AIDS, tuberculosis (TB), and malaria)” (Molyneux, 2008), and 
devoted little or no attention to these diseases most of which are amenable to 
mass preventive chemotherapy (Molyneux et al, 2005).
The most common of these neglected diseases are STH (affects over a billion 
people worldwide), schistosomiasis (over 200 million infected), LF (over 120 
million infected), trachoma (around 80 million infected) and onchocerciasis 
(about 37 million infected) are among the most prevalent NTDs globally 
(WHO, 2012). Interventions targeted at these diseases when applied have 
been successful (Molyneux, 2004; Molyneux et al, 2005, Molyneux, 2008). 
Among this group of neglected diseases are a sub-group with which marked 
reductions in prevalence and incidence have occurred in the last 2 decades. 
These include LF, onchocerciasis, and trachoma (Hotez et al, 2006; 2009). In 
spite of the enormity of the global burden of these diseases financial support 
for their control and elimination efforts has been limited until recently. Support 
for research and development in the field of NTDs have also been inadequate 
(Hotez, 2008; Moran et al, 2009). Development of new diagnostic tools, drugs 
and vaccines NTD control has not been forthcoming. The contribution of the 
NTDs to the attainment of Millennium Development Goal (MDG) 6 is not
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acknowledged since it receives no specific mention in the MDG document 
(UN, MDGs Report, 2009), although in recent years the G8 communiques 
have referred to the NTDs through strong advocacy efforts (Molyneux, 2008; 
Molyneux, 2010).
Geographically they tend to be concentrated in low and middle-income 
countries in Africa, Latin America, Asia and Middle East. These diseases tend 
to be of limited priority in national health systems. They often overlap 
geographically resulting in situations where many people or communities are 
infected with more than one of the infections-polyparasitism. As a group of 
diseases they cause enormous economic and social burden to many 
countries (Conteh et al, 2010). They cause blindness, debilitation, deformation 
or maiming through subtle processes. The economic productivity of young 
adults in their prime of life is weakened, childhood growth and cognitive 
development is impaired resulting in social stigmatization and discrimination 
(Hotez et al, 2009). The severe disability often occurs after years of virtually 
silent infection, leaving patients unaware of the need to seek care. These 
diseases cause irreversible damage if not detected and treated on time. Other 
of the WHO classified NTDs-trypanosomiasis, rabies, visceral leishmaniasis- 
can kill within weeks or months once an advanced stage is reached are not 
treated in time often through misdiagnosis (Hotez et al, 2009).
Policy makers are now beginning to appreciate the importance of the NTDs as 
a public health problem of the world’s poorest people (Hotez et al, 2009) and 
the contribution their control would make towards the achievement of the 
MDGs. After many years of neglect suffered by issues concerning these 
diseases and individuals who suffer these conditions, some progress has 
been made. Effective medicines are available and strategies defined for their 
treatment or prevention with the formation of public-private partnerships, drug 
donations made by ithe pharmaceutical industry who have made large
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quantities of these medicines available at no charge to endemic countries. 
Technical guidelines and tools for use by national programmes are being 
developed by WHO in collaboration with the private sector, non-governmental 
organizations, international agencies and other United Nations organizations 
(Grepin et al, 2008).
Landmark achievements have been made on the global front (WHO, 2010; 
Molyneux et al, 2011). The estimated number of people affected by blinding 
trachoma has been reduced from 360 million in 1985 to about 80 million 
presently. Onchocerciasis has been controlled in 10 previously highly 
endemic West African countries where it is no longer a disease of public 
health and socio-economic significance. The Onchocerciasis Control 
Programme has been successful in preventing about 600,000 cases of 
blindness and freed and secured 25 million hectares of land for agricultural 
purposes resettlement. The World Health Organization and its partners have 
recently launched the integrated strategy for fighting 4 of the highest-burden 
NTDs, which are onchocerciasis, LF and soil-transmitted helminthiasis. 
Large-scale use of safe and single-dose drug treatments namely preventive 
chemotherapy is the core of this innovative strategy. All 4 diseases are 
amenable to prevention using drugs that can be acquired at no cost or at a 
substantially reduced cost. These medicines are so effective and safe that 
they can be administered pre-emptively to all at-risk communities leaving out 
the need for case finding or diagnosis (Grepin et al, 2008).
The strategy of integration is one that could enhance implementation of the 
NTD control or elimination especially for those that are managed with mass 
preventive chemotherapy. Integration refers to the creation of linkages among 
existing programs to improve the delivery of health interventions given 
existing commitments and resources (Grepin et al, 2008). Common control 
activities and lower costs associated with scaling up provide strong reasons 
for integration of partnerships and can help improve efficiency and
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effectiveness with one of its major advantage being cost savings (Brady et ai, 
2006, Lammie et ai, 2006, Hotez et al, 2006). With integration, joint activities 
of separate programmes are carried out together and coordinated centrally. 
These include joint drugs distributions, multi-disease evaluations or joint 
training sessions for community distributors. In terms of policy, joint advocacy 
development and implementation, assessment of needs and disease priorities 
for a combination of specific disease programmes, technical and financial 
guidelines development and programme activity coordination are probable 
areas for integration. Further policy integration could involve development of 
multi-disease indicators and well coordinated incentive structures for 
community distributors (Grepin et al, 2008). With regards to the organisational 
structures of the integrated programme the single or specific disease 
programmes could be merged into a one entity or forming a new 
organizational structure to embrace activities of all the programmes being 
integrated. Organisational integration would involve the formation of a new 
partnership for community-based distribution or the merging of one disease 
programme with another where one disease programme has a clear 
comparative advantage over the other and assist harmonization and synergy 
(Grepin et al, 2008).
Integration can therefore occur at several levels of the health system. The 
costs and benefits of integration would depend on the level at which it is 
integration is taking place. These may include the global level, national or 
regional level as well as the local levels that could be the district, village or 
community. Global level integration is one, which occurs between 
international partnerships and other international health organizations 
involved in financing, planning, and implementation of disease-specific 
programmes. Examples are major Public Private Partnerships (PPPs) working 
in a joint collaboration for the development of multi-disease evaluations within 
the policy domain (Widdus, 2005). Nationally or regionally integration could
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happen between national or regional disease-specific programmes, Non- 
Governmental Organizations (NGOs) and other national or regional partners 
as could be found among programme coordinators or coordination of activities 
at the national level in order to guide activities at the lower levels of the health 
system which are the regional, district and community levels (Grepin et al, 
2008).
Locally at the district, village or community levels integration within the NTD 
programmes could occur between health workers, NGOs, community 
volunteers and relevant community based partners. The ability for districts to 
combine training sessions for community distributors into a single training 
session is an example of integration at the local level (Grepin et al, 2008). The 
degree to which integration occurs depends on its operationalisation. This 
could happen though either through coordination, collaboration or 
consolidation (Grepin et al, 2008). Coordination will involve “information 
sharing or communication among separate programmes for the purpose of 
simplifying implementation of the respective programme”. This often happens 
with programmes working together at the national level to develop an annual 
implementation plan. Increased cooperation among disease-specific 
programmes happens with collaboration. There is sharing of resources or 
personnel and multiple programmes join together to procure vehicles and 
other equipment that are used by all the programmes. Consolidation occurs 
when actual implementation of portions of an entire programme is taken over 
by another programme. The replacement of a multiple single-disease training 
sessions with a single once a year training session for multiple-disease 
programme typifies a case of consolidation (Grepin et al, 2008).
The benefits of integration for the future of NTD Programme implementation 
are immense. As the opportunities of undertaking integrated NTD control 
programmes are being exploited for the good of these "neglected populations” 
the challenges of integration should also be carefully addressed to ensure
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optimisation of the benefits of integration to NTDs. Integration is able to 
improve delivery of NTD control programmes in resource-poor settings in sub- 
Saharan Africa in delivering health services in an efficient and cost-effective 
way (Grepin et al, 2008). An example of integration at the global level is 
demonstrated by the collaboration for research between the Gates 
Foundation and organizations like Schistosomiasis Control Initiative (SCI), 
CDC and the Carter Centre among others. The WHO also is responsible for 
the broader policy recommendations and has coordinated the production of 
guidelines for countries including the integrated guidelines for the 
development of national integrated control (WHO, 2006c)) working in 
collaboration with other academic and research institutions. The African 
Programme for Onchocerciasi Control (APOC) has also offered technical 
coordination support to countries for the development of national policies on 
integrated control of NTDs (Hodgkins et al, 2007). At the local level 
harmonised incentives for community drug distributors, which present a huge 
challenge to many health programmes, is another area for improved 
integration between NTD programmes and communities (Grepin et al, 2008).
The value and need for integrated control of the NTDs is because these 
diseases exhibit geographical overlap (Molyneux et al, 2005) and affected 
individuals “exhibit polyparasitism” (Raso et al, 2004, Fenwick et al, 2005) 
where one individual harbours more than one parasite. The need for countries 
to coordinate and integrate NTD control activities is imperative. Also many of 
the drugs employed for chemotherapy are capable of treating other conditions 
in addition to those they are specifically targeted against (Rao et al 2002; 
Heukelbach et al; 2004, Lawrence et al, 2005; Taylor et al., 2005). Integration 
brings about increased cost-effectiveness (Conteh et al, 2010) with PPPs 
internationally involved with the different diseases to coordinate their in­
country efforts to achieve treatment of several conditions. With co-ordination, 
efforts at employing ivermectin, albendazole, praziquantel, and azithromycin
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through some six PPPs involved in their distribution could impact morbidity, 
blindness and skin diseases at minimal costs (Fenwick et al, 2005).
Several challenges of integrated control of these neglected tropical disease 
that require attention are possible development of drug resistance requiring 
further drug development research, feasibility of integrating several different 
vertical control programmes, the political difficulty of convincing PPPs to work 
together through cooperation and integration of their control activities 
(Widdus, 2005, Brady et al, 2006; Kabatereine et al, 2010). Treatment costs 
of delivering the rapid impact package aimed at the 7 NTDs (schistosomiasis, 
trachoma, IF, onchocerciasis, hookworms, tricuriasis and ascariasis) 
(Kabatereine et al, 2010) is minimal compared to cost of treatment provided 
for other similar public health interventions. A greater impact in terms of 
reduction in stigma, disability, morbidity and mortality that is a quicker and 
more cost effective means of reaching the MDGs (Molyneux, 2008; Grepin et 
al, 2008) is achieved.
1.8 Preventive Chemotherapy (PC)
The drugs often employed for mass treatments involving LF, onchocerciasis, 
schistosomiasis, soil transmitted helminths and trachoma are ivermectin, 
albendazole, mebendazole, praziquantel and azithromycin respectively. 
Preventive chemotherapy (PC) and transmission control is a strategy that has 
been developed to help prevent, control, eliminate or even eradicate this 
group of neglected tropical disease which can be addressed with mass 
treatment using "safe and effective drugs”. Mass preventive chemotherapy 
campaigns are employed for the treatment of whole communities identified to 
be endemic for particular diseases such as LF, onchocerciasis, 
schistosomiasis, soil transmitted helminthiasis and trachoma (WHO, 2006c).
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Treatment is targeted at the eligible population within the communities rather 
than infected individuals. Such treatments have the objective of conferring 
protection on whole communities against infection rather than treating 
individual members of the community. For such communities the disease 
prevalence should be above a certain threshold and would not require 
subjecting individuals to initial clinical or laboratory investigations. These 
drugs are therefore administered on a large scale, in a coordinated approach, 
without individual diagnosis in an identified endemic area. Due to different 
disease overlaps and the need for coordination a designed treatment 
algorithm is always required (WHO, 2006c).
The main objective of the Ghana LF elimination plan was to initiate and 
implement a programme of activities aimed at controlling and eventually 
leading to the elimination of the disease as a public health problem from 
Ghana (GHS, 2000).
1.9 Specific objectives to eliminate lymphatic filariasis in Ghana
1. To improve knowledge in endemic communities on the cause and 
transmission of LF through the use of appropriate information, 
education and communication (IEC) methods
2. To reduce and finally break transmission of LF through mass 
administration of antifilarial drugs
3. To reduce morbidity associated with LF through appropriate clinical 
and home management of hydrocoele and elephantiasis
The main strategies that were adopted for control and elimination of LF were 
mass treatment of the human population to break the transmission cycle of 
the infection followed by morbidity control to alleviate the suffering of those 
affected by the disease and reduce morbidity and pathology. These
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strategies were integrated into the health system and pre-existing control 
programmes aimed at other public health problems such as onchocerciasis 
and intestinal parasite infections. Vector control was not proposed as an 
integral part of this control programme but was to be advocated for to be 
linked with the malaria control programme, which focused on bed net 
distribution. Opportunities for integration of insecticide treated nets with 
filariasis as a national policy was explored as part of vector control efforts 
without initiating or being at the forefront of vector control to prevent 
duplication of malaria control activities. MDA was carried out in accordance 
with the WHO recommended strategies. These strategies were not based on 
selective treatment of infected individuals who were microfilaraemic but 
treatment was to eligible individuals in entire endemic populations using 
ivermectin and albendazole since Ghana is co-endemic for onchocerciasis 
and LF (WHO, 2000). The strategy of PC is employed for LF, onchocerciasis, 
schistosomiasis, soil transmitted helminthiasis and trachoma control among 
others (WHO 2006). Though diethylcarbamazine (DEC) was the main drug 
employed for treating LF in endemic countries particularly in Asia it was not 
recommended for those countries that were co-endemic with onchocerciasis 
due to the severe reactions they could elicit (WHO, 2008). Ivermectin 
(200pg/kg) and albendazole (400mg) as a single dose are given annually in 
countries coendemic for LF and onchocerciasis.
A second important component of the plan was morbidity control involving 
clinical management of individuals with overt clinical filarial disease. This 
required identification of people with lymphoedema or elephantiasis and 
hydrocoeles, training of the communities and individual patients on the 
appropriate care of the elephantoid limbs and hydrocoeles surgery for men 
with hydrocoeles. Centres where the surgeries could be done and surgeons 
needed to be identified, while community health workers were to be trained to 
provide training for affected communities on lymphoedema management. The
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disease controi team was to work with the communities to demonstrate the 
proper care of the elephantoid limbs while affected people were encouraged 
to form elephantiasis management clubs to share experiences with each other 
on the washing of the limbs.
A team of surgeons with adequate skills for undertaking hydrocoeles 
surgeries were to be mobilized to undertake outreach visits to selected 
districts centres with the equipment and infrastructure for surgery on affected 
men mobilized from endemic district communities. Information, Education and 
Communication (IEC) strategies involved the development of health education 
materials with the help of feedback from communities and to provide them 
with information on the cause, transmission and control of LF. Improved 
participation of communities in the programme was expected from the 
communities through an understanding of the various methods of delivering 
this strategy resulting in health education materials and training manuals 
better tailored for use by the programme. A social scientist was identified and 
employed to coordinate the IEC activities.
Within the scope of the initial strategic plan for the control and elimination of 
LF several activities including baseline data collection for monitoring of 
infection within endemic populations was undertaken, after completion of 
mapping creating an LF endemicity map for Ghana. Yearly clinical, 
parasitological, immunological, and entomological assessments were carried 
out in sentinel and randomly selected sites as part of the monitoring 
processes. Management and support systems for programme 
implementation were provided from the national, regional and district levels of 
the health service. At the national level a secretariat was established at the 
Ghana Health Service while technical support was sought from the Noguchi 
Memorial Institute for Medical Research since these institutions have been 
involved in research activities on LF in Ghana providing the critical baseline
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data for the Programme. A Programme Management team led by a 
Programme Manager, an epidemiologist and a public health physician, a 
social scientist with expertise in health education, a data manager and a GIS 
specialist and other technical officers with responsibility for directing, 
implementing and supervising the programme from the national level was 
established. Each endemic region appointed a regional coordinator to 
coordinate implementation of the programme in the region. These regional 
coordinators were often the Regional Disease Control Officers who worked 
under the direct supervision of the Deputy Regional Directors in-charge of 
Public Health (DDPH). At the district level the District Disease Control Officer 
had the responsibility for coordinating the programme under the supervision of 
the District Director of Health Services (DDHS). At all levels of the regions and 
the districts planning, coordination and integration of the programme of 
activities were undertaken including organizing drug distribution and 
coordination of morbidity control and public education within their catchment 
areas.
Three levels of cascaded training were used to build capacity for filariasis 
control and also disease control in general. They were the regional and district 
level training of trainers for the health staff followed by sub-district level 
training for community drug distributors.
Monitoring and evaluation of all activities was carried out using a checklist 
developed for each activity drawing on the experience of other disease control 
programmes within the Ghana Health Service. Planned supervision of drug 
distribution and morbidity control activities in randomly selected communities 
was carried out. Monitoring and evaluation of selected parasitological and 
immunological indicators have been carried out since the inception of the 
programme. MDA coverage reported to the programme has been monitored 
with coverage surveys. The details of monitoring and evaluation of the
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programme through longitudinal and cross-sectional surveys will be discussed 
in subsequent chapters.
1.10 Implementing the Lymphatic Fiiariasis Elimination Programme in 
Ghana
The Ghana Lymphatic Fiiariasis Elimination Programme (GFEP) was 
established in June 2000. Mapping of the LF in Ghana identified 41 endemic 
districts, which were selected for elimination activities (Gyapong et al, 2002). 
There were 8 borderline districts, which were added on to make 49 in order to 
ensure the programme’s aim of total elimination could be achieved. Recent 
re-demarcations of the district boundaries have increased the number of 
endemic district from 49 to 61 and then recently to 74 (ghanadistricts.com, 
2010).
In order to improve knowledge in endemic communities the programme 
developed various activities that included
1. Training programmes at the regional, district and sub district levels of 
the programme to equip health workers and community drug 
distributors with the knowledge to enable them undertake sensitization 
of endemic communities
2. At the community level community meetings were held to provide 
information to the community members on the disease, the availability 
of tools for managing the condition and management of lymphoedema, 
hydrocoeles and the importance of mass treatment of endemic human 
populations
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3. The national level undertook design and procurement of additional 
tools for undertaking sensitization and social mobilization for 
implementation of drug distribution. These tools were posters, flyers, 
morbidity control manuals and newly developed and designed flip 
charts for teaching limb washing.
4. Posters, flyers and morbidity control manuals were distributed to the 
regions for onward distribution to districts, then finally to the sub 
districts and communities for use.
5. Radio programmes were used to provide health education to the 
endemic communities as part of the social mobilization strategies.
1.11 Study Rationale
The World Health Assembly resolution (WHA. 50.29) for the elimination of LF 
as a public health problem from endemic areas set in motion a series of 
global, regional and country activities aimed at ensuring the achievement of 
this final goal. In line with the proposed strategies for LF elimination, Ghana’s 
country programme undertook mapping of LF to establish the endemicity of 
the disease in Ghana. This was followed by programme implementation 
activities such as MDA with ivermectin and albendazole, morbidity control and 
monitoring and evaluation.
This thesis assesses the achievements made to date of the LF programme 
and its relation to NTD programme evolution in the context of the different 
levels of the health system.
In Ghana available WHO guidelines and technical support have been followed 
for mapping, programme implementation and monitoring and evaluation. 
Ivermectin and albendazole, praziquantel and mebendazole have been made 
available to endemic communities for the treatment of LF and other neglected
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tropical diseases. Many operational research activities have been undertaken 
to determine the impacts through process, outputs and outcomes indicators. 
This study therefore determined the impacts of the LF programme on 
recommended programme indicators and documented the impacts on the 
other preventive chemotherapy NTDs and the health system.
Prior to setting up country programmes, endemic countries were supported to 
map out the disease using the antigen card tests (Weil et al, 1997). They were 
then further supported to draw up implementation plans for LF elimination 
activities after completion of the mapping exercise. In order to follow the 
progress of elimination programmes impact studies are conducted in selected 
sentinel sites by elimination programme. However, lack of human, materia! 
and financial resources in the face of programmes up-scaling plans has 
resulted in modifications to the original strategies and plans for monitoring and 
evaluating the performance of the programme. In spite of all the challenges 
experienced in the elimination process, the programme has reported 
significant gains in reducing microfilarial load in endemic areas after 
completing several rounds of treatment. Targeted coverage of about 80% of 
total population has eluded some programme areas due to challenges with 
MDA. Some programmes have also reported significantly higher coverage of 
greater than 80% of their total endemic population. It was therefore, important 
to objectively and independently assess the impact of multi-drug treatment in 
endemic districts and at various stages of programme implementation, using 
available impact assessment tools, in order to study the reduction in parasite 
prevalence or density against the reported coverage and surveyed coverage. 
In doing this, an attempt was made to estimate the end point of Ghana’s 
elimination programme by using the epidemiological assessment tools and 
methods for determining the end point of programme implementation.
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Several technical groups and committees have suggested building synergies 
between public health programmes as a way of sustaining the programmes 
and exploring the possibility of integration of programmes. The 
Onchocerciasis Control Programme also employs mass treatment of endemic 
communities with ivermectin (Mectizan®) as a control strategy similar to the 
IF Elimination Programme. The Trachoma Control Programme distributes 
antibiotics using the Community-Mass Treatment approach that is employed 
by the LF Programme. The Soil Transmitted Helminthiasis control programme 
uses albendazole, one of the drugs employed for mass treatment by the LF 
Elimination Programme. Formerly, these programmes operated independently 
of each other in Ghana with duplication of functions and costs. As part of the 
impact assessment for the programme, possible synergies and opportunities 
for integration have been studied.
The LF Elimination Programme was implemented as a specific disease 
control programme since its inception in the year 2000. However in 2004, this 
programme was merged with the Onchocerciasis Control Programme in 
Ghana. These two programmes were co-implemented and integrated into the 
health system. In 2006, the NTD Control Programme was conceived, a plan of 
work was drawn up, a stakeholders meeting held to discuss the programme’s 
plan of work; implementation of the programme started in February 2007. The 
integrated NTD Control Programme which manages and coordinates LF, 
onchocerciasis, trachoma, schistosomiasis and soil transmitted helminthiasis 
has been in place since 2007.
The LF Elimination Programme therefore provided the platform for 
implementation of the NTD Control Programme in Ghana. During this period 
the Onchocerciasis Control Programme was re-launched, the schistosomiasis 
and the soil transmitted helminths control programme was launched in 
collaboration with the School Health Education Programme of the Ghana
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Education Service and given a national character. The Trachoma Elimination 
Programme was implemented under the Eye Care Division but, however, 
some activities were planned and co-implemented together. This study and 
thesis documents co-implementation of the IF Elimination Programme with 
the Onchocerciasis, Schistosomiasis and Soil Transmitted Helminths Control 
under the umbrella of the NTD Control Programme stressing that the NTD 
Programme is fully integrated into the national health care plan.
1.12 Hypothesis for Current Study
This study tested the hypothesis that applying the current MDA strategy with 
the minimum expected coverage rate (65%) of the total population will not 
achieve interruption of LF transmission within the period proposed by WHO 
(4-6 years) but wilt have significant impact on LF and on other NTDs targeted 
by preventive chemotherapy and transmission control and the health system.
1.13 Objectives
The main goal of this study was to determine the impact of MDA on the 
prevalence and transmission intensity of LF and investigate the suitability of 
the community-directed approach as a vehicle for developing an integrated 
treatment strategy targeting other NTDs amenable to MDA.
The specific objectives are
1. To determine the impact of anti-filarial drug treatment on antigen 
prevalence and microfilaria! prevalence, density and load in selected 
communities and districts.
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2. To determine the impact of drug treatment and morbidity management 
on affected individuals by investigating the change in quality and 
quantity of morbidity in selected communities in 5 endemic districts.
3. To determine the endpoint of MDA in 5 selected districts by monitoring 
for new infections among children less than 5 years.
4. To undertake a longitudinal comparison between reported and 
surveyed treatment coverage since the inception of the PELF for 
disease specific and integrated surveys conducted under both the 
lymphatic filariasis elimination and the integrated NTD Control 
Programme.
5. To undertake a compliance study with selected communities endemic 
for LF.
6. To determine the Knowledge, Attitude and Practices (KAP) to LF and 
its elimination and for other preventive chemotherapy diseases in 
Ghana.
7. To determine the impact of LF control programme on other NTDs such 
as onchocerciasis and schistosomiasis and the health system in 
Ghana.
The study focused on the process from inception of the LF Elimination 
Programme, monitoring its implementation through surveys and determination 
of the impact of the programme both on parasitological and antigenic 
indicators of the microfilaria worm and also its impact on the NTD Control 
Programme. An attempt to determine the possible end points of MDA, which 
would signify interruption of W. bancrofti transmission on the programme, will 
be undertaken. Process, outcome and output indicators for the programme 
were identified, analyzed and applied for the discussion in this thesis.
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Chapter 2
Literature Review
Chapter 2: Literature Review
2.1 Introduction
Filarialial diseases are a major cause of acute and chronic morbidity in the 
tropical and subtropical parts of the world. The availability of safe, single­
dose, drug treatment regimens capable of suppressing microfilaremia to very 
low levels, along with improvements in techniques for diagnosing infection, 
has resulted in the adoption of this major mosquito-borne disease for global 
elimination of LF (WHA 54.9). The GPELF was launched in 2000 with the 
principal objective of breaking the cycles of transmission of W.bancrofti and 
Brugia spp. through the application of annual MDA to entire at-risk 
populations. Although significant progress in initiating MDA programs in 
endemic countries has been made, emerging challenges to this approach 
have raised questions regarding the effectiveness of using MDA alone to 
eliminate LF without the inclusion of supplementary vector control.
2.2 History of Lymphatic Filariasis and other filarial worms
The story of LF spans several decades and continents through the work of 
many scientific scholars. Several species of insects and also worms were 
studied and have made significant contributions to this story leading to the 
eventual discovery of the definitive parasite and intermediate hosts along with 
vivid description of the disease state and presentation. The roles played by 
different organisations and institutions in packaging this knowledge into a 
global control effort, which could lead to the eventual global elimination of LF 
disease remains in sight.
The microfilaria or the larvae of the adult worms which cause LF was first 
described in 1863 by M. Demarquay. The parasite was found in human
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hydrocoele fluid from an individual in Havana, Cuba. He called the worms 
embryos because they did not have any internal organs. Manson also found 
and described an inch long worm that swam in water with purposeful and 
snakelike movements. Being convinced that these organisms were 
transmitted through drinking water, he said the worms escaped from the body 
of the mosquito when they fell in the water and were passed on to humans 
when they drank the water to cause the disease. However, in 1900 GC Low 
and S. P. James disproved the above thoughts though another scientist called 
Cobbold held on to similar views.
Manson in 1883 tried to describe the transmission of the filarial larva and 
indicated that these larvae were deposited in humans during the act of biting 
by the mosquito. The first male filarial bancrofti was described in 1888, though 
female filarial bancrofti had already been described. This male filarial 
bancrofti was found in material sent to India by Sibthorpe (Sibthorpe, 1888). 
About 16 years elapsed during which period very little was reported on Filaria 
bancrofti. However, Guitera found Filaria sanguinis hominis in chyluria of 4 
Cuban cases in the US. Chyluria and filaria infections were found in persons 
living in Charleston, South Carolina in people who had never left this area. 
Information available suggested that the parasite occurred extensively in 
southern US. Mastin provided further information in 1888 to also emphasise 
the fact that Filaria sanguinis hominis was widespread in the southern states 
or the south Atlanta and in the Gulf Coasts. In these areas the lymphatics 
were the principle sites where the disease manifestation was found. 
Symptoms described included chyluria, lymphscrotum and elephantiasis of 
the scrotum (Indian Medical Gazette, 1940).
Many scientists continued to work on filaria disease. Maitland in 1894 wrote 
about a case of filarial disease of the lymphatics in which the adult filarial 
worm had been removed from the arm and chest. In British Guiana, Daniels
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and Conyers in 1896 reported the incidence of the manifestations of filariasis 
varied in different races, which inhabited the colony. They also noted that a 
proportion of elephantiasis patients had microfilaria in their blood and were 
also able to say that attacks of lymphangitis were more frequent in the rainy 
season and also that trauma to the affected limb tended to lead to an attack of 
lymphangitis.
Henry also described enormous distention of the lymphatics of the urinary 
tract and sometimes the thoracic duct in persons dying of parasitic chyluria in 
1896 in Columbia, South Carolina. Daniels (1898) in British Guiana said the 
common geographic distribution of elephantiasis and Filaria bancrofti meant 
that elephantiasis was caused by filarial bancrofti. Another finding by Manson 
in April 1897 was a female filaria that emerged from a small tumor he excised 
from West Indian. This parasite survived for a period of 12 hours in normal 
saline. He also showed that blood microfilaria abounded in blood at night. 
Autopsies conducted on people who had committed suicide found greater 
numbers of microfilaria in lung capillaries, malpighian tubules of the kidneys 
and lymphatic cysts of the retroperitoneal tissues.
In 1900 Lethrop and Pratt were able to classify the presentation of filariasis as 
follows;
• Enlarged lymph glands or varicose groin glands
• Dilated lymph vessels, lymphangiectasis or lymphatic varix
• Rupture of dilated varices giving rise to chyluria, chylocele, chyluous 
ascities and chylous diarrhoeas
• Cutaneous lymphatic obstruction presenting as oedema, lymph 
scrotum or vulva and mostly as elephantiasis
• Secondary pyogenic infections such as cutaneous lesions,
lymphangitis, cellulitis and abscess
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Other scientific findings led to the description of the causative agents. J. H. 
Salisbury found certain ova in urine he referred to as new and distinct species 
of nematodes. In a second patient he found ova, which were not associated 
with haematuria but instead milky urine with granular cystine which was dense 
and scanty. Dr. T. R. Lewis in 1872 discovered minute filariae in human blood 
and also microscopic worms in blood and also in urine in persons suffering 
from chyluria. Dr. Prospero Sensino made further discoveries. He found 
filariae worms in the blood of a young Egyptian boy. In the same boy he also 
found filaria worms in urine and that of another patient. Dr. William Roberts in 
May 22, 1876 confirmed some of the earlier observations of Dr. Bancroft and 
Dr. Roberts.
Discovery of the adult worm was made by Dr. Bancroft in 1876. He directly 
associated the finding of worms in patients with chyluria, haematuria, 
spontaneous lymphatic abscess, a peculiar soft varix of the groin, a 
hydrocoele containing chylous fluid and forms of varicocoele and orchitis. He 
also found cases of elephantiasis of the leg, elephantiasis of the scrotum or 
lymph scrotum and concluded that these findings were also associated with 
the filarial parasite. The parasite as found by Bancroft was published in the 
‘Lancet’ and named Filaria Bancrofti.
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2.3 Mosquito as a Vector
Dr. Patrick Manson announced the discovery of larvae of filarial sanguineus 
hominis in the stomach of mosquitoes in Jan 4, 1878 and then on March 7, 
1878, Dr Spencer Cobbold communicated a detailed account of Dr. Manson’s 
investigation. He indicated that filaria underwent metamorphosis within the 
mosquito. He reported in the paper that the female mosquitoes after gorging 
itself with human blood went to stagnant water to digest the blood and deposit 
its eggs. The duration of this period was 4-5 days when filariae also 
underwent remarkable changes. They then incorrectly indicated that they 
escaped into water and were transmitted to humans when they drank this 
water. Within the human being further development happened to the filariae 
ending in sexual maturity of the parasite. Fertilization between these sexually 
mature forms of the parasite resulted successive swarms of the embryo, 
which were discharged by the female.
2.4 Discovery of the Adult Worm
The adult parasite was discovered on December 21, 1876 by Dr. Bancroft and 
verified on August 7, 1877 by Dr. Lewis, on October 16, 1877 by Dr. Silva 
Aranjo, on November 12, 1877 by Dr. F. Dos Santos in conjunction with Dr. J 
de Moura using a case of lymphatic abscess of the arm. Dr. Aranjo found the 
adult and embryonic filariae in the same patient who also manifested other 
disorders such as chyluria, craw-craw, lympho-scrotum and scrotal 
elephantiasis. These disorders used to be found separately but were found 
together by Dr. Aranjo and attributed to Wucherer’s embryonic filariae. A 
number of affections or conditions, which, used to be regarded as distinct but 
were caused by the presence of filariae were regarded by Dr. Bouret- 
Ronchiere as different of one and the same disorder or condition. This was 
termed as Wucherer’s helminthiasis. Description of the developmental stages
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of Filarial Bancrofti was reported in the Lancet of June 22, 1878 by Mr. D. H. 
Gabb of Hastings. The finding was summarised as follow;
1. Filaria bancrofti is the sexually-matured stage of certain microscopic 
worms hitherto obtained either directly or indirectly from human blood
2. Wucherer’s Filaria, Filaria sanguinis hominis, Trichina cystical, 
Filariaose dermathemaca are frequently associated with the presence 
of certain diseases of warm climates
3. Chyluria, intertropical endemic haematuria, varix, elephantiasis, lymph 
scrotum and lymphoid affections referred to as helminthoma elastic, 
cutaneous disorder called craw-craw and leprosy
2.5 Pathology and Pathogenesis of Lymphatic Filariasis
Although LF remains among the major causes of disability among the tropical 
infectious diseases, dramatic advances have been made in the approach to 
its diagnosis, epidemiology and treatment, the molecular composition of the 
parasites that cause these infections, and in the factors underlying the 
pathology seen (Nutman, 2001).
In order to establish the infection in an individual many infective bites over 
several months to years are required. The natural course of infection as well 
as experimental infections of “volunteers” suggests that the filarial parasites 
are not inherently aggressive infectious agents. Experimental infections of 
humans with infective larvae result in transient, low-level microfilaremia, if at 
all. Non-endemic individuals with limited exposure show no evidence of 
persistent infection or pathology. Non-endemic individuals exposed to 
repeated infections show accelerated pathology. Normal, immune-competent 
residents in an endemic area show either (a) no pathology (endemic normals) 
because they are subject to the relatively low levels of infection or (b) chronic 
pathology if they are repeatedly infected. It appears that only those individuals
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rendered immunologically tolerant to filarial parasites become productively 
infected with the filarial parasites. The intensity of transmission may underlie 
the differences in clinical presentation seen in diverse global pockets of 
endemicity (Rajan et al, 2005).
Poor sanitation and rapid growth in tropical and sub-tropical areas of the world 
resulting in more mosquito breeding sites in the tropics and sub-tropics has 
resulted in more people being infected with the disease. Preventive measures 
include mass treatment of entire endemic communities with medicines that kill 
the microfilaria. The other strategy is to incorporate vector control as a part of 
the elimination programme. The mosquitoes that transmit W.bancrofti bite at 
night and peak biting time is between 2200 hours and 0200 hours. Preventive 
measures that are employed include the use of insecticide treated nets and 
participating in the annual MDA with ivermectin and albendazole (in areas 
where onchocerciasis is co endemic with LF) which kill the microfilaria in the 
blood stream. While these drugs do not kill the adult worms reducing the 
numbers of circulating microfilaria prevents transmission of the infection.
2.6 Vectors of Lymphatic Filariasis
The vectors of W.bancrofti are mosquitoes. Several mosquito vectors are 
capable of transmission but geographic location determines the vectors 
responsible. In Africa the commonest vector is Anopheles species, while the 
Culex, Aedes and Mansonia transmit the disease in Asia and the Pacific 
(WHO, 1992). The geographic distribution of the agents of LF tends to be 
quite wide. While W.bancrofti is found throughout the tropics, Brugia malayi is 
limited to Asia and Brugia timorils only found in Indonesia. Many infective 
mosquito bites over months to years are required to establish the infection 
with W.bancrofti or other filarial parasites. The risk of acquiring the infection 
among short-term visitors to endemic areas is low. Transmission of
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W.bancrofti due to the availability of the vectors, parasites and infective larvae 
in all months of the year emphasizes the risk of transmission exists 
throughout the year (WHO, 1992).
2.7 Life Cycle of Filarial Parasites
Three main parasites are responsible for LF in humans. These parasites are 
W.bancrofti, Brugia malayi and Brugia timori. While the majority of the 
infections found are caused by W.bancrofti, infection with B. 
malayi and B.timori are found only in Asia. Other known filaria worms include 
Onchocerca volvulus, which causes onchocerciasis Loa loa, Mansonella 
Persians, Acanthocheilonema streptocerca, and Mansonella ozzardi (Ottesen 
2006; Bockarie et al 2009).
LF is a parasitic disease caused by a microscopic thread-like worm 
associated with the lymphatic system. The adult worm can only live in the 
lymphatic system. This disease is spread through the bite of an infected 
mosquito. When the mosquito takes a blood meal from a subject infected 
W.bancrofti, microfilaria circulating in the blood enter the mid gut of the 
mosquito. After a period of between 7-12 days following a period of 
development the infected mosquito bites another person and the infective L3 
stage of these parasites are deposited onto the skin and enter the blood 
stream after penetrating the skin. This involves the microscopic L3 passing 
from the mosquito through the skin and reaching the lymph vessels. In the 
lymph vessels the larvae grow into L4 adults, which can live for up to an 
estimated seven years. The adult worms are capable of mating to release 
millions of microscopic microfilaria into the blood stream. Adult worms live in 
the lymphatic vessels and lymph nodes. W. bancrofti exhibits a nocturnal 
diurnal subperiodicity. They tend to be evenly distributed throughout the blood 
stream at night, making them available for ingestion and transmission by the
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mosquitoes. During the day-time they accumulate in the small vessels of the 
lungs with few of the parasites in peripheral blood (Ottesen, 2006).
Figure 2.2: Life Cycle of W.bancrofti (CDC, 2009)
Wuchereria bancrofti
Mosquito Stages
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2.8 Clinical Manifestations and Diagnosis
LF is a leading cause of permanent and long-term disability. Affected 
individuals suffer pain, disfigurement and sexual disability. It is stigmatising 
with those affected often being shunned by members of their communities. 
Those with visible signs of the disease are not able to get married and are 
rejected by family members. This disability associated with this disease 
renders patients unable to work, which impacts their families and 
communities.
The disease is often not life threatening and but causes permanent damage to 
the lymphatic system and kidneys. Lymphatic dysfunction and accumulation 
of lymphatic fluid occurs and causes swelling in the arms, breast, legs and 
genitals of men known as lymphedema. The swelling and decrease in the 
function of the lymphatic system compromises the body’s ability to fight 
infections in infected individuals. Bacterial infections of the skin and lymph 
system occur with hardening and thickening of the skin called elephantiasis. 
Because the swellings asscociated with filarial pathology are often irreversible 
and associated with bacterial infections, careful daily washing of the swollen 
area with soap and water, use of anti-bacterial cream on wounds to stop the 
bacterial infections, limb elevation and exercising of the affected part of the 
body prevents swelling from getting worse and improves lymph flow.
Certain vascular endothelial growth factors (VEGF-C) are implicated in 
lymphatic dysfunction.. However, the pathology of lymphoedema and 
hydrocoele depends on many factors, which include lymphatic dilatation and 
accumulation of fluid in affected tissues (Debrah et al, 2007). Hydrocoeles of 
non-filarial origin may have other causes such as testicular tumor, scrotal 
trauma, epididymo-orchitis among others and are important in differential 
diagnosis (Noroes et al, 2010). The pathogenesis involves inflammation of the
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scrotal areas leading to the flow of peritoneal fluid into the scrotum (Noroes et 
al, 2010).
Beyond lymphedema, there is a broad array of symptomatology that directly 
or indirectly alters lymphatic structure and function. Although bancroftian 
filariasis results in damage to the lymphatic system most of those infected 
show few outward signs of infection and can only be diagnosed when tested. 
Very few people develop lymphedema due to accumulation of fluid and 
improper functioning of the lymph system with swelling of the affected part of 
the body. The parts of the body often affected by lymphedema are the legs, 
arms, breasts, and genital area. The resultant swelling and decreased 
functioning of the lymphatic system reduces the capacity of the body to fight 
bacterial infections especially in the skin and lymphatic system. There is 
thickening and hardening of the skin, a condition referred to as elephantiasis. 
The scrotal swelling that results in men is called the hydrocoele. Other clinical 
manifestations of bancroftian filariasis are pulmonary eosinophilia 
characterised by cough, shortness of breath and wheezing accompanied by 
increased levels of immunoglobulin E and antifilarial antibodies.
Filarial infection, from an immunologic point of view, is one of the most 
complex parasite infections. Moreover, these parasites have finely tuned 
immune subversion strategies that enable escape from the innate immune 
system. As different stages of the parasite interact with different types of 
antigen-presenting cells that, in turn, may play a significant role in shaping the 
subsequent adaptive immune response. (Semnani et al, 2004).
The usefulness of ultrasonography in the diagnosis of bancroftian filariasis 
has been demonstrated in the paediatric population. The technique has been 
able to show the change in location of the adult worms which occurs around 
puberty in males (Fox et al, 2005).
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Diagnosis of bancroftian filariasis is a challenge. However, the gold standard 
for diagnosing the active infection is the identification of the microfilariae 
parasites in the blood smear taken at night due to the nocturnal periodicity of 
the parasite. The nocturnal periodicity requires that blood collection is done at 
night to coincide with the peak of the appearance of the microfilariae; Giemsa 
or haematoxylin and eosin staining of the thick smear is made on a slide for 
microscopic examination. Concentration techniques can be applied for 
increased sensitivity such a Nuclepore filtration, centrifugation or lysis of red 
cells to enhance visibility of parasites. Other serologic techniques for the 
detection of elevated levels of antifilarial IgG4 in the blood for the detection of 
the infection by bancroftian filariasis are available.
The polymerase chain reaction (PCR) is a useful and sensitive test for the 
diagnosis of LF. It also allows for differentiation of the species of the filarial 
parasite in human hosts, animal hosts and mosquito vectors in endemic areas 
(Nuchprayoon et al, 2005). Though the most widely used method for 
diagnosis of filariasis is microscopic examination of microfilariae from blood 
samples, the limited sensitivity associated with diagnosis of filaria by 
microscopy makes it unsuitable for large-scale microfilaria screening in LF 
endemic areas. It also requires considerable expertise to distinguish among 
filarial parasite species because of their rather similar morphological features. 
Identification of filarial infection using traditional morphologic methods can be 
difficult and lead to misdiagnosis(ltoh et al, 2007). It is relatively easy to 
monitor the reduction in prevalence and intensity of filarial infection. However, 
confirming this elimination is a more complicated and time-consuming 
process. The use of the ELISA test has been demonstrated to be a practical 
and useful for confirmation of the elimination of filariasis (Itoh et al, 2007).
Laboratory tools to monitor infection burden are important to evaluate 
progress and determine endpoints in programs to eliminate LF (Tisch et al,
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2008). All infection indicators are expected to continue to decline five years 
after cessation of MDA; however, Bm14 antibody may persist in the greatest 
proportion of individuals. Data suggest that Bm14 antibody may be a sensitive 
test to monitor continuing transmission during and after MDA aimed at 
eliminating transmission of W. bancrofti (Tisch et al, 2008).
The duplex Doppler sonography is a non-invasive tool for visualizing adult W. 
bancrofti and for monitoring the effects of antiflarial treatment. Since therapy 
with DEC/Albendazole appears to be more effective at killing adult W. 
bancrofti, this treatment can be followed by de novo development of 
hydrocoeles supporting the fact that dying adult worms play an important role 
in the pathogenesis of filarial hydrocoeles (Hussein et al, 2004).
In China, a minimum of 10 years was required for the elimination to be 
achieved. Annual mass drug treatments with DEC (or ivermectin) and 
albendazole are being given in filariasis-endemic countries in the GPELF. 
Annual treatment needs to be repeated for at least five years. To determine if 
additional mass treatments are necessary, the filariasis elimination program in 
each country must have reliable information to compare with the pre control 
baseline data in sentinel sites, and trends in prevalence and intensity of the 
parasite to deterimine the impact of control on transmission. The ICT card 
antigen tests targeting children are a suitable way to obtain this information as 
they are the cohort of the population which should have been protected from 
acquisition of the parasites after the control programme began (Itoh et al, 
2007).
Xeno-monitoring is a powerful tool for monitoring the impact of MDA on 
filariasis endemicity and transmission. The use of xeno-monitoring in the 
context of filariasis elimination programs also provides a powerful tool for 
assessing the impact of MDAs. The use of xeno-monitoring -based target that
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might be used with other targets such as microfilaria rate for filariasis 
elimination programs in areas where filariasis is transmitted by Culex 
mosquitoes (Farid et al, 2007). It needs to be noted that it is relatively easy to 
monitor the reduction in prevalence and intensity of filarial infection, however, 
confirming elimination is a more complicated and time-consuming process.
2.9 Treatment of Bancroftian Filariasis
The present treatment of choice for bancroftian filariasis is a combination of 
ivermectin (200pg/kg) and albendazole (400mg dose) given as a single dose 
annually is employed for the mass drug treatment of endemic populations in 
areas that are co-endemic for IF and onchocerciasis. DEC (6 mg/kg/day) in 
combination with albendazole (400mg dose) is administered annually in areas 
that are only endemic for LF and has no onchocerciasis. Caution is needed in 
treating with ivermectin and albendazole in areas where L loa is endemic as 
ivermectin can cause severe adverse reactions in infected individuals with 
high Lloa parasitaemias (Ottesen et al, 1994; Bradley et al., 2001).
The Global Program to Eliminate Lymphatic Filariasis (GPELF) has been 
implemented to reduce human microfilaraemia to levels low enough to break 
the transmission of the disease by using single annual doses of albendazole 
in combination with DEC or ivermectin (Schwab et al, 2005). Available 
evidence does not support a difference in the efficacy of diethylycarbamazine 
alone as compared with DEC plus albendazole in the treatment of W. 
bancrofti, neither is there any statistically significant differences between the 
two drug regimens in decreasing the microfilaria positive rate at 12 and 24 
months at a single dose treatment with either drug regimen (Bockarie et al, 
2007).
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Although the primary goal of the program is to interrupt transmission of 
W.bancrofti additional public health benefits also are expected because of the 
known anthelminthic properties of the drugs. Substantial reductions in 
intestinal helminth infections are associated with mass treatment of filariasis 
and are consistent with the conclusion that high levels of coverage for the LF 
program can decrease transmission of geohelminths (De Rochars et al, 
2004). LF elimination programs provide important collateral benefits through 
the reduction of intestinal helminth burdens. To increase compliance as the 
LF program grows, health educational messages should place greater 
emphasis on other ancillary benefits of the program (De Rochars et al, 2004).
Combination treatment with ivermectin and albendazole could be expected to 
reduce the rate of selection for resistance to either of these anthelmintics 
provided that the resistance mechanisms involve different genes. However, it 
has recently been found that ivermectin selects on tubulin in the filarial 
nematode O. volvulus (Eng KLJ and Prichard RK, unpublished data). The 
implications of combination treatment on genetic selection need to be 
examined in future studies. Based on these findings, it is imperative to 
continue monitoring for the presence of this mutation, to detect early evidence 
of possible resistance selection and to correlate this with responses to 
treatment (Schwab et al, 2005; Osei-Atwenboana et al, 2007).
Standardised and reliable methods to evaluate the efficacy of anthelminthic 
drugs and recommended tests to monitor drug resistance in nematodes of 
veterinary importance in the field are available (Coles et al., 1992). Although 
there are as yet no convincing reports of drug resistance in human soil 
transmitted helminths, close monitoring of drug efficacy is needed to detect 
any possible treatment failure that may be due to increasing resistance or 
reduced efficacy (Osei-Atweneboana et al, 2007). Moreover, strategies need 
to be designed, including sustaining drug quality, in order to maintain the
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efficacy of the drugs presently available and so reduce the risk of developing 
resistance (Albonico, 2003).
The high prevalence of HIV and parasite infections in sub-Saharan Africa, 
results in large geographical overlaps and therefore the potential for 
interaction between these two types of infections in co-infected individuals. 
Helminthiasis may increase susceptibility to HIV and contribute to a more 
rapid progression toward AIDS. Treatment of helminth infections is thus likely 
to be particularly beneficial to HIV patients and has been found to be 
associated with a significant decrease in HIV plasma load. Apart from 
helminth infections, some protozoan infections interact with HIV. Thus, 
malaria has been shown to be an important factor in promoting the spread of 
HIV in sub-Saharan Africa (Nielsen et al, 2007). The findings suggested that 
DEC affected HIV load through its effect on the filarial infection rather than 
through a direct (pharmacodynamic) effect on HIV. Global efforts to control LF 
by annual mass treatment with DEC may have a beneficial effect on the 
HIV/AIDS epidemic in areas where HIV and LF co-exist (Nielsen et al, 2007).
Ivermectin and DEC are used in mass treatment programs for the elimination 
of LF because of their effects on microfilaremia. However, the effects of 
treatment on adult worms and the degree of individual variation in efficacy are 
unclear (Rajan, 2004). Elimination and reduced production of microfilaria from 
the blood by ivermectin is greater than with DEC, though some individuals 
respond poorly. The strong reduction in overall Mf production is good for 
control of LF, but the prospects of elimination will be diminished if part of the 
population systematically responds poorly to treatment (Stolk et al, 2005).
Important factors identified in the interruption of transmission due to W. 
bancrofti are a minimum of 6 rounds of MDA and good treatment coverage 
may help to interrupt transmission of the parasite. While high vector densities
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may partly nullify the reduction achieved in vector infection and infectivity 
rates by MDA; achievement of a microfilaria prevalence rates of 0% in 
communities and 0% infection rate in mosquitoes may be necessary to totally 
interrupt transmission particularly in Culex (Ramaiah et al, 2003).
Greater understanding of the pathogenesis of LF and methods to control this 
infectious disease has been made recently (Taylor et al. 2005; Taylor et al., 
2010). Discovery that W. bancrofti contain endosymbiotic Wolbachia raises 
the possibility that endotoxin-like or other putative molecules produced by 
these organisms induce inflammatory reactions that contribute to lymphatic 
inflammation, bias filarial-specific immunity and regulate the reproductive 
potential of the parasite (Taylor, 2003; Debrah et al, 2006, 2007; Taylor et al. 
2010).
Indeed, a key finding from our coupled economic and epidemiological analysis 
is that when initial uncertainty regarding eradication occurs and prospects for 
resolving this uncertainty over time exist, it is economically beneficial to adopt 
a flexible, sequential, eradication strategy based on controlling chronic 
disease initially (Michael et al, 2008).
Bancroftian filariasis is a major public health problem in Sub-Saharan Africa, 
where the level of transmission by the mosquito vector, human infection rates 
and clinical morbidity are among the highest in the world. Coordinated 
research, involving the disciplines of epidemiology, vector biology, 
immunology and genetics, has led to new insights into the ecology and 
pathogenesis of human LF. Recent work using this knowledge should be 
helpful in assessing local and global strategies aimed at eliminating 
W.bancrofti and in guiding research that will facilitate achievement of the 
elimination goal.
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Chapter 3
Materials and 
Methods
Chapter 3: Materials and Methods
3.1 Description of Study Areas
3.1.2 Republic of Ghana
The Republic of Ghana is in the centre of the West Coast of Africa. The total 
land area is 238,537 sq. km and has 3 francophone countries sharing borders 
with Ghana. These are Togo on the east, Cote d’Ivoire to the west and 
Burkina Faso to the north and northwest. Ghana has a coastline which 
extends for about 560 km with the Gulf of Guinea or the Atlantic Ocean. The 
combination of low altitude and proximity to the equator gives Ghana a typical 
tropical climate. The rainfall figures are highest in the forested southwest and 
lowest in the north. The rainy season is different in the north and south of the 
country. In the north the rainy season falls within the months of May and 
September and in the south there are two rainy seasons, which fall within May 
and June and from September to October. The Harmattan winds blow from 
the northeast during the dry season bringing dust from the Sahara 
(Government of Ghana, 2006)
Ghana is typically divided into 3 ecological zones. These are the Coastal 
Savanna which is the sandy coastline backed by a coastal plain and also has 
several rivers and streams crossing it, the Forest zone which is found in the 
middle belt and western parts of the country which are heavily forested with 
many streams and rivers and finally the Northern savannah which is drained 
by the White and Black Volta rivers into the Volta lake. The Volta Lake has 
been artificially created for the generation of hydroelectric power is one of the 
largest artificial lakes in the world.
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Figure 3.1: Map of Ghana (Government of Ghana, 2006)
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The climate is typically tropical with temperatures and rainfall, which vary 
according to distance from the coast and elevation. The average temperature 
recorded annually is about 26°C. There are two rainy seasons. The minor one 
occurs from April to June and the minor one between September and 
November. The north has one rainy season, which begins in March/April and 
ends in September. The dry season or harmattan results from a dry desert 
wind which blows from the north-east between December and March, 
lowering humidity and creating warm days and cool nights in the north, 
however, in the south the effects of harmattan are most pronounced in 
January.
3.2 Demographic Profile of Ghana
With reference to the 2010 Population and Housing Census, Ghana’s 
population is estimated to be about 24,658,823 in 2010. The population 
growth rate is estimated at 2.5 percent. This is made up of 48.8% males and 
51.2% females. About 20% of the population is children under 5 years of age 
and 27.3% of the population are children between 5 and 15 years (school- 
aged). About 70% of the population live in rural areas and are mainly 
engaged in agriculture and fishing. Infant mortality rate is estimated at 65 per 
1000 live births based on Demographic Health Survey data of 2008. The 
under 5 mortality is estimated at 100 per 1000 live births (DHS, 2003; DHS, 
2008). There are many ethnic groups with diverse cultures and perceptions 
and also groups with religious beliefs and practices that may influence their 
attitudes and practices towards trachoma, LF, onchocerciasis, 
schistosomiasis and soil transmitted helminths infections (GHS, 2007).
Administratively Ghana is divided into 10 regions and 170 districts. Each 
region is headed by a political administrator (Regional Minister) under whom 
the Regional Director of Health Service works. There have been several re-
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demarcation of districts by recent governments resulting in the change in the 
number of districts from 110 to 138 and then to the present 170. The purpose 
has been to ensure the equitable distribution of resources for the efficient and 
effective administration at the local level under the local government system 
headed by the District Chief Executive and the District Assembly under whom 
the District Director of Health Service functions. All districts have been 
subdivided into an average of 7 sub-districts with each sub-district covering a 
defined geographic area of between 20,000-30,000 people. The proportion of 
Ghanaians living in urban areas has increased significantly since 1960, when 
only 23% of Ghanaians lived in urban areas. This proportion has since 
increased to 29% in 1970, 32% in 1984 and 44% in 2000 (GSS, 2000; GSS 
2010).
Several ethnic groups form Ghana’s human population. The largest grouping 
constituting 49% is made up the Akans (GHSS, 2000; GHSS 2010). Ghana 
was one of the strongest economies of Africa in the fifties, but political 
instability affected the economy, which declined rapidly. In recent times there 
is an increase in economic growth of 6 percent measured in GDP. Agriculture 
is the heart of the economy and cocoa remains the most important export 
commodity. Industrialization and mining are increasing as indicated in the 
Ghana Growth and Poverty Reduction Strategy II (IMF, 2012).
3.3 Economy
There has not been any significant change in Ghana’s economy over the last 
2 decades with Agriculture being the most important area of economic activity, 
followed by services and then industry. Agriculture contributes 34% of the 
Gross Domestic Product (GDP), (GSS, 2008) and employs about 50% of the 
population (GSS, 2002). This sector is the fastest growing at 10% and 
contributes a third of the country’s GDP. Ghana’s leading export commodities
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are cocoa, gold and timber. Among the reforms introduced into the 
educational system in the last decade in Ghana are the introduction of pre­
school education into the government basic school system, countrywide 
introduction and implementation of the Capitation Grant which is offering free 
education to pupils in government basic schools, the free School Feeding 
Programme aims at improving the nutritional status of children and has also 
increased school enrolment The Getfund (Ghana Education Trust Fund) has 
also provided educational infrastructure to improve teaching and learning 
(IMF, 2012).
3.4 Health Structure
The Ministry of Health (MOH) has the overall responsibility for the total health 
services of the country; and is responsible for the overall sector-wide policy 
formulation, monitoring and evaluation of progress in achieving targets. The 
MOH prepares an Annual Programme of Work, which is funded with collective 
resources from Government of Ghana (GOG), internally generated and donor 
funds.
The Ghana Health Service (GHS) is the implementing agency of the Ministry 
of Health responsible for health service delivery. Health management in 
Ghana is decentralized within the GHS. It involves District Health 
Management Teams (DHMTs), Regional Health Management Teams 
(RHMTs) and Headquarters. Complementing this arrangement are 
institutional/ health facility management teams. Each of these management 
levels is a budget and management centre (BMC) responsible for a defined 
programme of work supported by a definite operational budget.
Health services in Ghana are delivered at three levels: Primary, secondary 
and tertiary levels. At the Primary level the Primary Health Care (PHC) is 
delivered by the District Health System. It comprises all institutions (clinics,
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health centres and hospitals) and individuals whether private, public or 
traditional. The health centre is responsible for providing clinical, public health 
and maternity services to the catchments population using a combination of 
facility-based, regular outreach and mass campaigns in close collaboration 
with communities, community institutions and leaders and village based 
health workers and health institutions. The district hospital serves as the first 
referral point in the primary health care service. They provide clinical (out­
patient and in-patient) and maternity services, and serves as a backup for 
health centres in the district. At the secondary level the regional hospital is 
the second referral level offering specialized services. The teaching hospitals 
form the apex of specialized care in the country and are labelled tertiary 
centres. Expenditure on health in 2006 was about 14% of total government 
budget (Ghana Health Service, 2011, Unpublished).
3.5 The Primary Health Care System
Health care delivery in Ghana is based on the PHC. However, not all parts of 
the country are adequately covered. Water supply and sanitation, which are 
components of the PHC, are particularly inadequate in many parts of the 
country. In almost all the regions there are areas, which are inaccessible at 
certain times of the year. NGOs, Missions, Private and Development Partners 
play leading roles in providing health care in some of the areas that are not 
adequately covered by the formal system. In addition, some of them also 
supply drugs, vaccines, equipment and provide water and sanitation facilities. 
It is noteworthy that they have helped in Expanded Programme of 
Immunization (EPl), Guinea Worm Eradication, Onchocerciasis Control, 
elimination of LF, control of Trachoma, Soil Transmitted Helminths and other 
child survival programmes. These health intervention programmes have been 
successfully integrated into the PHC in Ghana. Community Health Planning 
Services (CHPS), is a new concept developed to bridge the gap of health
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delivery between accessible and inaccessible areas (Five Year Strategic 
Framework for Service Delivery, 2007-2011, Ghana Health Service, 2008).
3.6 The Five Start-Up Districts for Lymphatic Filariasis Elimination
3.6.1 Ahanta West District
Ahanta West District is located at the southern most point of the country and 
the entire West African Sub-Region with its capital Agona Nkwanta also called 
Agona Ahanta. The Ahanta West District has a total land area of 591 square 
kilometers. The population of Ahanta West from Ghana 2010 Population and 
Housing Census IS 106,215 which is made up of 6568(52%) females and 
60635 (48%) males with as average household size of 6. The district is made 
up of 19 towns. The major economic activity in the district is agriculture, 
employing about 59% of the population. Most of the people are small-scale 
farmers. Coconut, oil palm and rubber are the main cash crops. Generally, the 
soils in the district are very fertile and their types range from loose sand to 
clay. The proximity to the central business district of Takoradi enhances 
business and trade in particular. Investment in cold storage has strong profit 
potentials. So far, mining has not had a significant input on the district even 
though available records show that the district is endowed with gold, diamond, 
manganese and clay. Some of the social facilities available in the district 
include roads, electricity, transport and telecommunication. The Ahanta West 
district, which once used to be covered largely with primary vegetation, is now 
covered mostly with secondary forest. The adverse effects of human activities 
on the environment include poor sanitation and health related problems. The 
District has a District Health Committee which is an advisory board and the 
District Health Management Team (DHMT). The DHMT plans, monitors, 
supervises to ensure that all health activities planned are implemented. The
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district has been divided into four sub-districts for the purpose of 
implementation of Health activities.
3.6.2 Kassena Nankana District
Kassena Nankana East District, one of the nine districts in the Upper East 
Region is located in the northern part of Ghana. The Republic of Burkina 
Faso, and the Bolgatanga, Bongo, Builsa, Sissala and Mamprusi West 
Districts border it. It stretches for 55 kilometres from north to south and 53 
kilometres from east to west. The district capital is Navrongo. The Kassena- 
Nankana District of the Upper East Region lies within the Guinea Savannah 
woodland of Ghana. In 2003 it was divided into 2 districts, Kassena Nankana 
East and Kassena Nankana West districts. For the purposes of this write up it 
is considered as one district. The Sissala District in the west, Bongo and 
Bolga districts in the east and northeast, Kassena Nankana West in the north 
and Northern region in the south, border it. There are two main climatic 
seasons. A short rainy season, which lasts from June to September, during 
which, many remote communities are inacessible due to flooding. The dry 
season lasts from October to May, with the harmattan winds peaking in 
January and February. The temperature ranges from 20°C to 40°C. The 
population of the District is mostly rural, apart from those living in Central 
Navrongo. Settlements in Kassena-Nankana, are dispersed with closely-knit 
extended families living in the same compounds. The average number of 
residents per compound is ten. The compounds are made up of several small- 
connected huts surrounded by the compound’s farming land. With the 
dispersed settlement pattern and no compact villages, health service delivery 
is often difficult. The District is divided into six sub districts - Central, North, 
South, East, West and North East. The District Hospital is the referral point for 
these sub-districts. The estimated population of the District from the 2010 
population and housing census is 180,611 made up of Kassena Nankana
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East (109,944) and Kassena Nankana West (70,667) living in some 108 
communities. It has a land area of 1,658 square kilometres and a population 
density of 97 people per km2. About 90% of the District is rural - only 10% of 
the population lives in the Navrongo Township (Government of Ghana,2006).
3.6.3 Awutu Efutu Senya District
Awutu-Efutu-Senya district another of the 5 start up districts of the LF 
elimination programme has recently also been divided into 2 districts namely 
Efutu Municipal and Awutu-Senya districts with a total population of 263,903 
according to the 2010 Population and Housing Census. Awutu-Senya district 
with its capital Awutu Breku forms part of the new districts while Efutu 
Municipal, which before 1988 was part of then Gomoa-Awutu-Effutu Senya 
District Council.
The Effutu Municipal is situated on the eastern part of the Central Region of 
Ghana. It is sandwiched by Greater Accra Region and Ga Rural, Agona and 
Gomoa. Agona Municipal, borders it to the north in the north-east by the West 
Akim Municipal, to the south by the Gulf of Guinea, to the east Gomoa District 
and Ga West Municipal, and on the west by the Gomoa District. Effutu 
Municipal covers an area of 417.3 square kilometers (163 sq miles) and has 
168 settlements (Government of Ghana, 2006).
3.6.4 Sissala District
Sissala district, one of the 5 start up districts of the LF programme, is now 
divided into Sissala East and West districts. Sissala East District is located in 
the northwestern part of Ghana in the Upper West Region. The district capital 
is Tumu. To the east, it shares boundaries with Kassena Nankana and Builsa 
district, both of the Upper East Region while its extreme southeastern portion 
shares a boundary with West Mamprusi District of the Northern Region. Its
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neighbours in the Upper West Region are Wa and Nadowli districts to the 
south and Jirapa district to the west. The Sissala East District is located in the 
north-western part of Ghana in the Upper West Region. The total land area is 
7,115 sq. km, which is about 39% of the landmass of the whole Upper West 
Region. The sheanut tree is significant economic asset to the district whose 
population is currently estimated at 56,528 (2010) with an annual growth rate 
of 1.7% and a population density of 12 persons per sq km, which is lower than 
the regional and national averages of 24 and 77 respectively. Patches of high 
population density are found in the relatively urban settlement such as Tumu, 
Wellembelle, Sakai, Nabugubelle, Nabulo and Bujan (Government of Ghana, 
2006) Sissala West district is located in the North Eastern part of Ghana. It 
shares Boundaries with the Jirapa Lambussie District to the West, Sissala 
East District to the East and Burkina Faso to the North and Wa East District to 
the South. The district sharing a border with Burkina Faso facilitates cross 
border socio-economic activities. However, this has its own implications for 
health and social stability.
3.6.5 Builsa District
The Builsa district is one of the nine (9) districts of the Upper East Region of 
Ghana. It is bounded on the North and East by the Kassena-Nankana District; 
in the west by the Sissala District and in the South by the West Mamprusi 
District and part of Kassena-Nankana District. With a total land area of 2,220 
square kilometres, the district accounts for over a quarter of the total land 
area of the Upper East Region thereby making it the largest district in the 
Region. The district capital is Sandema (Government of Ghana, 2006). A 
significant portion of the district falls within the Volta Basin and is dissected by 
the White Volta and its tributaries, namely the Sissili, Kulpawn, Belipieni, 
Bukpegi and Asebelika. Most of these watercourses, however, are seasonal 
and dry up during the extended dry season. The vegetation is characterized
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by savanna woodland and of deciduous, widely spaced fire and drought 
resistant trees of varying sizes and density with dispersed cover of perennial 
grasses and associated herbs. Over time, the savannah has been reduced to 
open park land with trees of economic value like baobab, acacia, sheanut and 
dawadawa dominating. Temperatures are high and the dry season is 
characterized by dry harmattan winds and wide diurnal temperature ranges. 
There is only one rainy season, which builds up gradually from little rains in 
April to a peak in August / September declining sharply and coming to a 
complete halt in mid-October when the dry season sets in. Greater part of the 
soil comprises of ground water laterite developed over the granitic formations. 
Soil textures vary within the district but coarse textured soils predominate with 
various amounts of loosely packed stones and concretions. The alluvial soils 
of the south are very suitable for rice production due to the seasonal flooding 
in the areas (www.ghanadistrict.com).
In these five start-up districts health professionals at various levels in these 
districts provide wide range of services in nutrition and child health. 
They also face similar challenges in health delivery. These include growth 
monitoring, micronutrient supplementation (Vitamin A supplementation 
and lodated salt monitoring), immunisation, exclusive breast-feeding, 
nutrition education and the early introduction of appropriate complementary 
foods for young children. The above sums up to further facilitate the process 
of healthy growth and development of the citizens of the Sissala East District. 
Apart from the above the DHA has special program areas, which include 
HIV/AIDS, Tuberculosis, Malaria, Guinea Worm, Trachoma and LF (Ghana 
Health Service, District Annual Reports, 2005-2008).
The major health care delivery problems in the districts include high maternal 
and child mortality rate. Other health challenges faced in these districts 
include inadequate health staff and logistics, high levels of malnutrition among
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children under five years, low health service utilization at facility level, 
inadequate staff accommodation among district health workers, inadequate 
in-service training for health staff and inadequate funding for programs such 
as the NTD Programme (District Annual Reports, 2005-2008).
3.7 Methods
3.7.1: Study Design
This study reviewed retrospective longitudinal data collected since the 
inception of the Ghana Filariasis Elimination Programme (GFEP) in 2000 to 
2005 and prospective cross-sectional data collection collected from 2006 to 
2010. The study built on available baseline and follow up programme data. A 
sample of 5 districts from the two main LF transmission zones in Ghana was 
selected for the assessments. These 5 districts have completed the minimum 
of 6 annual rounds of programme implementation. Data from the health 
system at various levels were also reviewed for assessing the health system. 
This included reports of coverage, prevalence study data and monitoring and 
evaluation data collected from the district, regional and national levels of the 
programme for LF and other preventive chemotherapy diseases being 
implemented together with the LF Elimination Programme. Available reports 
and interviews with health workers and the community members were 
employed to determine the impact of the programme to eliminate LF on the 
health system, Onchocerciasis Control, Schistosomiasis and Soil Transmitted 
Helminths Control as other public health programmes being presently 
implemented in an integrated approach with the LF Elimination Programme
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3.7.2: Cross-sectional Study
The goal of the prospective cross-sectional studies was to evaluate the LF 
elimination programme after 6 years of programme implementation. This 
study looked at compliance with the annual mass drug treatment programme 
with ivermectin and Albendazole, and also included a knowledge, attitude and 
practice study in the 5 districts that have completed 6 rounds of mass drug 
treatment and 4 other districts that are implementing the integrated NTD 
Control Programme. Compliance was determined, as the number of times 
individuals surveyed had participated in the annual MDA by swallowing the 
drugs administered under direct observation. Coverage on the other hand, 
determined the participation of an individual in an annual MDA for any 
particular year under direct observation.
The sample frame for this study was the population within the start-up districts 
of the LF elimination programme. Each district was considered as a single 
unit, from which 30 clusters or communities were randomly selected for the 
assessment.
3.7.3: Longitudinal Study
Retrospective Longitudinal Data was employed by assembling and organizing 
routine programme data from annual reports. Programme monitoring data 
was also gathered and organized from sentinel surveys. These data included 
microfilaria prevalence and density data and filarial antigen prevalence data. 
These data have been collected using the WHO recommended methods, 
sometimes modified to suit the programme situation. For the first 2 years of 
programme implementation, a coverage survey was conducted using the 30 
cluster sampling method for each of the 5 start-up districts. These surveys 
were conducted in 2001 and 2002. Subsequent surveys selected 30 clusters
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from all the endemic areas combined. However, a total population census was 
conducted for these subsequent assessments. Therefore 6 communities were 
selected from each of the 5 endemic regions and 3 communities selected per 
district. A total of approximately 20,000 people were involved annually in the 
coverage surveys from 2003 to 2005.
From 2006 with the inception of the integrated NTD Control Programme to the 
present, integrated surveys involving LF and other preventive chemotherapy 
and transmission control diseases, which have undertaken MDA, have been 
undertaken in selected districts. The results of these integrated cross- 
sectional surveys have been compiled, analysed and reviewed as part of this 
thesis.
The method for the longitudinal impact assessment for microfilaria prevalence 
and density and filarial antigen prevalence were also based WHO guidelines. 
For the first two years of programme implementation two sentinel and one 
cross-check sites were selected for each implementing districts according to 
the WHO. For each of these sites 100 people were randomly sampled for the 
assessment involving the collection of night blood samples and preparation of 
the slides for examination under the microscope for microfilaria. Parasite 
prevalence and community parasite densities were then determined to follow 
up on the impact of the MDA. As the programme gradually up-scaled this had 
to be changed to two sites per a maximum population of 1,000,000 due to 
resource constraints. Baseline blood surveys were done before the first mass 
drug distribution, followed by another survey after the third distribution at mid­
term and then another after the fifth distribution after end of term.
3.7.4: Sample Size Calculation
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The prospective cross-sectional study involved a coverage survey. Non- 
compliance with treatment and Knowledge, Attitude and Practice (KAP) were 
also assessed. This part of the study focused on the 5 start-up districts. A 30- 
cluster sampling method was applied in determining the sample size for the 5 
districts. Estimated population sizes of 40 individuals from 8 households were 
interviewed within each of the 30 clusters. An estimated total minimum 
sample size of 6,000 individuals was interviewed in the study in Ghana.
The sample size was calculated (http://surveysystem.com/sscalc.htm, 2007 
accessed 10 December 2011) using the formula below:
SS = Z2 * (P) * (1-P)
C2
This sample size formula gave the minimum number of households to 
interview per district.
‘P’ is the prevalence of the variable of interest which is the coverage in this 
case. The target coverage is 80%, however the minimum coverage required is 
65% of the total population of the district.
‘C’ is the allowable error with which the estimate of the prevalence that will be 
accepted. If the ‘P’ is the 60% if then ‘C’ could be 5% or even 10%.
‘Z’ is the value for 95% confidence level (1.96)
The sample size ‘SS’ is the minimum number of households to be selected 
per district. The average number of persons per household is usually 5 in 
Ghana and so for the 30-cluster sampling method if 8 households are to be 
visited in each the 30 selected communities, then 5*8*30=1200 individuals
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had to be interviewed for the coverage survey. This made available a total of 
6000 (1200*5) for the 5 districts.
3.7.5: Study Tools
Questionnaires (appendix I and II) were designed for the compliance and the 
KAP study. Individual interviews with household heads or their 
representatives who could be a spouse, child were conducted for each 
selected household. The questionnaires had both open-ended and closed- 
ended questions and a table for all the household members. The designed 
questionnaires were pre-tested before the actual fieldwork both at the national 
level and in the field before data collection.
For the blood surveys, an estimated number of 4,500 people were surveyed. 
Two sentinel and one cross-sectional site were surveyed for each district for 
microfilaraemia. The microfilaria prevalence, count and densities were 
determined for each community surveyed.
For the adults, a night blood test was carried out. After the site for the finger 
prick has been cleaned, a lancet was used to carry out the finger prick and 2 
drops each of 50 microlitres was taken using a micropipette and each 
dropped on a clean slide. A thick and a thin film of the blood were prepared. 
The slide was then dried and processed by dehaemoglobinisatton using 
methylated spirit, and then stained using Giemsa for microscopic reading in 
the laboratory. The parasite count was then done and the microfilaria parasite 
prevalence and densities determined.
To determine the end point of MDA, sentinel communities with microfilaria 
prevalence rates of less than 1% among the adult population are to be 
selected from available sentinel data. Antigen tests were then to be conducted 
on 300 children aged from 2-4 years using the ICT card tests. If no child was
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found to be positive for the antigen test, 5 communities in which no knowledge 
of microfilaria and antigen prevalence rates are known are to be selected and 
also submitted to a similar process to determine the possibility of halting MDA 
in these selected districts (WHO, 2001b). For the test a finger prick will be 
done using a lancet after the site has been cleaned with methylated spirit and 
then about 100 microlitres of blood was taken using a micropipette. This blood 
will be dropped on an Immunochromatographic Test (ICT) card and the 
results of the antigen test read immediately after 10 minutes, according to the 
manufacturer’s instructions.
Due to the unavailability of the ICT card tests and the need to possibly 
develop other possible tests for use by programmes to determine the end 
point of MDA, the Og4C3 antigen and Bm14 antibody ELISA tests using filter 
paper spot blood was employed for this study. This child survey was 
conducted concurrently with the adult surveys. While the samples for children 
were collected during the day within the communities, those for the adults 
were collected at night.
Filter paper was cut into 1cm squares and labeled. Blood spots obtained from 
the children of about 60pl was dropped on the filter paper, which was air- 
dried, placed in zip lock rubber and frozen in a cold room at temperatures less 
than 0°C. The antigen (Og4C3) and antibody (Bm14) kits were procured and 
applied for determining positive and negative antigen and antibody tests 
results. Both antigen (Og4C3) and antibody (Bm14) tests were conducted on 
each sample (Appendix III).
To measure the impact of morbidity management two surveys were 
conducted. One assessed the impact of morbidity management on patients 
with hydrocoeles or lymphoedema, while the other evaluated the hydrocoele 
surgery programme in one region. Assessment of the lymphoedema
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management and hydrocoele surgery programme involved the same 
communities selected for the MDA coverage assessments. In these 
communities, cases of hydrocoeles and elephantiasis were identified and 
prepared questionnaires administered. These questionnaires focused on their 
knowledge, attitude and practice to LF morbidity. Awareness of the 
lymphoedema management manual, free hydrocoele surgery programme and 
the impact of morbidity control activities on their condition and general health 
assessed by questionnaire.
Patients with hydrocoeles were also selected from the same communities 
using the community registers. They were categorized into those who have 
had the drug treatment and surgery and those who have only had the drug 
treatment. Those who had the surgery were interviewed as a way of 
assessing the success of the surgery and proportion of men who have 
benefited from the surgeries determined as a measure of the success or 
otherwise of the hydrocoele surgery programme. Quality of life assessment 
was also carried out for the cases that had benefitted from the free hydrocoele 
surgery programmes.
The impact of the programme on the health system was assessed at all 4 
levels: the national, regional, district and community. This was done by 
reviewing programme information available from all these levels of the health 
system. The impact of the LF elimination programme on other public health 
programmes was assessed using the Schistosomiasis, Soil Transmitted 
Helminthiasis and Onchocerciasis Control Programmes. These assessments 
were undertaken by examining programme management, funding, and 
delivery of the programme in terms of timing of interventions and monitoring 
and evaluation.
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Clearance to undertake the community surveys was dependant on the 
community leaders and opinion leaders who were contacted and their 
permission sought before the community blood surveys were conducted. 
Consent of parents was also sought for all children who were involved in the 
blood surveys. Informed consent forms were designed and applied for the 
study wherever applicable.
Outcome Indicators
1. Microfilaria prevalence
2. Microfilaria density
3. Microfilaria antigen prevalence
4. Quality of life indicators for hydrocoelectomy beneficiaries
5. Identify areas for integration that are being implemented and other 
potential areas for integration
6. Achievements and challenges of integration
Expected Outcome
1. Reduction in microfilaria prevalence
2. Reduction in microfilaria density
3. Reduction in antigen prevalence
4. Reduction in size of the limbs of patients with lymphoedema
5. Improved quality of life among beneficiaries of hydrocoelectomies
3.8 Handling and Managing of Data
For all the field surveys data collection tools were developed as part of the 
proposal development. In the case of the questionnaire these tools developed 
were pretested in the field in communities that had not been selected for the
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surveys. The pretesting was used as a dual activity to pre-test the questions 
while it was also used as an assessment of the field workers. Poor performing 
field workers were excluded at this stage while the fieldwork was shared 
among the remaining workers who had acquired adequate skills with the 
training provided to undertake the field activities. The completeness and 
accuracy of the field data was checked by the research student with the help 
of technical officers on the programme and all corrections made before the 
data was entered in epi info 6. With the support of a data manager then the 
completed tools, counts, documents with the figures were submitted. The 
name of the project, date and signature was appended to this summary sheet. 
Data entry screen was done in duplicate and double entry done for the data. 
Problems encountered during data entry, analysis and report writing were 
dealt with by the research student with the support of a data manager
Tools for the blood surveys are also developed as part of the proposal 
development stage and directly applied during the fieldwork. Ethical approval 
was obtained from both Liverpool School of Tropical Medicine and the Ethical 
Review Committee of the Ghana Health Service and Ministry of Health for this 
study.
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Chapter 4
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Page | 75
Chapter 4: Longitudinal Monitoring of Mass Drug Administration
4.1 Introduction
Annual treatment of entire at-risk populations diagnosed to be endemic for LF 
is the mainstay of control and possible elimination of the disease (Ottesen et 
al, 1997; 1999; 2008; WHO, 2010; WHO, 2012). This requires achieving and 
sustaining adequate coverage with MDA for periods long enough to ensure 
interruption of transmission within endemic population. For LF elimination, this 
has been estimated to require a minimum of 5-6 rounds of annual MDA for 
entire at-risk populations in order to achieve interruption of transmission 
(Ottesen et al, 1997; 1999; 2008; WHO, 2010; WHO, 2012). The GAELF 
therefore recommends 5 rounds of effective MDAs to bring the community 
microfilarie load to less than 1% and 1/1000 in children born since the 
initiation of MDA with evidence of infection (WHO, 2006; WHO, 2011). 
Ghana’s country programme like other endemic countries faced the challenge 
of achieving this objective in the face of other responsibilities in health since 
this requires high geographic (100%) and therapeutic treatment coverage 
(80%) of implementation units for elimination to be possible (WHO, 2005).
The concept of community-directed treatment was developed as a simple, 
effective and sustainable strategy implemented within the context of the socio­
economic constraints of the health system. This strategy depends on the 
endemic community’s ability to mobilise, train and treat the community 
members with ivermectin for onchocerciasis following the standard 
procedures and guidelines provided by African Programme for 
Onchocerciasis Control (APOC) (WHO, 1996). For LF elimination the strategy 
is to provide a single dose of the 2-drug regimen albendazole and ivermectin 
(in countries endemic for onchocerciasis) once a year for all eligible persons 
within the at-risk communities for LF (Ottesen et al, 1997, Ottesen, 2000). To
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complement the community-directed treatment strategy, knowledge of the 
geographic distribution of the disease, effective drug treatment, an effective 
delivery system, political commitment by the national governments and 
international and local community of partners are essential (Gyapong et al, 
2005).
Several factors affect the transmission of LF and, therefore, the possibility of 
elimination. This effort is directed at diagnosis, treatment and prevention of 
the infection in whole at-risk populations instead of individuals using the 
double drug regimen of albendazole and ivermectin in Ghana. The goal of the 
Ghana Filariasis Elimination Programme is to interrupt transmission of 
W.bancrofti by targeting identified endemic communities and instituting MDA 
aimed at reducing community parasite load to such low levels that 
transmission can no longer be sustained (Ghana Filariasis Elimination 
Programme, 1999) and the infection would die out naturally. It has been 
estimated this will require 5-6 rounds of annual MDA with ivermectin and 
albendazole. About 80% of the total endemic population that represents 100% 
of the population eligible for treatment is the target (WFIO, 2000).
The safety of ivermectin and albendazole has been shown to be widely 
acceptable (Gyapong et al, 2003; Mohammed et al, 2008; Simonsen et al, 
2010). Ivermectin is effective and well tolerated for decreasing microfilaria in 
LF. The side effects experienced with ingestion of ivermectin is related to 
inflammatory reactions to dead parasites especially the microfilariae while the 
intensity of side effects is proportional to the individuals pre-treatment worm 
load (Brown et al, 2000). It is, however, not recommended for use in 
pregnancy (Pacue et al, 1990). Albendazole is also, safe with few side effects 
that may be related to the drug itself (Bradley et al, 2001). Albendazole is able 
to reduce W. bancrofti microfilaraemia progressively over a period of 6-12 
months (Gyapong et al, 2005). Ghana Programme employs the single dose,
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two-drug treatment regimen of ivermectin and albendazole once in a year to 
interrupt transmission. Used together their safety profile remains the same 
(Awadzi et al, 2003) while albendazole improved the outcome of ivermectin in 
decreasing mf density or enhance the clearance of mf. Indeed at high doses 
albendazole has high macrofilaricidal activity (Ottesen, 2006; Jayakody et al, 
1993).
Dose-poles are employed to determine the dosage of the ivermectin required 
for treating all eligible individuals. Exclusion of pregnant women is done using 
the history of the last menses of post-pubertal females and can be unreliable 
although the evidence obtained from inadvertent treatment does not give rise 
to concern (Bradley et al, 2001; Gyapong et al, 2003). Other categories of 
individuals excluded from treatment during MDAs include the seriously sick, 
children less than 90cm which is estimated to correspond to the age of 5 
years, and lactating mothers of children less than a week old (WHO, 1996).
The community-directed treatment approach has been found to be the most 
effective method of drug distribution in Ghana and compliance is ensured by 
applying the directly observed treatment strategy (DOTS) (Gyapong et al, 
2001). The process requires effective social mobilisation strategies that 
involve health education using the mass media, IEC materials and community 
meetings. Sometimes social marketing strategies are also employed (Ghana 
Health Serice, 2004, Unpublished). These strategies inform and sustain the 
interest of the communities in the distribution programme in Ghana.
4.2 Mass Drug Administration in Ghana (Community Directed 
Treatment for Lymphatic Filariasis in Ghana)
The strategy of MDA has been the bedrock of the GRELF (WHO, 1996), 
within the African sub-region and also in Ghana. This strategy is based on the
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fact that there is a large reservoir of individuals in endemic populations who 
harbour the filarial worms and yet show no outward signs of the infection 
(Simonsen, 2008). In order to ensure elimination of transmission, therefore, 
there is the need to ensure annual treatment of all these individuals over a 
minimum of 6 years (Simonsen, 2008). This is because mass treatment has 
been adequately demonstrated to have an impact on reducing the 
transmission of LF. The community-directed treatment approach has been 
demonstrated to be the best approach for achieving adequate coverage rates 
with the MDA programme. The process is greatly enhanced by the 
involvement and mobilisation of women, youth and minority groups in the 
communities (Gyapong et al, 2001; Brieger et al, 2002).
Earlier research carried out by various groups particularly in Africa have 
established the community directed treatment approach was an effective 
method of achieving the target programme coverage of 80% of the total 
population or 100% of the eligible population in all identified endemic areas of 
a country (Gyapong et al, 2001; Amazigo et al, 1998). This strategy of 
community directed treatment was first designed and implemented by the 
Onchocerciasis Control Programme of the WHO after discovery of ivermectin 
for the treatment of onchocerciasis in endemic communities (Amazigo et al, 
1998). This was referred to as the community-directed treatment with 
ivermectin (CDTI). This strategy ensures sustainability of national 
onchocerciasis control programmes through improved ownership with 
significant cost-savings (Amazigo et al. 1998). This strategy has also provided 
the impetus for development of the primary health care in remote and difficult 
to reach rural communities (Hopkins, 1998) and is being applied for the 
control of the other NTDs, particularly those requiring MDA
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4,3 Compliance
Compliance with ivermectin and albendazole treatment is key to the 
achievement of elimination of LF. Factors important in ensuring compliance 
include socio-demographic characteristics, perception of personal 
susceptibility, knowledge about the cause/transmission of the disease, 
knowledge about the signs and symptoms of onchocerciasis, available 
treatment, benefits and dangers of taking ivermectin, organisation of 
distribution of ivermectin, work and selections of community-directed drug 
distributors (CDDs), social influence and support to take ivermectin and on 
barriers and supports towards compliance with ivermectin treatment (Nuwaha 
F et al, 2005). Others include perceiving CDDs as doing their work well, 
believing that measuring height is the best way to determine one dose of 
ivermectin, having social support from one’s family saying that ivermectin 
prevents onchocerciasis and in this case LF and perceiving radios as 
supporting treatment with ivermectin (Nuwaha F et al, 2005). The role of 
health education in ensuring compliance is significant. This influences the risk 
perception of communities, rationale for using dose poles for determining 
dosage, benefits of ivermectin as an effective drug against LF and/or 
onchocerciasis and knowledge about possible side effects such as itching, 
dizziness, headache, nausea and swollen limbs which disappear on their own 
after a while (Nuwaha F et al, 2005,).
The role of CDDs in ensuring compliance during the community-directed 
treatment process involved the availability of CDDs from within the community 
for the training, drug distribution and reporting (WHO, 1996). They should be 
trusted and respected members of the communities and should play a role in 
health education (WHO, 1992). Continuous motivation and support to do their
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work contributes to the improved performance of CDDs in their work (Amazigo 
et al, 2002; Katabarwa et al, 2005;; Brieger et al, 2011).
Ghana is endemic for most of the diseases designated as the NTDs and has 
been running disease specific control programmes covering the Trachoma, 
LF, Onchocerciasis, Schistosomiasis and Soil-transmitted Helminthiasis which 
overlap geographically (Ghana Health Service, 2007, Unpublished). 
Furthermore, some of these programmes use the same drugs for treatment 
and use similar strategies of drug delivery. In view of the existence of these 
common factors, there was the need to integrate these related activities in 
order to maximize available resources and rationalize the operation of the 
various programmes, which employ various drug packages for mass 
treatment. These drug packages include ivermectin and albendazole, 
ivermectin only, albendazole/mebendazole only, praziquantel only, 
praziquantel and albendazole/mebendazole and azithromycin. Ghana runs 
the integrated programme and employs different drug packages determined 
by disease endemicity and overlap. Implementation of programmes to control 
or eliminate diseases like LF, onchocerciasis, trachoma, schistosomiasis and 
soil-transmitted helminths, through annual MDA, has been in place for many 
years now. There has been increasing emphasis on the integration of some 
activities of these vertical disease control programmes aimed at improving 
programme efficiency and saving economic and human resources. Integrated 
assessment of coverage started in 2007 and is presented as part of the 
longitudinal assessment of programme data.
Surveys to determine the impacts of the programme have been achieved 
through longitudinal monitoring of reported coverage or regular coverage 
surveys and a cross-sectional coverage survey carried out as part of this PhD 
study. Some of these surveys had Knowledge, Attitude and Practice (KAP) 
components for both LF only and NTDs including LF for the integrated 
NTD/PCT programme have been carried out. An NTD KAP survey was
Page | 81
conducted to aid the development of IEC materials and an advocacy and 
communication strategy has also been undertaken. All coverage indicated in 
the write-up is total population coverage and not eligible coverage. The total 
population coverage is defined as the number of individual treatments in a 
given geographic areas with the denominator being the total at-risk population 
expressed as a percentage (WHO, 2005).
4.4 Presentation of Survey Results
Since the inception of the LF elimination programme assessments of 
treatment coverage through surveys have been undertaken to enable 
determination of the reliability of reported MDA coverage. These have been 
undertaken annually within 3-6 months of implementing MDAs. The methods 
for undertaking these surveys have not been uniform though information 
generated has been applied for informing programmatic decision making. 
Initial surveys undertaken were LF disease specific but since the 
implementation of the integrated NTD programme integrated surveys 
involving other preventive chemotherapy diseases being implemented have 
been carried out. Surveys undertaken (Table 4.1) include surveys to 
determine treatment compliance with ivermectin and albendazole over several 
years. The surveys have been quantitative, cross-sectional and exploratory 
focusing on the MDAs using ivermectin and albendazole and programme 
implementation for the first 5 rounds of programme implementation.
Since year 6 integrated surveys, which involve assessments for LF and other 
preventive chemotherapy diseases, have been conducted (Table 4.1). In year 
1 and 2 the LF programme had just been initiated and the surveys apart from 
being conducted to assess the reported coverage also had the objective of 
describing the programme development or the scaling up process of the 
community-directed treatment (COMDT) method (Gyapong et al, 2001). This
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method had been adopted as the strategy for ensuring adequate coverage 
with the MDAs and exploring other practical methods for sustaining mass 
treatment of LF to facilitate the global elimination of this public health problem 
(Gyapong et al, 2000; Amazigo et al, 1998). All other subsequent surveys, 
though they had similar objectives, varied in the depth and conduct.
KAP surveys and also morbidity assessment surveys have also been 
undertaken to inform the programme’s advocacy and health education 
strategies. These data have been assimilated as longitudinal data for analysis 
and discussion (Table 4.1).
4.5 Results of Surveys
4.5.1 Year One (2001) Coverage Survey
Assessment of year 1 treatment was undertaken in all the start-up districts, 
namely Ahanta West, Kassena Nankana, Awutu Efutu Senya, Sissala and 
Builsa districts. For year one the reported coverage ranged from 71.0% in 
Awutu Efutu Senya district to 87.4% in Sissala district. Surveyed coverage 
ranged from 71.4% in Kassena Nankana to 85.8% in Sissala district. The 
differences in coverage for the surveyed and reported coverage for each of 
the districts were between 1.6% to 12.6%. The differences were less than 
10% for 3 districts and more than 10% for 2 districts. The coverage reported 
for 3 out of 5 districts were therefore reliable (Table 4.2).
4.5.2 Year Two (2002) Coverage Survey
In year two coverage surveys were repeated for the 5 start up districts. 
Reported coverage ranged from 75.7% in Sissala district to 88.5% in Ahanta 
West district. Surveyed coverage ranged from 75.7% in Kassena district to
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88,5% in Sissala district. The difference in coverage ranged from 2.5% to 
12.7% with two districts having coverage of above 10% (table 4.3).
4.5.3 Year Three Coverage Survey Results
In year three MDA was conducted for 30 implementing districts having scaled 
up from 14 districts. A total at risk population of 3,696,893 was targeted with 
about 9,100,000 tablets of ivermectin and 3,522,000 of albendazole. About 
2,622,722 individuals were treated with total population coverage of 70.9% for 
year 3 MDA. Year 3 MDA was followed by a coverage survey to validate the 
reported coverage. The 30-cluster-sampling method was applied but all 30 
implementing districts were considered as one unit from which the 30 
community clusters were selected. Instead of further sampling in these 
communities the entire community populations were surveyed. All individuals 
living and present in the community at the time of the survey were sampled for 
these surveys. These 30 communities were selected from 10 sub-districts in 9 
districts (Table4.1, 4.4 and 4.5), which included 4 of the 5 start-up districts. 
Two of these sub-districts were selected from one district.
A total of 10,721 individual from 2116 households were sampled. The total 
number treated was 7870 with total population surveyed coverage of 73.4%. 
The reported total population coverage was 70.9% giving a difference of 
2.5%, which was within the acceptable limits of up to 10%. For each of the 9 
districts surveyed the surveyed coverage ranged from 64.2% in Awutu Efutu 
Senya district to 83.8% in Nanumba district. Reported coverage ranged from 
67.0% in Mpohor Wassa East district to 88.8% in Ajumako Enyan Essiam. 
The difference between the reported and surveyed coverage by district also 
ranged from 0.0% in Nanumba where both reported and surveyed coverage 
were the same to 23.0% in Ajumako Enyan Essiam district, which had the 
highest reported total population coverage.
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Table 4.2: Coverage Survey Results for Year 1 undertaken in 2001
District Reported
Coverage
Surveyed Coverage Coverage Difference
(surveyed-reported)
Kassena Nankana 84.0 71.4 -12.6
Builsa 74.2 75.9 1.7
Sissala 87.4 85.8 -1.6
Awutu Efutu Senya 71.0 64.9 -6.1
Ahanta West 83.0 71.6 -11.4
Table 4.3: Year Two Coverage Survey Results
District Reported
Coverage
Surveyed Coverage Coverage Difference
(surveyed-reported)
Ahanta West 88.5% 82.0% -6.5%
Kassena Nankana 82.2% 75.7% -6.5%
Awutu Efutu Senya 96.7% 84.0% -12.7%
Sissala 75.7% 88.5% -12.8%
Builsa 79.4% 81.9% +2.5%
Three of these districts had differences of more than 10%, which made the 
reported coverage for those districts unreliable. Six of the districts had the 
difference between the surveyed and the reported coverage less than 10%, 
which is within acceptable, limits making the reports from 6 districts reliable. 
The total national reported coverage for year 3 was 70.9% and therefore a 
difference of 2.5% was also noted nationally which is within acceptable limits 
of less than 10% making the national reported coverage reliable. Wider 
differences between the surveyed and reported coverage were observed at 
the community level. At the community level, reported coverage ranged from 
47.2-91.9%, and surveyed coverage ranged from 60.4-78.8% and the 
difference between the surveyed and reported coverage ranged from 0- 
30.3%. The deviation was from 1.0% in Wogu in Nadowli district and Kubalin 
in Nanumba district to 31.9% in Fumbisi Central in Builsa district. Those with a 
difference of less than 10% were 13(N) while those with more than 10% was
Page | 87
17. At the community level reliability of the coverage for this survey is less 
than at the district and nationally.
4.5.4 Year Four Coverage Survey
The Programme completed four rounds of implementation activities with the 
completion of all activities for year 4 of programme implementation in the year 
2004. In year 2004, the programme scaled up from 30 in year 3 to 40 of the 
total of then 49 endemic districts. Coverage surveys were conducted in 10 of 
these endemic districts, which were selected conveniently taking into 
consideration the presence of sentinel communities for monitoring. The 
coverage surveys were conducted in 10 of these endemic districts with 
sentinel sites for monitoring of immuno-parasitological indicators (Tables 4. 6 
and 4.7),
A total of 30 communities of three each from each of these 10 sentinel 
districts were chosen for the coverage survey. In order to improve on the 
reliability of the survey of the limited number of selected communities a total 
community census was conducted for the coverage assessment. These 10 
districts included the five start-up districts of the programme, which are 
Ahanta West, Awutu-Efutu-Senya, Sissala, Builsa, and Kassena-Nankana 
districts. The others are Nzema East, Agona, Nadowli and East Mamprusi and 
West Mamprusi, which came on board the programme at later phases of the 
programme’s up-scaling plan. The survey tool was in two parts. The 
household head interview involved the household head or the representative 
and the household interview involving all members of the household. A total 
population of 20,912 was surveyed, 15,745 individuals had ingested the 
tablets with surveyed population coverage of 75.3%, The total population 
coverage reported was 73.9% giving a difference of 1.4% between the 
reported and surveyed coverage. The reported total population coverage
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calculated for year 4 of MDA is reliable at the national level. At the community 
level the surveyed coverage ranged from 50.1%-90.4%, the reported 
coverage ranged from 52.2-96.2% with differences, which ranged from 1.2- 
35.9%. Those communities with a difference or more than 10% were 18 in 
number and those with coverage of more than 10% 12 in number. Generally 
more community level reported coverage was reliable. At the district level the 
surveyed coverage ranged from 67.2-85.4% while the reported coverage 
ranged from 65.8-87.6%. The difference between the reported and surveyed 
coverage ranged from 1.1-20.4% with seven districts having a difference 
between surveyed and reported coverage above 10% and three with 
coverage less than 10%. The coverage reported by the programme for year 4 
MDA was reliable at the national level.
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Table 4.7: Year Four Coverage Survey Results by District
Year Four Coverage Surveys Results by District
Region District
Number
Sampled
(N)
Number
Treated
(N)
Surveyed
Coverage
(%)
Reported
Coverage
(%)
Difference
(%)
Western
Ahanta
West 1335 998 74.8 85.8 -11.0
Nzema
East 1923 1468 76.3 75.2 1.1
Central Agona 1156 777 67.2 87.6 -20.4
AES 1712 1274 74.4 82.4 -8.0
Northern
West
Mamprusi 4747 3215 67.7 75.4 -7.7
East
Mamprusi 2260 1826 80.8 74.4 6.4
Upper East Builsa 1891 1451 76.7 74.3 2.4
KND 2013 1443 71.7 65.8 5.9
Upper West Nadowli 1374 1173 85.4 66.6 18.8
Sissala 2501 2120 84.8 79.5 5.3
National
Summary 20912 15745 75.3 73.9 1.4
For the five start-up districts adequate coverage of more than 65.0% has been 
recorded in all districts since the inception of the programme till the year four 
of programme implementation. Reported coverage for year four ranged from 
74.4% in Awutu Efutu Senya district to 84.8% in Sissala district while 
surveyed coverage ranged from 74.3% in Builsa district to 82.4% in Awutu 
Efutu Senya district (Table 4.7 and 4.8). The deviation of the surveyed 
coverage from the reported coverage ranged from 1.1% in Kassena Nankana 
and Ahanta West districts to 8.0% in Awutu Efutu Senya districts. These 
deviations are below the allowable threshold of 10% implying that the 
coverage as reported by the districts was reliable.
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Table 4.8: 2004 Coverage Survey Results for the Five Start-up Districts
Coverage Survey Results for Year Four
District Reported (%) Surveyed (%) Difference (%)
Kassena Nankana 75.9 74.8 -1.1
Builsa 76.7 74.3 -2.4
Sissala 84.8 79.5 -5.3
Awutu Efutu Senya 74.4 82.4 8.0
Ahanta West 74.8 75.9 1.1
Table 4.9: Longitudinal Surveys in Start-up Districts
Coverage District
Kassena
Nankana
Builsa Sissaia Awutu
Efutu
Senya
Ahanta
West
Year 1
Reported (%) 82.2 79.4 75.7 96.7 88.5
Surveyed (%) 82.0 84.0 88.5 75.7 71.0
Difference (%) -0.2 4.6 12.8 -21.0 -17.5
Year 2
Reported (%) 84.0 74.2 87.4 71.0 83.0
Surveyed (%) 71.4 75.9 85.8 64.9 71.6
Difference (%) -12.6 1.7 -1.6 -6.1 -11.6
Year 3
Reported (%) - “ 82.7 86.0 72.8
Surveyed (%) - - 67.2 66.1 73.1
Difference (%) - - -15.5 -19.9 0.3
Year 4
Reported (%) 75.9 76.7 84.4 74.4 74.8
Surveyed (%) 74.8 74.3 79.5 82.4 75.9
Difference (%) -1.1 -2.4 5.3 8.0 1.1
Trends in coverage in these five start-up districts indicate that coverage as 
reported has generally been adequate, though deviations between reported 
and surveyed coverage above 10% was observed in some districts for some 
years. In year one, three out of these five districts had deviations of more than 
10%, two out of five in year two, three out of four in year three (since Kassena 
Nankana district was not surveyed in year three) and none of the five districts
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had a deviation of more than 10% in year four demonstrating that reliability of 
the reported coverage had improved by year four (Tables 4.8 and 4.9).
4.6 integrated Post-MDA Coverage Surveys for Lymphatic Filariasis 
and Trachoma
The first of the integrated surveys assessed MDA for LF and trachoma was 
conducted in year six. This integrated evaluation of mass treatment 
campaigns to interrupt transmission of W. bancrofti and blinding trachoma 
was conducted in the Jirapa-Lambussie district of the Upper West region after 
year six of implementation of annual mass treatment (Figure 4.1). It involved 
30-cluster sampling in one conveniently selected district, which was co­
endemic for LF and trachoma. The objectives of this survey included the 
determination of potential barriers to acceptance of combination drugs for 
MDA. Household access to water and latrines as related to the trachoma 
elimination campaign was also assessed. This survey assessed ivermectin 
and albendazole treatment for LF and azithromycin treatment for trachoma in 
this district. Potential barriers to community acceptance of combined 
administration of medicines for trachoma and LF MDA were explored as part 
of this study.
4.6.1 Objectives
The purpose of the survey was to conduct an integrated coverage survey to 
evaluate community participation in MDAs, to eliminate LF and blinding 
trachoma, in a co-endemic district in Ghana.
4.6.2 Methods
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The study was a cross-sectional exploratory study. A two-stage cluster 
sampling was used to select 30 clusters of 10 households in Jirapa- 
Lumbussie district, which is co-endemic for both LF and trachoma (Figure 
4.1). The district has a population of 96,834 (GHS, 2006). All adults in each 
household were interviewed using a short questionnaire with visual aids of the 
tablets used in the mass treatment programme to identify reasons for 
participation and non-compliance as well as their views about taking the drugs 
together in a combined distribution. All adults 18 years and older in each 
household were interviewed using a structured questionnaire after informed 
consent had been obtained from participants. In addition, a few household 
observations relating to LF and trachoma interventions were made by the 
interviewers with the consent of the head of household. This survey was 
conducted prior to the implementation of the integrated NTD Control 
Programme.
Coverage of water supply was 84% but people still do not have adequate 
access to potable water. The supply systems available in the district include 
piped water, boreholes and hand-dug wells. Individuals without access to 
potable water resort to unprotected sources of water. Poor sanitation 
continues to be a major problem in the District (Government of Ghana, 2012).
4.6.3 Results
Clusters of 10 households were sampled per community and in all 299 
households were interviewed. Information on a total of 1,435 people, 
comprising 773 children under 18 years old and 662 adults above 18 years, 
was collected. A total of 2,435 people were sampled. The district reported 
coverage of MDA for LF using ivermectin and albendazole 93.0% while the 
surveyed coverage was 82.0%. The deviation of the surveyed coverage from
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the reported coverage was 11.0% which is more than the allowable difference 
of up to 10% (WHO, 2000; 2006).
Treatment coverage of 63.8% was achieved among the under-18 year old 
members of the households during the survey. Among the adults above 18 
years, coverage of 68.9% was recorded from the survey. The overall district- 
surveyed coverage observed was 66.9% for the trachoma treatment. The 
district reported overall treatment coverage of 92.5%. The reported coverage 
for the trachoma treatment is unreliable since it is way above the surveyed 
coverage and also falls outside the 5% margin of error (Table 4.11). The 
results of the surveys of the MDA coverage for both LF and trachoma showed 
a district difference of 11.0% and 25.6% respectively. The reported coverage 
of both treatments are in themselves unreliable since it is estimated that the 
ineligible population is estimated between 15-20% so coverage is not 
expected to be higher than 85%. However, these reported coverages are 
significantly higher than 85% while the deviation of the surveyed coverage 
from the reported coverage are more than 10% in both cases indicating that 
coverage as reported by this district is unreliable.
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Table 4.10: Results of Post-MDA Round 6 Integrated Coverage Surveys
Round 6 Post MDA Integrated Coverage Survey for LF and Trachoma
District Sub-District Community Surveyed Reported Difference
Jirapa- Jirapa Talagona 63.6 62.4 -1.2
Lumbussie Gbare 79.2 73.5 -5.7
Kuchene 88.5 97.5 9
Komporo 77.8 93.5 15.7
Baazu 81.3 95.1 13.8
Ving-Ving 88.1 76.2 -11.9
Hamile Sigri 77.3 94.6 17.3
Muoteng 64.3 97.2 32.9
Han Han 58.3 97.0 38.7
Kenne 82.4 85.1 2.7
Deriyiri 75.8 97.1 21.3
Chapuri 88.4 94.2 5.8
Piina Kpare 88.9 81.4 -7.5
Gberikuo 71.4 95.3 23.9
Piina 80.6 98.5 17.9
Tabier 84.0 95.9 11.9
Samoa Gbal 89.5 86.0 -3.5
Tuggo Buboo 83.3 85.5 2.2
Konzokala 91.3 95.8 4.5
Doggoh 79.1 97.1 18
Kul-ora 81.4 63.1 -18.3
Kanne 85.5 86.1 0.6
Ullo Mwofopaala 80.0 96.8 16.8
Taayaaguri 98.5 95.1 -3.4
Nabiri 77.8 97.6 19.8
Ul-Kpong 91.8 98.9 7.1
Yagha Yagha 92.6 97.6 5
Tie 77.5 93.3 15.8
Boyelle 79.5 96.7 17.2
District
Summary
82.0 93.0 11.0
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Table 4.11: Surveyed and Reported Coverage
Disease Surveyed Coverage (%) i Reported Coverage (%) Difference(%)
Lymphatic Filariasis 82.0 93.0 11.0
Trachoma 66.9 92.5 25.6
4.7: Knowledge, Attitude and Practice Survey for Lymphatic Filariasis 
and Trachoma
4.7.1 Lymphatic Filariasis (LF)
Some 584 adults were interviewed for the assessment of their knowledge 
about the LF. Majority (33.6%) had heard about the disease from the radio, 
while 23.1% heard about the disease from health workers. About 55.5% of the 
respondents associated LF with big feet, 7.9% with the mosquito, while 1.5% 
knew nothing about the disease, however most (89.4%) of respondents had 
seen a patient with a big leg before which they associated with LF. Most 
(63.2%) people indicated that LF could be treated with medicines. Though 
80.1% of respondents had seen a patient with a big scrotum before, only 
48.3% knew it could be treated with surgery. The majority (68.7%) of 
respondents knew taking tablets could help prevent the disease while other 
means of prevention included sleeping under mosquito nets (29.3%). 
Misconceptions about its prevention remained common among respondents.
Majority of the people (94.3%) remembered the LF drug distribution carried 
out in the community for the year six and 88.5% of them remembered taking 
the tablets. Most (85.3%) of them were given the tablets by community 
volunteers and the others received them from health workers. Among those 
who had taken the treatment, 2.2% had taken the drugs once; 19.2% have 
taken it 2 times; 49.1% have taken it three times; 10.6% have taken it four 
times; 5.8% have taken it for five times; 7% of those questioned did not 
remember ever taking ivermectin and albendazole during the mass treatment
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exercise. Most (88.7%) of the respondents indicated that they took the 
ivermectin and albendazole to prevent them from becoming infected with LF. 
About 16.3% of the respondents said they took the drugs in order to stay 
healthy while 8.2% took the drugs to stop the spread of LF. Other reasons for 
taking the drugs included the desire to feel better (0.9%), others (1.4%) took 
the drugs because they were free while a few (0.7%) took the drugs for no 
reason. Most of the interviewees (82.9%) indicated they had complied with 
treatment since MDAs started. Apart from those who were ineligible for the 
treatment other reasons given for not taking the treatment among the non- 
compliers included absenteeism, fear of side reactions and unwillingness to 
take orthodox medicines. Others said the ODD did not cover their area with 
the treatment.
4.7.2 Trachoma
Majority (81.8%) of respondents knew about trachoma as a disease and 
51.4% associated it with blindness out of the 62.8% who knew the disease 
affected the eyes. Direct involvement of health workers in providing education 
for communities members seem to be low (27.4%) since majority (49.0%) 
heard about the disease from the radio. Only 2.9% of respondents were 
aware of the availability of surgical treatment for trachoma while 11.3% knew 
about the use of face washing. However as regards prevention, respondents 
said it depended on taking of medicines (49.3%), face washing (40.2%), 
personal hygiene (34.9%) and environmental cleanliness (34.4%). On the 
whole, 84.1% of respondents indicated that trachoma was a problem in their 
communities.
About 78.1% of respondents remembered trachoma treatment with 
azithromycin taking place in their communities in year six while 66.1% had 
participated in the treatment which was said to have been administered by a
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community drug distributor by 64.6% of respondents while 8.9% said health 
workers. About 12.2% of respondents had taken the azithromycin once, 
18.7% twice, 27.2% three times, 7.2% four times while 6.2% could not tell. 
Similar reasons for taking or not taking ivermectin and albendazole were 
assigned to taking azithromycin. Among the children, 56.4% cleaned their 
faces. Children in 35.1% of the households washed their faces more than 
once a day but 4% washed their faces once a day and 52.5% wash once a 
week. Methods of disposal of faeces were poor. About 75.9% of households 
disposed of stools from children into the environment outside the homes, 
1.3% just left them standing in the homes while only 1.3% of households 
disposed off stools from children properly into latrines.
Some 73.6% of respondents said they were willing to take the drugs 
ivermectin/albendazole and azithromycin tablets in combination. Those who 
were not willing to take the tablets in combination said they were afraid they 
would get sick (30.1%). About 17.8% of respondents think the drugs would 
make them weak; 2.4% said they cannot swallow all the tablets; 9.4% think
the tablets would be too many to take at a time; 1% do not like taking
medicines. Majority (93.6%) respondents accessed boreholes as their main 
source of water. About 4.3% of them use surface water, 1.3% use
unprotected wells, 0.3% use an unprotected spring and another 0.3% use
rainwater. Access to toilet facilities was low (10.7%) while 4% of household 
members did not use the available toilet facilities (table 3). Many people 
defaecate in the bush or in open spaces. Houses in the communities are so 
dispersed and therefore the facilities available even for the communities are 
so far away from most of the people and they therefore find it more 
convenient to use the bush or open spaces around the houses.
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4.8 Discussions, Conclusions and Recommendations
For this integrated survey 30-clusters of ten households were selected from 
ten sub-districts of the districts. A total of 2,435 people were sampled. 
Coverage of 82% and 66.9% were obtained for the LF and trachoma 
treatments respectively in the survey. These coverage figures compared to 
the reported coverage figures of 93% and 92.5% for LF and trachoma 
respectively. These results show that the reported coverage for both diseases 
are unreliable since the difference between the reported and surveyed 
coverage are above the 10% acceptable threshold. However, it needs to be 
ascertained whether the coverage as reported was the eligible coverage and 
not the total population coverage as reporting requires. The district health 
administration is likely to have reported eligible coverage while the 82% and 
66.9% obtained from the survey is indicative of the total population coverage. 
A check on the coverage report shows that most of the ineligible population 
was not captured in the report and did not form part of the denominator. 
Majority of the people (73.6%) interviewed were willing to accept the 
combination drug administration with the only barrier being the fear of 
possible side reactions from the combined drugs which individually produced 
some known reactions.
The reported treatment coverage for LF and trachoma for the Jirapa- 
Lambussie district are unreliable. There is, therefore, the need for effective 
monitoring and supervision by district and regional officers to ensure efficient 
treatment and reporting. Also, district officers to ensure that the reports 
collated and sent to the region are reliable should verify reports by community 
volunteers. Again the region should verify reports from the district to ensure 
that figures being sent to the national office were reliable. There should also 
be further training of volunteers to ensure proper reporting, and volunteers
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and health staff be monitored to prevent falsification of reports. Members of 
the communities had high levels of awareness of LF and trachoma, and their 
treatment and prevention. Radio (73.2%) was the main source of information 
in the district. The major concern of these people is the number of tablets and 
the fear of side reactions. Threat to the control of trachoma in the district is 
mainly the lack of access to toilet facilities in the communities, forcing most of 
the people to defecate in the bush and in the open providing the habitat for 
the breeding of Musca sorbens (Emerson et al, 2004) the flies involved in the 
transmission of trachoma. For the programme to eliminate trachoma to 
succeed there is the need for the provision of enough facilities for appropriate 
waste disposal for the communities.
Most people are willing to accept the combined administration of drugs for the 
treatment of LF and trachoma. Intensive and appropriate education should be 
carried out prior to the implementation of the combined drug administration 
programme so as to allay the fears of the people about a possible reaction to 
the different tablets to be taken together. Strategies to ensure compliance with 
combination drug treatment need to be carefully designed taking into 
consideration the concerns of the community members.
4.9 Round 7 Post MDA Integrated Coverage Assessments for 
Lymphatic Filariasis and Trachoma
The first year of implementing the integrated NTD programme for the 
preventive chemotherapy diseases involved five regions - Western, Central, 
Upper East, Upper West and Northern regions. This was started in year 7 
(2007) following the initial implementation of the LF elimination programme 
from 2000 to 2006. The type of package administered was based on the 
endemic status of the regions or districts involved. The drug packages for this 
round of MDA implementation were ivermectin and albendazole for LF only or
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in combination with onchocerciasis treatment, Zithromax/Tetracycline and 
ivermectin/albendazole for trachoma and LF only or in combination with 
onchocerciasis treatment and ivermectin only for onchocerciasis. This survey 
was undertaken as a longitudinal monitoring activity of MDA essential for 
assessment of the progress of the preventive chemotherapy programme. It 
helps identify poor treatment coverage in order for timely and appropriate 
interventions to be undertaken to improve coverage and eventually reduce 
immune-parasitological indicators.
The objectives of the post-MDA treatment survey were;
1. To validate reported coverage rates
2. To determine age and gender specific coverage
3. To collect information on reasons for non-participation of endemic 
community members in MDAs to inform future implementation of 
advocacy and IEC strategies
4. To collect information on the activities of CDDs
4.9.1 Method
The second integrated coverage survey employed three districts conveniently 
selected from three categories of districts. The selection of these districts was 
based on the coverage obtained in the last MDA. This survey assessed LF, 
onchocerciasis and trachoma MDAs. The 3 districts, which are Agona in the 
Central region, Central Gonja in the Northern region and then Bawku West in 
the Upper East regions, were conveniently selected for this survey. These 
districts therefore represent areas, which either had a high (80% or more), 
medium (65% to less than 80%) or low (less than 65%) coverage as shown in 
Table 4.12. Agona and Bawku West districts were endemic for LF while 
Central Gonja was endemic for LF and trachoma.
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Table 1.12: Selected Districts for the Second Integrated Coverage Surveys
Performance Low performing Average performing High performing
District Agona-Central region Central Gonja-Northern region Bawku-West-Upper
east region
Drug Treatment Ivermectin/Albendazole Ivermectin/Albendazole and Ivermectin and
Package Azithromycin Albendazole
Coverage 41.6% 70% 83%
Twelve communities (Table 4.13) were randomly selected from each of these 
districts. Compound selection was done by first demarcating the community 
into sections with the help of the local health staff. The centres of the small 
communities or of sections of larger communities were identified during the 
survey and the field workers identified and trained assembled there. A 
pencil/pen was spun in the centre and field workers directed based on the 
direction of the pencil pointer. The first compound encountered in that 
direction was entered and one household interviewed within that compound. 
Households were randomly selected and in order to obtain a minimum 
population size of 254 per community, a minimum of 43 households were 
selected for each interview. The household questionnaire was in two parts. 
The first part was applied for interviewing the head of the household and all 
members of the households interviewed with the second part. In addition to 
the household surveys, all community drug distributors who were available 
during the survey were also interviewed using a second questionnaire 
designed for the community drug distributor’s interviews.
4.9.2 Presentation of Results
In total 36 communities were selected from a total of 16 sub-districts for the 
survey. The total number of people surveyed in all the three districts together 
was 9,296. About 2502 people were surveyed in Agona, 3203 people from 
Bawku West and 3,591 people from Central Gonja (Table 4.13). Comparing
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the surveyed coverage to the reported coverage for ivermectin and 
albendazole treatment shows that surveyed performance in the districts was 
actually better than what was reported to the programme. Apart from Bawku 
West where the difference between the reported district coverage and the 
surveyed coverage was just 4.4%, Agona and Central Gonja had differences 
of 21.3% and 15.8% respectively which are higher than the WHO acceptable 
difference of 10% (Table 4.13). These significant positive differences between 
the reported and surveyed coverage might be due to the submission of earlier 
incomplete reports to the programme which were never updated.
A total of 1673 (18.0%) individuals out of the total registered population did 
not take the drugs for various reasons. Of this number 794 (47.5%) were in 
Agona, 389 (23.3%) from Bawku West and 490(29.3%) from Central Gonja. 
Among those who did not take the drugs were those who belonged to the 
ineligible population who formed about 45.1% of the total surveyed 
population. Among those that were eligible but were not treated, 47.5% (Table 
4.14) were absent for various reasons and formed the largest proportion of 
eligible population that was not treated. The rest either refused the treatment 
for fear of side reactions or did not know about the treatment programme. 
This, therefore, suggests that the timing of the MDA needs to be reviewed to 
ensure that absenteeism is reduced to the barest minimum. In order to 
minimize other refusals and apathy towards mass drug distribution often due 
to community fatigue from several years of experiencing mass drug 
distribution, it is also suggested that more innovative behavioural change 
communication strategies be designed, adopted and implemented as part of 
the programme.
4.10 Household Head Survey
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The household head survey involved interviews with 1756 household heads 
or their representatives. About 32.9% of the total number was interviewed in 
Agona, 24.8% from Bawku West and 42.3% from Central Gonja (Table 4.13). 
The majority (84.9%) of the household heads interviewed were aware of the 
drug distribution programme and also aware that the drugs prevented LF. 
Another 23.9% knew the drugs were also for onchocerciasis, which is 
representative of those that live in the onchocerciasis endemic areas, 20.4% 
knew the drugs were also for trachoma, 24.7% knew the drugs prevented 
STH and 0.6% wrongly thought the drugs also prevented schistosomiasis 
(Table 4.15). These findings demonstrate that the health education 
component of the programme had been well received and understood and the 
endemic status of the communities in which they lived. About 4.7% of the 
respondents mentioned other diseases the different drug packages prevent 
and included cancer, cholera, leprosy, malaria, polio, sickle cell disease and 
stroke among others. Though this is a small proportion of respondents, the 
need to target everyone with improved health education becomes essential in 
order to achieve target coverage of 100% of all the eligible (approximately 
80% of the total population) people with the drug treatment exercise. About 
83.8% of the respondents perceived themselves to be at risk of acquiring 
infection with the diseases prevented by the different drug packages while 
15.0% said they were not at risk. About 2.1% did not know and could be 
added to the category of those who said they were not at risk of these 
diseases. About 47% respondents said people refused the treatment, while 
37.2% said people did not refuse the treatment. About 15.8% did not know 
about the treatment (Table 4.14). Based on these responses, it can be 
deduced that though a large number of people consider themselves to be at 
risk of the diseases, many people might be refusing the treatment for various 
reasons. This perception of risk according to the survey did not match 
participation of the household heads in MDAs by matching number of times 
drugs have been distributed and number of times it has been taken.
Page | 110
Awareness and compliance with drug distribution over the period of 
implementation of annual MDAs by the household heads was not 
encouraging, Agona district completed five rounds of MDA prior to this survey 
while both Bawku West and Central Gonja had completed four rounds. Most 
of the household heads were aware of three rounds of MDA, followed by two 
rounds before four rounds of MDA. Participation in MDAs by these household 
heads seems to follow a similar trend. Most of the household heads 
interviewed had participated only twice, followed by those who had 
participated three times and then four times (Figure 4.2). Household heads 
play the role of breadwinners in the home making their availability for 
participation in the MDAs limited, however, for a major activity like MDAs it is 
expected that other household members would inform them of the exercise.
4.11 Community Drug Distributor’s Survey
Forty eight CDDs were also interviewed as part of this year seven post-MDA 
survey. In all only nine of the 39 CDDs were female. Majority (85.4%) were 
married, were mainly farmers (45.8%) and mostly Christians (56.3%). Most of 
the CDDs were educated as expected since the work of CDDs requires some 
level of education to understand the disease, transmission and treatment in 
order to provide some health education with the treatment. They are 
expected to be able to dose, record and report appropriately. Though, only 
4.2% of the CDDs had had tertiary education, as many as 79.2% had had 
secondary education. About 8.3% had only primary education while another 
8.3% had had no education. In contrast to the above findings of the household 
survey as many as 97.9% of the distributors knew the drugs prevented LF, 
43.8% knew the drugs prevented onchocerciasis and 16% knew the drug 
prevented trachoma (Figure 4.17). About 43.8% also knew the drugs
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prevented the soil transmitted helminthiasis while none of the CDDs 
interviewed said the drugs they administered prevented schistosomiasis.
Table 4.13: Comparison of Surveyed and Reported Coverage for Second
IntegratedCoverage Surveys
District No of
clusters
surveyed
No of
households
surveyed
Surveyed
population
Population
that
ingested
the drugs
Surveyed
coverage
(%) by
district
Reported
coverage
by
district
Difference
(surveyed
coverage
- reported
coverage)
by district
Agona 12 577 2502 1575 62.9 41.6 21.3
Bawku
West
12 581 3203 2800 87.4 83 4.4
Central
Gonja
12 598 3591 3080 85.8 70 15.8
Total 36 1756 9296 7455 80.2
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Table 4.14: Reasons for Non-compliance for Second Integrated Coverage Surveys
Reasons for not taking the drugs District
Agona Bawku West Central
Gonja
Total
Not Eligible Height less than
90cm
275 105 151 531
Pregnant/lactating 64 41 78 183
Seriously Sick 19 14 7 40
Sub-Total 358 160 236 754
Proportion (%) 45.1 41.1 48.2 45.1
Eligible, but
did not take
the drugs
Refused (Fear of
side reactions)
15 6 24 45
Did not know 56 24 0 80
Absent 365 199 230 794
Proportion (%) 46.0 51.2 46.9 47.5
Other 51 5 0 56
Sub-Total 436 436 436 436
Proportion (%) 54.9 112.1 89.0 26.1
Total 794 389 490 1673
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Table 4.15: Household Heads’ Knowledge about Diseases Prevented by Mass Drug
Administration
Yes No
Diseases Prevented Number (N) Percentage (%) Number (N) Percentage (%)
Lymphatic Filariasis 1490 84.9 200 11.4
Onchocerciasis 420 23.9 1270 72.3
T rachoma 359 20.4 1331 75.8
Schistosomiasis 11 0.6 1679 95.6
STH 433 24.7 1257 71.6
Others 83 4.7
Table 4.16: Risk Perception of Household Heads
Parameter Yes No Don’t Know
Number Percentage Number Percentage Number Percentage
At risk of
diseases
1472 83.8 263 15.0 21 2.1
Did people 826 47.0 653 37.2 277 15.8
refuse
treatment
Want drugs 1508 85.9 171 9.7 53 3.0
distributed
same way
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Figure 4.2: Participation of Household Heads in MDAs
45
0 1 2 3 4 5 6 Not
available
■ No. of times drug have been distributed
■ No. of times responded has taken drugs
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Table 4.17: Community Drug Distributor’s Knowledge about Diseases Prevented by MDA
Diseases Drugs Prevent Yes No
Number (N) Percentage(%) Number (N) Percentage (%)
LF 47 97.9 1 2.1
Onchocerciasis 21 43.8 27 56.3
Trachoma 16 33.3 32 66.7
Schistosomiasis 0 0 48 100
Soil Transmitted Helminthiasis 21 43.8 27 56.3
Others 4 8.3 44 91.7
Figure 4.3: Risk Perception among the Community Drug Distributors
El Yes ■ No
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Most of the CDDs (81.3%) considered themselves to be at risk of the 
diseases they were helping to distribute drugs for. The challenge here to the 
programme is that as many as 18.8% of CDDs might not be able to convince 
community members to take the drugs since they themselves did not perceive 
the community to be at risk of the diseases they distributed for (Figure 4.3).
There was a direct relationship between the number of times the CDD had 
distributed the drugs and the number of times they themselves have taken the 
medicines (Table 4.18) implying that CDDs themselves complied well with the 
drug treatment programmes they worked for. The same proportion of CDDs, 
who had distributed the drugs six or eight times, had also taken the treatment 
the same number of times. About 27.1% of the CDDs had distributed drugs 
three times and 31.3% had also taken the drugs three times, 22.9% and 
20.8% and also 16.7% had distributed the drugs 6 times and the same 
proportion had again taken the drugs six times. The fact that most of the 
CDDs had distributed the drugs fewer times than the drugs had been 
distributed in those districts is indicative of the attrition rate of these CDDs 
which establishes the need for the annual refresher training programmes prior 
to the drug distribution exercise (Table 4.18).
Table 4.18: Community Drug Distributor's Participation in Taking of Medicines
themselves
Number of times CDDs distributed drugs Number of times CDD has taken drugs
Number (N) Percentage (%) Number (N) Percentage (%)
13 27.1 15 31.3
11 22.9 10 20.8
8 16.7 8 16.7
7 14.6 8 16.7
6 12.5 6 12.5
3 6.3 1 2.1
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The reasons given by 72,3% of the CDDs who had indicated that people 
refused the treatment included politicization of the treatment programme, 
religious reasons, inability to abstain from alcohol on the day of the treatment 
and low risk perception among some individual community members.
Almost all (97.9%) of the distributors had received training for the job and 
89.6% thought the training was adequate. About 93.8% said they had been 
trained to do health education while a smaller proportion of the 91.7% had 
actually been involved in health education (Table 4.17). Tools for undertaking 
health education were available to 60.4% of the CDDs while 31.3% 
complained of non-availability of tools for undertaking health education. All 
(100%) of the distributors had applied the house-to-house distribution method 
for undertaking the distribution exercise and treatment was also directly 
observed (100%) by the CDDs. Ironically 20.8% of the CDDs had also left 
drugs at home for persons who were absent during the exercise. All 48 CDDs 
interviewed (100%) had used the dose poles to determine the dosage for drug 
administration. About 95.8% of the CDDs had been involved in other health 
programmes which included polio (77.1%), Vitamin A distribution (35.4%), the 
anti-malaria programme, HIV/AIDS control programme activities and others 
such as measles immunization, family planning and guinea worm 
programmes (Figure 4.7). The number of distributors that worked in the 
communities visited for the surveys varied from one to ten. Most (35.4%) of 
the distributors had worked in communities, which had two distributors which 
is the average for most communities. Only 56.3% of the CDDs thought the 
number of CDDs that had worked communities were adequate in-terms of 
numbers. About 85.4% of the CDDs interviewed had received reports of side 
effects. These included itching (52.1%), rashes (41.7%), fever (85.4%), 
headaches (10.4%), Muscle pains (8.3%), dizziness (14.6%), vomiting (4.2%) 
and diarrhoea (16.7%). Other side effects reported included abdominal pains 
and swellings of various parts of the body. Some 31.3% of the respondents’
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reassured patients who suffered the side reactions, 58.3% referred the patient 
to the health centre, and one person representing 2.1% personally took the 
patient to the health centre while another 2.1% did other things such as 
personally administering piriton, an anti-allergic drug to the patient.
All the CDDs interviewed said they would continue to work as distributors for 
the following reasons which included that the work was important for the 
health of the community (89.6%), 20.8% saw it as part of their work, 4.2% 
mentioned that they like the allowances that came with the work, while 14.6% 
gave other reasons such as the acquired skills, others enjoyed the voluntary 
work, they enjoy the voluntary work and some also said “they were married to 
their communities,” meaning they felt strongly attached to the community so 
much so that they would do anything to keep their communities in good 
health.
The CDDs interviewed had many suggestions to help improve the quality of 
future mass drug distribution exercises. About 10.4% suggested the need to 
recruit more distributors, 8.3% wanted the programme to make sure that there 
were adequate tablets of the drugs for distribution, 4.2% said there was the 
need to train all distributors while others specified the need to properly 
motivate CDDs by providing allowances or increasing the per-diems paid and 
also providing logistics such as bicycles, rain coats and boots. They also 
suggested that drugs should be distributed early, made available to everybody 
and some tablets left behind for absentees. They also requested that CDDs 
should do re-visits to provide treatment to absentees. Proper management of 
side effects should also be done through health education and provision of 
free treatment to those who displayed side reactions were also mentioned.
Most of these CDD survey findings are indicative of the need to improve on 
the content of the training provided to CDDs without unnecessarily
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overloading them. Monitoring and supervision of activities of the CDDs is just 
as important considering the limited skills they have in carrying out the tasks 
involved in accomplishing MDA. Communities should be also guided to 
undertake some self monitoring, especially of the activities of their local 
CDDs, to ensure that the right things were done.
4.12 Knowledge, Attitude and Practice (KAP) Study of Preventive 
Chemotherapy Neglected Tropical Diseases in Ghana
Integrated MDAs started in 2007, before then the onchocerciasis programme 
had already started in 1999 with lapses in both geographic and therapeutic 
coverage, the LF programme started in 2000 and had successfully completed 
8 annual rounds of MDAs in 2008, Soil Transmitted Helminthiasis undertook a 
round of nationwide treatment in 2007 targeted at the school children. The 
first Schistosomiasis treatment took place in 2008 after an initial countrywide 
mapping. Since the inception of the integrated NTDs programme in 2006, the 
programme has continued to use disease specific IEC materials as part of its 
behavioural change communication strategy.
Disease specific materials developed in the past needed to be reviewed, 
updated and combined for the entire integrated preventive chemotherapy 
programme. Trachoma is endemic in only two regions and the programme 
has recently interrupted transmission but has a backlog of trichiasis cases that 
require surgical interventions in order to ensure total elimination of trachoma 
from the country. The main strategy of the NTD Disease Control Programme 
is PCT based largely on the common factors associated with mass drug 
delivery for each of these five PCT diseases namely LF (the focus of these 
thesis), onchocerciasis, soil transmitted helminthiasis, schistosomiasis and 
trachoma. Implementing an effective communication strategy will involve 
determination of the factors associated with MDA acceptance. Both
Page | 120
community and school based surveys will be conducted in this study. 
However, to enhance the uptake and participation by the communities in 
these surveys and in the MDA information on community perspectives of 
these diseases and MDA will be required to inform the process of developing 
the communication strategies.
This study therefore sought to determine the actual and desired sources of 
awareness and information about MDA activities and the perceptions of 
community members on MDA activities in both school based and community 
settings. The attitudes of community members to implementers of the MDA 
activities affect their participation in the treatment exercise and therefore such 
determination will help identify barriers to successful implementation of MDA. 
Health education has also played a key role in communities understanding the 
causes, signs and symptoms, prevention, and treatment for each disease of 
these preventive chemotherapy diseases. Lack of this understanding 
influences the perception of community members of these diseases and the 
distribution programmes and hence their health seeking behaviour. The 
actual and desired sources of awareness and information about these 
diseases, their prevention and treatment are equally essential in the design of 
information and communication strategies. The use of acceptable of 
commonly used channels of communication to communities contributes 
significantly to success rate of such strategies. Through these tools for 
effective communication and information on MDA to communities and schools 
can be identified and implemented.
The main objective of this survey was to determine the knowledge and 
information gaps of the NTDs and MDA process and activities in Ghana.
4.12.1 Method
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This study was a cross sectional survey of knowledge, attitude and practice of 
community members on four selected NTDs (LF, Onchocerciasis, 
Schistosomiasis, and Soil Transmitted Helminthiasis) in four regions of 
Ghana. This was an exploratory cross-sectional survey that applied both 
quantitative and qualitative methods. The country was divided into zones 
based on the number of NTDs prevalent in each zone. From each zone, one 
region was purposively selected to represent regional difference (Figure 4.4). 
A district was then selected randomly within the region.
Upper West region was selected from zone one where all five NTDs (LF, 
onchocerciasis, schistosomiasis, soil transmitted helminthiasis and trachoma) 
are endemic. Sissala district was randomly selected from the Upper West 
region. Western region was selected as one of four regions endemic for LF, 
onchocerciasis, schistosomiasis and soil transmitted helminths from zone 2 
and Tarkwa/Nsuaem district randomly selected. From zone 3, which is 
endemic for onchocerciasis, schistosomiasis and soil transmitted helminths, 
the Volta region was selected because Ashanti region has similar 
demographic characteristics to the Western region. Hohoe district was 
subsequently selected. The Greater Accra Region (GAR) was selected 
because it was the only region in zone 4 endemic for LF, schistosomiasis and 
soil transmitted helminths, Ga East district was randomly selected from this 
region.
4.12.2 Sampling Method
A total of 840 households were selected for this study. The EPI “30 x 7” 
cluster sampling method was used for selection of sites for the quantitative 
data collection for each district. In each cluster, 7 households were selected at 
random and interviewed using a structured questionnaire. A total of 210 
households for each selected district in a region were sampled. Focus group
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discussions (FGDs) and In-depth Interviews (IDIs) were used for the 
qualitative data collection. Six community level FGDs were conducted for 
men, women and school aged children (1 male group and 1 female group). 
Six IDIs were conducted with CDDs, teachers and opinion leaders. In all, a 
total of 24 FGDs were conducted for the entire study. Ethical clearance was 
sought from the Ghana Health Service Ethics Review committee. Informed 
consent was also sought from communities and participants at all the major 
phases of the study. Data storage, analysis and reporting were done in 
formats that did not reveal the identity of study respondents.
4.12.3 Presentation of Results
In all 210 respondents were selected from each of the four study areas. This 
gave a total of 840 respondents in the study. Out of this, 318 (37.9%) were 
aged 45-65, 223 (26.5%) were aged 25-34 and 219 (26.1%) were between 
35-44. More males 447 (53.2%) were recruited than females 393 (46.8%) 
largely because most household heads were males. Close to three quarters 
598 (71.2%) were married.
Table 4.19: Demographic characteristics of Respondents for Knowledge, Attitude and
Practice (KAP) study
Region
Sex: Greater Accra Volta Upper West Western
Male 88(41.9%) 108(51.4%) 147(70.0%) 104 (49.5%)
Female 122(58.1%) 102(48.6%) 63(30.0%) 106 (50.5%)
Level of Education:
Primary School 43 (20.5%) 44 (21.0%) 22 (10.5%) 29(13.8%)
Middle School 40 (19.0%) 72 (34.3%) 4 (1.9%) 47(22.4%)
Junior High School 53 (25.2%) 38 (18.1%) 10(4.8%) 46(21.9%)
Senior High School 29 (13.8%) 22 (10.5%) 6 (2.9%) 22(10.5%)
Vocational/Technical School 8 (3.8%) 4 (1.9%) 0 (0.0%) 4(1.9%)
Tertiary 5 (2.4%) 14 (6.7%) 3(1.4%) 2(1.0%)
None 29 (13.8%) 15(7.1%) 164(78.1%) 59(28.1%)
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Other 3(1.4%) 1 (0.5%) 1 (0.5%) 1(0.5%)
Main Occupation:
Industry 2(1.0%) 1(0.5%) 0(0.0%) 4(1.9%)
Farming (fish, animal, crop) 15(7.1%) 121 (57.6%) 179(85.2%) 127 (60.5%)
Public/civil servant 1(0.5%) 7 (3.3%) 5(2.4%) 4(1.9%)
Artisan 32(15.2%) 27(12.9%) 4(1.9%) 7(3.3%)
Trading 99(47.1%) 39(18.6%) 13(6.2%) 48(22.9%)
Manual Labour 9 (4.3%) 1(0.5%) 1(0.5%) 0(0.0%)
Unemployed 16(7.6%) 8(3.8%) 4(1.9%) 11(5.2%)
Student 9(4.3%) 2(1.0%) 2(1.0%) 1(0.5%)
Others 27(12.9%) 4(1.9%) 2(1.0%) 8(3.8%)
Most respondents 622 (74%) were Christians, 161(19.2%) were Moslems, 
40(4.8%) did not specify their religion and 17 (2.0%) were traditionalist. More 
than half 442 (52.6%) of the respondents were farmers, engaged in fishing, 
animal or crop farming and traders formed 199 (23.7%) of the total sample. 
Household heads interviewed were mostly male (70.0%), while those 
interviewed in the Volta and Western regions had an almost equal sex ratio of 
1:1; however many more women (58.1%) than men (41.9%) were interviewed 
as household heads in the Greater Accra region.
Among the four regions, the one with the lowest education among the 
household heads is the Upper West region with 78.1% having no education, 
followed by the Western region with 28.1%, then the Greater Accra Region 
with 13.8% and finally the Volta region with 7.1%. Household heads have 
considerable influence on their household members in terms of education and 
their participation in health programmes. Education gives them a better 
understanding of issues and likely to enhance their participation. On the other 
hand, educated households have found it difficult to accept treatment from 
people with less education than themselves, as is often the case with 
community-directed drug distributors. Unemployment among these household 
heads was highest in the Greater Accra region (7.6%), followed by the 
Western region (5.2%), then the Volta region (3.8%) and finally the Upper
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West region with the lowest unemployment rate of 1.9% among these 
household heads interviewed. Except in the Greater Accra Region, which had 
the lowest proportion of household heads being farmers (7.1%), in the other 
three regions farming was the main occupation of most of the household 
heads interviewed.
4.12.4 Common Health Problems
During the qualitative data collection respondents mentioned various 
conditions (fever, malaria, headaches, stomach aches, bodily pains, jaundice, 
eye problems, skin rashes, ring worms, boils, Buruli ulcer, swollen scrotum, 
measles, goitre, swollen leg, shingles, tooth ache, piles, stroke, coughs and 
colds, high blood pressure, and chicken pox) as the common health problems 
in their communities. Partial and total blindness was also mentioned as a 
major health problem in a few of the study communities. While most of the 
above mentioned health problems were not mentioned in every community, 
malaria was mentioned as a major health problem during almost all the 
interviews.
Though NTDs were also mentioned as health problems, they did not come up 
in most of the responses until they were specifically inquired about. However, 
in almost all the IDIs and FGDs from the Upper West most of the NTDs came 
up spontaneously but schistosomiasis was seen not to be a common 
phenomenon among community members interviewed.
The ‘neglect’ suffered by the NTDs does not only emanate from policy 
makers. Communities that suffer these diseases do not appreciate these 
diseases as the most important conditions they suffer and which require 
attention from individual community members and therefore their participation 
in their control activities especially MDA is affected. The onus, however, lies 
on government, particularly the Ghana Health Service, through its
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implementation activities to help them to appreciate the importance of these 
diseases, as has been the case with the other diseases such as malaria.
4.12.5 Sources of treatment
When the signs are recognized, victims or caregivers usually take various 
actions depending on the signs and seriousness of the disease. The type of 
treatment to be sought depended on the perceived cause of illness. Those 
who perceived that the causative agent is pathological sought orthodox or 
herbal treatment and those who perceive the disease to be caused by spells 
sought treatment with spiritualists. Though the use and availability of herbal 
preparations as well as faith healings in the communities are common and are 
practiced, orthodox treatments are the predominant sources of treatment for 
both public and private health facilities. However, in some cases, 
combinations of all are practiced.
The role played by spirituality in the lives of many Ghanaians cannot is 
important. In such situations therefore, such persons could be made to 
appreciate that inasmuch as they sought spiritual attention for ailments this 
could be married with orthodox medicine safely making them stand to benefit 
from both. Spiritualists could also be employed, trained and used as channels 
for disseminating health information on these diseases to enhance 
acceptance of MDA for the NTDs. Strategies for engaging spiritualists should 
be designed as part of the programme’s IEC/BCC strategies.
4.12.6 Mass Drug Administration
Out of the total number of 840 household heads interviewed, 739 (88.0%) 
said they were aware of drug distribution in their communities including 
schools, while 101 (12.0%) said they were not aware of drug distribution in
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their communities. Of those who were not aware of drug distribution in their 
communities, 70 (69.3%) were from the Greater Accra region, 19 (18.8%) 
were from Volta, 11 (10.9%) from Western and the 1(0.5%) from the Upper 
West region. Greater Accra has smallest proportion of the region being 
involved in MDA reflecting the challenging nature of urban MDA. This is 
followed by the Volta region which is non-endemic for LF and with only some 
of its districts and communities undertaking treatment for onchocerciasis. 
Western and Upper West regions are endemic for both LF and onchocerciasis 
and were among the first regions to start undertaking MDA in Ghana. 
Awareness of MDA in these two regions is therefore expected to be higher 
than Greater Accra and Volta regions.
During the FGDs and the IDIs, knowledge and awareness of the drug 
distribution program in the study communities was quite high. Majority of the 
communities found the distribution channels appropriate and acceptable and 
testified that the program was of great benefit to them. Some communities 
however, complained that they were not informed of their children taking part 
in the drug distribution in schools and would have appreciated that they be 
made aware of this. Some parents on the other hand were comfortable with 
their children taking part in the exercise despite rumours that some children 
lost their lives after taking the drugs on an empty stomach. It was evident 
during the FGDs that most of the participants or their relations had either used 
or heard about the drug distribution. Those who had benefited from it testified 
about the efficacy or effectiveness of the drug. They also stated that after 
children had been treated for STH, they no longer had frequent episodes of 
illness as in the past and worm infestation was reduced.
Strategies to improve on information dissemination during the process of MDA 
are necessary in Greater Accra. Most communities were informed of the drug 
distribution programme by gong gong beaters, CDDs, radio stations and
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health workers in the different communities. Of those who had heard of Drug 
Distribution Programme, 405 (54.8%) said they were informed about the 
distribution programme by Gong gong beaters, 213 (28.8%) by community 
volunteers, 110 (14.9%) by health worker and 108 (14.6%) said they were 
informed through radio stations. Other modes by which they received the 
information were through neighbour/friends 44 (6.0%), family members 28 
(3.8%), and at school 13 (1.8%) (Figure 4.5). High awareness of MDA and its 
benefits, particularly to children, has been demonstrated by this study, 
however, public education and prior information given to communities before 
the exercise if not adequate will adversely affect the MDAs by increasing the 
refusal rates.
4.12.7 Mode of Distribution
When community members were asked about the mode of distribution of the 
drugs during the qualitative data collection, majority of the respondents 
indicated that the chiefs of the various communities are the first persons to be 
contacted on the arrival of the drugs in the community after which an 
appropriate time for the distribution could be scheduled. Community members 
provided several descriptions for the mode of distribution. Some respondents 
said the drugs were distributed centrally and others said it was shared from 
house-to-house. Respondents said the drug distribution was a yearly 
programme and the communities had at the time of the study benefited about 
six times however, others said the drugs were distributed only once and 
nothing had been heard of the distribution exercise again. All respondents 
indicated that heights were measured to determine the quantity of drugs to be 
given.
People who had taken alcoholic beverages were denied the drugs and 
advised to come at a time they had taken no alcohol. Some said the drugs
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were given to the school children under a direct observation treatment (DOT) 
method supervised by teachers who were given special training on the drug 
and the distribution exercise. The school children were instructed to report the 
occurrence of any side effects to their teachers. Various time estimates were 
given for the last MDA. These varied from less than one month to over 12 
months. Many 460 (62.2%) mentioned that it was to prevent/treat 
elephantiasis, 247 (33.4%) said it was to prevent/treat onchocerciasis, 
prevent/treat STH, 45 (6.1%) said it was to prevent schistosomiasis and 41 
(5.5%) said it was to prevent/treat hydrocele.
Regional disease endemicity seemed to have played a significant role in the 
response to the purpose of the last MDA (Figure 4.6). Less than a quarter of 
respondents mentioned other reasons as the purpose of the last drug 
distribution. These included protecting them from insects; to keep them in 
good health; to protect them from trachoma and also to protect them from 
diseases generally. Majority of respondents (24.3%) from Greater Accra 
mentioned elephantiasis, followed by schistosomiasis and then soil 
transmitted helminths; the majority (49.9%) from Volta mentioned soil 
transmitted helminths followed by onchocerciasis and schistosomiasis. In the 
Upper West region majority (46.3%) mentioned hydrocoeles followed by 
elephantiasis and then onchocerciasis. In the Western region majority (37.8%) 
mentioned schistosomiasis, followed by elephantiasis (32.8%) and then 
onchocerciasis (Figure 4.6).
One important aspect of the study was to determine if communities were 
aware of the purpose of the mass distribution programmes. During the FGDs 
and the IDIs almost all community members were aware of the purpose of the 
MDA however, there were misconceptions as to the type of illness the drugs 
targeted. While some are of the view that the drugs were for preventing polio 
in children others are of the view that the drugs are to expel worms from their
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bodies. Some also think the main purpose of the onchocerciasis drugs was to 
prevent them from being infected with the disease when bitten by the black 
flies. Nevertheless, the communities are aware that the drugs for the school 
children are for expelling intestinal worms, majority of the respondents 
believed that the drugs are preventive drugs against NTDs, namely trachoma, 
schistosomiasis, LF and onchocerciasis.
Awareness of the distribution process was also very high. Most of the 
respondents 555 (75.1%) said the distribution was done from house-to-house, 
187 (25.3%) said it was done at a central point from a community centre. 
Some 38 (5.1%) said it was done from a central point from a school, 14 
(1.9%) said it was done from a central point from the chiefs palace and 12 
(1.6%) said it was done at a central place from the market place. Some 
respondents mentioned other places including health centres, residence of 
the community volunteer and central point from the street. Very few of the 
respondents 4 (0.5%) did not know where the last drug distribution took place.
The number of drug distributions that had taken place in the various 
communities varied from 1 to 20, however, over 603 (81.6%) mentioned that 
there had been between 1-5 drug distribution programmes in their community 
with an average of 3.5 and a mode of 3.
Most respondents 674 (91.2%) who were aware of MDA in their communities 
said they had taken the drugs administered during the drug distribution 
exercise. When asked how they felt after taking the drugs, 422 (62.6%) said 
they felt nothing, 121 (18.0%) said they experienced itching, 96 (14.2%) said 
they had swellings and 39 (5.8%) said they felt dizzy. Thirty-eight (5.7%) said 
they felt weak, 13 (1.9%) said they had fever and 9 (1.3%) said they vomited 
after taking the drug. Other experiences were chills 7 (1.0%), Nausea 7 
(1.0%) and various forms of bodily pains 9 (1.2%).
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Considerable satisfaction was expressed about either the absence of side 
effects or the insignificant adverse events of the drugs during the focus group 
discussions as well as the IDIs. Some perceive the drugs to have no adverse 
effects, especially when it is given after enough meals and making sure that 
the right dosage was given. There were a few of the respondents who either 
experienced or heard rumours of adverse reactions of itching, dizziness, 
rashes and abdominal discomfort, after taking the drug. Some also said they 
heard rumours of deaths as a result of taking the drugs though not from their 
communities.
Figure 4.6: Purpose of Last MDA
60 -i---------------------------------------------------
49.9
Greater Accra Volta Upper West Western
Region
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This is how some of them put it:
“When we heard the first time that the children were going to be given drugs, 
some of us went for our children because we heard that some children fell into 
Coma in some places hence we refused but the subsequent ones we allowed” 
Agbesia female group-Volta Region
7 heard that some two children died at Hohoe due to the drugs they took. 
What I heard was that, the children were given drugs which they did not eat 
and they died so when our children take it they will die.”
Agbesia female group-Volta Region
Some also perceived adverse events as a sign of the drugs being effective
“the drugs are effective because I was feeling dizzy after taking them”
Loggu Upper West
“you hear sounds from your stomach after taking the drugs and this indicates 
the effectiveness of the drug”
Butenga-Upper West Region
“it is effective because anytime I take it I become seriously weak and sleep 
the whole day”
Bonaa-Upper West Region
In spite of the fact that some respondents experienced side effects after 
taking the drug, 707 (95.7%) of respondents said they would still take the drug 
anytime it was administered to them. The two most common reasons given as 
to why they would still take the drug included protection from elephantiasis 
521 (70.5) and removal of all forms of disease from their body 82 (11.1%).
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Other reasons given were the fact that the disease was common in their 
communities and also that the drugs produced no adverse reactions. Besides 
the respondents themselves, 655 (88.6%) said everybody in their household 
took the drug, 53 (7.2%) said not everyone in their household took the drug 
and 31 (4.2%) said they did not know if everyone in their household took the 
drug. The main reasons for people not taking the drugs were for fear of side 
reactions (40.3%) and 41.8% could not assign reasons why people did not 
taken the drugs.
The different endemic status of regions and districts determines the drugs 
administered under mass drug treatment and also the schedule of these 
treatment programmes which accounts for the knowledge displayed by the 
different respondents from the different regions on the issues pertaining to the 
purpose of the distribution exercise and the timing. However, the effect of side 
reactions on participation, though appearing not to be significant regarding the 
fact 95.7% of respondents said they would still comply with treatment in spite 
of experiencing and hearing about possible side effects. Side effects have 
always been a problem in the implementation of MDA (Dodoo et al, 2007) and 
often results in many distribution programmes recording low coverage.
4.12.6 Attitude towards Mass Drug Administration
The health benefits of MDA were well appreciated by individuals interviewed. 
The programme should take advantage of these positive community 
perceptions to reinforce messages that would enhance the uptake of MDA 
within communities. The general perception of people towards MDAs was that 
if some community members refused to take the drugs the diseases will still 
remain or will spread. During the interviews, 395 (53.5%) said if some 
community members refused to take the drug, the disease will still remain in 
the community, and 306 (41.4%) said the disease will spread. However, 110
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(14.9%) of respondents said they did not know what the effects will be if some 
community member refused to take the drugs. Majority of the community 
members as well as the opinion leaders interviewed were of the view that the 
drugs are very effective and has reduced the time spent in taking the sick to 
the health facilities but has also reduced their health spending. They also said 
that it has reduced delays in seeking treatment for sick children until the 
illness sometimes worsened when care givers do not have the resources 
readily available to send their children to the nearest health facilities in the 
communities. Some are of the view that, after the children have been treated 
with the drug, they no longer had frequent episodes of diseases as in the 
past.
Most respondents 472 (63.9%) said nothing will prevent them or their family 
members from taking the drugs distributed at school or at home once they 
were eligible for the treatment and had not taken alcohol. Generally 
comments about the drug treatment were positive except for issues on side 
reactions. But respondent (99.2%) indicated that negative comments would 
deter them from taking the drugs (Table 4.4). When asked for their 
suggestions as to how to improve future MDAs, 315 (42.6%) said there should 
be more drugs during the distribution exercise, 136 (18.4%) said there should 
be more announcements before the distribution exercise, 75 (10.1%) said 
there should be more volunteers during the distribution exercise and 11 
(1.5%) said they should be given food before the distribution exercise. Other 
suggestions included education of community members and forcing everyone 
in the communities to take the drugs. The challenge of inadequate drugs and 
logistics had been recognized by many of those interviewed and should 
influence programmes to ensure proper planning to ensure adequate supply 
of logistics for the programme. A premium should be placed on a well-planned 
and executed health education programme as an integral part of programme 
implementation.
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The notion particularly among the women’s groups that tablets are not 
suitable for young children and perceive syrups as the option for children 
should not be dispelled since it was reported in 2007, 4 deaths of preschool 
children was recorded in Ethiopia due choking on albendazole tablets. 
Children groups also are of the view that the tablets should be made smaller 
to allow ease in swallowing. Though mass treatment does not necessarily 
target preschool children, the younger children involved should be 
encouraged to chew the tablets in order to prevent any acute severe adverse 
reactions associated with swallowing (WHO, 2007).
4.12.9 Community Based Drug Distribution
Community resource persons referred to as Community Drug Distributors 
(CDDs) with minimal to moderate education are trained as drug distributors to 
advice and dispense drugs appropriately at community level (WHO, 2012). 
Either the chiefs or the head teachers of the various schools in the various 
study communities selected almost all the CDDs. The choice of a distributor 
for the MDA is dependent on whether the person is already a community 
health volunteer or a teacher. However, while some opinion leaders are of the 
view that more CDDs be trained, participants of some FGDs think that 
teachers who are not indigenes should not be trained as CDDs as they may 
leave the community after some time or simply because they want other 
members to be given the opportunity to serve their community. Some are of 
the view that the distribution should rather be done by health personnel 
particularly nurses and with that people will be more at ease and attach more 
importance and seriousness to the exercise because people collect the drugs 
but refuse taking them.
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Majority of community members interviewed were comfortable with the 
available central point or house-to-house distribution system and particularly 
with the house-to-house distribution method which made it possible to leave 
drugs behind or to do revisit treatment for absentees. In order to prevent the 
spread of communicable diseases such as tuberculosis during the distribution 
process however, the house-to-house method or individual visits to the 
distributor were preferred to the central point distribution which promotes 
crowding of community members associated with the spread of 
communicable diseases.
"For me gathering at a common point for the drug distribution is not good, 
because, some people have TB and at a gathering like that, you may contract 
some disease from other people, I think it is the duty of the CDD to move from 
house to house because the community is not the large one.”
Men Fodome Agbesia Volta Region
“To me it is not good we are gathered in one place but it should be from class 
to class”
Female child Flelu-Volta Region
4.12.10 School Based Drug Distribution
While some parents from the FGDs prevented their children from taking the 
drug because of the rumours of the death of some school children in nearby 
communities as a result of taking the drug, most of them were comfortable 
with their children taking part in the exercise despite rumours that some 
children died after taking the drugs on an empty stomach. Many (92.8%) of 
the respondents said MDAs were good for their children. Many (77.5%) of the 
respondents who had children in school had been told (75.6%) about drug 
distribution in their schools and had given the consent (99.8%) for the children
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to participate in the distribution. About 2.8% of respondents said school-based 
distribution was not acceptable. Based on these findings the IEC/BCC 
materials should be able to identify and emphasise the specific benefits of 
mass drug distribution targeted at school-aged children to reinforce the 
benefits of these distribution programmes.
During the qualitative data collection, majority of the communities found the 
distribution channels appropriate and acceptable and considered that the 
program was of great benefit to them. Some communities however, 
complained that they were not informed of their children taking part in the drug 
distribution in schools and would have preferred if prior information had been 
given to them as parents. The strategies of both community-based distribution 
using community-directed distributors and teachers for distribution of drugs in 
the school-based distribution programmes, raised some serious concerns 
about the use of teachers who are non-indigenes. In addition respondents 
raised the need for more information, especially prior to implementing the 
distribution programme. Research has however shown that better coverage is 
obtained with CDDs rather than health workers (Gyapong et al, 2001) as a 
result the use of indigenes as a distributor is recommended by the CDTI 
strategy for drug distribution. School-based distribution programmes should 
also not ignore community education in their implementation since these 
school children live in communities.
4.12.11 Knowledge of Lymphatic Filariasis
In Ghana, LF is considered a public health problem. With the exception of 
Volta and Ashanti regions, the other regions of the country are endemic. As 
part of the objectives of this study, community members’ knowledge of was LF 
was assessed. In all 824 (98.1) of respondents said they had heard of LF a 
few 16 (1.9%) said they had not heard of the disease. Of those who had not
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heard of LF 8 (50.0%) were from the Volta region, 4 (25.0%) from the Greater 
Accra region, 3 (18.8%) from Western region and 1 (6.2%) from the Upper 
West region. The order of knowledge conforms to endemic status of 
respondent’s regions. Volta region is non-endemic, Greater Accra is partially 
endemic, Western is mostly endemic while Upper West region is entirely 
endemic for LF. According to the FGDs, there is no single local name for LF. 
However community members know the differences between Elephantiasis 
and hydrocele. Ewes refer to Elephantiasis as “Zibo” and hydrocele as “Evo"; 
the Gas refer to them as “Nanehela” and “Shinkpamaduru” respectively. The 
Akans also refer to Elephantiasis as “Ogyampi”.
The sources of information on LF varied. CDDs (26.3%), health workers 
(22.9%), friends and family (22.9%) and radio (25.7%) were the main sources 
of information. Other minor sources included posters, TV and community 
events which will require less emphasis during the development of the 
communication strategies. The most common known symptom by 
respondents is the enlarged legs and scrotum. In all 803 (97.5%) and 289 
(35.1%) mentioned enlarged legs and enlarged scrotum respectively as the 
signs and symptoms of hydrocele. Besides these two signs, 41(5.0%) 
mentioned enlarged arms, 11 (1.3%) mentioned painful swollen groin and 11 
(1.3%) also mentioned high fever. Four respondents (0.5%) also mentioned 
enlarged breast as a sign of LF. From the perception of the children’s FGD 
anyone wearing trousers with big bars reaching beyond the ankle (a sign of 
concealing swollen leg), is identified as having elephantiasis. Community 
members are also of the view that painful swollen legs with rashes on them 
are signs of elephantiasis. Concerning people with hydrocele, walking with 
opened legs because of the enlarged scrotum identifies them.
The presentation of LF was well known, though only 33.7% of respondents 
indicated that there were people with the disease in their communities. About
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97.5% of respondents said it presented as enlarged legs. A smaller proportion 
of respondents mentioned enlarged scrotum (35.1%), enlarged arms (5.0%) 
and enlarged breasts (0.5%). Knowledge on the transmission of LF was 
inadequate as only 6.1% of respondents knowing it was transmitted through 
the bite of a mosquito. Equally only 55.0% of respondents said taking drugs 
could prevent LF and 1.2% said it could be prevented by sleeping under 
mosquito nets.
Most of the individuals affected by the disease were said to have gone to the 
government or private health facilities (87.0%), 13.6% went to herbalists and 
3.0% went to a spiritualist. Treatment administered to patients with 
elephantiasis and hydrocoeles were generally unknown (49.4%), but 42.0% 
mentioned tablets while 10.1% mentioned surgery.
Figure 4.7: Knowledge of Lymphatic Filariasis Disease
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4.12.12 Attitude toward LF patients
In the communities patients are said to be generally treated with sympathy 
(37.1%) while 28.3% said people were generally indifferent to these patients. 
Interestingly, 12.3% of respondents were willing to marry patients with LF 
while 30.2% were willing to share things with them. Others were willing to 
share food, clothes, and shoes and make body contact with these patients.
During the FGDs when participants were asked about the causes of LF some 
mentioned that sores which do not heal can gradually turn into elephantiasis, 
for example, being pricked by a nail or a concrete product and not taking 
proper care of the sore. Some were also of the view that when a person’s leg 
gets into contact with cement and is not washed off it causes elephantiasis. 
There is also the belief that LF is caused by spiritual manipulations
“They said when someone has hydrocele, something might have been placed 
in the farm for him; so whenever he steps in the farm, he develops hydrocele. 
They said if a calabash is being carved and it falls you can get hydrocele. If 
you break a calabash, you’ll get hydrocele.” Misconceptions about disease 
transmission especially with regards to LF have been rife since the inception 
of the programme, however greater efforts need to be put in health education 
to correct these misconceptions. Information gaps identified by respondents 
included prevention (37.9%), transmission of W. bancrofti (36.0%), treatment 
(27.3%) and while about 29.4% wanted to know everything about the disease.
As expected few people knew about the management of elephantiasis mainly 
because this education is targeted at patients with the condition, whose 
assessment will give better picture of knowledge on the management of 
patients with lymphoedema. Stigmatisation of patients with LF continues to be 
an issue that requires dealing with using the IEC/BCC strategies. This should
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acknowledge physical challenges of LF patients while dwelling on some of the 
incorrect perceptions of disease transmission.
4.12.13 Knowledge of Onchocerciasis
About 57.7% of all the respondents had heard about onchocerciasis. The 
source of this information varied from healthworkers (39.8%), radio (29.7%), 
CDDs (22.1%) and friends and family (18.6%). Other sources of information 
like posters, community events, community leaders and school events were 
insignificant. Of those who had heard of onchocerciasis, 185 (38.1%) were 
from Volta region, 168 (34.6%) were from the UWR, 98 (20.2%) were from 
western region and 34 (7.0%) were from the GAR (Figure 13).
Figure 4.8: Knowledge of Onchocerciasis
greater Accra 
7%
About 44.5% of respondents knew onchocerciasis was acquired through the 
bite of a blackfly. Others mentioned the mosquito (17.3%), poor hygiene 
(11.5%) among other modes of acquiring the infection. About 31.3% did not
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know how the disease was transmitted. The most predominant presentation of 
onchocerciasis indicated by respondents was blindness (48.9%), itching 
(31.8%), and skin rashes (17.3%). Few of the respondents knew about 
nodules (4.9%), lizard skin (4.3%), and skin depigmentation (1.2%) while 
13.2% did not know these onchocerciasis presentations. During the FGDs 
and IDI’s, nodules, itching of the body, painful, itchy and watery eyes that lead 
to partial and total blindness, was mentioned as symptoms of onchocerciasis, 
which was generally said to be caused by the bite from flies. Flowever, the 
cause of trachoma was not explicitly stated. Most (57.1%) of the respondents 
knew the disease could be prevented by drugs while the others indicated 
other wrong methods of prevention such as the use of insecticide treated 
nets, good hygiene and wearing of shoes and protective clothing among 
others. About 18.8% of respondents did not know.
4.13 Attitude
About 43.1% of respondents knew people in their communities with 
onchocerciasis. About 27.2% wanted to know about the disease transmission, 
31.1% wanted to know about its prevention and 32.2% its treatment. About 
37.1% wanted to know about everything while 7.6% wanted to know about the 
signs and symptoms of onchocerciasis.
4.14 Knowledge of Soil Transmitted Helminthes (Intestinal worms)
In all, 806 (96.0%) of them had heard of intestional worm infestation. Of 
these, 301 (37.3%) heard it from health workers, 254 (31.5%) heard it on 
radio, 266 (33.0%) heard it from a friend/family and 127 (15.8%) from a ODD. 
Other responses included; television, school teachers. Most of the 
respondents were able to mention at least one means of by which people got 
infected with intestinal worms apart from 21.7% of respondents who said they
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did not know. Responses included poor hygiene (37.6%), contaminated water 
(26.8%), poorly cooked food (26.6%) and contaminated vegetables (15.6%). 
Other modes of transmission mentioned included sugary foods, poverty, 
eating seeds and flies. Not wearing shoes was mentioned by only 3.5% of 
respondents. The mentioned signs and symptoms of worm infestation 
included nausea and vomiting (71.0%), swollen belly (40.2%), loss of appetite 
(27.3%), diarrhoea (14.9%), anal and body itching (13.0%), weakness 
(11.3%) and anaemia (11.8%). Few respondents mentioned fever, headache 
and fatigue. About 26.7% of respondents said they de-wormed their children 
every 3 months while 25.8% said they never de-wormed their children. The 
others dewormed their children once a year (14.5%), once in a while (14.5%), 
or when the child was sick (8.6%). During FGDs and IDIs, interviewees said a 
child with swollen belly is seen as potentially having Soil Transmitted 
Fielminths. However, victims may experience abdominal discomfort, nauseous 
feelings after eating and sometimes vomit after meals, indiscriminate spitting, 
they have diarrhea, loose appetite and are always lean and weak. They are 
quick to complain of hunger immediately after meals. Body itching after 
bathing was also described as a characteristic of intestinal worm infestation. 
The following quotes depict what respondents had to say:
“A person with worms loses appetite and whenever the person tries to eat 
he/she feels like vomiting”
Opah Community men
“For Soil Transmitted Helminthes, the person loses weight and become thin 
and weak if it is a child; he/she will vomit any food faker?” Tiisah Men
When respondents were asked what they would want to know with respect to 
STH (intestinal worms), 278 (34.5%) said they would want to know how one 
gets worms, 274 (34.0%) said they would want to know everything about the
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disease. Some 207 (25.7%) said they would want to know about the effects of 
worm infestation, one third 268 (33.3%) said they would want to know more 
about the treatment of worm infestation, and 73 (9.7%) said they will want to 
know about the signs and symptoms.
4.15 Knowledge of Schistosomiasis
In most of the communities, members depend on rivers or ponds as source of 
drinking water however, most of them agreed that the water bodies polluted 
with human waste, inflow of waste from gutters during the rains and misuse 
such as washing and swimming render the water from such sources as 
unwholesome for human consumption. Some respondents reported that many 
community members had resorted to drinking ‘sachet’ water. On how to 
preserve the quality of the water bodies, many were of the view that activities 
that caused the pollution must be stopped. In all, 766 (91.2%) of respondents 
interviewed said they had a river/pond in their community or nearby where 
they washed (71.4%), swam (45.2%), bathed (43.6%) and fished (29.9%). 
Some 28.6% of respondents farmed near a river or pond. About 54.3% of 
respondents indicated that some members of the communities sometimes 
urinated or defecated into these rivers or ponds. Majority (85.1%) of 
respondents, however, knew diseases that could be transmitted through water 
contact and these included schistosomiasis (53.0%), Guinea worm (48.5%), 
diarrhoeal diseases (23.2%) and typhoid (8.5%). Buruli ulcer and worm 
infestation were mentioned as other diseases that could be transmitted 
through water. These streams and rivers were a major source of drinking 
water for most (48.8%) of the respondents. Another major source was the well 
or borehole (43.5%), pipe borne water (30.0%) and sachet water (17.5%). 
Other known sources of drinking water included springs, water tankers and 
rain water. As many as 91.3% of the respondents had heard about 
schistosomiasis and knew it was associated with blood in the urine (87.9%)
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and painful urination (36.4%). Few mentioned blood in stools (4.0%) or did not 
know (4%). About 51.5% of respondents said one could become infected by 
swimming in rivers or ponds, drinking contaminated water (27.4%), bathing in 
rivers or ponds (26.6%) or eating contaminated food (8.0%). Some 21.0% of 
respondents did not know.
Focus group discussion participants also demonstrated that, recognition of 
schistosomiasis is determined by specific signs and actions exhibited by 
victims rather than just the mere sight of the victims while some observations 
are that victims experienced blood in urine, in others the bloody urination was 
accompanied by pain in the groin and lower abdomen. A few respondents 
mentioned bloody stools and diarrhoea as signs of schistosomiasis.
“Actually schisto, ‘Wudordof’ you wouldn’t be able to tell unless the person 
tells you, or you see the person urinating".
Focus group discussion participants are aware of schistosomiasis and while 
some of them are of the view that the schistosomiasis is caused by working 
long hours under the scorching sun, others think drinking dirty water causes it. 
Overall there seems to be good knowledge that, schistosomiasis is a water 
borne disease. In some communities schistosomiasis is seen as affecting 
children rather than adults and it is as a result of the children bathing in 
contaminated water bodies and stagnant waters.
“Long hours of working in the sun causes me to urinate blood”
Man Kojo Ashong
When respondents were asked what measures could be taken to protect 
people from contracting the disease, 408 (53.2%) said one should avoid 
swimming in rivers and ponds, 209 (27.2%) said taking drugs could protect 
one from the disease, 205 (26.7%) mentioned avoiding bathing in
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rivers/ponds, 92 (12.0%) mentioned avoiding washing in the rivers and ponds 
and 33 (4.3%) said avoiding wading in rivers and ponds. Other responses 
included health education, provision of safe drinking water and practicing 
good hygiene.
When asked what measures community members felt should be taken to 
prevent contamination of water bodies, 387 (46.1%) said people should not 
urinate, 369 (43.9%) or should not defecate in water bodies, 279 (33.2%), 
reported potable water should be provided and 140 (16,7%) said communities 
should be provided with toilet facilities, 105 (12.5%) and sewage disposal 
facilities. Other responses included fencing off water bodies, health education 
and treatment of the water source.
When respondents were asked what they would want to know with respect to 
schistosomiasis, 340 (40.5%) said they would want to know how one gets 
worms, 313 (37.3%) would want to know how it’s treated, 272 (32.4%) said 
how one can contract the disease, 170 (20.2%) said they would want to know 
the effects of the disease and 66 (7.9%) said they would want to know the 
signs and symptoms.
4.16 Available and Preferred Channels of Communication
Out of the total number of 840 households heads interviewed most felt that 
community members should be informed of drug distribution exercises 
through gong gong beaters 388 (46.6%) which are local drummers who beat 
the drums to attract attention for community announcements, health workers 
235 (28.0%), radio announcements 190 (22.6%) and through the national 
information service 98 (11.7%). In Greater Accra, 107 (51%) answered gong 
gong beaters, 78 (37.1%) said information service, 49 (23.3%) radio, and 24 
(11.4%) answered television. In the Volta region respondents felt that 
community members should be informed of these exercises through chiefs
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106 (50.0%), gong gong beaters 100 (47.6%), and health workers 61(29.0%). 
Only 13 (6.2%) of respondents in the Volta region mentioned any form of 
mass media. In the Upper West community members wanted to be informed 
of MDA activities by health workers 101 (48.0%), gong gong beaters 43 
(20.5%), chiefs 37 (17.6%), and radio 29 (13.8%). In the Western region 
respondents felt that community members should be informed of MDA 
activities through gong gong beaters 138 (65.7%), Radio 99 (47.1%), Health 
Workers 67 (31.9%), and chiefs 44 (21.0%). As a mode of communicating 
these health education messages, the majority 600 (71%) of the respondents 
mentioned health talks. Other significant forms mentioned included 
community durbars 193 (23.0%), radio 166 (19.8%), drama or theatre 91 
(10.8%), posters 66 (7.9%), and television 48 (5.7%). At the regional level, the 
health talk remains the most listed response for desired form or potential 
format of health education messages: Greater Accra 102 (48.6%); Volta 177 
(84.3%); Upper West 149 (71.0%); Western 172 (81.0%). Although it is still 
the highest response, it is worth noting that under 50% of respondents listed 
health talks in the Greater Accra region, while over three quarters of 
respondents in the other three regions listed health talks. Community durbars 
were an important form in which people would like to receive health messages 
in the Volta region 51 (24.3%) and Greater Accra 69 (32.9%), while radio was 
an important method of sending health messages to respondents in the Upper 
West 51 (24.3%) and the Western region 60 (29.0%).
Health education preference was distinctly different among peri-urban and 
rural dwellers when the views of community members were sought during the 
FGDs and IDIs. While in the peri-urban community education on radio and 
television during talk shows and posters were their preferred sources of health 
education. The first option for rural dwellers is by beating the gong-gong 
under the direction of the community chief. Interpersonal communication 
seems to be another option for rural dwellers compared with urban dwellers.
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Rural dwellers were also of the view that educational messages be presented 
in a drama form where the actors should be people from outside their 
communities. Others wanted the education on market days since women, who 
are predominantly care givers sell their produce and wares on market days. 
Others want some of the drugs to be given on the day the talk is given. 
Urban dwellers wanted the education on the drugs on radio and in the 
evenings when most people would have returned from work. They asked that 
adverts are made on the local FM station in the mornings before work or in 
the evenings after work. Overall fifty percent of respondents interviewed 
stated that village and community meetings were their preferred locations for 
health information to be distributed. This remained consistent in three of the 
four regions. In Greater Accra, community members preferred health 
information to be given at home 80 (38.1%) and in schools 77 (36.7%). There 
is no significant difference between preferred locations for men and women.
The study revealed that overall religious gatherings 43 (51.7%) followed by 
women’s groups 216 (25.7%), and men’s groups 177 (21.1%) are the most 
listed types of events in the communities (Table 4.20). However, there are 
some distinct regional differences that should be noted. In the Greater Accra 
and the Volta regions religious gatherings remained the most important form 
of social gathering listed with Greater Accra, 131 (30.2%) and Volta 167 
(35.8%) respectively. However, in the Upper West region women’s group 
gatherings are reported by a much higher percentage of people at 131 
(62.4%) followed by men’s group gatherings at 109 (51.9%). In the Upper 
West region 37 (8.5%) of respondents listed religious gatherings. When 
asked where community members go for entertainment Community centres 
221 (26.3%), drinking spots 189 (22.5%) and parks 183 (21.8%) were the 
most frequented locations.
Page | 148
Table 4.20: Types of Meetings that take Place in Study Communities
Yes
Response n=840 Freq %
Religious gathering 43 51.7
Political gathering 89 10.6
Women's group 216 25.7
Men’s group 177 21.1
Work association 115 13.7
Other, specify 288 34.3
In Greater Accra drinking spots are the most reported location for 
entertainment 109 (51.9%). For all communities, 523 (62.3%) mentioned the 
community chief as the most important person to contact with important 
information. Other important points of first contact listed were Assembly 
men/women 96 (11.4%) and community elders 91 (10.8%). Although 
community volunteers were only 51 (6.1%) it is interesting to note that 
community members listed community based volunteers higher than health 
workers 27 (3.2%) Respondents in the Upper West listed community based 
volunteers as the second most important person to contact with important 
information at 36 (17.1%). However respondents said that normally they 
would go to see a health worker for information or advice on health 438 
(52.1%). Family members and spouses were also an important source of 
information for respondents on health issues (Table 4.21).
Table 4.21: Sources of Information
Yes
Response n=840
Frequency(N) Percentage
(%)
Friends 66 7.9
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Family member/relative 223 26.5
Spouse (husband/wife) 145 17.3
Teacher 10 1.2
Health worker 438 52.1
Other, specify 129 15.4
4.17 CROSS-SECTIONAL COMBINED KNOWLEDGE, ATTITUDE AND 
PRACTICE , COVERAGE AND COMPLIANCE HOUSEHOLD 
ASSESSMENTS
4.17.1: Introduction
Cross-sectional quantitative exploratory surveys were conducted as part of 
assessments of the epidemiology and control of LF in Ghana. These surveys 
were undertaken in the first 5 start up districts of the programme and included 
epidemiological and coverage assessments. Parasitological surveys were 
conducted on blood collected from among the adult populations and antigen 
and antibody filter paper assays conducted on blood collected from children 
from 0-5 years were used to assess the impact of MDA on the first 5 start up 
districts all of which had completed the minimum of 6 rounds of MDA using 
ivermectin and albendazole under the LF Elimination Programme in Ghana. 
Combined KAP coverage reliability and compliance assessment surveys were 
conducted as part of these cross-sectional surveys. Finally an assessment of 
the morbidity control programme for cases of elephantiasis and hydrocoele 
were carried out employing designed quantitative assessment surveys for 
both identified patients and other community members.
4.17.2: Method of Combined KAP, Coverage and Compliance 
Assessment
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Quantitative surveys for the household heads employed the 30-cluster 
sampling method for household selection. For each of the 5 districts 30 
communities were randomly selected from a list of all its communities without 
taking into consideration the sub-district demarcations. From each of the 
selected communities 10 compounds or houses were randomly selected from 
each of the communities. This was done by spinning a pen and the trained 
data collectors assigned in different directions determined by the pointer of 
the pen. If the pen pointed in a particular direction more than once the pen 
was span again until a new direction determined by the pointer was found. In 
each identified house or compound the first identified household was selected 
and interviewed, therefore only one household was interviewed for each 
compound visited, in each household the household head or his 
representative was interviewed for the first part of the survey for the KAP 
assessment.
4.17.3: Results and Discussions on Combined KAP, Coverage and 
Compliance Assessment
A total of 1508 household heads were interviewed from 28 sub-districts. The 
number of household interviewed in each sub-district varied from 10 to 148. 
The proportions of household heads interviewed were equal for all the 5 study 
districts. The proportion of males interviewed as household heads 
represented 50.7% while women formed 49.3%. Most household heads 
(74.9%) were married with 25% being either single (9%), divorced (6%) or 
widowed (10%). Flousehold sizes varied from 1 to 20. Flouseholds with sizes 
with up to 5 people formed 72.5%, followed by those between 6-10 (25.4%), 
then those from 11-15 (1.9%) and then those greater than 15 (0.1%) (Figure 
4.22). Flouseholds with a size of 4 formed the greatest proportion of 21.8%, 
then 3 with 18.4% followed by 5 with 17.5% however, the average household 
size in Ghana, which is five (GDFIS, 2000).
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Table 4.22: Household sizes for Compliance Survey
Household Size (N) Frequency N) Percent (%)
<5 1094 72.5%
6-10 383 25.4%
11 -15 29 1.9%
>15 2 0.1%
TOTAL 1508 100%
■ Enlarged scrotum H Enlarged arms
■ Painful and swollen groin n Fever and Chills
■ Enlarged legs
■ Enlarged breast
Figure 4.9: Symptoms of Lymphatic Filariasis
Almost all the respondents (99.4%) knew about elephantiasis, the common 
name for LF. For the symptoms of LF, majority (93.6%) of the respondents 
knew it affected the limbs, while 88.1% said it also affected the arms, and 
82.0% also said it could affect the scrotum as well. Very few of the 
respondents knew it could affect the groin (3.3%), the breast (1.0%) or have 
the symptoms of fever and chills (6.6%) (Figure 4.9).
On the mode of transmission of infection, only 31.8% of respondents knew the 
mosquito could transmit the disease, 10.1% said the disease could be 
acquired through contaminated food while 27.2% said it could be acquired
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through contaminated water. With regards to the causative organism for the 
disease, 35.3% agreed worms were responsible for the disease, 1.4% said it 
was viruses while 3.6% said bacteria were responsible. Knowledge about the 
disease transmission was highly inadequate making it difficult to influence any 
behaviour change that will be required to improve compliance with treatment 
and control of the disease. However, information on disease causation and 
transmission though provided as part of public health education prior to the 
MDAs, the understanding of community members was limited considering the 
level of education particularly in rural communities.
■ Taking Drugs
■ Sleeping in ITNs
________ J
Figure 4.10: Available Preventive Measures
In response to how to prevent LF, 66.7% of inten/iewees indicated that drug 
treatment, then 28.6% said keeping the environment clean could help prevent 
the condition while sleeping under insecticide treated nets accounted for 
22.3% of responses (Fiugre 4.10). About 98.5% of respondents were aware of 
MDA for LF in their communities, but 91.5% of them were able to indicate that 
2 different drugs were administered during this exercise. Only 59.4% of 
household heads were aware that children below a certain height could not 
take the drugs, 74.5% were aware that pregnant women were not eligible for 
the treatment, 14.0% knew some breastfeeding mothers could not take the 
drugs, and 15.7% knew that seriously sick people were not supposed to take 
the drugs.
About 64.6% of household heads indicated that everyone in their household 
had taken the drugs, while 78.1% were aware of possible side effects of 
taking the drugs but only 36.9% were able to name some of these side effects
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which included rashes (25.4%), swelling of certain parts of the body (16,2%), 
headache (24.3%), fever (19.8%) and chills (5.4%). Inspite of the possible 
side reactions 92.7% of the respondents said they would continue to 
participate in the MDA if the drugs were given again, however in terms of the 
number of times they had participated in the MDAs, though all these 5 districts 
had undertaken MDAs over a minimum of 6 annual rounds, only 30% of 
household head respondents had taken the drugs 6 times. About 58.8% of 
household heads interviewed knew someone with elephantiasis or a 
hydrocoele while only 10.1% of households interviewed had a hydrocoele or 
elephantiasis patient present in that household. Only 26.8% of respondents 
were aware of the availability of treatment for patients with hydrocoele or 
elephantiasis. It should be noted that most cases of elephantiasis are 
irreversible which is a well-known fact shared with communities as part of 
health education inspite of the fact that hydrocoeles are treatable.
4.17.4: Compliance with Treatment
Generally compliance with treatment improved from year 1 to year 6 in all the 
5 start up districts of the programme. The ineligible population comprising of 
individuals of <90cm, the pregnant, severely sick and breastfeeding mothers 
with children less than a week old, did not show any significant difference in 
trends from year 1 to year 6 (Table 4.23). The absentee population however 
showed a downward trend from year 1 to year 6 with a reduction in the 
incidence of side reactions also from year 1 to year 6 (Table 4.23).
Table 4.23: Reasons for Non-compliance
Year of
MDA
Surveyed
Coverage
(%)
<9Qcm Pregnant Severely
III
Breast­
feeding
Absent No
Side
Effects
Side
Effects
Year 1 25.9 5.8 0.5 0.8 39.4 22.9 0.2-0.5
Year 2 30.4 6.2 0.5 0.8 0.3 36.8 22.6 0.2-0.4
Year 3 39.5 6.9 0.6 0.8 0.2 31.7 36.6 0.2-0.7
Year 4 56.4 7.7 0.6 0.8 0.2 20.9 51.8 0.3-0.9
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Year 5 68.1 8.2 0.6 0.6 0.1 15.1 63.4 0.4-0.7
Year 6 71.9 7.6 0.5 0.5 12.7 67.2 0.3-0.9
Table 4.24: District Compliance from Year 1 to Year 6
District Frequency
(N)
Year 1
(%)
Year 2
(%)
Year 3
(%)
Year 4
(%)
Year 5
(%)
Year
6
(%)
Sissala 1154 31.5 33.2 38 47.2 60.5 64
Kassena 1321 13.6 18.5 32.1 57.3 71.1 75
Nankana
Builsa 1582 39.3 47.8 58.8 77.4 83.8 85.9
Awutu Efutu 1259 14.9 18.7 24.8 45.7 61.6 67.8
Senya
Ahanta West 1460 26.9 29.8 24.8 50.3 60.3 62.6
Total 6776 25.9 30.4 39.5 56.4 68.1 71.9
Figure 4.11: MDA Compliance from Year 1 to Year 6
r
Treatment Compliance^) MDA
Surveyed
Coverage
<%)
J
Figure 4.12: MDA Compliance from Year 1 to Year 6 by District
Figure 4.13: Differences between Reported and Surveyed
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Difference between Reported and Surveyed Coverage over 6 
Years in Start Up District
year 1 year 2 year 3 year 4 year 5 year 6
•"•Total 48.0 42.4 29.4 18.3 3.0 8.7
■^"Sissala 35.7 43.9 32.5 32.3 13.0 12.0
—KND 54.6 51.6 29.7 8.5 -5.1 2.0
•"■Builsa 29.5 18.5 11.3 -3.1 -18.8 -2.9
"■•Awutu Efutu Senya 72.8 57.8 51.9 36.7 14.3 16.4
^^•Ahanta West 43.3 41.0 47.3 25.6 13.1 19.0
4.17.5 Coverage
Compliance showed an exponential increase from year 1 to year 6 for all five 
districts together and also for the individual districts (Figure 4.11). The 
differences between the reported and surveyed coverage each of the 
surveyed districts also showed reductions in trends from year 1 to year 6. 
Determination of treatment compliance through the questionnaire was 
undertaken for all household members by interview. Results obtained showed 
improved trends from Year 1 to Year 6 exponentially all the 5 districts and for 
the aggregated data for all the districts. In Year 1 treatment coverage for all 
the 5 districts increased from 25.9% to 30.4% in Year 2, then to 39.% in Year 
3, 56.4% in Year 4, 68.1 % in Year 5 and finally 71.9% in Year 6 (Figures 4.11 
and 4.12). Individually each of the districts also showed similar trends in 
compliance from Year 1 to Year 6. There was however, a slight increase from 
year 5 to year 6. This observation was also made for all the 5 start up districts.
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From the inception of the programme in year 1 to year 6, the there was a 
gradual up-scaling of the programme with lessons learnt being applied to 
improve on programme delivery in subsequent years. The proportion of the 
ineligible population however is not expected to change much since the 
programme is not expected to have any effect on these indicators. However 
as the worm load in the communities reduced with treatments undertaken, the 
incidence of severe adverse reactions is expected to reduce significantly as 
was observed.
As expected, treatment compliance improved as the programme delivery 
improved. Knowledge attitudes and beliefs of LF also improved. However the 
observed increase in the difference between reported and surveyed coverage 
due to reduced compliance from year 5 to year 6 could be due to the 
introduction of the integrated preventive chemotherapy programme which 
included other programmes like onchocerciasis, soil transmitted helminths, 
schistosomiasis, trachoma and LF. Since this was a new programme involving 
different implementation strategies the programme delivery suffered and this 
reflected in reductions in coverage and compliance. The timing of the funding 
for this activity was also delayed to the rainy season when farming activities 
interfered with the drug distribution programme with observed reduced 
coverage.
4.17 Conclusion
NTDs are one of the worst conditions in terms of their deforming, stigmatizing 
nature and long term sequelae. However, little attention is given to the control 
of these diseases. Generally, there is little awareness of the four NTDs 
studied. This is a clear indication that the population are largely unaware of 
the causes and are most likely unaware of the prevention.
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On the whole, there is a high level of acceptance of drug distribution in 
schools. There is also high level of awareness of MDAs. However the process 
is characterized by poor communication on the drug distribution exercise to 
parents and the general public. The high level of acceptance is not based on 
an understanding of the purpose of the drug distribution exercise but because 
it emanates from the Ghana Health Service. Despite the high acceptance 
rate, most people did not know the purpose of the exercise.
Despite the fear of side effects, there was still high level of acceptance. 
However, there is the likelihood of a high level of drop-out as people are 
concerned after hearing of the negative comments. For now the spread of 
negative comments has been minimal but if a conscious effort is not made to 
educate the general public, coverage for the NDA would be greatly affected. 
There is great awareness of the importance of the whole community taking 
the drug as respondents were aware of the fact that if some community 
members do not take the drugs, the disease will still remain and possibly 
spread in the communities. Notwithstanding the high level of acceptance of 
MDAs, lack of education and communication on the distribution means that 
some people do not take the drug. In the Upper West region, some people 
refused to take the drugs because they could not abstain from alcohol prior to 
the taking the drug. There were also general incidences of refusal as a result 
of fear.
There are very distinct regional differences on how people felt communities 
should be informed about drug distribution exercises. Overall gong gong 
beaters were the preferred method of disseminating information about drug 
distribution exercises in the communities. Religious gatherings could be an 
effective way of communicating to community members about MDAs. Chiefs 
are an important channel to effective implementation of health programmes in 
the various communities.
Page | 158
Generally, the electronic mass media is a preferred choice of communication 
for people in the Greater Accra and Western regions. Information services are 
most appreciated in Accra. Although the cell phone remained statistically 
insignificant (1%) it is interesting to note that persons who responded to this 
came from the two most rural areas (i.e. Volta and Upper West regions).
4.18 Recommendations
Results from the study demonstrate that people are less interested in knowing 
the signs and symptoms of NTDs, thus developing educational materials 
should focus on treatment and prevention rather than the signs and 
symptoms. Chiefs are an important channel for the implementation of 
preventive chemotherapy programmes, they should therefore be part of 
research that focuses on community directed interventions. There is the need 
for the development of an effective behaviour change communication (BCC) 
tool because the results showed that people’s knowledge on the causes of 
these diseases did not influence their lifestyle.
There has been a significant amount of education that the medicines 
distributed are equally good for children, but there is still the notion, 
particularly among the women’s groups, that tablets are not suitable for the 
young children; they suggested that children be given syrup. Some of the 
children’s group also suggested the drugs be made smaller for them. It may 
not be possible for the programme to address such concerns but the 
programme should publish and provide such information to partners who are 
able to influence decisions on the formulation of drugs used for such 
programmes as they eventually improve compliance.
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The LF Elimination Programme as a disease specific programme has 
demonstrated improvements in knowledge on the disease and its 
transmission and prevention. Positive attitudes and practices of LF was 
demonstrated by improvements in compliance from year one to year six and 
the willingness of communities to continue to comply with subsequent 
treatments. Anticipated challenges associated with community fatigue after 
several years of MDAs and issues of urban MDA would require that these 
challenges including that of integration with other preventive chemotherapy 
diseases would require new, innovative and effective advocacy, behavioural 
change communication strategy to improve programme visibility and its 
acceptability to both rural and urban communities while soliciting local 
government support to the integrated programme.
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Chapter 5
Assessment of Clinical 
Manifestations of 
Bancroftian Filariasis in 
Selected Districts
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Chapters: Assessment of Clinical Manifestations of Bancroftian 
Filariasis in Selected District
5.1 Background
Hydrocoeles and lymphoedema often known as elephantiasis of the limbs are 
major clinical disabilities that occur as a result of infection with W.bancrofti 
and are the commonest clinical presentations of LF disease. (Dreyer et al, 
2000). The disease LF can be found among individuals of all ages, sexes and 
but particularly among those of low socioeconomic status (Dreyer et al. 2000). 
The clinical spectrum of the disease is wide beginning with the infected but 
symptomless carriers, through to those with the disease and who are 
microfilariamia positive, to those with chronic manifestations of the disease 
(Dreyer et al. 2000). There are significantly more infected people in a given 
population than those with chronic disease manifestations. Therefore only a 
small fraction of those infected proceed to develop the chronic disease 
(Addiss et al, 1995; Gyapong et al., 1998; Lammie et al, 1994).
5.2 Ghana’s Situation
Pre-independence health reports indicated the presence of elephantiasis in 
Ghana (cited by Gyapong et al, 1996 from Department of Health, 1936-1937). 
Other clinical reports indicated that elephantiasis and hydrocoeles were 
common in the early 1990s (Gyapong et al, 1996). A population survey 
indicated that 12.6% of compounds visited in Northern Ghana had at least 
one resident with visible or reported elephantiasis of the leg (Gyapong et al, 
1995).
Hospital records showed that hydrocoelectomies accounted for 20% of 
surgeries undertaken in district hospitals (Gyapong et al, 1994). Microfilaria
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prevalence was found to be 41% in these populations (Gyapong et at, 
1993,1994). The press reported an outbreak of elephantiasis also in 1990s 
(Gyapong et al, 1996). Prevalence of reported elephantiasis is 0.6% (range 
0.0-11.8%) and that of hydrocoeles is 5.5% (range 0.0-19.5%). The average 
cost of hydrocoelectomies was more than a months’ income of the average 
worker in Ghana (Gyapong et al, 1996).
5.3 Global Programme
The World Health Organization (WHO) launched the GPELF in 2000. Since 
then progress in scaling up MDA has been good (WHO, 2009) with 
impressive health benefits (Ottesen et al, 2008) but morbidity management 
has generally lagged behind despite excellent national programmes (Brantus 
2009; Suma et al 2002; Mathieu et al 2008). Chronic manifestations of LF 
make it the second leading cause of disability with an estimated 40 million 
people affected by the disease (Zeldenryk et al, 2011). It causes physical 
debilitation, social stigmatization, and economic loses (WHO, 1995) which 
makes participation in daily community activities difficult (Zeldenryk et al, 
2011).
The GAELF and the participating countries should devote more attention to 
morbidity control activities to address the physical suffering of affected 
individuals with the added complex psychosocial issues that affected 
individuals face (Zeldenryk et al, 2011) has been emphasised. Interruption of 
transmission alone has no short-term effect on the prevalence or incidence of 
chronic disease, particularly elephantiasis of the leg and advanced uro-genital 
disease (Fan et al, 1995). Addressing the needs of those already affected 
enhances community acceptance of measures to interrupt transmission. 
Other factors worsening the negative effects of lymphoedema-related stigma 
are poverty, poor access to health care resources and limited education, poor
Page | 163
social support affect, the coping strategies of affected women and the 
negative effects of lymphoedema related stigma (Person et al, 2009).
The present strategies of the GAELF focuses on research, training and 
integration of lymphoedema management into the health system (WHO, 
2010b) instead of the proposed reporting of number of people trained in 
lymphoedema management. Additionally however, lymphoedema 
management, number of hydrocoele surgeries performed and number of 
lymphoedema patients treated, the number of cases who are actively 
maintaining self care activities, number of cases who have seen a reduction in 
ADL attacks or the number of patients with new disability or with reduced limb 
swelling due to lymphoedema on the other hand provides better information 
for public health monitoring (Kumari et al, 2007) and decision making. The 
number of support groups instituted, involvement in income generation 
activities and patients returning to work or school (Zeldenryk et al, 2011) could 
also be applied to measure the impact.
5.4 Pathology and Pathogenesis of Lymphatic Filariasis Disease
The main, obvious and most common clinical manifestations of LF are 
hydrocoele and lymphoedema (Dreyer et al, 2000). In filariasis endemic areas 
infection with W.bancrofti may be responsible for the development of 
lymphoedema and hydrocoeles, however this chronic presentation of the 
disease may be found in a minute fraction of the population (Addiss et al, 
1995, Gyapong et al, 1998; Lammie et al, 1994; Sahoo et al, 2000.). Evidence 
in support of filarial worms being the causative agents of the disease has 
been provided by ultrasound findings by locating the living adult worms in 
intra-scrotal lymphatics (Dreyer et al, 2000). Death of the macrofilaria has 
been found to trigger off acute clinical manifestations in both hydrocoele and 
lymphoedema cases. An uncomplicated acute filarial lymphangitis is common
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in endemic areas but does not necessarily lead to acute lymphoedema 
(Dreyer et al, 2000).
Little is understood of the pathogenesis of the chronic disease, however 
inflammatory process mediated by the host immunity, secondary bacterial 
infections and genetic predisposition seem to play a role in the development 
of elephantiasis and hydrocoeles (Pfarr et al, 2009). The disease may be 
classified into the ‘acute inflammatory’ and ‘chronic obstructive syndromes’, 
which do not necessarily have the same pathogenesis (Chan et al, 1998). The 
differences in the outcome of these chronic diseases in different individuals 
are attributable to different immunological responsiveness to the filariasis 
parasites in endemic populations with some amount of genetic regulation 
taking place (Bouma et al, 2003). The role of host genetic factors in the 
development of either elephantiasis or hydrocoele is not yet established 
(Panda et al, 2011). The role of Wolbachia bacteria, rather than the filarial 
nematode in filarial disease and the use of the antibiotic doxycline have 
gained more importance with recent studies in the management of LF 
(Lammie et al, 2002; Taylor, 2003; Taylor et al, 2005; Hoerauf 2005). The 
pathological changes that occur within the skin of patients with lymphoedema 
include the lymphocyte and monocyte accumulation, endothelial cell 
activation, lymphatic dilatation and fibrosis with modification of connective 
tissue in the long-term (Dreyer, et al. 1999, 2000). Formation of the 
granulomatous nodule, which impedes lymphatic flow, predisposes the 
affected individual to secondary bacterial infections leading to fibrosis, 
lymphatic obstruction and finally lymphoedema (Pfarr et al, 2009).
Other manifestations of LF include chyluria, chylocoeles and lymph scrotum. 
Chyluria results when dilated lymphatics leak fluid into affected sites or drain 
the fluid through an existing channel such as the urinary tract. Chyocoele 
results when this fluid accumulates within an organ. These disease
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manifestations have been strongly associated with bancroftian filariasis in 
endemic areas (Dreyer et al, 2000).
The spectrum of clinical presentations of LF includes sub-clinical 
lymphangiectasia and acute filarial lymphangitis (AFL) (Dreyer et al, 2000). 
Infected individuals who carry the adult worms may experience dilatation of 
the lymphatics due to immune reactions between the host’s and the adult 
worms (Dreyer et al, 1996; Dreyer et al, 1996; Nordes et al, 1996; Noroes et 
al, 1997; Dreyer et al, 1999; Amaral et al, 1999). Subclinical lymphangiectasia 
does not result in obstruction of the lymphatics. The death of the adult worm 
ends this inflammatory reaction with the formation of a granulomatous nodule, 
which is detected when physical examination of the scrotal region is carried 
out (Dreyer et al, 1996; Nordes et al 1996; Nordes et al 1997; Amaral et al 
1999; Dreyer et al 1999).
Flydrocele, chyluria, chylocele and lymph scrotum develop as a result of the 
presence of the adult worm, lymphangiectasia, location of adult worm nests 
and the sequence of the adult worm death (Dreyer et al, 2000). 
Lymphangiectasia and inflammatory reactions are different components of the 
lymphatic pathology that result from adult worms toxins and immune reactions 
to the damaged or dead worms (Nordes et al, 1997; Dreyer et al, 1998). 
Lymphangiectasia may be present in all individuals who harbor living adult 
worms but can remain subclinical for undetermined periods of time, or evolve 
into chronic disease. (Dreyer et al, 2000) Death of the adult worms is 
associated with episodes of acute lymphangitis (AFL) or may be sub-clinical 
with no complaints from affected patients. However predisposition to 
secondary bacterial infections may be found with lymphangiectasia in the skin 
of the upper and lower limbs, breasts, scrotum and penis. Recurrent bacterial 
infections promote the progression of lymphscrotum to scrotal lymphoedema 
and elephantiasis (Dreyer et al, 2000).
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The disease may be difficult to diagnose the reasons being that not all 
individuals with the disease have an active infection and also not all those 
with the clinical presentation may be infected with LF (Dreyer et al, 2000). 
Finally, similar clinical presentations do not necessarily follow the same 
pathogenesis (Dreyer et al, 2000). The fact that filarial worms are a cause of 
pathology is supported by ultrasound findings of living adult worms in the 
intrascrotal lymphatics (Dreyer et al, 2000). The dying adult worms were also 
found to trigger the acute disease in cases of hydrocoeles and lymphoedema 
(Dreyer et al, 2000).
Podoconiosis, non-filarial elephantiasis as a differential is diagnosed based 
location, history, clinical findings and the absence of microfilaria or antigen on 
laboratory diagnosis (Davey, 2010; Tomczyk, 2012). It is another of the NTDs 
found in tropical Africa, central and south America and northern part of India. 
Podoconiosis is chronic, non-infectious and results in below-knee swelling of 
the legs among those who live and walk bare-footed on red clayey soil. The 
disease often develops before the fourth decade of life. Many of the affected 
became bed-ridden because of frequent acute attacks (Davey, 2010; Alemu 
et al, 2011; Tomczyk, 2012). Podoconiosis is another disease of farmers, 
uneducated, and poor. It is more prevalent among females than males, 
imposes a huge burden in affected communities and countries and often 
requires similar interventions as with filarial elephantiasis to prevent, treat and 
control the disease apart from drug treatment. Prevention and treatment is 
mainly by the wearing of shoes and foot hygiene (Davey, 2010; Alemu et al, 
2011; Tomczyk, 2012).
5.5 Morbidity Management in Bancroftian Filariasis
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An estimated 29 million men have urogenital manifestations of LF, including 
hydrocele, chylocele, and lymphedema and elephantiasis of the scrotum and 
penis. Hydrocele can be successfully treated with simple surgery depending 
on the resources and infrastructure available. Similar to the legs, the skin of 
the scrotal wall and penis are prone to secondary bacterial infections and 
acute attacks (Dreyer et al, 2000). Basic hygiene can stop the acute attacks in 
the genital area and improve the patient's condition, although the definitive 
solution for advanced lymphoedema and elephantiasis of the genitals remains 
a challenge (Seim et al, 1999).
Presently the main strategy for the control of LF is MDA to identified endemic 
communities with different drug combinations of ivermectin and albendazole 
or DEC and albendazole depending on the causative parasite responsible for 
the disease in these locations (Ottesen, et al, 1997). These medicines are 
able to prevent transmission of W.bancrofti and thus provide protection for 
generations against the disease in endemic areas (Ottesen et al, 1997). 
However, these medicines are not able to prevent morbidity in those who are 
currently at-risk of developing the disease irrespective of the person’s history 
of infection. The role of bacterial super-infections in the development of 
lymphoedema and its progression to elephantiasis is important. Morbidity 
management, which relies on effective strategies to control secondary 
bacterial infections in order to achieve the best disease prevention at the 
community level, is presently available. Hydrocoele repair also helps to 
reduce sexual disability associated with bancroftian filariasis (Dreyeret al, 
1997).
Alleviating the suffering of individuals affected with morbidity due to LF has 
been found to have marked impacts in affected individuals and communities 
at large. Measuring the impacts of morbidity management presents a 
challenge in the absence of clear indicators for making this determination.
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Improvements in the physical and socio-economic well being of those affected 
have the ability to present a clear picture of effective morbidity management 
strategies for LF.
Though the development of LF is unclear recurrent episodes of acute 
lymphangitis does constitute a major risk factor in the development of chronic 
lymphoedema and elephantiasis (Dreyer et al, 1999). LF causes significant 
disability related to the intensity and frequency of episodes of ADL (ADL) 
(Rani et al, 1995; Shenoy et al, 1995; Dreyer et al, 1999 ;). The relationship 
between the number of ADL attacks and the grade of edema is established 
(Shenoy et al, 1995) and frequency of ADL episodes is directly associated 
with the progression of lymphoedema characterized grades of lymphoedema 
(Rani et al, 1995; Shenoy et al, 1995; Dreyer et al, 1999;).
ADL is an important clinical manifestation of the infection. Its recurrence has 
led to the progression of the disease and also has important socioeconomic 
implication since they cause significant loss of person day’s work (Shenoy et 
al, 1995). Two distinct disorders accompany lymphangitis in LF endemic 
areas (Dreyer et al, 1999). Acute filariasis lymphangitis (AFL) is caused by 
the death of the adult worm, often asymptomatic or with a mild clinical course 
and rarely causes residual lymphoedema. The other which is acute 
dermatolymphadenitis (ADLA) is not caused by the filarial worms but often 
results from secondary bacterial infections and is the common cause of 
lymphoedema and elephantiasis (Dreyer et al, 1999).
The socioeconomic effect of ADLs is the loss of days of work (Shenoy et al, 
1995) but basic lymphedema management has the advantage of reducing 
ADLA frequency (Addiss et al, 2010). Lymphatic damage related to the adult 
worm results in increased susceptibility to these repeated bacterial infections, 
which lead to progression of lymphedema and elephantiasis. The central core
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of lymphoedema treatment is the prevention of these acute attacks through 
basic hygiene using soap and water, and through cure and prevention of 
small skin lesions with application of topical antifungal and antibiotic cream. 
This approach is feasible at the community level and it can prevent acute 
attacks, thereby preventing lymphoedema progression as well as causing a 
certain degree of regression, even in advanced cases (Seim et al, 1999).
The clinical spectrum of disease is documented and includes people who are 
micro-filaraemia positive but without symptoms of the disease as well as 
those with symptoms of the disease. The GAELF emphasizes the need to 
combine transmission control and morbidity management mainly foot care 
aimed at prevention of secondary bacterial infections (Suma et al, 2002). 
Effective but inexpensive sustainable treatment for lymphoedema of the 
extremities is available. The vast majority of acute attacks or lymphangitis in 
filariasis-endemic areas are caused not by the filarial parasite but by 
secondary bacterial infections (Montestruc et al, 1960; Dreyer et al, 1997; 
Shenoy et al, 1995; Olszewski L et al, 1997;).
Lymphoedema management has been identified to improve MDA coverage 
and accelerate interruption of transmission and this has become crucial to the 
success or failure of the elimination programme particularly in situations of 
systematic non-compliance with MDA as a challenge to LF elimination (Boyd 
et al, 2010). Basic lymphoedema management with its emphasis on hygiene 
and self-care is possible and effective in resource-poor environments, which 
are endemic for LF (Addiss et al, 2010). Antibiotics or antifilarial medicines do 
not seem to affect the frequency of ADL attacks, however these simple 
hygiene measure combined with foot care and application of topical antibiotics 
or antifungal cream are effective in reducing the frequency of ADL attacks 
(Shenoy et al, 1995).
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In managing morbidity in LF many have advocated for the formation of ‘Hope 
Clubs’, but the rural settings where most of the cases are found presents a 
challenge to the formation of these lymphoedema management support 
groups. The role of community drug distributors in the morbidity control 
programme is particularly important because of overburdened health staff and 
lack of incentives for drug distributors. The success of the lymphoedema 
management programmes will depend on the involvement of community drug 
distributors and should therefore address several pertinent issues.
5.6 Rationale
The process of ensuring morbidity control of LF disease involves compiling a 
morbidity register and training health workers and CDDs on the use and 
application of the lymphoedema management manual. ‘Hope clubs’ or 
‘lymphoedema management support groups’ are also encouraged and the 
programme had an active one at the national level. Free hydrocoelectomies 
are also provided. Training support from the West Africa Morbidity Project 
(WAMP) on the WHO recommended method for hydrocoele surgeries and 
organizing surgical camps with regional and district level medical officers has 
been undertaken.
Several benefits of lymphoedema management have been noticed with 
patients that have participated in this programme. They include elimination of 
bad odour, prevention and healing of entry lesions with improvement of 
individual’s confidence, reduction in size of the affected limbs, improvements 
in patient’s ability to work or attend school. Contacts between communities 
and health workers have improved where this has been implemented with 
improvements in MDA compliance. Eventually the quality of life of the patients 
is generally improved with reduced reliance on other family members due to 
improvements in their productivity.
Page | 171
Funding presented a huge challenge to the implementation of the morbidity 
control activities under the programme. Misconceptions about the disease 
have also brought its own challenges with patients accepting the simple 
measures taught for lymphoedema management. These are affected by the 
lack of clean water in most of the rural areas for effective and hygienic limb 
washing. Most endemic rural communities where cases of elephantiasis are 
found are scattered, with poor road infrastructure, making the formation of 
these ‘lymphoedema management groups’ impossible where they are most 
needed. The challenge of forming the lymphoedema management support 
groups has been occasioned by geographical scattering of cases of 
elephantiasis with little or no monitoring and supervisory visits from health 
workers. Lack of earmarked funds for supervisory visits led to low compliance 
among patients with lymphoedema management measures.
Integration of morbidity control activities into control activities of other NTDs 
whose main strategy hinges on morbidity control has been challenging with 
inadequate human, logistic and financial resources. In the case of hydrocoele 
surgeries out-of-pocket payment is demanded for surgeries undertaken as 
part of routine hospital activities and which are not reported to the 
programme. Where funds have been provided for reimbursement for surgery 
payment rates have not matched economic rates.
Ghana began the implementation of the activities of the LF Elimination 
Programme in 2001. The specific objectives of the LF programme are to 
interrupt the transmission of the disease through the annual mass 
administration of anti-filarial drugs, and to alleviate the suffering of those with 
the disease through lymphoedema management for those with lymphoedema 
or elephantiasis and hydrocoele surgeries for those with hydrocoeles.
Page | 172
To meet the overall goal of LF elimination one of the specific goals of the 
programme is to provide alleviation of the suffering of cases of morbidity 
involving cases of lymphoedema or elephantiasis or hydrocoeles. The aim of 
the programme was to provide hydrocoelectomies to 60% of all identified 
cases of hydrocoele and teach lymphoedema management or undertake 
home-care of swellings of all identified cases of elephantiasis. This involves 
regular washing of the affected limb or body part, regular exercising at the 
joints of the affected limb, regular elevation of the affected limb, and proper 
care of wounds including antibiotic treatment of the affected limb (New Hope 
Manual) (Dreyer et al, 2000). The need to identify these cases of 
elephantiasis and hydrocoeles to inform estimates of numbers and 
organisation of the process is essential and the reason for the need to register 
the cases during the household distribution of ivermectin and albendazole. 
Individual household members were simply asked if anyone in the household 
had elephantiasis or scrotal swellings during the process of MDA. All cases 
were noted and the numbers recorded and reported as part of the MDA 
reports submitted annually. Annually the number of cases reported was 
updated and may include cases that had been identified in previous years.
All identified cases of lymphoedema were provided with the Lymphoedema 
Management Manual adopted by the programme from the New Hope Manual 
and produced locally with local pictures to provide guidance to patients 
(Dreyer et al, 2000). These were given to patients, after the health workers or 
community drug distributors had taken the patients through the process. The 
patients with elephantiasis were also supposed to be organised into 
lymphoedema management support groups, where apart from the training 
they receive in the management of their condition, they also provide emotional 
support and counselling to each other to lessen the stigma associated with 
the condition.
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Evaluations of lymphoedema management in Ghana have not been done as 
compared to that undertaken for hydrocoele surgeries. The fact that 
elephantiasis or lymphoedema once established is irreversible and can 
discourage patients from participation in the treatment or management 
regime. Hence, assessment of the effectiveness of the morbidity control 
activities under the programme was essential.
Surveys to assess the impacts of morbidity control activities in the first 5 
programme districts and hydrocoele surgery activities in the Upper West 
region were undertaken as a main objective.
The specific objectives were;
• to assess morbidity control activities in selected districts
• to assess the effectiveness of the WHO recommended technique of 
conducting hydrocoele surgeries in the Upper West region
• to assess the impact of the hydrocoele surgery on the socioeconomic 
lives of the beneficiaries
• to assess the impact of the surgery on the overall health status of the 
beneficiaries
• to assess the impact of hydrocoelectomies on individuals’ productivity
• to assess the impact of hydrocoelectomies on individual’s quality of life
5.7 Method
Cross-sectional morbidity control assessments were conducted in 5 districts 
for hydrocoele and elephantiasis patients while cross-sectional evaluation of 
hydrocoele surgeries involving patients who had benefitted from free 
hydrocoele surgeries was also undertaken. These were done after 
compilation of longitudinal programme data on morbidity for analysis, 
presentation and discussion.
Page | 174
5.8 Cross-sectional Morbidity Control Surveys
Cross-sectional morbidity control programme assessment was undertaken as 
a component of the cross-sectional surveys. A 30-cluster sampling method 
was applied to the 5 districts. An estimated population of 40 from 8 
households was interviewed within each of the 30 clusters for each of the 5 
districts. An estimated total of 6,000 individuals were interviewed for the 
coverage and KAP interviews in the study in Ghana. During this survey cases 
of lymphoedema or hydrocoele or cases of lymphoedema and hydrocoeles 
were identified in the households visited and the cross-sectional assessment 
of morbidity control activities questionnaires administered to these identified 
IF cases.
5.9 Hyrdrocoele Surgery Assessment in Upper West Region
This part of the study was conducted in all the then 5 districts of the Upper 
West region. They are Wa, Nadowli, Jirapa-Lambussie, Lawra, and Sissala 
districts. A list of the 1254 cases of hydrocoele surgeries performed from year 
2 to year 5 of the LF Elimination Programme were produced with their 
address noting carefully the communities in which the cases were located for 
tracing. About 350 communities were identified for tracking the cases. 
Designed questionnaires with both open-ended and closed-ended questions, 
were applied for the interview. All cases identified were administered with the 
questionnaire and then examined physically for recurrence of the hydrocoele 
by trained field workers. The listing of the cases was done from the Wa 
Regional Flospital in the Wa District, Nadowli Flospital in Nadowli District, 
Jirapa Hospital in Jirapa-Lambussie District, Lawra and Nandom Hospitals in 
Lawra District and Tumu Hospital in the Sissala District, where the surgeries 
took place.
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Male nursing students were selected and trained as field workers for this 
survey in order to ensure the participants were comfortable particularly 
because it involved examination of their genitals in their homes. Again nursing 
students were used because they have some knowledge of clinical medicine, 
which made it easy for them to understand the topic, and also made the 
patients allow them to do the examination. Aside being trained to conduct the 
interviews, they were also trained to examine for recurrence of hydrocoeles, 
presence of hernias, presence of lymph scrotum, lymphoedema of the penis 
and post-surgical wound infection. The training also enabled them to 
distinguish between hydrocoele and hernia, recognize lymphoedema of the 
penis, lympho-scrotum and fluid in the scrotum. Translation and back 
translation of the questionnaire into the local dialect was also done together 
with role plays. Both qualitative and quantitative data collection methods were 
applied.
5.10 Presentation of Results
5.10.1 Longitudinal Programme Data
At the inception of the programme health workers were trained to work with 
the CDDs to ensure registration of all cases of limb and scrotal swellings 
(suspected cases of hydrocoeles) in their respective endemic districts. The 
difference between hydrocoeles and hernias, both of which are common 
scrotal swellings, presented a challenge to health workers, the community 
drug distributors and the patients. Some of the cases registered were actually 
hernias and not hydrocoeles. For the purpose of providing surgical treatment 
for the cases of hydrocoeles, the identified cases are mobilised and screened 
to ensure that they were hydrocoeles by urologist and medical officers 
equipped with the skills to provide hydrocoelectomies during surgical camps
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and then continue to provide these surgeries after the training on a routine 
basis.
Regular annual updates of morbidity registers were undertaken under the 
programme. About 10,541 cases of limb swellings or elephantiasis and 5030 
cases of scrotal swellings were identified nationally in years 5 and 4 
respectively. Between the 5 initial or start-up districts in the programme, a 
total of 1598 cases of scrotal swellings and 1795 cases of limb swellings or 
elephantiasis were identified in year 7 and year 3 respectively (Table 5.1). 
These are the highest values recorded for any particular year since the 
commencement of the IF Elimination Programme.
Table 5.1: Annual Trends in Reported Hydrocoeles and Elephantiasis Cases from all
Implementation Districts
Year
Dist.
Reports
At-Risk
Pop Treated
MDA
reported
coverage Elephantiasis Hydrocoeles
Surgeries
undertaken
1 5 33,686 246,743 73.9 - - -
2 14 1,643,211 1,217,936 74.1 2812 1366 703 (51 + 652)
3 30 3,696,893 2,622,722 70.9 8091 4950 244
4 40 5,378,143 3,971,869 73.9 9931 5030 432
5 60 6,907,375 5,141,482 74.4 10541 4478 365
6 61 8,851,923 6,359,200 71.8 8449 4196 244
7 61 9,278,935 5,932,174 63.9 3845 1109 0
8 74 10,334,602 7,313,521 70.8 - - 228
9 74 10,199,142 7,882,290 77.3 - - 0
10 74 9,963,010 74,918,873 75.2 - - 27
Total 40,687,937 - - 1744
During surgical camps several doctors from the regional and district levels 
were trained and about 1744 cases have been provided with free surgery 
under the programme (Table 5.1). Most of these surgeries were carried out in 
Ahanta West districts and all the districts in the Upper West region.
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Elephantiasis (lymphoedema) and hydrocoeles (scrotal swellings) were 
reported from year 2 to year 7. The number of cases of elephantiasis 
registered increased from 2812 in year 2 to 10,541 in year 5 and then reduced 
to 3845 in year 7. The number of cases of hydrocoele, though many were 
other scrotal swellings registered, numbered 366 in year 2 and this also 
increased to 5030 in year 3 and then reduced to 1109 in year 7. Since Year 
8, no new cases of either hydrocoeles or elephantiasis were registered during 
the process of mass drug distribution.
Table 5.2: Annual Trends in Reported Hydrocoele Cases from the 5 Start-up Districts
Reported Cases of Hydrocoeles
Year
Ahanta
West
Awutu Efutu
Senya Builsa
Kassena
Nankana Sissala Annual Total
Year 2 - 7 - 108 144 259
Year 3 110 16 465 628 94 1313
Year 4 295 30 574 414 107 1420
Year 5 189 21 618 490 79 1397
Year6 187 4 442 445 40 1118
Year 7 183 29 670 716 - 1598
TOTAL 964 107 2769 2801 464 7105
For these 5 start-up districts on the programme, between a total of 107 to 
2769 cases of suspected hydrocoeles or scrotal swellings were reported with 
most of the reported cases coming from Kassena Nankana and Builsa 
districts from the Upper East region. The districts reported 2801 cases and 
2769 respectively. Ahanta West reported of 964 cases, Sissala reported 464 
with Awutu Efutu Senya reporting just 107 cases. Though Builsa district did 
not report any cases in the Year 1 of the programme it reported almost the 
same number of cases in total to that reported by Kassena Nankana. Ahanta 
West reported no cases in Year 1 but in subsequent years reported more 
cases than Awutu Efutu Senya and Sissala districts. Awutu Efutu Senya
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district reported the smallest numbers of cases for each of the years and 
produced the smallest number of cases in total (Table 5.2).
Table 5.3: Annual Trends in Reported Elephantiasis Cases from 5 Start-up Districts
Reported Cases of Elephantiasis
Year Ahanta West Awutu Efutu Senya Builsa Kassena Nankana Sissala Annual Total
Year 2 - 5 - 206 14 225
Year 3 118 11 694 953 19 1795
Year 4 189 3 741 617 25 1575
YearS 181 6 626 609 14 1436
YearS 67 10 622 583 80 1362
Year 7 - 16 0 35 - 51
TOTAL 555 51 2683 3003 152 6444
Cases of elephantiasis were reported from the 5 start-up programme districts. 
Ahanta West and Builsa districts did not report cases in Year 2, but reported 
cases in subsequent years. Kassena Nankana and Builsa again reported the 
highest number of cases of elephantiasis of 3003 and 2683 respectively. 
Ahanta West reported 555 cases, Sissala district with 152 cases and Awutu 
Efutu Senya district reported the lowest of 51 cases in total (Table 5.3).
5.11 Cross-Sectional Assessment of Morbidity Control Activities
The hydrocoele surgeries are conducted in hospitals in the endemic districts. 
In order to ensure that hospitals in endemic districts have the capacity to carry 
out the recommended technique for the hydrocoele surgeries, there was the 
need to retrain the medical officers in the recommended technique of 
hydrocoelectomy. Through the West African LF Morbidity Project doctors in 
hospitals in selected endemic areas have been trained to perform these 
hydrocoele surgeries using the WHO recommended technique. The capacity
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of the medical officers was further strengthened to provide pre-, peri- and 
postoperative care for hydrocoele cases as a urogenital manifestation of LF.
Hitherto to this support the programme with the support of some of its earlier 
partners in Year 2 undertook its first Hydrocoele Surgery Training in the Upper 
West region during which 9 medical officers were trained and 50 surgeries 
undertaken with support of 3 urologists who facilitated the training. In Year 4 a 
total of 1254 cases of hydrocoele surgery were performed in the Upper West 
region alone (Table 5.4).
Table 5.4: Number of Patients who underwent hydrocoelectomies in various hospitals in
Upper West Region from September 2002 to December 2005
Cross-sectional morbidity control programme assessment was undertaken as 
a component of the cross-sectional surveys. A 30-cluster sampling method 
was applied to the 5 districts. An estimated population of 40 from 8 
households was interviewed within each of the 30 clusters for each of the 5 
districts. An estimated total sample size of 6,673 individuals was interviewed 
for the coverage and KAP interviews in the study in Ghana. During this survey 
cases of lymphoedema or hydrocoeles or cases of lymphoedema and 
hydrocoeles were identified in each of the households visited and the cross-
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sectional assessment of morbidity control activities questionnaires 
administered to these identified LF cases.
The total number of individuals interviewed was 269 made up of patients with 
hydrocoele or elephantiasis living within the sampled communities of the 5 
initial/start-up districts of the programme. No cases with both lymphoedema 
and hydrocoele were identified.
Figure 5.1: Sex Distribution of LF Patients Interviewed
■ Male
■ Female
5.12 Social and Economic Characteristics of Identified Cases
The respondents were made up of 179 (66.5%) males and 90 (33.5%) 
females (Figure 5.1). About 176 (65.4%) were married, 12.1% were single, 
6.7% were divorced and 10% were widowed. About 2 (0.7%) of the 
respondents did not have their marital status indicated on the questionnaire. 
The majority of those interviewed were involved in farming (71.0%), followed 
by fishing (8.6%), then trading (6.7%). Those who worked as teachers (1.5%) 
or artisans (3.7%) were in the minority.
5.13 Assessing Management of Elephantiasis
About 40.9% of the patients with elephantiasis indicated that they were aware 
of the availability of treatment for persons with elephantiasis. Flowever, 28.6%
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said the available treatment was a form of medication, while 30.1% said they 
were aware of surgical treatment. Those that indicated both surgery and 
medication were 38.7% while those that indicated other forms of treatment 
formed 40.9% (Table 5.5).
Table 5.5: Knowledge of Available Treatment for elephantiasis
Available Treatment
for elephantiasis
Frequency(N) Percentage (%) Percentage (%)
Medication 77 28.6 Yes = 40.9%
Surgery 4 30.1
Medication and Surgery 23 38.7
Other forms of treatment 6 40.9
NA 159 59.1 No = 59.1%
269 100.0 100.0
Only 6 (2.2%) of the 269 cases interviewed owned a copy of the 
lymphoedema management manual which was produced and distributed to all 
endemic regions and districts by the elimination programme in Ghana and out 
of this number 5 had been taught the application of this lymphoedema 
management manual (Table 5.6).
Table 5.6: Ownership and Application of Lymphoedema Management Manual
Response Ownership of Manual Application of Manual
Frequency(N) Percentage (%) Frequency(N) Percentage(%)
Yes 6 2.2 5 1.9
No 104 38.7 3 1.1
NA 159 59.1 261 97.0
Total 269 100 269 100
Inspite of the fact that few (2.2%) of the respondents owned copies of the 
lymphoedema management manual (Table 5.6) more knew about the proper 
care of lymphoedema and actually practiced some of the prescribed methods 
limb care. About 8.2% of the patients practiced limb washing, 7.1% practiced 
limb exercising but only 0.7% practiced limb elevation. About 2.6% of the
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patients knew and had undertaken proper care of wounds on the affected 
limbs, which might involve the application of antibiotics (Table 5.7).
Figure 5.2: Application of Manual
■ Yes
■ No
■ NA
Table 5.7: Practice of Lymphoedema Management
Applied care of affected limb Frequency (N) Percentage (%)
Limb washing 22 8.2
Exercising 19 7.1
Limb elevation 2 0.7
Proper wound care 7 2.6
Other 49+12 23.3
NA 158 58.7
Total 269 100
Among those that knew about the management of lymphoedema cases and 
also applied all or some of methods, 3 (1.1%) indicated that they noticed no 
change in the frequency of acute attacks, and though 2 (0.7%) actually 
indicated that inspite of undertaking this practice of lymphoedema 
management they had actually noticed a increase in the number of acute 
attacks they experienced in a year while 13 (4.8%) had actually noticed a 
decrease in the number of acute attacks they experienced in a year (Table
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5.8). These proportions, though small, indicate the expected outcome of home 
management of lymphoedema. It is expected that patients who diligently 
applied the measures taught in the lymphoedema management manual would 
notice a decrease in the number of acute attacks suffered by these 
elephantiasis patients until these acute attacks finally ceased. Also about 10 
(3.7%) of the patients interviewed had noticed a decrease in size of the 
affected limbs after practicing limb washing, elevation, exercising and 
undertaking the proper wound care. Some 6 (2.2%) of patients had noticed 
no change while 2 (0.7%) said the affected limbs had actually grown bigger 
(Table 5.8).
5.14 Assessing Management of Hydrocoeles
Generally most 137 (50.9%) patients were aware of the availability of 
treatment for hydrocoele, while 23 (8.6%) were not. 116 (43.1%) had 
attempted to seek treatment for their condition, while 44 (16.4%) had not. 
These forms of treatment included both orthodox and non-orthodox treatment 
for cases of hydrocoeles (Table 5.9).
Table 5.8: Outcome of Lymphoedema Management among Elephantiasis Patients
Outcome of Lymphoedema Management among Elephantiasis Patients
Changes in
acute attacks
Frequency
(N)
Percentage
(%)
Change in size
of limb
Frequency
(N)
Percentage
(%)
No change 3 1.1 No change 6 2.2
Yes, increasing 2 0.7 Yes, getting bigger 2 0.7
Yes, decreasing 13 4.8 Yes, getting smaller 10 3.7
NA 251 93.3 NA 251 93.3
Total 269 100.0 Total 269 100.0
Page | 184
Table 5.9: Treatment Seeking Behaviour of Hydrocoele Cases
Response Awareness of Hydrocoele Surgery Treatment Attempts to seek treatment
Frequency Percentage Frequency Percentage
Yes 137 50.9% 116 43.1%
No 23 8.6% 44 16.4%
NA 109 40.5% 109 40.5%
Total 269 100.0% 269 100.0%
Among the respondents, 22 (8.2%) indicated they knew about certain forms of 
orthodox medication which could be applied in the treatment of hydrocoele. 
About 80 (29.7%) knew that surgery was the main form of treatment and while 
43 (16%) knew about surgery and medication was available treatment for 
hydrocoeles. The others, that formed 5.6% and numbered 15, knew about 
other forms of treatment not indicated (Table 5.10).
About 86 (32%) of the respondents had had surgical treatment for their 
hydrocoeles, and 65 (24.2%) said the outcome of the surgery was good, 
however, 16 (5.9%) said the outcome was bad due to complications of the 
surgery. About 33 (12.3%) of the patients had benefitted from free surgical 
treatment while (54) 20.1% did not and had to bear the total cost of this 
surgery (Table 5.11).
Table 5.10: Known Forms of Available Treatment among Hydrocoele Patients
Known Forms of Available Treatment among Hydrocoele Patients
Type of Treatment Frequency Percentage
Medication 22 8.2%
Surgery 80 29.7%
Medication and surgery 43 16.0%
Other forms of treatment 15 5.6%
NA 109 59.5
Total 269 100.0%
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5.15 Results of Assessment of Hydrocoelectomy in Upper West Region
Out of the 1254 cases listed only 302 could be located for participation in the 
survey, and therefore 952 cases could not be followed up for the survey. 
Majority (50.3%) of the survey participants were located in Lawra district, 
followed by Jirapa-Lumbussie (18.2%), Wa (12.3%), Nadowli (11.9%), Sissala 
(6.0%) and the least (1.2%) came from outside these 5 districts though these 
4 people identified had their names on the list of hydrocoele surgeries 
performed under the programme but resided outside but close to the region 
(Figure 5.3). The average age of the respondents was 54 years with the 
youngest being 4 years (suggesting possible congenital hydrocoele) while the 
oldest was 92 years. The average household size was 8.2 people
Figure 5.2: Participation in Survey by District
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Figure 5.4: Educational Status of Respondents
80.0 —
■ %of respondents
Figure 5.5: Reasons for not attending school
■ %of respondents
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Table 5.11: Costs and Outcomes of Surgical Treatment
Costs and Outcomes of Surgical Treatment
Offered Freque Percent Was Freque Percent Treatme Frequen Percenta
Surgical ncy age treatme ncy age nt cy ge
treatment? nt free? outcom
e?
Yes 86 32.0% Yes 33 12.3% Good 65 24.2%
No 73 27.1% No 54 20.1% Bad 16 5.9%
1 0.4% Other 1 0.4% Other 6 2.2%
NA 109 40.5% NA 181 67.3% NA 182 67.7%
Total 269 100.0% Total 269 100.0% Total 269 100.0%
Among the respondents, married ones formed 85.1%, 2.3% were 
divorced, 3.3% were widowed and 9.3% were single. As expected in 
rural areas of the northern part of the country the educational level of 
respondents was generally low. Over 70.5% of them had received 
schooling and could neither read nor write. The remaining 29.5% had 
had some level of education most of which was rather low. Those who 
had had some primary or completed primary education were 11.9%, 
middle school or Junior Secondary education, some secondary or 
completed secondary education was 13.3% and those with tertiary 
education was 4.3%. Among those who had had some education, 
17.5% of them could read and 17.9% could write. 37 (12.3%) study 
participants were eligible to be in school but only 10 (3.3%) were 
actually in school. About 16% of the 213 respondents who had not had 
any formal schooling had had non-formal education (Figure 5.4). 
Several reasons were given why these eligible participants were not in 
school. About 3.0% said it was because they were sick, 1.5% disabled, 
8.3% indifferent, 59.1% needed to work, 1.5% because of cost, 14.4% 
attributed it to a family misfortune and 12.1% said it was because there 
was no nearby school (Figure 5.5).
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5.16 Clinical Background and Short-Term Surgical Results
The Upper West region has 6 health facilities capable of undertaking 
hydrocoele surgeries and these are the facilities, which were attended 
by the study participants for their surgery. About 43 (4.2%) of the 
evaluated surgeries were done at the Wa Hospital, 34 (11.9%) at 
Nadowli (, 36 at Jirapa, 56 at Lawra, 120 at Nandom and 13 at Tumu 
Hospitals respectively. The study participants had had their 
hydrocoeles for an average 9.5 years with 36 of them having been 
operated for recurred hydrocoele after a previous surgery (Figure 5.6).
The medical records of the study subjects indicated that 30.8% of the 
respondents had bilateral hydrocoele and had undergone excision 
(169) or eversion hydrocoelectomy, while the rest had no record of the 
surgery performed. According to the available surgical records almost 
all the surgeries (99.3%) were performed under local anaesthesia. Only 
one case was done under general anaesthesia while no record was 
found for one case. Antibiotic prophylaxis was applied in 299 (99.0%) 
of the surgeries. The duration of hospital stay for patients was between 
1-31 days depending of the rate of recuperation and incidence of post- 
surgical complications with an average hospital stay of 6.6 days. 
However, complications and co-morbidities were found in the medical 
records of only one case following surgery. The main post-surgical 
complications reported were bleeding and infection. Some 20.2% of 
respondents reported infections within 10 days of the surgery and 
10.9% reported bleeding within the same period post-surgery.
Figure 5.6: Distribution of Cases among Health Facilities
Page | 189
43 I
O G “7
18.5
Jirapa m■"■i 11.9
—■■■ 11.3
0.0 10.0 20.0 30.0 40.0 50.0
F* r o p> o rt: i o m )
5.17 Long-Term Surgical Outcomes
The time interval between the surgeries of the study participants and 
the time of the evaluation averaged 1.9 year. During this period 3.7% of 
the participants reported recurrence of the hydrocoeles. The wounds of 
22.8% of the patients had healed by secondary intention. About 16.9% 
of the study participants indicated in their interview that they had some 
problems after the surgery. On physical examination, 1.7% of the 
respondents were found to have lymph-scrotum, 0.7% had 
lymphoedema of the penis, 12.3% had hernia and 9.9% had some fluid 
present in the scrotum which could not be confirmed by the field 
workers to be hydrocoeles.
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5.18 Cost of surgery
The study participants after spending an average of 6.6 days in hospital also 
spent an average of 118.2 days to achieve total recovery after their surgeries. 
About 55% of them had to pay some monetary contribution for the surgery or 
medicine. About 85.1% of the patients had someone accompany them for 
surgery. Average direct cost per surgery to patient was 0128,655.00 ($14.30) 
and to the caregiver was 047,000.00 ($5.22). Average indirect cost of surgery 
to patient was 02,092,200.00 ($232.47). Average indirect cost of surgery to 
caregiver was 0127,050.00 ($14.12). The average total cost of surgery was 
therefore 02,394,905.00 ($266.10) per case.
5.19 Treatment-Seeking Behavior and Cost of Post-Surgical Treatment
About 222 (73.5%) of the study participants indicated that they sought further 
post-surgical treatments for various symptoms they associated with the 
surgery. About 137 (45.4%) of these people sought this post-treatment from 
Government/Mission hospitals or clinics, 5 (1.7%) from a private clinic or 
hospital, 4 (1.5%) from traditional healer, 38 (12.6%) from a community health 
worker and 38 (12.6%) from a pharmacy or chemical seller (Table 5.12).
About 31.5% of patients who sought post-surgical treatment paid for 
consultations and/or medicines out of pocket and in 0.6% of cases were 
accompanied by another person on these visits. The average direct cost of 
post-surgery treatment was 086,789.37 ($9.64) and the average indirect cost 
was 048,963.75 ($5.44). The average total cost of post-surgery treatment to 
patients therefore was 0135,753.12 ($15.08). For those who sought post­
surgery treatment from government or mission facility, 91.2% of them said the 
treatment helped very much,
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8.1% said it helped a little and 0.7% said there was no difference. About 3 
(60%) of the 5 (1.7% of total) who went to a private facility said it helped very 
much, 1 (20%) said it helped a little and the other 1 (20%) said there was no 
difference. For those who went to the traditional healer, 3 (75%) said the 
treatment helped very much and 1 (25%) saw no difference. About 97.1% of 
those who went to the community health worker said the treatment helped 
very much and 2.9% said it helped a little. Treatment from the pharmacy 
helped 78.4% of the patients who went there very much and 21.6% of them, a 
little (Table 5.12).
Table 5.12: Post-Surgery Treatment Seeking Behaviour
Source of
treatment
No. of patients
Seeking
Treatment
Proportion of
Patients
Seeking
Treatment (%)
Response to Treatment (%)
helped helped a little
no
difference
Gov./Mission
clinic/hosp 137 45.4 91.2 8.1 0.7
Private
clinic/hosp 5 1.7 60 20 20
Traditional
healer 4 1.5 75 25 0
Community
health worker 38 12.6 97.1 2.9 0
Pharmacy 38 12.6 78.4 21.6 0
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5.20 Patient Quality of Life
About 92.4% of the respondents had no problem with the hydrocoele surgery, 
7.0% had some problems and 0.6% wished they had not had it done at all 
however, about 88.5% of the respondents had the problems they had with 
their hydrocoeles solved after the surgery.
Table 5.13: Post-surgery treatment-seeking behavior of patients
Source of treatment No. of patients Percentage
Gov’t/mission clinic/hosp 137 61.7
Private clinic/hosp 5 2.3
Traditional healer 4 1.8
Community health worker 38 17.1
Pharmacy 38 17.1
Total 222 100.0
5.21 Quality of Life after Hydrocoele Surgery
The study participant’s quality of life was also measured by their response to 
their ability to work, change in economic life, family and sex life questions on a 
graded scale. The response rate however varied for each of these questions 
though not significantly. For their ability to work the response rate was 99.3% 
but 63.3% of respondents thought their ability to work was much better, 25.0% 
said a little better, 6.7% but said no difference while 5% said there was no 
difference. The response rate for the question on economic life was 97.7%, 
however much better response came from 42.7% of respondents, a little 
better 28.2%) and 25.4% and 3.7% for no difference and worse respectively. 
The response rate on changes in family life showed 56.5% for much better, 
22.4% for a little better, 19.1% for no change and 2.0% for worse (Table 
5.14). The response rate for changes in sex life was the lowest (90.3%).
Page | 193
About 40.3% of respondents said it was much better, 14.6% said a little 
better, 3.7% said there was no change and then 3.7% said it was worse 
(Table 5.14).
Though hydrocoele surgery had generally improved the quality of life of the 
beneficiaries of the hydrocoele surgeries greater impacts of the surgeries 
were expected than what the responses provided. The difference between 
those groups that had indicated they had experienced change and those who 
are not experienced any change or had had those indicators worsen (fig 5.7 
and 5.8). With regards to their sex life the group that experienced 
improvements formed 54.9% and those that did not experience any 
improvements formed 45.1%, a difference of 9.9%. The group that 
experienced improvements in family life was 78.9%, those that experienced 
no improvement was 21.1% with a difference of about 57.9% between the two 
groups. The group that experienced improvement in their economic life after 
the surgery was 70.8% and those that did not were 29.2% giving a difference 
of 41.7% between the these two groups. Finally the group that experienced an 
improvement in their ability of work was 88.3% while those that did not formed 
11.7% giving a difference of 76.7% (Figure 5.7 and Figure 5.8).
Page | 194
Table 5.14: Change in Quality of Life (QoL)
Aspect of life Degree of change No. of people Percentage
Age
Range Mean
Ability to work
Much better 190 63.3 4-90 50.1
A little better 75 25.0 6-90 59.8
No difference 20 6.7 28-85 59.3
Worse 15 5.0 15-92 60.4
Response Rate 300 99.3
Economic life
Much better 126 42.7 4-90 48.8
A little better 83 28.2 25-90 58.3
No difference 75 25.4 18-92 60.1
Worse 11 3.7 31 -77 56.8
Response Rate 295 97.7
Family Life
Much better 169 56.5 4-92 50.4
A little better 67 22.4 19-90 60.5
No difference 57 19.1 31929 59.6
Worse 6 2.0 31 -85 61
Response Rate 299 99.0
Sex Life
Much better 110 40.3 23-90 51.1
A little better 40 14.6 25-90 58
No difference 113 41.4 18-92 60.3
Worse 10 3.7 33-80 59.8
Response Rate 273 90.4
Figure 5.7: Changes in Aspects of Life
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Figure 5.8 Differences between Experience of Change and No Change
Sex Life
Family Life
Economic life
Ability to work
■ Difference
Based on these results it can be inferred that hydrocoele surgery made the 
greatest impact on the study participants ability to work, followed by their 
family life, and then their economic life. Hydrocoele surgery made the least 
impact on the sex life of the study subjects.
Table 5.15: Improvements in Patients Pre- and Post-surgery Problems
Problem Pre-surgery Post-surgery
Age of those with problems
post-surgery
Range Mean
% of respondents with any 
problem in mobility
66.6 9.9 26 -92 68.4
% of respondents with any
problem in self care
34.8 3.6 59-77 69.4
% of respondents with any
problem in usual activities
59.8 12.3 59-77 69.1
% of respondents with any 
problem in pain/discomfort
82.7 24.2 59-77 68.3
% of respondents with any
problem in anxiety/depression
71.8 17.6 61 - 77 68.0
Generally the quality of life of the patients improved after surgery. These were 
measured by study participants indicating whether or not they noticed 
improvements in their mobility, self care, and ability to undertake daily
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activities, problems with pain or discomfort, problems with anxiety or 
depression. About 66.6% of the respondents indicated that they had problems 
with mobility pre-surgery but only 9.9% still had problems with mobility after 
the surgery. Improvements in self care were from 34.8% pre-surgery to 3.6% 
post-surgery. About 59.8% of the patients said they had problems undertaking 
usual activities within their communities but 12.3% said they still had these 
problems post-surgery. The number of individuals with pain and discomfort 
associated with the hydrocoeles also improved from 82.7% pre-surgery to 
24.2% post-surgery. With regards to anxiety and depression, 71.8% the 
respondents indicated that they had symptoms indicative of this conditions but 
this improved to 17.6% (Table 5.15). The age range of respondents who 
complained of the various symptoms were 26-92 (mean 68.4) years for 
problems with mobility, 59-77 (mean 69.4) years with problems with self-care, 
59-77 (mean 69.1) years with problems with usual daily activities, and then 
61-77(mean 68.0) years with problems with anxiety or depression (Table 
5.15). With a mean age of all respondents being 54 years it can be assumed 
that old age was associated with these post-surgery problems considering 
that the mean age for each the set of patients with these pre- and post­
surgery problems was approximately 70 years.
Table 5.16: Infections observed in cases operated at the various facilities
Hospital Cases examined Cases infected % of cases infected
Wa 43 10 23.3
Nadowli 34 9 26.5
Jirapa 36 7 19.4
Lawra 56 17 30.4
Nandom 120 23 19.2
Tumu 13 3 23.1
TOTAL 302 69 22.8
The prevalence of postoperative infections observed among respondents 
operated on at the different facilities ranged from 19.2% to 30.4% with an
Page | 197
average of 22.8% for all the cases (Table 5.16). Field workers picked up these 
infections through physical examination of the surgical scars. These serve to 
delay the healing process and contributed to the post-surgical problems 
experience by respondents. This could also be associated with age since 
immunity and ability to fight infection reduces with age and could result in the 
post-surgical pain and discomfort, reduced mobility resulting in problems with 
self-care and usual daily activities of the individual. The end effect could be 
anxiety and depression.
For the qualitative data collected the findings indicated that most of the 
participants started having problems with hydrocoele after a mean period of 
2.6 years from the onset of the condition. The problem was attributed to 
headaches, general pains, abdominal pains and discomfort and pulling 
sensation among 72.6% of respondents. About 11.7% attributed it to inability 
to walk and 3.9% attributed it to the large size of the hydrocoele. However, 
those that said their problems had been mitigated by the surgery attributed 
this to the absence of headaches, general pains, chills and abdominal 
problems but 1.0% of respondents and 15.2% said they could now walk.
Respondents attributed reduction in their ability to work after the surgery to 
pain, weakness and simple inability to work as before and weakness. Those 
who said their economic situation is worse were 8 because they cannot work 
or don’t work anymore. Those who said the surgery has made their family life 
worse than it was before the surgery gave reasons of not being able to 
provide for their families any longer and one said that surgery made him 
weak.
Those who said the surgery made their sex life worse than before attributed it 
to their inability to achieve an erection and feelings of pain and inability of the
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wife to become pregnant after the surgery. Two people said they wished they 
hadn’t gone for the surgery because the swelling had even grown bigger.
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Figure 5.9: Patients’ Quality of Life after Surgery
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When respondents were asked for suggestions as to how to make the surgery 
better, they had been satisfactorily treated with no problem and asked that the 
health system continued with the good work. They also suggested money 
should not have been collected from them. They asked for mosquito nets to 
be provided in the hospital, for drugs to be made available in the hospital and 
more drugs to be given to patients, others asked for financial help to facilitate 
work on his farm, while some wanted regular examination and health 
education on hydrocoele to ensure better health for them.
The hydrocoele surgery evaluation was conducted in the Upper West Region 
in year 6 of the IF Elimination Programme implementation. The objectives of 
the survey were to assess the effectiveness of the technique used in 
hydrocelectomy in Ghana and the impact of hydrocoele surgery on the overall 
health and the socio-economic life of beneficiaries of the service.
A total of 302 beneficiaries were identified for the survey in the Wa, Nadowli, 
Jirapa-Lambussie, Lawra and Sissala Districts with very few of them residing 
in districts outside the region. All these surgeries had been done at the Wa, 
Nadowli, Jirapa, Lawra, Nandom and Sissala Hospitals.
The recommended technique, which was used for almost all of the surgeries 
evaluated, was total excision of the hernia sac, the tunica albuginea. Of all the 
evaluated cases, 3.6% reported recurrence but upon examination, 9.9% were, 
however, found to have fluid present in scrotum indicating recurrence. 
Excision remains a good technique for hydrocoelectomy since more than 90% 
of the cases did recover with no recurrence. The hydrocoele surgery 
programme has thus made a significant impact on the effective delivery of 
hydrocoelectomy service in the districts whose medical officers and surgeons 
the programme has retrained. There were improvements in the socio­
economic life of the study participants after the surgery. Their general state of
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health status also improved. There were a few problems with the surgery and 
there was a high level of satisfaction (92.4%) with surgery among the 
respondents.
Hydrocoeles aside from limiting mobility are also associated with stigma 
(Babu et al, 2009) and restrict migration or travelling for socioeconomic 
purposes. Successful surgery will contribute to increased migration to urban 
areas, farms and other areas with greater income generation potential. These 
are factors that might have come into play resulting in the absence of many of 
the successfully treated individuals from their communities. Majority of the 
respondents, 70.5%, had not had any formal education. The region is 
generally rural and deprived in terms of social amenities and services, and the 
primary occupation of more than 90% of the people is farming (*Annual 
Report, 2006). This is even supported by the reasons given by those 
respondents who were of school- age but were not in school. About 12.4% of 
them said it was because there was no school close by, and 59.1% said they 
needed to work, probably on their parent’s farms. The mean of the time 
interval between the onset of the individual hydrocoele and the surgery was 
9.5 years. This could be due to the absence of quality and reliable service and 
more importantly the absence of free hydrocoele surgery services prior to the 
LF Programme’s surgical interventions, which started in year 2. Activities of 
the programme have also created awareness of the condition and also 
avenues for surgery, which could be free.
The surgical technique applied was mainly total excision of the hydrocoele 
sac as recommended by the WHO, which was not the technique of choice 
prior to this programme for hydrocoele surgeries. In the past eversion of the 
sac was the technique of choice. The cases were also mainly done under 
local anaesthesia. Antibiotic prophylaxis was appropriately given considering 
the challenge of maintaining strict pre- intra- and post-operative sepsis in such
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district peri-urban environments. Average hospital stay was also 6.6 days 
another means of minimizing post-surgical infections. However, 20% reported 
post operative infection, and 10.9% bleeding within 10 days following surgery. 
Upon examination, 22.8% of them were found to have had infection of the 
wound. Infection rates ranged from 19% in Jirapa and Nandom to 30% in 
Lawra which is high across all operating facilities. This is also linked to poor 
socio-economic infrastructure and limited hospital equipment and medicines 
required. These facilities are known to be constrained in the performance of 
such surgeries. Most patients are discharged home to live under relatively 
unhygienic conditions and had to start visiting their farms to work where the 
wounds are further exposed sources of infection. Furthermore, about 44.7% 
of them did not seek any treatment after surgery and even some of those that 
sought it might have done so only after infections had set in.
Indirect costs to patients due to average hospital stay of 8.6 days and 118.2 
days off work for full recovery was about GH02O9.22 ($232.47). As mainly 
patients were mainly farmers more days were required for total recuperation 
post-surgery before work and most would not work during the recovery period. 
Loss of income during this period accounts for most of the indirect costs. 
Costs to the caregiver was both directly of GH04.7O ($5.22) and indirectly of 
GH012.71 ($14.12). An estimated direct cost to patient was GH01,286.55 
($14.30). Also it costs the caregiver an average of 047,000.00 ($5.22) directly 
and 0127,050.00 ($14.12) indirectly due to the number of days spent with the 
patients in the hospital. The patient pays on average 01,286.55 ($14.30) as 
direct cost of surgery which is made up of cost of surgery, medicine, transport, 
food and other costs related to the surgery. Patients did not pay for the actual 
surgery but other related costs. However, the average total cost of surgery of 
02,394,905.00 ($266.10) is a huge economic loss to the patient or the family 
as a whole.
Page | 203
Post-surgery treatment was sought mostly from the government facility, 
followed by the community health worker and the pharmacy, and then private 
facility and traditional healers who also follow in that order (Tables 5.12 and 
5.13). The main reasons for this observation are financial and physical 
accessibility to the service. Government facilities though strategically sited 
close to communities tend to offer cheaper and more reliable services. It is 
cheaper to receive treatment from government facility and the community 
health worker. These facilities are also close to the people and where they are 
lacking, the community health workers are available to help fill the gap. Few of 
the participants visited the traditional healer. Modernization has distanced 
most people from such traditional healers due to past experiences and the 
success rates evident from the health services compared to the traditional 
healers. Financial constraints might have led the few that visited the traditional 
healers to seek their help.
Many (90%) of the study participants said surgery had solved their problem 
causing some (11.6%) to change their occupation for better ones. As a result 
of surgery they now enjoy better quality life and demonstrated by the ability to 
work achieving an improved economic prospects, family life and sex life 
(Figures 5.7, 5.8, 5.9 and 5.10) though a few said the quality of their life had 
not improved or actually worsened (2-5%). This group has an average age of 
between 56.8-61 years (Table 5.8, 5.9 and 5.10) and thus age could be the 
determining factor rather than surgery. The group that had erectile problems 
were aged between 50-80 (average 67.8%). This present state of good health 
might have caused the high levels of absenteeism during the evaluation as a 
result of migration to Southern Ghana for better job opportunities.
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5.22 Discussion
In Ghana LF has been found to be prevalent in the northern and southern 
parts of the country leaving the central belt almost clear of the disease. In 
managing morbidity, surgery has been found to be very effective with few or 
no cases of recurrence of hydrocoele. Recurrence was mainly due to poor 
surgical technique. However, the management of lymphoedema with limb 
washing, exercising and limb elevation presents significant benefit and hope 
for patients with the condition but the challenge is that total remission is not 
possible though patients who have adhered religiously to this management 
have experienced marked improvements in the condition of the affected limbs.
The programme provides free surgical treatment to hydrocoele patients in 
endemic areas when available. But this support has been inconsistent and 
has not been available during the last 5 years. When it was available it was 
restricted to the Upper West region due to the source of the funding which 
focused on this region. Recent efforts to extend the provision of hydrocoele 
surgery have focused on training for surgeons on total excision 
hydrocoelectomies.
Generally attention devoted to morbidity management on the programme by 
all partners including the Government of Ghana through the programme has 
been inadequate, though what has been provided in terms of surgical 
treatment for those with hydrocoeles has made significant impact on the 
conditions of the patients involved. The same can be inferred for patients with 
lymphoedema who have had the opportunity of being educated on 
lymphoedema management and have been able to apply the skills learnt. 
More males than females were identified with the LF disease and to 
participate in the study. None of the identified cases had both elephantiasis 
and hydrocoeles. Men aside being possible cases of elephantiasis also
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develop hydrocoeles which is not found among the women accounting for the 
greater number of men who had the disease and were interviewed. Most of 
these patients were also married and were mainly subsistence farmers. Apart 
from the finding that the disease affected more men than the women; the 
other observed socio-economic characteristics are similar to those generally 
observed in the country.
Some patients who had been provided with information on lymphoedema 
management and had also been able to undertake these taught skills had 
however indicated that their condition was worse since the number of acute 
attacks they experienced had increased or the size of their affected limbs had 
also increased. This observation is often indicative of lack of compliance 
among the patients due to poor understanding of these taught skills. They are 
therefore unable to properly apply them or they do not practice the limb 
washing, limb elevation, limb exercising and proper case of wounds on the 
affected limb. Some started but also stopped at a point when they realized 
that these are practices they are expected to adhere to for the rest of their 
lives particularly when they saw little, slow or no improvements in their 
condition though they apply these measures.
The longitudinal programme data indicated that majority of the registered 
cases of limb swellings were cases of lymphoedema or elephantiasis that 
were planned to be provided with the lymphoedema management booklets for 
the purpose of ensuring lymphoedema management for these patients. Due 
to challenges of funding the lymphoedema management component became 
inactive with time and discouraged the health workers and the CDDs from 
continued registration of the cases. Also many districts did not register the 
cases from the time the programme began implementation. The number of 
cases therefore reported formed only a small proportion of both elephantiasis 
and hydrocoele. The scattered nature of the cases geographically particularly
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of elephantiasis registered also hindered the formation of Lymphoedema 
Management Support groups or ‘Hope Clubs’ recommended as part of the 
lymphoedema management process.
According to prevalence surveys on LF undertaken prior to the inception of 
the programme, there was an indication that the disease was more prevalent 
in the northern parts of the country than in the south (Gyapong 2000; 
Gyapong et al, 1993, 1994). Even though it is suspected that there were 
significant gaps in the collection and reporting of the cases of hydrocoele the 
information gathered tends to support the known geographic distribution of 
disease. Over the years though free hydrocoele surgery treatment was 
provided for mobilised cases in surgical camps and on a routine basis it was 
not expected to have impacted significantly on the numbers registered 
annually though through this programme greater awareness of the disease 
and the availability of surgical treatment might also have encouraged many 
identified cases to seek treatment for their condition. The number of reported 
cases is therefore an indication of the efficiency with which the health workers 
implement the programme because all districts are expected to have cases 
and even though some districts reported no cases in Year 1 cases were 
reported in subsequent years. The number of cases reported each year was 
supposed to be updated in subsequent years and therefore could include 
cases that had been identified in earlier years.
With elephantiasis it is not expected that the reported number of cases 
undertaken annually will change significantly since the condition is chronic, 
irreversible and the swelling does not undergo any significant reduction or 
improvements with the size of the affected limb. However, the measures 
introduced are able to reduce and eventually stop the occurrence of acute 
attacks thus preventing the affected limb from getting worse in size. For the 
cross-sectional morbidity surveys, more males than females were identified
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with the LF for interview. None of the identified cases had both elephantiasis 
and hydrocoeles. Men aside being possible cases of elephantiasis also 
develop hydrocoeles which is not found among the women thus accounting 
for the greater number of men who were interviewed. Most of these patients 
were married and were subsistence farmers. Apart from the finding that the 
disease affected more men than the women; the other observed socio­
economic characteristics are similar to those generally observed in the 
country.
The total number of individuals interviewed wase 269 made up of patients 
with hydrocoele or elephantiasis living within the sampled communities of the 
5 initial/start-up districts of the programme.
5.22.1 Assessing Management of Elephantiasis
Awareness of treatment for elephantiasis among patients was low (40.9%) 
and the kind of treatment referred to seem to be different for different 
categories of the patients interviewed as none of them indicated the 
recommended hygiene measures, limb exercising or elevation (Tables 5.15 
and 5.16). Ownership of the lymphoedema management manual produced 
and distributed by the programme was also very low (2.2%) in spite the fact 
that the programme had produced and distributed many copies of this 
manual. The few that had the manual had been taught its application. 
Interestingly a few more people who did not have the manual knew about the 
proper care of lymphoedema, implying that in the absence of the manual 
teaching the patients the proper management and ensuring adherence to the 
measures was possible and should be undertaken.
Added to the low awareness and practice of lymphoedema management 
among respondents, 3 (1.1%) of those practicing lymphoedema management
Page | 208
indicated that they noticed no change in the frequency of acute attacks. About 
2 (0.7%) actually indicated that inspite of undertaking lymphoedema 
management they had actually noticed an increase in the number of acute 
attacks they experienced in a year while 13 (4.8%) had noticed a decrease in 
the number of acute attacks experienced in a year. These low proportions 
agree with the expectation that patients who knew and diligently applied the 
measures taught in the lymphoedema management manual would notice a 
decrease in the number of acute attacks suffered by patients until these acute 
attacks finally ceased. Reductions in the size of the affected limb among 
patients who also knew and practiced lymphoedema management, is also an 
expected outcome while advanced cases may experience minimal or no 
change in the size of the affected limb (Dreyer, 2000; Brantus, 2009).
5.22.2 Assessing Management of Hydrocoeles
Assessment carried out with hydrocoele cases indicated that awareness of 
the availability of treatment was much higher than in the case of elephantiasis. 
Patients also knew about hydrocoele surgeries being the main orthodox 
method of treatment. This is expected as hydrocoeles are well recognised by 
the population. Some of the cases of hydrocoele benefitted from free surgery 
and individuals were happy with the outcome. This is indicative of the role the 
programme had played in reducing morbidity due to hydrocoele. This aspect 
of the programme, which has had more support in, terms both of funding and 
technical assistance and should be encouraged. Unfortunately the few who 
indicated that the outcome of the surgery was unsatisfactory would serve as 
poor advocates for the programme and MDA.
5.23 Conclusions
Page f 209
The free hydrocoeie surgeries organized by the National LF Programme has 
made a major and positive impact on the physical, social and economic life of 
the people who have benefited from the service. They would hitherto not have 
been able to access hydrocoeie surgery due to the cost constraints. The 
surgery has greatly improved the general health and physical state of the 
beneficiaries from a pre-surgery level of 58.6% to post-surgery level of 85.6%. 
In spite of the fact some patients had problems with the surgery, a high 
proportion of them (92.4%) were very satisfied with the surgery.
Excision is the recommended technique being used and is also what the West 
African Morbidity Project is promoting. The technique remains effective even 
though there were few recurrent cases. More than 90% of the cases did not 
recur. The programme has therefore made a great impact on the delivery of 
quality hydrocoeie surgery service to patients in the study districts. This is 
because about 76.5% of all the cases done in the Upper West Region from 
2000 to December 2005 were undertaken with the support of the LF 
Elimination Programme.
There were improvements in the socio-economic life of the study participants 
after the surgery. Their general state of health also improved in spite of a few 
post-operative challenges some of the cases had experienced. Hydrocoeles 
asides from limiting mobility are also associated with stigma (Perera et al, 
2007: Flotez, 2008) and restrict migration or travelling for socioeconomic 
purposes. Successful surgery resulted in migration to urban areas, distant 
farms and other areas of with greater income generation potential.. These are 
factors that might have come into play resulting in the absence of many of the 
successfully treated individuals from their communities.
Activities of the programme have also created awareness of the condition and 
availability of free surgery. The programme has therefore made available
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quality, reliable and more importantly free hydrocoele surgery services to 
alleviate the suffering of patients. This is despite poor socio-economic 
infrastructure, limited hospital equipment and medicines required. Facilities 
are known to be constrained in the performance of such surgeries. Most 
patients are discharged home to live under less ideal conditions and began 
farming to work where the wounds would be exposed to infection from the 
soil. Furthermore, about 44.7% of them did not seek any treatment after 
surgery and even some of those that sought it might have done so only after 
infections had set in.
Loss of income during this period of the surgery and recuperation accounts for 
most of the indirect cost to patients. Other indirect costs were accounted for 
time spent with patients by caregivers. However, the average total cost of 
surgery of 02,394,905.00 ($266.10) represents a huge economic loss to the 
patient or the family as a whole.
Post-surgery treatment was sought mostly from the government facility, 
followed by the community health worker and the pharmacy, and then private 
facilities and traditional healers who also follow in that order (Tables 5.12 and 
5.13). Government facilities are often strategically sited close to communities 
to offer cheaper and more reliable services to patients. Few of the 
participants visited the traditional healer. Modernisation has distanced most 
people from such traditional healers due to past experiences and the success 
rates evident from the health services compared to the traditional healers.
Surgery had caused most of the patients to enjoy a better quality life 
demonstrated by the ability to work and improved economic life, family life and 
sex life (Figures 5.7, 5.8, 5.9 and 5.10). This present state of good health 
might have caused the high levels of absenteeism during the evaluation as a 
result of migration to Southern Ghana for better job opportunities.
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In order to achieve the elimination targets of LF, the need to reinforce 
morbidity control activities is essential. Registration of all identified cases of 
both scrotal and limb swellings should be done and regularly updated. 
Training of heath workers and community drug distributors to enable them 
effectively play the role of also training and supervising lymphoedema 
management among patients while helping to identify all cases within 
endemic communities. There should also be follow up and confirmation of all 
cases of hydrocoele from other causes of scrotal swellings. Training of 
doctors in hospital within endemic areas on the recommended method for 
undertaking these hydrocoele surgeries is absolutely essential so they can 
better handle these surgeries in order to prevent recurrence of the condition.'
It is recommended that the districts improve access to the service. 
Furthermore, it is recommended that the activities of the LF Elimination 
Programme be given a higher emphasis in the other regions as has been 
done inthe Upper West Region to enable the people benefit more from the 
available package.
Partnerships in support of morbidity control and in particular in support of free 
hydrocoele surgery should be encouraged. Apart from their role in alleviating 
the suffering of cases of hydrocoeles and elephantiasis they serve as a strong 
community advocacy tool for endemic communities.
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Chapter 6: Impact of Mass Drug Administration on 
Immunoparasitologic Indicators of Bancroftian Filariasis
6.1 Introduction
The Ghana Filariasis Elimination Programme (GFEP) was set up in June 
2000 after completing its mapping process and developing an endemic map 
to guide the programme. The employed strategy of MDA was based on the 
WHO guidelines for preparing and implementing the LF Elimination 
Programme in countries, which are co-endemic for LF and onchocerciasis. 
This strategy recommends the use of ivermectin and albendazole treatment 
regimens to be undertaken annually for identified implementation units (WHO, 
2000). These guidelines also recommend the need for a surveillance plan for 
the programme, which should involve both endemic areas and non-endemic 
areas. In Ghana monitoring the progress of the LF elimination programme 
using immuno-parasitological indicators involved several surveys during the 
lifetime of the elimination programme. The main activities were mapping the 
distribution of the disease (Gyapong et al, 2002), baseline data collection from 
selected sentinel sites, longitudinal monitoring surveys and surveys to 
determine the end point of MDA.
Though it was anticipated that 5-6 years of MDA (WHO, 2000; WHO 2001) 
should be adequate to ensure elimination of LF, operational research 
experience has provided evidence to the contrary. Up to six years of MDA has 
been found to be inadequate to ensure a reduction in mf parasite prevalence 
to levels (less than 1%), which are unable to sustain transmission of LF. 
Various scenarios that make this challenging include areas with evidence of 
high mf prevalence and density before the commencement of MDAs and 
areas of with low coverage or compliance with MDA (Addiss, 2010). Urban 
environments contribute to low compliance or coverage due to socioeconomic
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factors and urban dynamics that challenge the distribution process (Addiss, 
2010). in all this, the local vector characteristics and the applied drug regimen 
also play an important role in determining the possibility of achieving 
elimination within the set time period (Addiss, 2010). Addressing these 
challenges requires further operational research with the development of tools 
and strategies to guide programme implementation (Addiss, 2010).
Monitoring the impactof MDA on transmission of IF in Ghana has involved 
several impact assessments surveys. These have largely been based on 
WHO guidelines and protocols, whose development and implementation have 
been led by the WHO and its partners. These include the ‘Programme 
Managers Manual for Implementing MDA in countries co-endemic for LF and 
onchocerciasis’ (WHO, 2000) and ‘Preventive Chemotherapy (PCT) in 
human helminthiasis: coordinated use of antihelminthic drugs in control 
interventions: a manual for health professionals and programme managers’ 
(WHO, 2006c). Challenges encountered by countries like Ghana in 
implementing these guidelines have contributed to the revision of these 
guidelines. Recent guidelines developed to guide the process of 
implementing mass chemotherapy and monitor the impacts including the 
determination of the end point of mass preventive chemotherapy for 
elimination programmes have been put in place particularly for LF (WHO, 
2000; WHO, 2006, Ottesen, 2006). Disease specific focus is still maintained 
to ensure that indicators for specific PCT disease monitoring are not lost and 
this has informed the methods employed for undertaking these impact 
assessments.
The district was designated as the implementation unit. Prior to beginning MD 
using ivermectin and albendazole, the programme set up sentinel sites and 
collected baseline data for longitudinal monitoring. Most endemic districts 
having completed the minimum of 5 rounds of MDA require programme
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decisions to stop MDA being an elimination programme. Since mapping the 
distribution of LF in Ghana, longitudinal impact assessment data has been 
regularly collected as part of the LF elimination strategy since inception of the 
programme; however this has often been tailored to the availability of 
financial, human and logistic resources.
The impact assessments undertaken during the programme since its 
inception have involved the collection of longitudinal programme data from the 
year 2000 to 2009, The major impact assessment of the five start-up districts, 
which were the first to complete the minimum of five rounds of MDA, was 
undertaken in 2007.
6.2 Methods for Longitudinal Monitoring of Immuno-parasitogic 
Indicators
Countrywide antigen prevalence data was initially collected for mapping of LF 
distribution in Ghana using the 50km grid method (Gyapong et al, 2002). The 
result was a prevalence map, which indicated that LF was endemic in 49 out 
of the then 110 endemic districts in Ghana (Gyapong et al, 2002). This has 
been used to guide MDA on the Ghana Filariasis Elimination Programme 
(GFEP), now part of the NTD Programme. Baseline microfilaraemia 
prevalence data was also collected and applied for monitoring the impact of 
LF in Ghana (Ghana Health Service Unpublished, 2004; Ghana Health 
Service Unpublished, 2007-2012).
The Ministry of Local Governments undertook several redemarcations of the 
administrative districts in Ghana. In 2003, the number of administrative 
districts changed from 110 to 138, and the number of endemic districts 
changed to 61. Then in 2007 there was another change to 74 endemic 
districts based on a change in administrative districts to 170. The programme
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also underwent a gradual up-scaling plan of implementation from the initial 
five start-up districts out of 110 districts to all of the present 74 districts in 
2006 (Table 6.1 and Figure 6.1) (ghanadistricts.com). For monitoring, the 
programme maintained the original 49 districts and further re-demarcated the 
country into evaluation units for the purpose of impact assessments.
Table 6.1: Upscaling Plan of the Ghana Filaraisis Elimination Programme Indicating the 
Number of Implementation Units (Districts) by Implementing Year
Implementing
Year
2000-
2001
2001-
2002
2002-
2003
2003-
2004
2004-
2005
2005-
2006
Total Number
of Districts
for Ghana
Number of 5 14 30 40 48 49 110
Implementation 6 18 38 51 60 61 138
Units (Districts) 8 24 46 61 72 74 170
Antigen prevalence data using ICT card antigen tests were collected for 
countrywide IF endemicity maps (Gyapong et al, 2002). The programme 
collected baseline and other longitudinal data to help monitor the impact of 
initiated MDA in several study communities referred to as sentinel and cross­
check sites.
6.2.1 Diagnostic Methods
Laboratory tests employed for these assessments included the collection of 
thick and thin blood smears for the detection of microfilaraemia and ICT card 
test for antigenaemia (World Flealth Organization, 2000). The Og4C3 and 
Bm14 ELISA tests were employed for the cross-sectional studies to detect 
new infections in children born after the institution of MDA. Selected sentinel 
and cross-check communities in districts that have achieved a microfilaraemia 
prevalence of less than 1% were employed to determine the possible end 
points of MDA in these districts and others with similar characteristics. With
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these tools for undertaking tests for filarial antigen and antibody detection and 
microfilaria detection in blood smears, baseline data, follow-up data and end 
point determination data were collected.
For the identified endemic districts the initial recommendation was to select 
two sentinel and one cross-check sites per an implementation unit or a 
population of a million for monitoring of the impact of the programme (WHO, 
2000). The characteristics of these sites were to have a stable and minimum 
population of 500, areas of high disease prevalence and high vector density 
among other parameters that enhance the transmission of IF. For this sample 
size of individuals’ night blood samples were collected for blood smear 
examination for microfilaraemia. During the sample collection the individuals 
with lymphoedema and hydrocoeles were registered and the prevalence of 
lymphoedema and hydrocoeles noted. Microfilaraemia prevalence and mean 
microfilaraemia density were calculated (WHO, 2000; WHO, 2006, Ottesen, 
2006).
The recommended frequency of monitoring involved collection of baseline 
samples, samples before the 4th round of mass drug distribution and then 
subsequently before every 2nd round of distribution. Finger prick blood taken 
at night was collected for the bloods smears from which microfilaria 
prevalence and microfilaria mean densities were calculated. After completion 
of a minimum of 5 annual rounds of MDA and monitoring the fall of prevalence 
to less than 1% in all sentinel and cross-check sites, the programme could 
continue to undertake an assessment of interruption of transmission or 
determination of the end point of MDA, now called the transmission 
assessment surveys (TAS) (WHO, 2000; WHO, 2006, Ottesen, 2006).
Modifications were made to the recommended WHO methods in 
implementation of monitoring and evaluation to match funding and logistic
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availability. Timing of the monitoring activities influenced the number of sites 
that could be visited for any particular annual survey. The number of people 
sampled depended on voluntary participation of community members in the 
surveys and therefore the resulting sample sizes.
6.3 Results and Discussions on Longitudinal Monitoring of Immuno- 
parasitological Indicators
6.3.1 Results of 2000 Immunoparasitologic Surveys
Baseline data was collected in 2000 before the first annual MDA in the 
programme’s five start-up districts. These districts were Awutu-Efutu-Senya 
district in the Central region, Ahanta West in the Western region, Builsa and 
Kassena Nankana district in the Upper East region and Sissala district in the 
Upper West region. Between four and six communities were visited for each 
of these districts in an effort to meet the recommended sample size of 
approximately 500 for this survey. For this survey, night blood smears for 
microfilaraemia and ICT card tests for antigenaemia were conducted for the 
samples collected in each of these districts. In all a total of 2607 people were 
sampled from these 5 districts with the sample size varying from 441 in Builsa 
district to 662 in Ahanta West district (Table 6.2). A total of 607 
microfilaraemic positive individuals were detected. The number of 
microfilaraemic positive individuals ranged from 90 in Sissala to 139 in 
Kassena Nankana district. Microfilaraemia prevalence was therefore between 
19.8% and 29.6% as the mode. The median was 23.4%. Antigen prevalence 
by the ICT card tests were between 33.1% and 45.4%. The average mf 
prevalence for the whole survey was 23.3% while that for antigen prevalence 
was 38.1% (Table 6.2).
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Table 6.2: Summary Baseline Survey Data Collected for the Five Start-Up Districts at 
Inception of the Programme
2000 Baseline Survey Data
Community
Number
Examined (N)
Microfilaria
Positive (N)
Microfilaria
Prevalence ICT Positive
ICT Antigen
Prevalence
Winneba 606 144 23.8 216 35.6
Kassena
Nankana 469 139 29.6 213 45.4
Sissala 429 90 21.0 159 37.1
Builsa 441 103 23.4 186 42.2
Ahanta West 662 131 19.8 219 33.1
National 2607 607 23.3 993 38.1
The disease prevalence in these districts was generally high (ref), which was 
a reason for their selection for the start-up programmes. In addition the initial 
research activities aimed at establishing the endemicity of LF were conducted 
in these five districts. Sissala, Builsa and Kassena Nankana districts also 
border adjacent endemic districts of Burkina Faso where the MDA with 
ivermectin and albendazole programme was also commencing making it 
epidemiologically prudent to complement this treatment by ensuring the 
Ghana programme treated the communities on its side of the border (Kyelem 
et al, 2003)
6.3.2 Results of 2001 Immuno-parasitologic Surveys
Prior to the second round of MDA a further survey was undertaken for 9 
districts (Table 6.3) mainly in northern Ghana. In all, 2 communities were 
visited for each district visited. About 200 people were sampled for each of 
these districts. Only Lawra had 175 people volunteer to participate in the 
survey. A total of 1775 people were sampled for these surveys and 1346 were 
antigen positive by the ICT card test. The average prevalence for the entire 
survey was 76%. Antigen prevalence therefore ranged from 59-85% (Table 
6.3).
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Table 6.3: 2001 Night Blood Survey Results showing Antigen Prevalence using ICT
Card Tests
2001 ICT Card Test Results
DISTRICT
Number of People
Tested (N)
Number of ICT Card
Test Positive
Antigen Prevalence Rate
Using the ICT Card Test (%)
Wa 200 169 85
Lawra 175 129 74
Jirapa 200 118 59
Nadowli 200 163 82
Sissala 200 155 78
Kasena Nankana 200 169 85
Builsa 200 156 78
Bongo 200 146 73
Bolga 200 141 71
SUMMARY 1775 1346 76
Serious technical challenges due to poor timing of the surveys and the ICT 
test card quality were encountered for this survey. This may have been due to 
the weather conditions as the surveys were undertaken in the cold dry dusty 
harmattan weather. Though samples were collected for both blood smears 
and antigen tests, the slides were heavily contaminated with dust particles 
making processing and reading of the slides impossible and so the results 
had to be abandoned. Vasoconstriction due to the cold weather made 
bleeding of individuals for the survey also difficult particularly between 10pm 
and 2am. The newly introduced ICT card test required reading of test results 
within 10 minutes of dropping the blood on the kit. Samples were collected 
and kept overnight leading to a high turnover of false positive readings. The 
results obtained for both the antigen card tests and blood slides for 
microfilaraemia could therefore not be applied for programmatic decision­
making.
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6.3.3 Results of 2002 Immuno-parasitologic Surveys
Surveys were conducted in 2002 in five districts in the Northern, Upper East, 
Central and Western regions. These surveys focused on the second set of 
new districts that were recruited for programme implementation. Participation 
in these surveys was generally low for Agona and Nzema East districts. A 
total of 1784 people from a total of 10 communities participated in the survey 
(Table 6.4). The ICT card tests for antigenaemia were only applied for Agona 
and Nzema East districts due to the limited availability of the ICT cards.
Microfilaraemia prevalence was generally low and ranged from 0% in Nzema 
East district to 7.4 percent in Agona district. East Mamprusi, West Mamprusi 
and Nzema East each had a prevalence of less than 1%. Bawku East had a 
prevalence of 4.2%. Antigen prevalence by the ICT card tests were 23.5% in 
Agona and 13.6% in Nzema East (Table 6.4). No antigen tests were 
conducted in the other districts surveyed.
6.3.4 Reults of 2003 Immuno-parasitologic Surveys
The 2003 blood surveys were an opportunity to conduct mid-term impact 
assessments of the programme’s first five start-up districts. Baseline data was 
also collected for a selection of districts that were being recruited into the 
programme for the first time. A total of 15 districts were sampled for this 
survey. Participation in the surveys was very low in some communities. 
Sample sizes therefore varied from 46 in Jirapa district to 557 in Shama 
Ahanta East, an urban area.
A total of 2514 individuals participated in the surveys. The ICT antigen tests 
were conducted on 1643 with an overall antigen prevalence of 5.8% and
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overall microfilaraemia prevalence was 3.9% (Table 6.5). At the regional level, 
antigen prevalence ranged from 3% in the Northern region to 39% in Upper 
East region while microfilaraemia prevalence was from 0% in the Northern 
region to 15% in Upper East region. Parasite counts were highest in the 
Upper East region followed by the Upper West region, but low in the Central 
and zero in the Northern region. Districts surveyed in the Upper East and 
Upper West regions had the highest prevalence levels for microfilaraemia of 
between 10% and 28.3% and 0% to 20% respectively. Northern and Central 
regions generally had low levels, though Western region had prevalence 
between 0.2% and 10%.
6.3.5 Results of 2004 Immuno-parasitologic Surveys
The 2004 blood surveys were undertaken in 10 districts (Table 6.6) and 
involved 25 communities. One district was visited in each of the six regions 
where these surveys were undertaken. A district was sampled from the 
Northern, Brong Ahafo, Eastern and Greater Accra regions. Four and two 
districts were surveyed in the Upper West and Upper East regions 
respectively. Twenty five communities were visited in an effort to improve on 
the number of samples required per site visited. The numbers of communities 
visited in each district were three in Northern, Eastern and Greater Accra 
regions, four in Upper East and Brong Ahafo regions while eight were 
surveyed in the Upper West region. The total sample size was 2933 (Table 
6.6).
The microfilaraemia prevalence obtained nationally was 5.9% with an antigen 
prevalence of 17.5%. District microfilaria prevalence ranged from 0.2% in 
Greater Accra region to 16.0% in the Upper West region. Antigen prevalence 
followed similar trends as for the microfilaraemia prevalence (Table 6.6).
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Table 6.4: 2002 Night Blood Survey Results showing Antigen and Microfilaraemia Prevalence
Number Positive (N) Prevalence (%)
Region District
Microscopy for
Microfilaraemia
ICT Card
Test for
Filaria
Antigen
aemia
People
Examined
ICT Card test
for Filaria
Antigenaemia
Microscopy for
Microfilaraemia
Upper East
Bawku
East 21 - 505 4.2
Northern
East
Mamprusi 1 - 230 0.4
Northern
West
Mamprusi 5 - 714 0.7
Central Agona 10 32 136 23.5 7.4
Western
Nzema
East 0 27 199 13.6 0.0
SUMMARY 5 37 59 1784 3.3 2.1
6.3.6 Results of 2005 Immuno-parasitologic Surveys
The 2005 blood surveys were conducted in 10 districts and involved 34 
communities. In order to obtain an adequate sample size for the surveys, 
several communities were visited in the selected districts. This survey was 
conducted before the round five of mass drug distribution of the five start-up 
districts (WHO, 2001) and involved the collection of samples for both antigen 
tests using ICT cards and bloods smears for microfilaraemia.
A total of 4822 individuals including 230 children less than five years with the 
rest belonging to different age groups were sampled. Among the adult 
population microfilaraemia prevalence was 2.1%, but antigen prevalence was 
2.6% within the under five age-group and 6.8% within the older age groups for 
the disaggregated data (Table 6.7). Nzema East, Awutu-Efutu-Senya and 
Sissala districts with sample sizes of between 15-22 had antigen prevalence
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among the under five age group of 0% while Ahanta West, Agona, Kassena 
Nankana, Builsa and Nadowli districts with sample sizes from 24-51 had 
antigen prevalence from 2.3-4.2% within the under five year group (Table 
6.7). No children under five years were sampled in East and West Mamprusi 
districts.
Table 6.5: 2003 Immuno-parasitologic Survey Results showing Antigen and
Microfilaraemia Prevalence
REGION
Number of
Districts
Sampled
Number of
individuals
sampled (N)
RESULTS (N) Prevalence (%)
ICT
Positive
Microfilaria
Positive ICT Microfilaria
Upper West 5 415 14 33 14 8.0
Upper East 4 353 39 53 39 15.0
Northern 1 486 3 0 3 0.0
Central 3 603 11 1 11 0.2
Western 2 657 28 11 5 4.3
NATIONAL 15 2514 95 98
5.8% (No.
Spld=1643)
3.9% (no.
Spld=2514)
REGION
Number
of
Districts
Surveyed
Number of
Communities
Surveyed
RESULTS
Number
of
People
Sampled
Number of
People
Positive for
Microfilarm
emia (N)
Microfilaraemi
a Prevalence
(%)
Number of
People
Positive
for ICT
Antigen
test
Antigen
Prevalence
(%)
Upper
West 4 8 729 117 16.0 146 20.0
Upper East 2 4 156 19 12.2 44 28.2
Northern 1 3 516 17 3.3 103 21.6
Brong
Ahafo 1 4 530 15 2.8 50 35.5
Eastern 1 3 519 5 1.0 5 1.8
Greater
Accra 1 3 483 1 0.2 38 7.9
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National 10 25 2933 174 5.9 386 | 17.5
Table 6.6: 2004 Blood Surveys Results showing Antigen and Microfilaraemia Prevalence
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Table 6.7: 2005 Summary Night Blood Survey Results showing Antigen and Microfilaraemia 
Prevalence and Antigen Prevalence among Children under Fiver Years
Region (5) Districts (10)
Number of
Communities
Microfilaraemia Id
Number of
Sampled
Microfilaria
Prevalence.
Adult
Antigen ICT
Prevalence
Under Four
Years ICT
Antigen
Prevalence
Western
Ahanta West 3 502 3.2 15.5 3.9
Nzema East 3 371 0.0 2.0 0.0
Central
Awutu Efutu
Senya 4 500 0.2 6.2 0.0
Agona 4 465 1.3 10.9 4.2
Northern
East
Mamprusi 3 474 0.0 0.4 -
West
Mamprusi 3 505 1.2 5.5 -
UWR
Kassena
Nankana 4 505 4.0 7.1 3.8
Builsa 3 500 3.6 11.2 2.3
UER
Nadowli 3 500 6.4 7.0 3.3
Sissala 4 500 0.0 1.5 0.0
National 10 34 4822 2.1 6.8 2.6
6.3.7 Results of 2007 Immuno-parasitologic Surveys
The 2007 blood surveys were part of the cross-sectional study undertaken. It 
focused on the five start-up districts and employed blood smear tests for 
microfilaraemia and Og3C4 and Bm14 ELIZA tests for filarial antigen and 
antibodies for determining the infection levels in children up to five years who 
were born since the inception of the mass drug distribution programme for LF 
elimination in these districts that have completed six rounds of mass drug 
distribution and needed a determination of the possible end points of the 
distribution programme. Two sentinel sites and one cross-check site were 
surveyed for each district. For each of these sites a sample size of 500
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individuals was targeted for the adult surveys. Sentinel sites with fewer 
numbers due to small population sizes or due to poor participation had 
adjacent communities visited to achieve the 500 samples required. The 
results of the Og3C4 and Bm14 ELISA tests are presented under the chapter 
on determining the end points of MDA.
For the 2007 blood surveys, five districts, 15 sub-districts with a total of 59 
communities, which are organized into 15 sentinel or cross-check sites. In all, 
a total of 7643 adult samples were collected for the blood smear tests for 
microfilaraemia. Out of this number 244 were found to be positive for 
microfilaraemia giving a total national prevalence of 3.2% for this major 
assessment involving Ahanta West, Awutu Efutu Senya, Kassena Nankana, 
Builsa and Sissala districts. Prevalence of microfilaraemia by district ranged 
from 0.6% in Awutu Efutu Senya district to 6.9% in Builsa district. In between 
these Kassena Nankana had a prevalence of 4.0%, Ahanta West had 2.2% 
and then Sissala district had 2.1%. The average number of individuals 
sampled for each of these districts was about 510 which is above the required 
sample size, Awutu Efutu Senya and Kassena Nankana districts had an 
average sample size of 432 and 489 (Table 6.8) which was less than 
recommended. Participation in the survey in these districts was therefore 
lower than the other three districts.
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Table 6.8: Summary Results of 2007 Blood Surveys by Sub-districts
Region District Sub-district No.
Comm
MF
Positive
Total
Surveyed
MF Prev. Parasites Density
Upper
West
Sissala
East Kunchugu 6 21 688 3.05 417 331.61
Sissala
West
Jeffisi 5 13 523 2.5 53 68.08
Gwollu 3 2 541 0.4 2 16.70
Upper
East
Builsa
Chuchuluga 4 18 536 3.4 224 207.82
Wiaga 3 35 344 10.2 352 167.95
Fumbisi 5 54 675 8.0 433 133.91
KND
Navrongo 4 12 507 2.4 186 258.85
Paga 4 27 411 6.6 588 363.69
KND South 3 19 550 3.5 110 96.68
Western
Ahanta
West
Apowa 4 29 719 4.0 535 308.09
Dixcove 3 4 348 1.1 12 50.10
Agona/Princess 3 2 504 0.4 12 100.20
Central
Efutu
Municipal
Winneba 3 3 349 0.9 113 629.03
Winneba 5 4 443 0.90 17 70.98
Awutu
Senya Bontrase 4 1 505 0.2 1 16.70
NATIONAL 59 244 7643 3.2 3055 209.09
Table 6.9: Summary Results of 2007 Blood Surveys by Districts Microfilaraemia Prevalence in 
the Five Start-Up Districts
Region District Positive Negative Total MF Prevalence (%)
Upper West Sissala (East+West) 36 1716 1752 2.1
Upper East Builsa 107 1448 1555 6.9
Upper East Kassena Nankana 58 1410 1468 4.0
Western Ahanta West 35 1536 1571 2.2
Central
Awutu Efutu Senya
(Efutu Municipal+Awutu
Senya) 8 1289 1297 0.6
NATIONAL 244 7399 7643 3.2
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The district prevalence for microfilaraemia was more than 1% for all the 
districts except Awutu Efutu Senya district. The Awutu Efutu Senya districts 
had a prevalence of 0.6%, followed by Sissala (2.1%) in the Upper West and 
Ahanta West (2.2%) in the Western region, then Kassena Nankana (4.0%) 
and Builsa (6.9%) (Table 6.8 and 6.9). This indicates that at the district level 
only Awutu-Efutu-Senya district could proceed to undertake the TAS leading 
to stopping MDAs. At the sub-district level prevalence ranged from 0.2 in 
Awutu Efutu Senya district to 10.2 in Kassena Nankana district. Also parasite 
counts were lowest (1) in Awutu Efutu Senya district and highest in Kassena 
Nankana district (588).
This assessment indicates that Awutu Efutu Senya district had obtained a fall 
in prevalence to below 1% at the district level and also had both its two 
sentinel and one cross-check site also with mf prevalence less than 1%. 
Awutu-Efutu-Senya district is therefore the only district that met the criteria for 
proceeding to undertake TAS leading to the possible decision to stop MDAs. 
Among these start-up LF programme districts only Awutu Efutu Senya district 
had produced evidence which could eventually lead to stopping MDAs in that 
implementation unit.
Figure 6.2: Summary Results of 2007 MF Prevalence by Districts
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6.3.8 Results of 2009 Immuno-parasitologic Surveys
In 2009, blood surveys conducted were conducted in 15 districts. This survey 
was carried out during the process of reviewing the LF Monitoring and 
Evaluation Manual which recommended surveys are conducted in one 
sentinel instead of two and then a cross-check site. Apart from one district in 
which the old method was applied all the other 14 districts followed this new 
WHO recommendation. In each of these districts, one sentinel and one cross­
check site were selected in accordance with new draft 
recommendations/guidelines for monitoring and determining the end points of 
MDA. A sample size of 500 was targeted for each of the sites visited. The 
draft recommendations that informed the method and the sampling for this 
survey had not been published when the surveys were started in Agona 
district and therefore two sentinel and one cross-check were sampled in 
Agona district surveys. Blood samples were taken for blood smears and 
microfilaraemia prevalence and densities determined for each site. District 
prevalence was determined from the aggregated data and further aggregated 
to provide information on national prevalence. A total of 31 sentinel and cross­
check sites were assessed in this survey.
A total of 15,175 people from 113 communities made up of 31 sentinel and 
cross-check communities and adjacent communities were sampled. About 
342 individuals were positive for microfilaraemia giving a national level 
prevalence of 2.3% with an mf parasite density of 405.5 mf/dl of blood for the 
parasite positive individuals. Microfilaraemia prevalence by districts ranged 
from 0.0-8.2% while prevalence by sentinel and cross-check site ranged from 
0.0-12.9% (Table 6.10 and 6.11). The results of the surveys indicated that out 
of the 15 districts surveyed the aggregated district prevalence data indicates 
that 8 out of the 15 districts have prevalence levels less than 1% and might 
therefore need to proceed to undertake the TAS which will eventually lead to
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the decision to stop MDAs in those districts or not. Out of the 31 sentinel and 
cross-check communities 17 (54.8%) of them had mf prevalence less than 1% 
while 14 (45.2%) had mf prevalence levels more than 1% (Table 6.11).
District assessment of the results by sentinel and cross-check sites indicated 
that seven districts had all of its assessed sites with prevalence less than 1% 
and therefore qualified for further assessment that would lead to stopping of 
MDAs while eight districts had at least one site with a prevalence of more than 
1% therefore did not qualify to continue with further TAS. MDA in all these two 
categories of districts therefore needs to continue.
Table 6.11: Results of 2009 Blood Surveys
NIGHT BLOOD SURVEY 2009
Regions (5) District
Number of
Communities
Microscopy
Sample
Size
Microfilari
a Positive
Prevalence.
(%)
Parasite
Count Density
Central (1) Agona 10 1199 0 0.0 0 0
Western (2)
Tarkwa Nsuaem 5 664 1 0.2 34 567.8
Axim Municipal 7 596 17 2.9 891 875.276
Upper West
(4)
Lawra 9 1074 81 7.5 2440 503.062
Nadowli 6 969 20 2.1 429 358.215
Wa 9 1228 101 8.2 2494 412.374
Jirapa 7 1325 33 2.5 452 228.739
Upper East (3)
Bolgatanga 9 1037 31 3.0 301 162.152
Bongo 8 1007 34 3.4 307 150.791
Bawku West 6 978 14 1.4 643 767.007
Northern (5)
West Mamprusi 8 1160 7 0.6 300 715.714
Tolon Kumbungu 9 1025 2 0.2 11 91.85
Savelugu Nanton 8 954 0 0.0 0 0
Zabzugu Tatale 6 956 0 0.0 0 0
Nanumba 6 1003 1 0.1 2 33.4
TOTAL 15 113 15175 342 2.3 8304 405.488
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6.4 Observed Trends from Impact Assessments
Generally downward trends have been observed across the five study districts 
with very significant reduction in microfilaria prevalence of LF microfilaria from 
the beginning of the programme to date (Figure 6.3). Using aggregated district 
prevalence data indicates that mf prevalence surveys have been consistently 
carried out in the five start-up districts from year one through to year nine as 
indicated by the available prevalence data. Similar downward trends can also 
be demonstrated by all implementing districts based on all survey mf 
prevalence data (Figure 6.4).
During the up-scaling of programme implementation, selection of districts was 
based on the prevalence level with higher prevalence districts beginning 
programme implementation earlier than the lower prevalence districts. Also 
districts that had been surveyed prior to the inception of the programme and 
whose data led to the establishment of the endemicity of LF in Ghana like 
Kassena-Nankana and Ahanta West districts were considered as start up 
districts for the programme. Other districts, which bordered Burkina Faso 
where adjacent districts had started LF programme implementation, were also 
considered (Gyapong et al 2002; Kyelem et al 2003). These factors informed 
the selection of the first five start-up districts for implementation of the LF 
programme in Ghana for year one and further selection for subsequent years. 
Metropolitan districts like Accra were added on to the programme very late 
due to anticipated issues with urban drug distribution.
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Figure 6.5: Observed Trends in Microfilaraemia Prevalence among the First Five Start-
Up Districts
Figure 6.6: Observed Trends in Microfilaraemia Prevalence among Selected Districts
from Second Set of Districts Joining the Programme
In AES prevalence levels have declined from 45.7% at baseline to 2.9% at 
mid-term, then further to 0.2% in before year six and finally 0.9% after year six 
which is less than the required threshold of 1% and therefore qualified to have 
further TAS undertaken for stopping MDAs. Ahanta West has also seen 
significant reduction of mf prevalence for the district from 28.5% at baseline to 
9.5% at mid-term, 3.2% before year six and 4.0% after year six. Inspite of the 
reduction demonstrated, the last mf prevalence of 4% indicates that MDAs will
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have to continue for at least another two years. Kassena-Nankana district 
reduction was from 35.5% at baseline to 5.5% at mid-term, further to 4.0% 
before year six and 6.6% after year six. The 6.6% mf prevalence being above 
the required threshold also meant that the programme in the district needed to 
continue with MDAs. In Builsa district reductions was from baseline of 25.5% 
to 28.8% which was slightly higher after three years of MDAs, then to 3.4% 
before year six and 10.2% after year six. Reductions in Builsa being 
inconsistent and ending with 10.2% therefore required further MDAs. Sissala 
district started with a baseline of 31.0%, moving down to 10.0%, but had no 
surveys undertaken before year six, however surveys undertaken after year 
six indicated a reduction to 3.1% (Figure 6.5), though MDAs have to continue.
It was noted that for each of these start-up districts with the exception of 
Sissala, there was an increase in prevalence from the pre-year six 
assessments to the post-year six assessments. The reason being that efforts 
were made to improve on the sample sizes employed for the surveys by 
moving into adjacent communities to ensure that the recommended sample 
size of 500 was achieved or sample size obtained was close to 500. This 
provided a better picture of the mf prevalence within these programme 
districts by increasing the power of the surveys.
Generally downward trends have been in observed in the second set of 
districts that joined the programme. Trends were also observed in districts 
that were at various stages of programme implementation with regards to the 
number of years of MDAs undertaken. A study of the second set of districts 
where the programme up-scaled included Wa, Lawra, Jirapa and Nadowli, all 
in the Upper West region all of which belonged to the second set of districts 
that joined the programme to eliminate LF. Wa district had started with a 
baseline of 21.0% to 19.0% at mid-term and finally to 12.9% after five years of 
MDA. Lawra has started with 20.0% at baseline, with marginal reduction to
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19.0% at mid-term and then finally to 5% after the fifth MDA. Jirapa and 
Nadowli on the other hand experienced a rise from a baseline of 15.2% and 
4.0% respectively to 28.1% and 17.0% respectively and finally reducing to 
11.0% and 0.4% respectively (Figure 6.6). Again the sample sizes applied for 
the surveys from baseline to the mid-term surveys where the programme 
made the effort to ensure meeting the required sample sizes must have 
accounted for the slight marginal reductions seen with Wa and Lawra districts 
and a rise in mf prevalence seen with Jirapa and Nadowli districts from 
baseline to mid-term. However, all the four districts demonstrated reductions 
in mf prevalence post year five MDA, though all but Nadowli (0.4%) have 
prevalence levels more than 1%. The programme can therefore proceed with 
further surveys and analysis, which might provide evidence for MDAs to stop 
in Nadowli district.
Similar downward trends have been observed among the third set of districts 
that joined the programme in its up-scaling plan. These include Bawku East 
and West districts, which used to be a single district at the onset of the 
programme. These districts only have baseline and mid-term prevalence data 
for demonstration of trends in microfilaria prevalence. Bawku East and West 
districts had baseline prevalence of 4.1% which declined to 1.8% on follow up, 
East Mamprusi had a baseline prevalence of 0.2% which dropped further to 
0% and West Mamprusi which had a baseline prevalence of 1.1% obtained a 
follow up prevalence of approximately 1.2% (Figure 6.7). This demonstrates 
trends in mf prevalence of districts which did not have significantly high 
prevalence levels at the onset of the programme and hence the decision to 
start implementation of MDAs much later in the up-scaling plan of the 
programme. After three rounds of annual MDA most of the districts in this 
category had achieved IF parasite prevalence levels, which might enable the 
programme to proceed with TAS to determine if transmission has been 
broken. East Mamprusi having attained this prevalence level requires sentinel
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and cross-check site analysis to help further demonstrate the need to proceed 
with further TAS that might lead to the decision to stop treatment.
6.5 Conclusions
Generally, microfilaria prevalence and other immuno-parasitoiogic indicators 
have shown significant downward trends in all districts on the programme. 
Microfilaria prevalence surveys were undertaken in spite of funding and 
logistic challenges. However technical challenges with the use of the ICT card 
antigen tests together with challenges of their availability reduced the value of 
antigen tests in programmatic decision-making.
Page | 238
Figure 6.7: Observed Trends in MF Prevalence among Selected Districts from Third Set
of Districts Joining the Programme
Baseline Follow-up
Bowku East/West
East Mamprusi
West Mamprusi
The first five start up districts have also made significant progress in the 
reduction of microfilarial prevalence, however the high prevalence obtained in 
previous studies undertaken prior to the inception of the programme and at 
baseline might explain the difficulty in reducing mf prevalence below the 
required 1% that would lead to a break in transmission in spite of initial rapid 
falls in prevalence following the initiation of MDA. However, the possibility of 
this occurring has been demonstrated by Awutu-Efutu-Senya district, which 
has reached the end point of MDA and will be moving into surveillance mode 
for two years. This will be discussed under the chapter on determining the 
endpoint of MDA.
Many districts particularly in the Northern region and Agona in the Central 
Region which started implementing MDA later in the up-scaling process have 
been able to reduce their microfilaria prevalence to less than 1% and need to 
undertake the TAS to determine the end point while noting that end point 
determination has been successfully undertaken in Agona district together
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with Awutu-Efutu-Senya district as one evaluation unit. Again this will also be 
discussed in the chapter on determining the end point of MDA.
In conclusion the recommended 5-6 years required to break the transmission 
of LF needs to be reviewed through further operational research with 
evidence presently available from the Ghana LF Elimination Programme. The 
number of years required to break transmission of LF seems to depend on the 
microfilaraemia prevalence at inception of the programme. It is important to 
note here that the role of other confounding factors in particular therapeutic 
coverage and compliance with MDA (Ottesen et al, 2008; Talbot et al, 2008; 
Cantey et al, 2010; Flodges et al, 2010), geographical coverage, mosquito 
vector characteristics, drug regimens (Bockarie et al, 2009) and other factors 
important to the successful implementation of LF elimination. These need to 
be considered in the process of monitoring and evaluation of MDA 
programmes (Kyelem et al, 2003, Addis, 2010). All these factors are 
important and integral to the achievement of elimination of LF.
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Chapter 7
Determining the End Points of 
Mass Drug Administration for 
Lymphatic Filariasis in Ghana
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Chapter?: Determining the End Points of Mass Drug Administration 
for Lymphatic Filariasis in Ghana
7.1 Introduction
Elimination programmes have a life span and therefore at the outset of the 
GPELF based on experiences in provinces of countries such as China that 
had been successful in eliminating LF (Xu et al, 2011) it was proposed that a 
period of between 5-6 years of annual treatments with ivermectin and 
albendazole was required to ensure elimination of LF from endemic areas 
after institution of treatment with coverage of circa 65% (Ottesen et al 1997; 
Ottesen, 2006). It was hypothesized that interruption of transmission could be 
achieved if prevalence of microfilaraemia declined below 1%, based on the 
China experience (Xu et al, 2011, Sudomo et al, 2010).
In the WHO 2001 LF report, to interrupt transmission of W.bancrofti was 
defined as “reduction in the disease incidence to close to zero as a result of 
deliberate efforts requiring continued and coordinated activities” (WHO, 2001). 
This meant that the entire at-risk population had to be covered with MDA over 
a time period long enough to bring about the desired effect of interrupting 
transmission. The drugs that were recommended were DEC (6mg/kg) and 
albendazole (400mg) or ivermectin (150ug/kg) and albendazole (400mg). 
DEC -fortified cooking salt daily over a period of 6-12 months is another 
option that is available to endemic countries (Ottesen, 2006, 1995). The 
GPELF works on the premise that the mass application of anti-filarial drugs is 
able to reduce microfilaria prevalence below a threshold necessary for 
continuing transmission of the infection by the local mosquito vector 
(Molyneux and Zagaria 2002; Ottesen, 2000). This introduces the need for 
sensitive, specific and standardized laboratory tools to help quantify the 
burden of infection within communities. Assessing progress and determining
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the end points of LF elimination programmes require effective laboratory 
diagnostic tools. Several tools have been developed to help programmes 
undertake these vital programme assessments. These tools include Bm14 
antibody test for antifilarial lgG4, Og4C3 antigen tests and ICT tests for 
Circulating Filarial Antigens (CFA) and night blood smears for microfilaraemia, 
which remains the Gold Standard for lymphatic microfilaraemia diagnosis 
(Weil et al, 2007, Moore et al, 1990).
The GPELF mainly employs two diagnostic tools which are detection of 
microfilaria (mf) in blood and detection of circulating filarial antigen (CFA) to 
implement its elimination strategy. CFA is detected by ICT rapid test and 
Og4C3 ELISA tests. These tests are useful when the parasite prevalence is 
relatively high but their sensitivity at low mf prevalence raises concern 
particularly in determining the end point of MDA and in the post-MDA 
surveillance phase (Weil et al, 2007, Fiappatz et al, 2008). End points 
determination and post-MDA surveillance for LF elimination programmes 
requires sensitive and reliable diagnostic tools to accurately define these end 
points and future surveillance (Flayley et al, 2010). A negative antibody 
serology test in children is a good indicator for cessation of transmission 
(Flayley et al, 2010). Flayley et al were able to demonstrate that filter paper 
sampling method was a sensitive and specific alternative to collection of blood 
collection surveys ((Flayley et al, 2010).
The Bm14 antibody tests are capable of detecting recent exposure to infective 
larvae and the presence of adult worms but the antigen and antibody tests are 
highly specific for LF with minimal to no cross-reactivity for other helminths 
which co-exist in populations where LF is endemic (Tisch et al, 2008). 
Antibody tests for monitoring LF infections was not useful in the past as 
individuals in endemic areas were constantly exposed to the infection and 
therefore antibody positive (Weil et al, 2007) but they could be useful tests in
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determining end points and in post-MDA surveillance in determining 
transmission among children born after the institution of MDA (Weil et al, 
2007). There are commercially available recombinant antigen detection tests 
with improved specificity due to reduced cross-reactivity with other parasitic 
diseases (Lammie et al, 2004). This made it a potential LF diagnostic test 
(Dissanayake et al, 1992).
Even though blood smears for detection of microfilaraemia is the essential 
parasitological method for establishing infection, antigen and antibody tests 
have also been shown to have several advantages over blood smears for the 
detection of microfilaraemia (Weil et al, 1996, 1997, 2007). These tests are 
sensitive and do not require night blood sampling in W.bancrofti endemic 
areas where microfilaraemia have nocturnal periodicity (Turner et al, 1993). It 
is noteworthy that Og4C3 antigens on which the ELISA (More et al, 1990) and 
ICT card test (Weil at al, 1997) are based is secreted by W. bancofti adult 
worms but not by Brugia species (Tisch et al, 2008). The Bm14 antibodies on 
the other hand may be present in individuals with W, bancrofti, B. 
malayi, or B. timori infection (Lammie et al, 2004).
Joseph et al (2010) clearly demonstrated the applicability of filter paper 
sampling method for detection of antifilarial lgG4 antibodies using the 
Filariasis CELISA, They indicated that this method was a feasible alternative 
for sero-epidemiological surveys. The filter paper sampling method is cost- 
effective, easy to undertake with limited sample variation resulting from 
changes in temperature since the blood spots are stable when completely 
dried at room temperature for up to a week (Coltorti et al, 1988). It is sensitive 
and has the added benefit of being applicable for post-MDA surveillance of LF 
(Joseph et al, 2010).
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Tisch et al (2008) established that the lgG4 antibody to Bin 14 is a good 
indicator for monitoring ongoing and recent transmission in children as 
sentinel groups (Tisch et al, 2008) in comparison to antigenemia which has 
the tendency to persist for months to years after the administration of anti- 
filarial drugs (Tisch et al, 2008). They determined the relationship between 
participation in MDA and changes in LF infection indicators and concluded 
that lgG4 antibody to Bm14 was a better indicator for monitoring the progress 
and possibly detect recrudescence or persisting transmission of W. bancrofti 
after MDA has ceased. Several years of annual treatments with anti-filarial 
medicines had resulted in marked reduction in microfilarial prevalence with 
less marked change to antibody and antigen rates (Tisch et al, 2008). 
However, these infection indicators continued to decline even after five years 
of stopping MDA with Bm14 antibodies persisting in the greatest proportions 
(Tisch et al, 2008). The Bm14 antibody tests could therefore be used as 
adequately sensitive tests for monitoring continuing transmission before and 
after MDA aimed at eliminating transmission of LF (Tisch et al, 2008).
For the detection of W.bancrofti infection, diagnostics for circulating Og3C4 
antigen and lgG4 antibody to the recombinant LF protein designated Bm14 
are employed. These tests are used for mapping LF endemic communities 
and are also applied to determine interruption of transmission (Lammie et al, 
2004, Ottesen, 2006). TropBio antigen enzyme-linked immunosorbent assay 
(ELISA) and the immunochromatographic (ICT) test rapid-card tests are 
commercially available diagnostic tests for the detection of LF infections in 
individuals (Melrose et al). In Ghana bancroftian filariasis is caused by 
W.bancrofti (Gyapong et al, 1996; Gyapong et al 2000; Boakye et al, 2004; 
Gbakima et al, 2005) which also occurs in many tropical and sub-tropical 
areas and accounts for 90% of cases of LF infection (Turner et al, 1993).
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The Gold Standard for the diagnosis of IF is the detection of microfilaraemia 
in blood samples (Moore et al, 1990). The use of this test has been the 
practice for research in LF, though it is often insensitive at low microfilaraemia 
densities (Moore et al, 1990). The need to collect the blood specimen at night 
makes the test less acceptable by community members and even the health 
workers (Moore et al, 1990). Many cases of active disease may also be 
amicrofilaraemia and therefore using microfilaraemia detection as an estimate 
of disease burden is bound to lead to an underestimation of the level of 
infection. (Moore et al, 1990; Ramzy et al, 2006; Ottesen et al, 2006; Farid et 
al, 2007).
Circulating filarial antigen (CFA) enzyme-linked immunosorbent assays 
(ELISA) were introduced in the early 1990s [Moore et al, 1990] and the 
immunochromatographic test (ICT) rapid card test for CFA in the mid-1990s 
(Wiel et al, 1997). These tests have transformed the diagnosis of bancroftian 
filariasis. The tests are sensitive, specific, not affected by periodicity and are 
capable of detecting both microfilaraemic and amicrofilaraemic cases (Moore 
et al, 1990; Simonsen et al, 1997; Ramzy et al, 2006; Ottesen et al, 2006; 
Farid et al, 2007; Weil et al, 2008; Weil et al, 2012). It is easy to perform on 
the field and requires little training for its application. It is user friendly and the 
preferred method for mapping LF disease endemicity (Molyneux and Zagaria 
2002; Gyapong et al 2002). The cost of the ICT card test, the need for it to be 
read within 10 minutes in the field and need for cold storage also presents 
significant challenges with its usage and economic accessibility to elimination 
programmes. ELISA tests for the detection of filarial antigens and antibodies, 
though cumbersome have remained an alternative to ICT tests for the 
diagnosis of filariasis and also for use in assessing interruption of 
transmission (Melrose et al, 2004) while investigations on the most 
appropriate diagnostic tests for determining the end points of MDA progresses 
(Weil et al, 2012).
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The Ghana Fiiariasis Elimination Programme (GFEP) was established with 
the aim of providing ivermectin and albendazole to all its endemic districts for 
the elimination of LF. This has been done through a gradual up-scaling 
process since 2000. By the year 2006 all the implementation units or districts 
endemic for LF in Ghana had started MDA and the 5 start-up districts had 
completed the minimum of 5-6 rounds of annual MDA (Ottesen, 2006, 
Ottesen et al 1997). All LF endemic districts have therefore completed 
between 5 and 10 rounds of annual MDA by 2010. Significant reductions in 
microfilaria prevalence had been recorded from the longitudinal blood surveys 
undertaken on the programme to eliminate the disease in Ghana. The 
challenge was therefore to find the evidence that elimination of LF had been 
achieved in these endemic districts as a demonstration of the ultimate 
success of the programme. The GFEP set but missed the year 2010 as the 
target for elimination of LF (Strategic Plan.Ghana Fiiariasis Elimination 
Programme, 2000) and also marked the midpoint of the GAELF that has an 
elimination target of 2020 (Addiss, 2010).
The GPELF has identified two important challenges to the elimination of LF 
which included the need for verifying elimination of LF and post-MDA 
surveillance (Addiss, 2010). The decision on when to stop treatment in Ghana 
became a challenging one since operational research conducted in Ghana 
has been inadequate to determine this. Surveys to develop, test and sharpen 
the tools for determining the end point of MDA were needed. With technical 
and financial support of the Bill and Melinda Gates Foundation, the Atlanta LF 
Support Centre and the Africa LF Support Centre based in Accra together 
with other countries a multi-country operational research activity was initiated 
in an attempt to develop and test the tools required for making this 
determination. The process involved refining technical definitions for 
assessing programme success, identifying determinants of success,
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identification of interventions that could be applied to supplement the current 
strategies of MDA were identified to be inadequate for achieving interruption 
of transmission. The development of guidelines to guide the process for 
implementing countries that had undertaken the minimum number of annual 
rounds of MDA was imperative (Addiss, 2010).
The elimination targets of LF involves achieving 5-6 rounds of annual 
treatments or MDA with ivermectin and albendazole in countries co-endemic 
for LF and onchocerciasis like Ghana and DEC and albendazole for countries 
that are only endemic for LF. Community microfilaria prevalence should also 
be reduced to below 1% among the adult population and antigen prevalence 
among children less than 5 years of age should be 0% according to WHO’s 
Monitoring and Evaluation manual (WHO, 2000, A Guideline for Programme 
Managers references). The initial WHO guidelines for determining the end 
points of MDA for programmes was defined by an antigen prevalence rate of 
less than one in 3000 children born after the initiation of MDA was required to 
stop MDA in an endemic district (WHO, 2005).
In Ghana there is the urgent need to scale down the elimination programme in 
order to free up the limited resources available for the implementation of the 
NTDs Programme from districts that have achieved elimination. The evidence 
to inform this process is urgently needed. A study to determine the most 
effective method for monitoring transmission of W.bancrofti and to determine 
the end point of MDAs was undertaken. These surveys were also employed 
by the programme to provide the evidence for stopping MDA in districts that 
met these criteria.
Current WHO Guidelines on how to determine national LF elimination 
program endpoints and for establishing post-MDA surveillance are based on 
diagnostic tools developed in 1999 (Addiss, 2010). Several diagnostic tests
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based on detection of human antibodies to recombinant antigens in blood and 
urine, parasite DNA circulating DNA in human blood or vector mosquitoes has 
been developed (Weil GJ et al, 2007). Studies were undertaken to first identify 
the most useful diagnostic tools for determining the end points in a Phase I 
study. ICT for antigen tests for children aged 6-7 years instead of those under 
5 years, blood smears for microfilaraemia among adults and PCR for 
circulating DNA tests were identified as useful tools for this purpose (Phase I 
Report for Ghana Studies, Unpublished). The process ended with the 
development of a new WHO standard protocol for determining the end point 
of MDA. Phase II studies were conducted to test the identified tools. The 
Phase II survey’s main aim was to test the new WHO standard protocol for 
determining the end point of MDA in 4 districts in Ghana. These districts are 
Efutu, Awutu-Senya and Agona East and West districts and had satisfied the 
criteria for proceeding with surveys to stop MDA. As part of this study 
important research questions within the framework of determining the end 
point of MDA were also addressed, however these will not be discussed in 
this thesis.
LF is targeted for elimination by the year 2020 through MDA, using a single 
dose combination of ivermectin and albendazole or DEC and albendazole for 
a period of 5-6 years. Many countries are reaching the target treatment cycles 
of 5-6 years MDA and the decision to stop needs to be addressed. To ensure 
the ultimate success of the GPELF, studies to find solutions to the challenges 
and potential barriers facing it today were funded by the Bill and Melinda 
Gates Foundation.
This study has passed through a first phase the purpose of which was to 
compare all available diagnostics to identify which would be most 
programmatically useful for the GPELF. This phase showed that ICT to detect 
antigen in children aged between 6-7 years is a practical tool that will help
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countries to decide when to stop MDA. The purpose of the present phase II 
study is to apply these tools to determine the end points of MDAs in selected 
sites.
The main aim of this survey was to test the new WHO standard protocol for 
determining the end point of MDA in 4 districts in Ghana. These districts are 
Efutu, Awutu-Senya and Agona East and West districts and had satisfied the 
criteria for proceeding with surveys to stop MDA.
7.2 Assessing Interruption of Transmission of Lymphatic Filariasis in 
Five Start-up Districts
In an effort to determine interruption of LF transmission in Ghana Og4C3 and 
the Bm14 test were applied. Antigen and antibody assays were performed on 
blood spots collected from children borne since the inception of MDAs. The 
antigen and antibody status of children born during this period most of whom 
are aged 1-6 years and who resided in the study communities for at least a 
year before this cross-sectional study to determine the appearance of any 
new infection was conducted. Most of these communities are high 
transmission communities where MDAs were first initiated at the inception of 
the programme in 2000/2001. Having achieved more than 6 annual rounds of 
treatment in the 5 study districts in Ghana and in many other districts an 
objective to determine the end point of MDA in these districts was undertaken. 
Specifically this study sought to undertake an assessment for new infections 
in children born since the commencement of annual mass treatments. By 
employing the available epidemiological assessment tools and methods the 
end point of this mass treatment programme could be estimated.
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7.3 Method
ELISA tests that rely on the principle of antigen-antibody reactions in the body 
were applied. Filarial parasite antigens are proteins which enter the human 
body and induce production of antibodies as part of the body’s immune 
response to the antigens. These antigens are found on the surface of the 
parasites and are recognized by the body to produce the antibodies, which 
bind to the specific antigens on the parasites in order to eliminate the antigens 
from the body as part of the body’s immune response to infections. Though all 
antigens may be cleared during this process some of the antibodies may 
remain in the body’s circulatory system for up to 6 months during which they 
remain detectable after which time they are eliminated by the body. Positive 
antigen reactions are indicative of active infections while positive antibody 
reactions may be indicative of active or recent infections and ongoing 
transmission.
7.3.1 BM14 Antibody and OG4C3 Antigen Tests
Bm14 antibody and Og4C3 antigen tests can be employed to detect the 
presence or absence of W.bancrofti antigens in infected or exposed 
individuals. Og4C3 antigen tests are capable of detecting W. bancrofti 
antigens while Bm14 tests are able to detect the presence of antibodies to W. 
bancrofti antigens in blood. Detection of antigens of W. bancrofti in blood 
employs the use of specific W. bancrofti antibody coated microtitre plates, 
which capture the antigens in the blood of affected individuals. Further 
reaction by titration of the complex with a substrate through attached enzymes 
presents as a colour change, which is measured as the absorbance of the 
solution. Similarly detection of the W. bancrofti antibodies in blood employs 
W. bancrofti antigen coated microtitre plates which are capable of capturing 
the antibodies in the blood. This is capable of also reacting with a substrate
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through an enzyme-linked process to present as a colour change measured 
as the absorbance of the final solution. The absorbance based on the colour 
intensity of the solution is proportional to the amount of antigens or antibodies 
detected or present in the blood sample. The higher the absorbance the more 
antigens or antibodies are detectable in a particular sample. A positive test for 
W. bancrofti antigen (Og4C3) is interpreted as an active infection. A positive 
Bm14 test is interpreted as exposure to the infection.
Positive tests for antigens and antibodies give high absorbance due to high 
titers because more molecules of W.bancrofti antigens or antibodies are 
present to bind to the antigens or antibodies respectively in the solution. 
Negative tests therefore indicate the absence of antigens or antibodies in the 
blood to bring about the positive reaction. These are based on the cut-off 
points for the titre values or absorbance, which fall between the positive and 
negative values. Absorbance values too high to be negative or too low to be 
positive were repeated to confirm the obtained positive or negative results. In 
such a situation, these samples were repeated to confirm positivity or 
negativity. In other cases the actual values were used depending on how far 
or close these values were to the negative or positive cut-off points. Since all 
the samples tested came from endemic areas that had reached the point of a 
possible break in transmission, intermediate or indeterminate results were 
considered as negative test results.
7.4 Results and Discussion of OG4C3 Antigen and BM14 Antibody 
Tests
These cross-sectional TAS employed the Og3C4 antigen and Bm14 antibody 
ELISA tests. About 300 blood samples were targeted per site and collected 
from children from 2 sentinel and 1 cross-check site from each of the 5 
districts. A total of 4,550 blood samples were collected and about 60pl of
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finger prick blood used to prepare a blood spot on filter paper. These spots 
were dried and stored below zero degrees in a cold room. Og4C3 antigen and 
Bm14 antibody tests were performed on these blood spots and analysis of the 
data carried out.
In all a total of 4112 Og4C3 antigen and 3888 Bm14 antibody tests were 
carried out. However, out of this total number, 259 (6.3%) of these Og4C3 
antigen test results were indeterminate while 788 (20.3%) of the Bin 14 
antibody test results were indeterminate. These test results were therefore 
discarded as being negative. A total of 36 of the Og4C3 antigen test results 
were positive giving an overall antigen prevalence rate of 0.9% among the 
children surveyed from the 5 endemic districts while the Bm14 antibody 
prevalence rate was 9.7% with 376 positive test results (Table 7.1). The 
Og4C3 antigen and Bm14 antibody tests could not be done on 438 and 670 of 
the samples respectively due to wastage of the test kits during the laboratory 
process. Analysis of the data is therefore based on 4112 samples processed 
for Og4C3 antigen and 3888 processed for Bm14 antibody.
Each of the districts had an Og4C3 antigen positive rate below 1% except 
Builsa district, which had a positive of 2.1% (Table 7.2), which is significantly 
high since no new infections are expected within this age group. Higher Bm14 
antibody prevalence rates were found in all sampled districts and these 
ranged from 8.1% in Sissala district to 13.1% in Kassena Nankana district. 
Builsa district had the highest number of positives recorded but because more 
people were tested Builsa had a Bm14 antibody prevalence rate of 11.2% 
(Table 7.3). These results indicate that though prevalence of the active 
infection was low as indicated by the Og3C3 antigen tests results exposure to 
the parasites as indicated by the Bm14 antibody tests was significant at the 
district level.
253
At the sub-district level, the Bm14 antibody test results ranged from 4.6% in 
Dixcove sub-district in the Ahanta West district with the highest of 22.2% in 
Paga in the Kassena Nankana district. The other sub-districts of Kassena 
Nankana also generally had high values of 31.2% and 11.8% (Table 7.4) in 
Kassena Nankana Central and Navrongo respectively. This further 
emphasizes the level of exposure at the sub-district level, which may be 
indicative of recent exposure or ongoing or active infection, or a recently 
cured individual. In the case of these surveys these sampled children have 
not be exposed to treatment with ivermectin and albendazole to date and so 
these prevalence levels of antibodies to W.bancrofti would indicate recent or 
active infection.
Individuals positive for the antigens are expected to be positive for the 
antibodies as well. However, very recent infections might not have generated 
enough antibodies to be detectable by ELISA. A person may also be positive 
for the antibody test but negative for the antigen test.
Table 7.1: Summary of OG4C3 Antigen and BM14 Antibody Test Results
SUMMARY TABLE OF OG4C3 AND BM14 TEST RESULTS
Test Total Number Positive Number Negative Indeterminate Indeterminate
Undertaken Tested Positive % Negative % (N) %
OG4C3 4112 36 0.9 3819 92.9 259 6.3
BM14 3888 376 9.7 2726 70.1 788 20.3
Table 7.2: Summary of OG4C3 Antigen Test Results by Districts
BM14 RESULTS BY DISTRICTS
District Total
Tested
Number
Positive
Positive
(%)
Number
Negative
Negative
(%)
Indeterminate Indeterminate
(%)
AES 526 43 8.2 351 66.7 131 24.9
Builsa 1036 116 11.2 705 68.1 215 20.8
KND 528 69 13.1 399 75.6 60 11.4
Sissala 851 69 8.1 612 71.9 173 20.3
Ahanta
West
947 79 8.3 659 69.6 209 22.1
Total 3888 376 9.7 2726 70.1 788 20.3
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Table 7.3: Summary of BM14 Antibody Test Results by Districts
OG4C3 Test Results by Districts
District
Total
Tested
Number
Positive
Positive
%
Number
Negative
Negative
%
Indeterminate
(N)
Indeterminate
%
AWUTU
EFUTU
SENYA
900 3 0.3 843 93.7 54 6.0
Builsa 851 18 2.1 782 91.9 51 6.0
KND 681 5 0.7 637 93.5 41 6.0
Sissala 948 4 0.4 863 91.0 81 8.5
Ahanta
West
732 6 0.8 694 94.8 32 4.4
TOTAL 4112 36 0.9 3819 92.9 259 6.3
Figure?. 1: OG4C3 Antigen and BM14 Antibody Test Results Among Children
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Figure 7.2: OG4C3 Antigen Test Results by Districts
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Figure 7.3: Summary OG4C3 Antigen and BM14 Antibody Test Results
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Figure 7.4: BM14 Antibody Test Results by District
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Figure 7.6: OG4C3 Antigen Test Results by Sub-Districts
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The antigen prevalence rates were generally lower than the antibody 
prevalence rates among children surveyed (Figure 7.1). Og4C3 antigen tests 
conducted on children gave results that showed a low prevalence of antigen 
in the children surveyed in these sentinel and cross-check sites. At the sub­
district level antigen prevalence rates were from 0.0% in several of the sub­
districts to 1.7% in Discove in Ahanta West district (Table 7.5). The sites, 
which had 0% prevalence rates, were located in Bontrase sub-district in 
Awutu-Efutu-Senya districts and KND Central in Kassena Nankana, Gwollu in 
Sissala, Agona and Discove sub-districts in Ahanta West. (Table 7.5) Based 
on these test results none of the districts qualified to stop MDAs since antigen 
prevalence in both sentinel and cross-check sites which is indicative of active 
infection was not 0% in all the 5 start-up districts surveyed. None of the 
districts could demonstrate a prevalence level of 0% in both sentinel and 
cross-check sites surveyed to indicate a break in the transmission of W. 
bancrofti.
7.5 Method for Testing the Stopping Criteria for Lymphatic Filariasis
Districts enroled for these assessments needed to meet the selection criteria. 
As an entry criteria districts or implementation units should have completed 5 
rounds of effective MDA and also have microfilaria prevalence from sentinel 
and spot check sites of less than 1% among the adult population. For this 
study the concept of the evaluation unit was also introduced which 
incorporated several implementation units or districts with similar 
characteristics in terms of number of completed rounds of MDA and 
microfilaraemia prevalence of less than 1% from both sentinel and cross 
check sites as a single unit for the evaluation (WHO, 2000; WHO, 2006, a,b; 
WHO, 2011a). For this survey the selected evaluation unit (EU) was made up 
of Awutu-Efutu-Senya, and Agona districts (Figure 7.8) in the Central Region 
recently re-demarcated into 4 districts (Government of Ghana, 2006) were
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identified for the study. The microfilaraemia prevalence in the selected 
districts for the Ghana study from the 3 monitored sentinel and cross-check 
sites at the last or post-MDA 5 survey were 0.9%, 0.9% and 0.2% respectively 
and had completed 7 and 8 rounds of MDA respectively. In Awutu-Efutu- 
Senya district the microfilaraemia prevalence at baseline before MDA ranged 
from 12.5% to 27.1% and between 0.0% and 2.9% at mid-term. In Agona 
district microfilaraemia baseline prevalence was between 0.0% and 13.8% 
and 1.3% before MDA 5.
The total population of the evaluation unit was 388,424 made up of Awutu- 
Efutu-Senya district with 200,717 and Agona with 187,707. The school aged 
population defined as children of school-going age who have been enrolled 
into school and receiving formal education for Awutu Efutu Senya district was 
about 54,796 and that for Agona was 51,167 which is 27.3% of the total 
population. School enrolment was 73,007 for AES and 64,948 for Agona. 
These were the actual figures for both public and private schools in both 
districts. There were 807 schools made up of 281 public and 526 private 
schools and the school enrolment was therefore more than 75%. Awutu Eutu 
Senya district had completed 9 rounds of MDA while Agona district had 
completed 8 rounds as at 2009. Both districts have completed 8 rounds of 
MDA and the reported coverage for each year is shown in the table 7.8 below.
Table 8: Reported MDA Coverage from 2001-2009 for Awutu Efutu Senya 
and Agona Districts
MDA Coverage (%) for Awutu-Efutu-Senya and Agona
Districts Year
2001 2002 2003 2004 2005 2006 2007 2008 2009
Awutu Efutu Senya 87.7 93.1 76.7 82.4 75.9 84.2 79.2 62.2 57.9
Agona - 91.7 85.1 87.6 76 77 88.1 87.9 75.6
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During this treatment period from 2001 to 2009 Awutu Eutu Senya had 
achieved adequate MDA coverage of between 88.1% and 70.2% from 2001 to 
2008. However, in 2009 the reported coverage by Awutu Eutu Senya was 
44.6% (Table 7.8), which is below the 65.0% threshold. The reasons for this 
low reported coverage in 2009 need further investigations, however the 
district was still considered for the TAS. Agona district reported coverage that 
ranged from 69.1% - 88.0% (Table 8). For the years 2008 and 2009 the 
district populations and population treated for the newly created districts in 
Agona and Awutu-Afutu-Senya districts were combined to give the treatment 
coverage for the districts.
Some 30 schools were randomly selected using the “Survey Sample Builder” 
software application. This was increased to 40 in order to obtain the required 
sample size of the age group 6-7 years due to the timing of the surveys. The 
communities in which the schools were located or communities which the 
schools served,were chosen for the community survey. Children aged 6-7 
years old and adults 16-45 years of age from the evaluation unit made up of 
Awutu-Efutu-Senya and Agona districts were surveyed. The school children 
were surveyed first. The cluster-sample school survey of children in class one 
and two (children aged 6-7 years) was applied. This involved the selection of 
a 1556 school children from 40 schools in the evaluation unit.
Adult sampling was done after the school participants have been sampled in 
communities where the school children live. Sampling of individuals or 
households for both school children and adults was done randomly. 
Immunochromatographic card tests (ICT) were performed on all study 
participants and positive individuals from both cohorts had follow-up PCR and 
microfilaraemia tests conducted on blood samples collected from them within 
14 days of the initial ICT test.
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The Standard Operating Procedures (SOPs) for blood collection and 
processing for analyses (LF Support Center, The Taskforce for Child Survival 
and Development, 2009) were employed for the surveys. Data analysis was 
done in Excel. Collection of day-time blood from school children aged six and 
seven years was undertaken in the selected schools. Parental consent was 
sought before blood collection was done. For the community survey, house- 
to-house registration of study participants was undertaken and day-time blood 
samples taken for processing in two Government hospital laboratories located 
in the study districts. In the field, blood was collected into Ethylene Diamine 
Tetra Acetic Acid (EDTA) coated tubes for transportation to the laboratory. In 
the laboratory, the blood collected in the EDTA tubes were processed as 
follows; ICT tests were done on each sample and the results recorded 
following the manufacturer’s instructions. A second ICT test was done on any 
sample that showed positive or indeterminate result for the first ICT. The 
study participant was then followed up and night blood collection was done. 
Blood films for microfilariae (microfilaraemia) identification with whole blood 
were prepared. Also, blood blots were made on filter papers and dried 24 
hours. All procedures were undertaken according to the SOPs provided for 
the study.
7.5.1 Core (Children) Survey
The core survey was employed to test the stopping criteria. A school-based 
cluster survey was employed in this study. School children in classes one and 
two aged between six and seven years were selected and included in the 
study. In instances where school children aged between six and seven years 
were found in classes other than classes one and two, they were also 
recruited into the study. The Manual for Survey Planners and the Survey 
Sample Builder application were used in calculating the sample size for the 
study. The target sample size was 1556 school children from a target of 30
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later increased to 40 schools. No sampling interval was utilized because a 
major limitation of the study was that schools had just re-opened in the rural 
areas and the likelihood of getting more than 50% of the children in school 
was small. Thus all children aged between six and 7 years in the schools 
were sampled. ICT antigen tests were performed on all persons sampled and 
positive test individuals followed up with blood smears for microfilaraemia and 
PCR tests.
7.5.2 Adult Survey
This survey also employed Awutu-Efutu-Senya and Agona districts as the 
evaluation unit. This was also a cross-sectional survey, which employed 
adults’ aged between 16 and 45 years selected from communities, which the 
selected schools served. The calculated study sample was 900, however a 
sample size of 1200 was applied to improve on the power of the study. Each 
community in which the schools were located were divided into 4 quadrants 
and 10 adults randomly selected from different households in each of the 
quadrants to make a total of 40 per community from each of the communities 
from which the initial 30 schools were found.
Diagnostic tests and sample processing was the same as that carried out in 
the core survey. ICT antigen tests were performed on all persons sampled 
and positive test individuals followed up with blood smears for microfilaraemia 
and PCR tests.
7.5.3 Ethical Considerations
Ethical clearance was sought from the Ghana Health Service Ethical Review 
Board and from the Liverpool School of Tropical Medicine. The consent of the 
heads of the selected schools and the parents of the selected children were
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sought before any sample was taken. For the adult survey, the consent of the 
participating adults was sought before blood was drawn.
7.5.4 Results and Discussions
Core Survey was employed to test the MDA stopping criteria that had been 
developed in the Phase I study. For the core survey involving school children 
aged 6-7 years, a total of 1577 were involved in the study selected from 40 
schools with a total school enrolment of 14,023 (Table 7.9). About 11% 
(Table 7.9) of the total school enrolment was therefore employed for the 
survey. About 687 (43.6 %) of the total sample size were children aged six 
years while 879 (55.7 %) were aged 7. The number of female children 
recruited into the survey was 817 (52 %), while the boys were 760 (48 %) 
(Table 7.10). There was no record of age for 11 (0.7 %) of the children 
surveyed (Table 7.10).
Table 7.9: Sample Size Overview
IU or District Number of
Schools Surveyed
Total Enrolment
or Population
Number of
Children Surveyed
Proportion (%) of
Children
Surveyed
Awutu-Efutu-Senya 26 9,723 1,122 12%
Agona 14 4,300 455 11.%
Total (n=) 40 14,023 1,577 11%
Table 7.10: Demographic Information
Age (Years) Male Female Total
6 330 357 687 (43.6%)
7 421 458 879 (55.7%)
No age recorded 9 2 11 (0.7%)
Total (n=) 760 (48%) 817(52%) 1577
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For the whole survey only 2 children tested positive for ICT antigenaemia 
giving an antigen prevalence of about 0.1% (Table 7.11). These tests 
repeated positive for the ICT, while PCR result was negative and no 
microfilaraemia was detected on blood smear. In all therefore there was no 
sample that tested positive for both PCR and blood smear, none was blood 
film positive and PCR negative nor microfilaraemia positive with PCR and 
blood smear positive or PCR or blood smear positive (Table 7.11 and 7.12).
Table 7.11: Test Results for Children’s Survey
Test
Result
1st ICT 2nd ICT PCR Blood
Smear
Microfilaraemi
a (PCR and
Blood Smear)
PCR
(+) and
Blood
Smear
(-)
Blood
Smear
(+) and
PCR (-)
Any
Microfilaraemi
a + (PCR
and/or Blood
Smear)
Positive 2/1562
(0.13%)
2/2
(100%)
0/2
(0%)
0/2
(0%)
0/2 0/2 0/2 0/2
Negative 1558/15
62
(99.7&)
0/2
(0%)
Invalid 1/1562
(0.06%)
0/2
(0%)
Not
tested
1/1562
(0.06%)
0/2
(0%)
Total 1562 2 2 2 2 2 2 2
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Table 7.12: Cross-Comparison Test Results for Children’s Survey (for ICT)
Test Index n= ICT PCR Blood Smear Microfilaraemia
(PCR or Blood
Smear)
ICT 1562 2/1562 0/2 0/2 0/2
(0.13%) (0%) (0%) (0%)
PCR 2 2/2 0/2 0/2 -
(100%) (0%) (0%)
Blood Smear 2 2/2 0/2 0/2 -
(100%) (0%) (0%)
Microfilaraemia (PCR 2 2/2 0/2 0/2 0/2
or Blood Smear (100%) (0%) (0%) (0%)
and/or
Microfilaraemia
Positive)
Table 7.13: Discordant Test Results
Test ICT Results PCR Results Blood Smear Number (n)
Results Positive Negative Negative 2
Total Discordant Results (n=) 2
Two discordant test results were obtained and these were the two children 
that tested positive for ICT antigenaemia but negative for PCR and blood 
smear examination (Table 7.12 and 7.13). These discordant results indicate 
that actual prevalence of infection based is about 0% since the antigen 
positivity could not be confirmed by blood smear which is a less sensitive test 
than the ICT test . Neither could this antigen positivity be confirmed by PCR 
which is a more sensitive test than the antigen tests though repeated ICT 
tests came out positive.
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7.6.1 Results of Adult Surveys
Table 7.14: Demographic Information
Age Male Female Total
16-20 years 110 155 265 (22%)
21-25 years 77 175 252 (21%)
26-30 years 61 177 238 (20%)
31-35 years 42 129 171 (14%)
36-40 years 34 114 148(12%)
41-45 years 32 91 123 (10%)
No age recorded 4 5 9 (0.7%)
Total (n=) 360 (30%) 846(70%) 1206
Table 7.15: Results for All Tests
Test
Result
1st Id 2nd
Id
PCR Blood
Smear
Microfilaraemia
(PCR and
Blood Smear
PCR
(+)
and
Blood
Smear
(-)
Blood
Smear
(+)
and
PCR (-
)
Any
Microfilaraemia+
(PCR and/or
Blood Smear)*
Positive 14/1199 14/14 1/14 0/10 0/14 0/14 0/14 1/14
Negative 1184/1199 0/14 13/14 10/10 10/14 “ “ 13/14
Invalid 0/1199 0/14 0/14 0/10 0/14 " *
Not
tested
1/1199 0/14 0/14 0/10 0/14
Total 1199 14 14 10 14 14 14 14
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Table 7.16: Cross-Comparison Test Results For ICT and/or Microfilaraemia positive for Adult 
Surveys
Test Index n= ICT PCR Blood Smear Microfilaraemia
(PCR or Blood Smear)
ICT 1199 14/1199 1/14 0/14 1/14
PCR 14 14/14 1/14 0/14 -
Blood Smear 10 10/10 0/10 0/10 -
Mf (PCR or Blood Smear) 1/14 14/14 1/14 0/14 1/14
Table 7.17: Discordant Test Results for Adult Surveys
ICT Result PCR Blood Smear n=
1 Positive Positive No Result 1
2 Positive Negative Negative 10
3 Positive Negative No Result 3
Total Discordant Results (n=) 14
The adult survey involving a total sample size of 1206 had the age group from 
16-20 years forming the biggest proportion of 22% (Table 7.14). The age 
group participation in the survey declined with ascending age. This ended with 
the age range of 41-45 having the least number recruited into the study. 
About 0.7% made up of 9 individuals had no age recorded for the adult 
surveys (Table 7.14).
Results of the ICT, PCR and blood smear for microfilaraemia tests conducted 
on blood samples collected for the adults surveys indicated 14 positives for 
both first and repeat ICT tests. Of this number only one was PCR positive and 
none blood smear positive (Table 7.15). All the 14 tests can be categorized as 
being discordant (Table 7.16 and 7.17) since none of the positive tests for ICT 
card antigen test was positive for neither PCR nor blood smear for 
microfilaraemia. Among the 14 positive test results for ICT, one was PCR 
positive but microfilaraemia negative.
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More girls than boys were recruited into the study. This is probably because at 
the primary level school enrolment for girls tends to be higher than that for 
boys (GDHS, 2003 and 2008; GHSS, 2000 and 2010). While for the adult 
population there was a decline in the proportion of adults recruited as the age 
range increased which also is in accordance with the population pyramid for 
the country (GGDHS, 2003 and 2008; GHSS, 2000 and 2010). More adult 
females were also sampled as compared to the adult males for the adult 
surveys, primarily because adult men leave the communities during the day to 
involve themselves in income generating activities leaving the women at 
home to cater for the children and other household needs including household 
chores. Women engaged in income generating activities tend to be located 
within the communities in which they reside.
Blood antigenaemia prevalence detection by the ICT card tests indicated an 
antigen prevalence of 0.1% among the 6-7 year old school children surveyed. 
However, this could not be confirmed with blood smear tests for 
microfilaraemia, which is the known gold standard test for LF infection in 
terms of sensitivity although the sensitivity of blood examination could be 
increased if blood filtration of a larger volume of blood through Nucleopore 
filters is employed (Ramzy et al, 2006). However in the settings in which this 
study was done this was not practicable. However the results are indicative of 
extremely low prevalence, and one, which should not sustain transmission 
although it does suggest that some transmission among children who were 
born after the inception of the LF treatment programme in the surveyed 
districts did take place.
The adult population had an ICT antigen prevalence of 1.2% suggesting 
higher infection rates among adults as compared to the 6-7 year old children. 
Adults are generally more exposed to mosquito bites than children 
considering that adult activities such as late sleeping habits, household
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chores and night entertainment predispose adults to more mosquito bites at 
night. However, in terms of the transmission dynamics of LF, adults might also 
have had a longer period of exposure with some adults not complying with 
mass treatment being reservoir of infection of the disease.
The low prevalence of W. bancrofti demonstrated by these surveys does 
demonstrate a possible break in transmission in these endemic districts 
surveyed as one evaluation unit. However, the need for post-elimination 
surveillance with the purpose of monitoring re-emergence of LF as has been 
shown in other programmes in India and recently in Zanzibar (Mohammed, 
2009) may raise the questions as to whether the evidence provided through 
these surveys are adequate to inform the decision to bring MDAs to an end.
Generally TAS have not included vector infectivity studies. Programmes have 
also not routinely monitored transmission of LF with vector studies. The main 
reasons have probably been due to lack of the required expertise to 
undertake this monitoring as part of routine programme activities. The role of 
the mosquito vector in the transmission of W. bancrofti and therefore the 
vector-parasite relationship is extremely important as some vectors have been 
demonstrated to be effectively transmitting LF even at low prevalence of the 
parasite. Vector-parasite dynamics and therefore vector infectivity should be 
considered in providing evidence to demonstrate interruption of transmission 
of filaria parasites.
The success of any LF elimination programmes is demonstrated by the 
decision to stop treatment. The ability to effectively monitor the disease and 
eventually take a decision to stop treatment depends on the availability of 
tools to make this determination. Current working hypothesis is premised on 
the China experience that transmission will be interrupted if microfilariaemia 
prevalence falls to less than 1% (Itoh et al., 2007; Addiss and the GAELF,
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2010). This recommended threshold might have to be reconsidered based on 
country experience requiring thresholds determined by factors such as the 
vector species, parasite type, drug regimen and treatment compliance.
In the light of the above discussion it can be concluded that overall prevalence 
of filaria parasites is low as demonstrated by the ICT card tests being the only 
one of the tools that produced positive test results. The results from the core 
school children study recommend that MDA be stopped, post MDA 
surveillance should be put in place in these 4 districts and a re-assessment of 
transmission carried out after two years
The antigen positive rate shown by the ICT card tests in the light of negative 
microfilariaemia may be explained the presence of residual adult worm 
antigens present in human circulation from resolved infections (Lammie et al., 
1994) which may persist for as long as 3 years post treatment due to slow 
clearance from the circulation (Eberhard et al. 1997; Nicholas et al., 1997; 
Tisch et al., 2008).
7.7 Conclusions
Conclusions based on the results of the two surveys conducted in 2007 
involving the five start up districts using the filter paper method and then in 
2010 involving one evaluation unit made up of 2 districts that included one of 
the 5 start up districts respectively are made. Transmission assessment 
surveys using the filter paper method conducted on the five start up districts in 
2007 demonstrated ongoing transmission of filarial infection requiring that 
MDA be continued in the five start up districts which included Awutu-Efutu- 
Senya district. Subsequent surveys in 2010 involving Awutu-Efutu-Senya 
district as part of testing the WHO’s stopping criteria established that 
transmission in this district as part of an evaluation unit assessed had been
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broken. These 2010 surveys conducted indicated that ICT prevalence in the 
community was very low (1.0%). All slides examined for W.bancrofti were 
negative. The annual MDA in Awutu-Senya, Efutu, Agona East and Agona 
West has been effective and MDA could be discontinued and a 2-year post 
MDA surveillance undertaken after which a re-assessment of transmission 
could be carried out.
These surveys have indicated that 5-6 years of MDA are not adequate to 
reduce microfilaraemia prevalence in Ghana to less than 1% for all the study 
districts according to the Og4C3 and Bm14 ELISA tests undertaken among 
the children less than six years in the five start up districts. High prevalence of 
infection in these districts at the outset of the programme could be the factor 
which is the most likely explanation for this situation. In these districts MDA 
coverage and compliance, discussed in chapter 4, though good according to 
reports received on the programme, might not be a true reflection of the MDA 
coverage on the ground. Urbanization, which is fast spreading in Ghana, 
presents many challenges to mass drug treatment programmes. These start­
up districts include many urban communities, which may have contributed to 
possible inadequate compliance with treatment among discrepancies with the 
calculation of coverage. Ghana employs ivermectin and albendazole for its 
MDA but compared to DEC and albendazole this treatment regimen might be 
less efficacious (Gyapong et al, 2005; Bockarie et al, 2009).
After a further two years of mass drug treatment, Awutu-Efutu-Senya district 
together with Agona district as a single evaluation unit has been able to 
interrupt transmission. This suggests that more than the 5-6 years would be 
required for other districts to interrupt transmission of W. bancrofti in Ghana. 
However, districts which started with a lower baseline prevalence than these 5 
districts but have undertaken the minimum of 5-6 rounds of MDA should have 
TAS undertaken which could lead to discontinuation of MDA in these districts.
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Resources available could be deployed to focus on the challenge of reducing 
prevalence in those districts with higher prevalence at baseline.
Operational research and programme experience indicate that, when five 
years of MDA are insufficient to reduce microfilaremia to levels that will not 
sustain further transmission, several factors may be in play. These include 
high prevalence and density of pre-MDA microfilaremia, low drug coverage or 
compliance, characteristics of the local vector, the drug regimen used, or 
other factors, such as the lack of social cohesion, especially in urban 
environments. In such situations, alternative strategies may be needed, 
including modified drug regimens (e.g., biannual MDA), vector control 
measures, or perhaps antibiotic treatment. The study demonstrated that LF 
elimination is feasible, even in areas with the greatest challenges, however 
continued operational research is necessary for providing guidance to 
programmes (Addiss, 2010).
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Chapter 8
Initiating a Schistosomiasis and Soil- 
Transmitted Helminth Control Programme 
Ghana-rationale, approaches and results
Chapters: Initiating a Schistosomiasis and Soil-Transmitted Helminth 
Control Programme in Ghana-rationale, approaches and results
8.1 Introduction
Ghana started implementing the National Neglected Tropical Diseases 
Programme (NTDP) in 2007 developing a 2-Year Plan of Work and receiving 
approval for the United States Agency for International Development (USAID) 
funded project. The disease control programmes that were incorporated into 
the plan were LF Elimination, Onchocerciasis Control, Trachoma Control and 
Schistosomiasis and Soil Transmitted Helminthiasis Programmes. The 
Filariasis Control Programme had completed mapping and was implementing 
the programme in all identified 61 endemic districts. The Onchocerciasis 
Control Programme had incomplete risk maps but despite that was also 
implementing the programme in 3204 communities from 66 endemic districts, 
Trachoma control was implementing the SAFE (Surgery, Antibiotics, Face 
washing and Environmental Control) strategy in its programme in 26 endemic 
districts after undertaking a mapping exercise. Data available from hospital 
and Health Centre records had indicated that Soil Transmitted Helminthiasis 
was endemic throughout the country and did not necessarily require a 
mapping exercise. Schistosomiasis, required to be mapped in order to focus 
control activities and to prevent wastage of resources. Stool samples 
collected for identifying Schistosoma mansoni was also used to identify soil 
transmitted helminths to serve as baseline data for monitoroing helminths 
infection.
Schistosomiasis is a water-borne disease of significant global public health 
importance (Steinmann et al., 2006) endemic in tropical and subtropical 
regions with fresh water snails acting as intermediate hosts. The infection is 
widespread in parts of Africa, South America, the Middle East, the Caribbean
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and Asia where it is a leading cause of morbidity and mortality (WHO, 2002; 
WHO, 2010). Schistosomiasis is confined to the tropics and subtropics and 
mainly affects the poorer segments of the population. The disease exhibits a 
focal distribution due to the dependence of the parasites on snail hosts 
(Lengeler, et ah, 2002; Hotez et al, 2009). Communities where 
schistosomiasis is found exhibit characteristics common to neglected 
populations. They are poor rural and urban settings which are usually 
underserved with basic social amenities and marginalised in particular access 
to safe water, sanitation and health education. Despite the high burden of the 
disease its control has not hitherto been prioritised in the national policy or 
political agenda (Hotez et al. 2008).
The disease is a major cause of morbidity and mortality. Estimates indicate 
that about 779 million people are at risk of schistosomiasis and 207 million 
people are infected with the disease. About 20 million people of those infected 
with the condition are estimated to have the severe form of the disease 
(Chitsulu et al, 2000). Schistosomiasis is ranked only next to malaria and LF 
globally as a parasitic disease in terms the estimated at risk population and 
the number of people infected with the disease. It is again estimated to cause 
an annual loss of between 1.7 and 4.5 million disability adjusted life years 
(DALYS) (WHO,2010; WHO, 2004; WHO 2002; Utzinger et al., 2004) though 
the global disease burden of schistosomiasis is suspected to have been 
seriously underestimated since other estimates have shown that this figure 
could even be much higher (King CH et al, 2005). Sub-saharan Africa has the 
highest burden of schistosomiasis where the highest prevalence and 
intensities of infection are found in school-aged children, adolescents and 
young adults (Woolhouse, 1998;Jordan et al., 1993). In sub-saharan Africa 
the negative impact of this infection on school performance seriously 
undermines social and economic development in heavily infected areas 
(Tanner, 1989; Weisbrod et al,1973; Nokes et al, 1999; Parker , 1992).
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Transmission of schistosomiasis has strong linkages to the development, 
provision and management of water resources in the tropics and sub-tropics, 
where transmission is either introduced or increased if already present as well 
as development of water and sanitation and knowledge (Hunter et al., 1993; 
Jobin, 1999; Oomen et al., 1988; Oomen et al., 1988). With regards to the at- 
risk population an estimated 660 million were concentrated in Africa from 46 
countries with 201.5 million estimated to be carrying schistosome eggs. The 
African region alone accounts for some 97% of the total number of infections 
worldwide and 87% of the global burden (Steinmann P et al, 2006).
8.2 Disease Causation, Transmission, Pathogenesis and Pathology
The disease causation, transmission, pathogenesis and pathology including 
the complications of schistosomiasis are well known and documented 
(Fenwick et al, 2006). Schistosomiasis is caused by schistosomes, which are 
parasitic trematode worms with five main species infecting humans. These 
are Schistosoma mansoni, S.japonicum, S, mekongi, S. guiniensis (formerly 
S. intercalatum), and S.haematobium (WHO, 2007). Transmission of 
schistosomiasis in Africa is mainly by S. mansoni and S. haematobium, 
though S. guineansis may be found in the rain forest areas of Central African 
Republic and Cameroon and into Congo and Democratic Republic of the 
Congo.
This human infection is mainly acquired through direct contact with freshwater 
infected with the larva of the parasite. The larvae also called cercariae 
penetrate the skin and then shed their tails to become schistosomula leading 
to localised dermatitis at the site of entry of the infected individual which 
eventually leads to the 3 broad categories of the disease manifestation which 
are allergic dermatitis, acute schistosomiasis and chronic schistosomiasis 
(Schwartz et al, 2000). An intermediate snail host of the genus specific to
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Schistosoma species is required to complete the transmission of 
schistosomiasis determines the distribution of the parasite.
Schistosomiasis has the ability to cause acute and chronic morbidity among 
those infected. The acute form of the disease occurs 14-84 days after contact 
with contaminated water. The clinical presentation of acute schistosomiasis 
includes fever, headache, generalized myalgia, right-upper quadrant pain and 
bloody diarrhoea. S. mansoni infected individuals may also present with 
respiratory symptoms. Chronic schistosomiasis generally presents 
pathologies linked to the gastrointestinal, the hepatic, and the neurologic, 
and/or genitourinary systems. The adult schistosome worms live in inside the 
hosts for many years inducing an immune response in the host to the 
schistosome eggs (WHO, 2007). Accumulation of the eggs is mostly found in 
the intestine and the liver for S mansoni and genitourinary tract for S. 
haematobium. Neural pathologies may result when schistosome eggs 
accumulate in the host’s central nervous system. Higher prevalence of 
epilepsy and transverse myelitis are observed in communities where 
schistosomiasis is highly endemic ((Strickland et al, 1991; Davis, 1996)).
The venous system of the human host houses the sexual stage of the female 
schistosoma parasite while the asexual stage is found in the intermediate 
freshwater snail. The sexual stages mate in the peripheral system of the 
human host and ovideposit in the portal circulation of the liver. The ova are 
deposited in the veins of the urinary bladder and the ureters in the case of S. 
haematobium white S. mansoni ova become deposited in the tributaries of the 
inferior mesenteric veins(Strickland et al, 1991; Davis, 1996). The 
distinguishing features of the ova are a terminal spine for the eggs of S. 
haematobium while that of S. mansoni has a lateral spine. These ova are 
produced and deposited within 4-6 weeks of penetration of the skin by the 
cercariae. Eggs enter the lumen of peripheral organs from where they are
283
finally expelled externally through urine or stool. The ova that that are not 
expelled reach distant organs often the liver, lungs and sometimes the central 
nervous system. The morbidity and prognosis of each infection is determined 
by quantity of ova that are produced. Miracidia develop in the ova, and when 
these reach fresh water they emerge from their eggs at a suitable temperature 
they hatch into the water and search for the snail intermediate host which are 
Biomphalaria and Bui in us for S. mansoni and S. haematobium respectively 
(Strickland et al, 1991; Davis, 1996). Miracidia enter the snail hosts within 24 
hours and undergo a complex cycle of asexual development which results in 
the release of hundreds of cercariae into water in 3-5 weeks. Failure to find a 
definitive host results in the death of cercariae in 2-3 days. In the definitive 
host the cercariae after penetration through the skin are called schistomules 
which migrate through the circulatory system of tissues of the heart, lungs and 
then the liver where they mature, mate and start the process of ovidepositing 
within 4-6 weeks of piercing the skin (Strickland et al., 1991; Davis, 1996).
The different stages of schistosome parasites elicit different clinical signs and 
symptoms. During penetration of the skin cercariae induce an allergic 
inflammatory reactions resulting in lesions called cercarial dermatitis 
characterized by itching and erythema formation. This reaction is exaggerated 
among visitors to an endemic area while indigenes rarely manifest this 
reaction, (Ahmed Ali El-Garem, 1998). As the schistosomules migrate through 
the hemolymphatic system of the heart and lungs especially in heavy 
infections, allergic reactions characterized by cough, fever and sometimes 
haemoptysis called larval pneumonitis occur. These may be accompanied by 
lymphadenopathy and hepatosplenic enlargement which occur as a reaction 
to antigens produced by the growing parasite (El-Garem 1998).
The adult worm is capable of living for up to 5-7 years in the human host 
without eliciting serious pathological effects. However, antigens produced and
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excreted from the gut of the adult parasite helps in the immunological 
diagnosis of positive cases and can also be used as an indication of the 
therapeutic response to treatment (Simpson et al, 1985). Antibodies produced 
in response to these antigens can also be used as indicators of the infection 
however once produced infected patients maintain a positive reaction for life 
even after successful treatment (Mott et al, 1982).
Antigen-antibody immune complexes formed in infected individuals are 
responsible for other disease manifestations. Acute stages of the infection 
due to oviposition can result in patients experiencing prolonged fever, rigors, 
sweating, myalgia and headache accompanied by urticarial rash, generalized 
lymphadenopathy and hepatosplenomegaly. Anorexia, nausea, abdominal 
discomfort and diarrhea with mucus or blood may also be experienced 
occasionally. When the soluble immune complexes are deposited in the 
glomeruli of the kidneys there is glomerulopathy especially in the case of S. 
haematobium infection (Barsoum et al., 1979).
Complications of schistosomiasis may be severe and life threatening. 
Urogenital signs and symptoms are common in S. haematobium with possible 
complications of bladder cancer and chronic obstructive renal failure (El- 
Garem, 1998).
Intestinal schistosomiasis due to S. mansoni infection may present with 
severe abdominal pains and production of bloody muco-purulent with polyp 
formation in complicated cases (Cheever et al., 1978) Cardiopulmonary 
schistosomiasis, larval pneumonitis, reactionary pneumonitis and 
Schistosomal Cor pulmonale are all presentations of schistosomiasis 
(Strickland et al., 1991). Hepatic (Hepato-Splenic) schistosomiasis 
characterised by hepatic and sometimes splenic enlargement may result in 
the complications of liver cirrhosis (Symmers, 1904). Ectopic schistosomiasis
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results mainly from lesions in the brain and spinal cord, skin, eyes and other 
organs. Ova reach these ectopic sites via vascular connections. Such 
pathology is focal and generalized seizures, headache, optic field defects and 
speech abnormalities may be met with in cerebral schistosomiasis while 
transverse myelitis with paraplegia may point to spinal affection (Strickland et 
al, 1991).
8.3 Control Strategies and Global Initiatives and Partnerships
The WHO strategy for schistosomiasis control focuses on reducing disease 
through periodic, targeted treatment with praziquantel WHO PCT (WHO, 
2007). Strategies for the control of the disease though also well known have 
suffered some setbacks in its implementation especially in Africa including 
Ghana. Significant is the need for proper mapping of the disease in endemic 
countries to guide implementation of control strategies. In Ghana some 
attempts have been made in the past to describe the epidemiology of 
schistosomiasis in some selected areas of interest to particular research 
scientists including the Volta Basin Project but these studies were insufficient 
to guide the implementation of a countrywide control programme. The need 
for this countrywide mapping of schistosomiasis became urgent with the 
inception of the integrated control programme for NTDs in Ghana.
The availability and use of praziquantel together with socio-economic 
development evident by improved water supply and sanitation have 
contributed to a decrease in the infected and at risk populations for 
schistosomiasis. However, in many areas water resource development 
projects have contributed to improvements in socio-economic status in Africa 
including in Ghana, but are associated with a simultaneous increase in the 
risk of infection with schistosomiasis (Southgate et al., 1997; Steinmann et al, 
2006). In Ghana these water resource development projects are the Volta
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Lake, Kpong dam and other smaller irrigation dams in the Upper East region 
(Hunter, 1990). It is also estimated that 106 million people making some 
13.6% of the total at-risk population for schistosomiasis actually live in close 
proximity to large dam reservoirs and irrigation schemes with three-fifths 
actually being closely associated with irrigation schemes (Steinmann et al, 
2006). Data have shown that in Cote d’Ivoire, Ghana, Senegal and Nigeria, 
introduction or an increase of urinary schistosomiasis prevalence was 
observed with the creation of large dams, however similar observations could 
not be made in the case of intestinal schistosomiasis (Southgate et al, 2001, 
Steinmann et al, 2006). This established policy of water resource 
development in many developing countries to help improve water supply and 
agriculture has led to the establishment of many small dams in areas which 
increase water contact and favour transmission of schistosomiasis (Hunter, 
1990, Southgate et al, 2001). Occupations like mining, fishing and farming 
also increase water contact and are also high risk factors for the spread of 
schistosomiasis (Atlas of global distribution of schistosomiasis).
There have been several schistosomiasis control initiatives both globally and 
at the country level. Most of these initiative were driven by the 54th World 
Health Assembly which in May 2001 passed resolution 54.19 signed by 200 
member states to attain by 2010, a minimum target of regularly administering 
anti-helminthic drugs to between 75% and 100% of all school-aged children at 
risk of morbidity. With this control strategy emerged in 2006 the term 
“preventive chemotherapy’ which was to be employed to control concurrently 
multiple neglected tropical diseasesNTDs (WHO, 2006). The need for drug 
treatment as the main preventive strategy to be complemented by improved 
access to safe water and improved hygiene and sanitation was pertinent 
(Utzinger et al, 2003). More importantly school-based control was to be made 
an integral part of the school health plans of the Ministries of Education 
(Bundy et al. 2006).
287
Several partnerships have greatly enhanced the implementation of health 
programmes in sub-saharan Africa with many successful and focused mass 
drug distribution programmes guided by mapping data. In Ghana the 
USAID/NTDCP which had selected Ghana as one of its 5 fast track countries 
in 2006 to support implementation of MDA had also provided support to 
ensure countrywide mapping of schistosomiasis with the hope that this would 
provide up-to-date prevalence data on schistosomiasis to further 
implementation of MDA with Praziquantel in all areas where needed 
particularly among the school-age population. The Schistosomiasis Control 
Initiative with its experience of mapping in several African countries had also 
supported six countries to also deliver over 40 million treatments against 
schistosomiasis and soil transmitted helminths (Fenwick et al, 2009) and was 
selected to provide technical support for this exercise in Ghana. For the 
successful implementation of this mapping a partnership involving USAID’s 
Neglected Tropical Diseases Control Programme (USAID/NTDCP) (USA), 
Schistosomiasis Control Initiative (SCI) of the United Kingdom (UK), the 
Ghana Health Service of the Ministry of Health (GHS/MOH) and the Ghana 
Education Service and the Ministry of Education (GES/MOE) in Ghana and 
the selected communities and schools had been absolutely necessary. The 
country programme was in the lead to provide coordination and leadership. 
National, regional and district level technical personnel from the health system 
undertook the field work. This was done to ensure proper integration of the 
programme right from the outset.
8.4 Schistosomiasis in Ghana
The need for mapping data to guide and direct the treatment for 
schistosomiasis is essential for planning countrywide control of 
schistosomiasis. The focal distribution of schistosomiasis (Lengeler et
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31,2002; Brooker et al, 2009a) requires detailed information on the 
geographical distribution at local level to prioritise and target treatment to 
areas most in need (Brooker et al, 2009a) to ensure cost-effectiveness of the 
control programme since praziquantel is not donated but procured at high cost 
to donors and countries. Recent data on the distribution, predicted or 
otherwise, of schistosomiasis which could be used to inform treatment based 
on WHO guidelines was not readily available. Urinary schistosomiasis in 
Ghana was first reported in 1895 and intestinal schistosomiasis was identified 
in 1920. Available historical data, which dates back to the 1970s indicated that 
urinary schistosomiasis was widespread throughout the country with the Volta 
basin having a prevalence as high as 80-90% in many communities living 
along the lake shore. Similarly, the Volta estuary was endemic with infection 
rates of 6.3% for S. mansoni and 76.2% for S. haematobium. Generally 
schistosomiasis was found to be highly endemic within communities located 
along rivers in all ten regions of Ghana. Schistosoma haematobium was 
known to be present in all regions though Schistosoma mansoni was only 
found mainly in the north-eastern and south-eastern parts of the country along 
the borders with Cote d’Ivoire and in the central part of the country. (WHO, 
1987).
In 1963 it was estimated that between 15 and 20% of Ghanaians had suffered 
schistosomiasis infection especially during their childhood years. Prevalence 
rates have been observed to have increased since 1965 from surveys 
undertaken along the Volta Lake. These surveys had showed a significant rise 
in prevalence rates between the two time periods particularly in the Northern 
region. Schistosoma haematobium was found to be endemic below the 
Akosombo dam and throughout south-eastern Ghana: S.mansoni, on the 
other hand was found only in north-eastern Ghana with overall prevalence 
being 2.4%. In large areas of Ghana ideal natural conditions which support 
the development of the snail intermediate hosts of schistosomes are found
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and are known to have expanded with the creation of the Volta Lake. The 
intermediate hosts implicated are B.pfeifferi, Bu. globosus and Bu.truncatus 
which are responsible for the transmission of intestinal and urinary 
schistosomiasis respectively and therefore show a similar distribution as the 
types of schistosomiasis whose transmission they are involved in (WHO, 
1987).
In a 2006 report, WHO estimated that Ghana had an estimated prevalence of 
schistosomiasis of 72.5%, in 2003 and therefore placed Ghana into the group 
of high schistosomiasis prevalence countries where annual praziquantel 
treatments were recommended for all school-aged children. The school-aged 
population in 2006 was estimated at 5,686,077. The recommendation was for 
all these children to be given praziquantel treatment once a year (WHO, 
2008). An identified challenge for ensuring treatment of all at-risk school aged 
population is the low school enrolment rates in some countries including 
Ghana. In Ghana school enrolment varies from 53.3% in the Northern region 
to 86.2% in the Ashanti region (GSS, 2009). This necessitates the need to 
devise methods for reaching out-of-school school-aged populations who may 
be at greater risk of infection compared to those in school by virtue of their 
lifestyle which increases their water contact than those in school. Being in 
school limits the time they can be in contact with water bodies. Mapping, 
therefore, helps countries to identify high risk groups for treatment as an initial 
move towards operationalization of a schistosomiasis control programme 
(Clements et al. 2006, 2008; Brooker et al. 2008). A significant challenge is 
the possible need to consider treatment for preschool-aged children (Stothard 
and Gabrielli, 2007) and other high risk groups such as fishermen, car 
washers and sand harvesters (Melman et al. 2009). All these groups require 
proper identification and organisation for treatment. Also mass treatment PC 
with praziquantel needs to be sustained annually for the entire at-risk 
population for a minimum of 5 years (Hotez et al, 2009) once treatment has
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been embarked on in order achieve an impact on transmission without going 
back to the pre-intervention prevalence of infection (Clements et al, 2009).
8.5 The Neglected Tropical Diseases Control and Schistosomiasis 
Mapping in Ghana
The NTD Control Programme in Ghana has been operational since the 
January 2007. The programme has implemented MDA in 5 regions of the 
country with ivermectin and albendazole for IF and Zithromax for trachoma. 
In addition, the School Health Education Programme (SHEP) has treated 
school-aged children in all regions of Ghana with Mebendazole for soil- 
transmitted helminths in February 2007 with the support of UNICEF.
Out of the 5 NTD diseases being controlled together with the strategy of mass 
chemotherapy in Ghana, LF and Trachoma had undergone countrywide 
mapping while onchocerciasis has had partial mapping with the details not 
being mainly available to the programme. Hospital records have confirmed 
that Soil Transmitted Helminthiasis is endemic throughout Ghana. The 
absence of countrywide up-to-date data on schistosomiasis in Ghana made it 
necessary to undertake surveys to update prevalence data as urinary and 
intestinal schistosomiasis are known to occur widely. The disease therefore 
needed to be mapped to establish its endemicity and also guide programme 
implementation. The SCI was identified to provide technical support for the 
mapping of schistosomiasis in Ghana as implementing partners for the USAID 
NTD Control programme with the experience of supporting other countries 
who have conducted similar mapping exercises in various sub-Saharan 
African countries.
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8.6 Objectives
School-based surveys to determine the distribution of schistosomiasis and soil 
transmitted helminths in Ghana. The main objective of the surveys was to 
provide empirical data for the geographic distribution of S. haematobium, S. 
mansoni and Soil Transmitted Helminths and to produce predictive maps on 
the prevalence of schistosomiasis and soil transmitted helminths in Ghana. 
The results of the mapping exercise was to produce maps which stratify the 
country according to the prevalence of schistosomiasis within 3 categories 
(above 50%, between 10-50%, below 10%). This information was used to 
guide schistosomiasis and soil transmitted helminths programme treatment 
strategies as part of the neglected tropical diseases.
8.7 Method
Parasitological risk mapping involving the collection of parasitological data 
from a selected number of sample locations which could be extrapolated 
across a wide geographical area to provide an estimate of what the predicted 
prevalence of infection will be across that area was applied. The sample 
locations were schools and a fixed number of children were recruited into the 
survey. Stool and urine were collected and microscopic examinations 
undertaken to provide accurate data on the intensity of infection which was 
incorporated into a model along with information on factors known to be 
associated with disease distribution, such as rainfall, temperature and altitude 
applied in order to produce a risk map of schistosomiasis for Ghana. This 
form of mapping allowed the prediction of levels of infection for both forms of 
schistosomiasis, as data on both S. haematobium and S. mansoni (and also 
soil transmitted helminthiasis) were collected during the surveys.
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8.8 The Process Parasitological Mapping in Ghana
The process of mapping schistosomiasis distribution was carried out through 
a series of steps (SCI, 2007).
8.8.1 Sample Size Calculations and Selection of sample locations
Due to the limited availability of recent data on prevalence within Ghana and 
the need to have data available to inform treatment decisions across the 
whole country, a decision was taken to produce a risk map to cover all 
regions. This required that the number of locations sampled had to capture 
enough information to be incorporated into the model without losing 
robustness and allow extrapolation to the whole country. A list of schools 
throughout the whole country was collected from the School Health Education 
Programme (SHEP) of the Ghana Education Service (GES) and with support 
from the spatial epidemiologists sample size calculations and a list of 
locations for the survey was undertaken.
A sample size of 77 private and public schools representing different locations 
were selected from 62 out of the total of the old 138 health districts from 9 of 
the 10 regions in Ghana. Sixty school children were selected from each of the 
selected schools for the survey (SCI, 2007, Unpublished). The breakdown of 
the list of schools selected by Region is indicated in the tables below.
The most recent list of all basic (class1-JSS 3) schools in the whole country, 
which is the geographical survey area for this survey was collected from the 
Ghana Education Service and applied for the sample size calculation and 
selection of locations for the purposes of the exercise. This list in exel 
electronic format served as the sampling frame for this survey. Ghana has an 
extensive system of water bodies with the Volta Lake being largest artificially
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created dam for the purpose of generating hydroelectric power. Some 
stratification was applied in the selection of schools with schools closest to 
Volta Lake and those in rural settings with water bodies being more likely to 
be selected. Those schools further away from water bodies and in rural 
settings were less likely to be selected during this stratification process 
(Soares et al, 2011). In all 77 schools were selected for survey and from each 
school 60 children - 30 boys and 30 girls - were randomly selected for sample 
collection. Each location was geo-referenced as part of the survey.
Table 8.1: Breakdown of number of schools by region
Region Number (N) of schools Surveyed
per Region
Ashanti 8
Brong Ahafo 13
Central 3
Eastern 6
Northern 22
Upper East 4
Upper West 7
Volta 7
Eastern 7
Total 77
Table 8.2: Summary table showing the numbers selected at each level for the survey
Level Number (N) Selected
Regions 9
Districts 62
Rural School 73
Urban Schools 4
All Schools 77
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8.8.2 Data collection, electronic capture and ethical considerations
The data for this study were collated from school-based parasitological 
surveys conducted in Ghana in 2008. The purpose of the survey was to 
provide schistosomiasis and soil transmitted helminths mapping information. 
The process of preparation, mobilisation and undertaking the fieldwork was 
done to cover the required number of schools in the minimal possible time 
without compromising the quality of the data collected. Infection data for 
schistosomiasis was captured as prevalence data, based on the presence of 
infection alone, and as intensity data, which measures the level of infection in 
the individuals examined. Data collected from within schools and from 
children within the schools included parasitological data in addition to actual 
GPS coordinates of the sampled location.
Stool and urine samples were collected from each child selected and a single 
urine slide and double Kato-Katz slides prepared from each stool sample. 
Microscopic reading of the slides was undertaken. Slides were identified as 
positive, if a single egg could be seen, or the number of eggs present counted 
to measure the level of infection. Parasite counts were carried out for each 
positive slide. In addition, information on the levels of STH was also recorded. 
For S. haematobium infection, intensity counts were obtained through urine 
filtration.
However, intensity counts, which were considered more accurate and 
informative, were also applied for this survey. The parasite prevalence and 
intensities for the different parasites having been calculated they were entered 
into epi 6 computer database.
295
As part of the survey, those found to be positive for schistosomiasis were to 
be treated with praziquantel, however, this could not be done because 
praziquantel was unavailable. However, mass treatment was planned for 
school children within all endemic districts. The ethical implication of this is 
that any positive children still had the opportunity to receive treatment during 
the MDA. This was timed to ensure that those positive were treated quickly 
after the surveys. This strategy also enabled the use of the data for monitoring 
treatment. This also prevented selected children from being treated twice 
(once during the survey and once during the MDA) which would not be 
reflective of the treatment programme.
After completion of the field work, the data generated was electronically 
captured in Epi info 6 and later imported into Microsoft Excel. The output of 
this step was therefore complete parasitological dataset in electronic format. 
Further analysis and production of the maps was undertaken with the support 
of a spatial epidemiologist. Predicted risk maps of schistosomiasis across the 
whole country were the products.
Ethical approval for the surveys were obtained from the ethical committees in 
the United Kingdom (St. Mary Hospital Research Ethics Committee, UK), 
however, in Ghana this activity was considered part of routine operational or 
implementation activities of the NTDP of the Public Health Division of the 
Ghana Health Service. The Ghana Education Service provided the permission 
to undertake these surveys in schools and duly wrote to inform all the 
selected schools of this planned activityAt the community level, written 
consent or informed consent did not have to be taken from the parents. 
Sample collection was considered non-invasive but the identity of the children 
and results of examination was kept confidential. Prior information was, 
however, passed through the School Health Education Programme (SHEP) 
coordinators and the head teachers to the children, the Parent-Teacher
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Associations (PTA) and the chiefs and other opinion leaders within the 
communities. The Chair of the PTA and other interested parents were invited 
by the team to be present during the sample collection, slide processing 
and examination under the microscope. They were given the opportunity to 
ask questions and also to examine positive samples under the microscope. 
Parents who did not want their children to participate in the survey were to 
send verbal information through the children or come to the school to inform 
the authorities themselves to ensure that their children did not participate in 
the survey. However, most of the parents who reported at the school were 
there to request that their children were sampled for the survey. Children after 
being given all the information were also provided with the option not to 
participate in the survey if they so wished.
8.8.3 Spatial Modelling
Parasitological risk mapping involving the collection of data from a selected 
number of sample locations which could be extrapolated across a wide 
geographical area to provide an estimate of what the predicted prevalence of 
infection was undertaken. The sample locations were schools and a fixed 
number of children (60) were recruited into the survey for each school visited. 
During the survey, the geographic location of each school was determined 
using a handheld global positioning system (GPS). This data used for the 
production of the predictive and spot maps for Ghana was from 4,445 children 
from 77 schools.
The output of this spatial modelling undertaken in collaboration with a spatial 
epidemiologist, was the production of a preliminary and then final stratified 
risk map of Ghana indicating prevalence of schistosomiasis across the 
country. Underlying this was the district administrative areas of Ghana.
This form of mapping allowed the prediction of levels of infection for both 
forms of schistosomiasis, as data on both S. haematobium and S. mansoni
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(and also soil transmitted helminths) was collected during the survey. The 
output was the production of a map, which stratified the country according to 
the prevalence of schistosomiasis within 4 categories (above 50%, between 
30-50%, between 20-10% and below 10%). However this was re-organised 
into 3 categories (above 50%, between 10-50% and below 10%) to guide 
mass treatment according to the WHO recommended treatment strategies.
8.9 Presentation of Results and Discussions
The process of establishing a control programme for schistosomiasis and soil 
transmitted helminths had previously suffered many setbacks. As part of the 
processes to initiate implementation of the Schistosomiasis and Soil 
Transmitted Helminths (SSTH) treatment this mapping process was carried 
out to identify the at-risk population. Products of data management, analysis 
and modelling included preliminary maps before the development of the final 
predictive maps (Figures 8.7-8-9).
Ghana has 10 regions; 9 of them were sampled for this survey. Within these 9 
regions, a total of 62 districts were sampled and from these 77 schools made 
up of 73 rural and 4 urban schools were surveyed. Eleven districts had 2 or 3 
schools selected from within them.
The main species of schistosomiasis identified during this survey was S. 
haematobium and S. mansoni with S. haematobium having a much higher 
prevalence rate of 17.8% nationally as compared to 1.2% for S. mansoni. 
Schistosoma haematobium was identified in all the regions but 5 regions had 
S. mansoni identified as well and therefore demonstrated co-endemicity for 
the two parasites. Out of the 62 districts sampled for the survey, 53(85%) 
demonstrated S haematobium infection and 7(11%) demonstrated S. mansoni 
and S. haematobium co-infection. Nine (15%) of the districts had no infection 
demonstrated for the survey. Of the 77 schools surveyed, 66 (86%) had
298
children with S. haematobium infection while 7 making 9% had S. 
haematobium and S. mansoni co-infections.
Schistosoma haematobium was identified in samples from 65 schools while S. 
mansoni was identified from 7 schools (Tables 8.1 and 8.2). Co-infection with 
S. haematobium and S. mansoni was demonstrated in all 7 schools from 
where S. mansoni were identified from stool samples. The remaining 70 
schools had S haematobium identified in 65 of them leaving 5 schools from 
where neither S. mansoni nor S haematobium was identified. Schistosoma 
haematobium was identified in 65 schools.
Generally, S. haematobium infection was much more prevalent than S. 
mansoni. All S. mansoni endemic districts and schools were co-endemic for 
S. haematobium. Nationally the highest school prevalence rate was 98.3% for 
S. haematobium recorded in the Eastern region and 65.5% for S. mansoni 
recorded in the Northern region respectively. The prevalence range was 
therefore 0.0-98.3% nationally. The highest prevalence was recorded in the 
Eastern region (98.3%) and the lowest in Brong Ahafo, Central, Northern, 
Upper West, Volta and Western region. The highest was in the Eastern region 
followed by Brong Ahafo (95.0%), Upper East (70.0%), Ashanti (68.3%), 
Northern (55.9%), Upper West (52.7%), Volta (39.0%), Western (36.7%) and 
then finally the Central (6.7%) regions in decreasing order.
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Figure 8.1: S. haematobium Prevalence Rates by Region
Figure 8.2: S. mansoni Prevalence Rates by Region
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Figure 8.3: Combined Prevalence Rates for S. haematobium and S. mansoni by Region
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The final risk map was stratified into areas where prevalence is more than 
50%, areas where prevalence is between 30-50%, 20-30%, 10-20% and the 
areas where prevalence is less than 10%. Prevalence maps were created for 
S. mansoni and S. haematobium and a third map for both. The combined map 
is the most significant for directing treatment with praziquantel, however the 
individual maps can also be utilised from a research perspective.
Preliminary analysis was carried out in June 2008 after data entry was 
completed. Ghana having undergone re-demarcation of the country’s 
administrative districts from an initial 110 districts to 138 had recently 
undergone further re-demarcation into 170 administrative districts. This 
presented a challenge for the analysis of the collected field data. Identifying 
the appropriate Ghana district map files for undertaking this task therefore 
presented a challenge as shape files for the 138 instead of 170 districts were 
applied. The data were entered in Epi Info 6 and cleaning of the data done
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and the information translated into a map for programme planning. Some of 
the problems noted with the data were improper recording of the school 
coordinates and non-matching of district names with those found on in the 
district shape files and this made it impossible to apply the coordinates to 
produce the preliminary map. However, the prevalence levels of S. mansoni 
or S. haematobium in the schools within districts were applied to the 
preliminary maps (Figures 8.1-8.3) and also in the selection of districts for the 
initial treatment in year 2008. The results were analysed according to the 
Schistosoma species identified and a composite map was produced since the 
control strategy is the same for both species of schistosome. Due to problems 
with the recording of the GPS co-ordinates, the districts from which the 
schools were sampled were used as the units of endemicity and 
implementation. Districts with prevalence levels of more than 50% and 
adjacent districts were designated as areas of high endemicity that required 
treatment of the school-aged population and associated communities, while 
those with prevalence levels of between 10 and 50% will require bi-annual 
treatment of school-aged children; those with a prevalence below 10% will 
only need to be treated twice during their primary schooling period.
The study showed 119 out of 138 districts in the country were endemic for 
schistosomiasis. A total at-risk school-aged population identified was about 
4,902,854 and required 14,708,562 tablets per year of praziquantel for 
treatment of the school-aged population in the whole country.
With production of the final schistosomiasis endemic maps 141 districts out 
the present district total of 170 have been identified as having endemicity 
levels for schistosomiasis that required regular treatment, however, the 
treatment strategies was dependent on the prevalence in the different districts 
(Figures 8.7-8.10).
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About 9 of the districts with a total population of about 322,525 had 
prevalence rates of more than 50% requiring annual treatment with 
praziquantel. About 118 districts with a population of about 5,768,310 had 
prevalence rates between 10% and 50% and required treatment with 
praziquantel every other year. Finally 14 districts with an estimated population 
of about 527,229 had prevalence rates less than 10%. For these 14 districts 
the strategy is to ensure that school-aged children were treated twice during 
their primary school period. First treatment is to be done when children 
entered primary school and second treatment on exit. This required that plans 
were made to ensure treatment for all these districts with an estimated total 
school-aged at-risk population of about 6,618,064. These estimates were for 
both S. mansoni and S. haematobium infections.
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Figure 8.4: Predictive map of S. mansoni
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Figure 8.5: Predictive map of Soil Transmitted Helminths
Predicted Prevalence
■ <0.10 
■ 0.10-0.20 
0.20-0.30
■ 0.30-0.50
■ <0.50 
Lake Volta
N
'4“
runs
0 40 80
"iKJometers
160
305
Figure 8.6 Predictive map of S. haematobium distribution
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The major soil-transmitted helminths (STH) in Ghana are Ascaris 
lumbricoides, Trichuris trichura, Necator americanus/Ancylostoma duodenale 
and Strongyloides stercoralis. All previous 138 districts, now 170 districts in all 
the ten regions of Ghana are known to be endemic for all these soil- 
transmitted helminths from hospital records since no definitive comprehensive 
countrywide prevalence studies had been done. The opportunity to collect this 
data presented itself with the schistosomiasis mapping. Final predictive maps 
produced for soil transmitted helminths have indicated that endemicity of soil 
transmitted helminths is low in most of the districts in Ghana (Figure 8.5). 
About 11 districts have prevalence of between 0.2 - 0.3, another 36 have 
prevalence between 0.1 - 0.2 with the rest being 123 in number out of the 
present 170 districts having prevalence rates less than 0.1. All these identified 
categories of district would require different treatment strategies for control. 
Those districts with prevalence, between 0.2 and 0.3 would require treatment 
yearly, while those with prevalence less than 0.2 would not require mass 
treatment programmes. This low prevalence of soil transmitted helminthiasis 
could be due to several years of MDA with ivermectin and albendazole for LF 
control. In February 2007, there was a nationwide school de-worming 
exercise that provided mebendazole to all school-aged children in the country. 
This exercise though initially challenged with rumours of school children 
experiencing severe side reactions including unconfirmed deaths (Doodo et 
al, 2007), damage control efforts embarked on through the collaborative 
efforts of the Ghana Health Service and the Ghana Education Service 
ensured the exercise was largely successful with good geographic and 
therapeutic coverage (Doodo et al, 2007). In addition, households in Ghana 
are in the habit of regularly de-worming children at semi-annual or even 
quarterly time intervals. However, further operational research is required to 
explain why some areas which have had several years of treatment with 
ivermectin and albendazole continue to have significant levels of soil 
transmitted helminths infestation among children.
Page | B09
8.10 Conclusion
The results of this mapping exercise confirm that schistosomiasis infection still 
remains a significant public health problem in Ghana. Soil Transmitted 
Helminthiasis is, however, not at present a significant health risk among the 
school-aged population probably due to previous consistent mass treatment 
programmes for LF and onchocerciasis with anti-helminthics. These 
programmes have been ongoing for many years mostly targeted at school- 
aged children with some targeted at whole communities under the LF 
Elimination Programme and the recent school-aged de-worming exercise of 
the School Health Programme of the Ghana Education Service and the NTD 
Control Programme of the Ghana Health Service. Many other local NGDOs 
present at the district level have also undertaken district level mass de- 
worming exercises which are not formally reported to Health or Education 
authorities and only appear in the national media.
With the completion of schistosomiasis mapping and the production of 
endemicity maps 141 districts have been earmarked for mass treatment. A 
total of 6,618,064 school-aged children have been identified as being at risk of 
schistosomiasis. Based on this figure some 16,545,160 tablets of 
praziquantel will be needed for treatment countrywide in a year.
Such information is needed to forecast for procurement and implementation of 
mass treatment with praziquantel and also albendazole and/or mebendazole 
for the school-aged population. The data will also be valuable in monitoring 
the impact of treatment of schistosomiasis and soil transmitted helminthiasis 
programmes implemented using the WHO recommended treatment 
guidelines on mass preventive chemotherapy.
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There is the need for further research to explore the reasons why there are 
certain areas of high soil transmitted helminths prevalence among school- 
aged children compared to other areas with similar socio-demographic 
characteristics with low prevalence, to inform programme decisions. In 
addition there is the need to validate the results of the exercise. These 
predictive maps have only enabled the programme to select whole districts for 
treatment. Schistosomiasis is focal in its transmission and therefore additional 
data collection might be required to help select smaller treatment units for 
praziquantel treatment, particularly using information on environmental, water 
contact and other factors influencing transmission.
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Chapter 9
Impact on Other Neglected Tropical Diseases: 
Remapping and Relaunching of Onchocerciasis
312
Chapter 9: Impact on Other Negected Tropical Diseases:
Re-mapping for re-launching of onchocerciasis control in Ghana
9.1 Introduction
The levels of Onchocerciasis endemicity were evaluated in 705 villages by 
rapid epidemiological assessment (REA) combined with limited skin snip test 
in 105 villages. The purpose was to determine the prevalence and distribution 
of onchocerciasis leading to the selection of endemic communities for 
community directed mass distribution of ivermectin in these endemic 
communities in Ghana. Sampling methods followed the WHO/APOC Rapid 
Epidemiological Mapping of Onchocerciasis (REMO) protocol (De Sole et al, 
1991, Macea et al, 1998, Noma et al, 1998) employing available topographical 
maps.
Onchocerciasis is another neglected tropical diseased, which relies on the 
preventive chemotherapy and transmission control (POT) strategy for control. 
It is filarial disease caused by the nematode O. volvulus, which is transmitted 
by the black fly Slmullum damnosum. The disease is endemic in 28 sub- 
Saharan countries in Africa including Ghana, in Yemen, and in small foci in six 
Latin American countries (WHO, 1995). It is highly debilitating, giving rise to 
severe visual loss and blindness and severe itching with dermal changes 
(Figure 9.1). The disease is often referred to as ‘river blindness’ because the 
populations that are worst affected live close to the fast-flowing rivers where 
the vectors breed. In these highly endemic communities, the disease has a 
serious socio-economic impact, as up to 40% of the adult workforce may be 
severely visually disabled, with additional debilitation caused by itching and 
dermal lesions (WHO, 1995). The pathological changes associated with O. 
volvulus infection include onchodermatits or onchocercal skin disease (OSD), 
lymphadenitis (resulting in hanging groin and elephantiasis of the genitals)
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and ocular lesions (blindness and impaired vision). Several other features of 
uncertain association, aetiology or pathogenesis have been described 
including low body weight, general debility and musculo-skeletal pain, 
epilepsy and dwarfism (Nwoke, 1992). The community prevalence rates, 
intensity or microfilarial worm loads determine the levels of the clinical 
manifestations.
The distribution, abundance and biting intensity of Simulium in endemic areas 
also contribute to disease transmission and the clinical manifestations. A large 
number of streams and rivers drain Ghana. These include a number of 
coastal lagoons, the huge man-made lake Volta among others which generate 
rapids which serve as breeding sites for the black fly vector. Several streams 
and rivers also become flooded during the rainy seasons creating the 
conditions for breeding of the black fly and onchocerciasis transmission 
(Macea et al, 1998, Noma et al, 2002).
The WHO-led former OCR relied on prolonged, regular larviciding of the 
vector breeding sites with rapidly biodegradable insecticides. An evaluation of 
the former OCR activities and its impacts on transmission revealed that 
transmission was virtually interrupted, and progression of eye lesions to 
blindness was halted as well as reduction to zero of new infections (Figures 9. 
2 and 9.3).
Ghana has been involved in the control of onchocerciasis since the inception 
of the former Onchocerciasis Control Programme, which was based in 
Ouagadougou since 1974. Onchocerciasis control interventions implemented 
in Ghana have included aerial larviciding, and the use of mobile treatment 
teams for distribution of ivermectin, but since 1998 Ghana employed the 
Community-directed treatment with ivermectin (CDTI) as its main strategy for 
control (Taylor et al, 2009). However, poor financial support coupled with
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management challenges led to erratic distribution of ivermectin with poor 
therapeutic and geographic coverage for most of the treatment areas. Since 
2004 when the LF elimination programme was combined with the 
onchocerciasis programme, the onchocerciasis programme has made 
significant improvements in its geographic and therapeutic coverage. Up to 
date mapping data was not available for the country and so the programme 
relied on historical data compiled from regional and districts health teams to 
guide treatment for onchocerciasis. With support from the African Programme 
for Onchocerciasis Control (APOC), this survey was led, coordinated and 
conducted by the PhD student.
The goal of the Ghana Onchocerciasis Control Programme is to reduce 
onchocerciasis prevalence to such low prevalence that it ceases to be of 
public health concern;
The specific objectives of onchocerciasis control in Ghana are;
• To maintain and sustain a drug therapeutic coverage of between 80- 
85% with a 100% geographic coverage.
• To reduce community microfilaria loads (CMFL) to less than 0.5/skin 
snip
• To reduce black fly infectivity rates to less than 0.5 per 1,000 flies in all 
endemic villages
Nine out of ten regions in Ghana are endemic for onchocerciasis and are all 
implementing the CDTI (community-directed treatment with ivermectin) 
strategy. The districts co-endemic for LF and onchocerciasis have 
consistently received ivermectin annually since the inception of the LF 
programme which distributes ivermectin and albendazole annually in meso 
and hyper-endemic areas. Since 2009 the programme has conducted twice a
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year treatment with ivermectin in all identified hyper- and meso-endemic 
communities. Meso-endemic areas are those with Onchocerca nodule rates 
between 20 - 39% while hyper-endemic areas range from 40% and above 
(Macea et al, 1998, Noma et al, 2002). The lack of empirical data to reinforce 
Ghana’s selection and treatment of onchocerciasis endemic communities led 
to this remapping of onchocerciasis.
9.2 Rapid Epidemiological Mapping of Onchocerciasis (REMO) in 
Ghana
Rapid epidemiological mapping of onchocerciasis (REMO) in Ghana was 
undertaken to accurately and rapidly re-map and identify communities 
suffering from onchocerciasis with the development of maps as standard tools 
to guide the country to prepare a national plan for onchocerciasis control and 
to re-launch mass treatment of identified onchocerciasis communities with 
ivermectin for the control of onchocerciasis. The REMO maps serve as tools 
for monitoring and evaluation of onchocerciasis control activities.
The main objective was to undertake re-mapping of onchocerciasis in Ghana 
using the method of rapid epidemiological mapping of onchocerciasis 
eventually leading to the selection of communities from hyper- and meso- 
endemic areas for distribution of ivermectin.
REMO is a simple, non-invasive and practical method that is easy to apply 
over wide-range of bio-ecological zones with no socio-cultural or religious 
restrictions. It involved the division of the country into bioclimatic or bio- 
geographical zones, each of which is reasonably uniform with regards to the 
potential for onchocerciasis (Macea et al, 1998, Noma et al, 2002). The 
selection of communities was optimally biased towards communities of higher 
risk of onchocerciasis in each of the zones, in order to determine whether
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onchocerciasis is present or not and if present to give an indication of its 
distribution and severity. Finally a measure of the level of endemicity of 
onchocerciasis in the selected communities using the rapid epidemiological 
assessment (REA) method based on nodule prevalence after nodule search 
in the sample of adults was undertaken.
Two types of communities are selected, the high-risk communities and those 
situated in the areas most likely to have the worst disease profile, and 
communities in the immediate vicinity of major potential vector breeding sites 
as revealed on the available topographical maps. Selection of the ‘high-risk’ 
or ‘first line’ communities which are those that are located close to the rivers 
(preferably those communities close to rapids) and without other human 
settlements between them and the river rapids, with preference being given to 
the isolated communities was undertaken. At least one high-risk community 
was selected in each district per stretch of the river, and along every 30-50 km 
stretch on the main river, and in the valley of each major tributary (Macea et 
al, 1998, Noma et al, 2002). Ideally an alternative village with similar 
characteristics to the original choice and likely to suffer the same challenge of 
onchocerciasis transmission was chosen for each of the high-risk villages 
selected. An alternative village was then surveyed if the original choice could 
not be located or reached or had unco-operative population.
For each of the high-risk villages or its alternative, the mapping group chose a 
related secondary village which was located at least 10km further away from 
the probable main source for the vectors (Macea et al, 1998, Noma et al, 
2002). The aim of the selecting secondary villages was to obtain some 
indication of the distribution and overall severity of the disease over a wider 
geographical area. Survey of a secondary village was only undertaken if at 
least some of the high-risk communities were proven to be meso- or hyper­
endemic for onchocerciasis. Rapid epidemiological assessment methods in
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REMO surveys should be undertaken in the dry months of the year when 
farming activities are less and villages are most accessible (WHO, 1993; 
WHO, 1995b). In each community, a random sample of 50 adult males or 
females aged more than 20 years were examined for the presence of 
onchocercal nodules. All the subjects investigated were engaged in rural 
occupations and resident in the community for at least two years. Males are 
preferred because they are more likely to be heavily infected as compared to 
females and they are more amenable to physical examination by palpation 
than females. Due to difficulties in obtaining adequate numbers of males for 
the surveys and willingness of women to be examined, women were also 
surveyed. This was done without prejudice to the standard requirement of 
examining of 50 adult males. In villages where there are fewer than 50 adult 
males available for examination, all the suitable consenting men and then 
consenting adults females were examined until 50 adults had been examined 
(Macea et al, 1998, Noma et al, 2002).
Validation of the results was undertaken within 2 months of the completion of 
the surveys using a team which included a group of independent experts, who 
surveyed a sample of villages where the original rapid assessments were 
conducted (WHO, 1995). The validation of villages involved selection of a 
stratified random sample method that took into account the different 
ecological zonal partners and levels of reported onchocercal endemicity.
9.3 Sampling and Results of REMO Surveys
The levels of endemicity were evaluated in 705 villages by rapid 
epidemiological assessment (REA), a method based on the examination of 
nodules (Ngoumou & Walsh, 1993). Initially a total of 753 villages were 
selected but only 705 were accessible at the time of the survey. The survey 
also combined nodule examination with skin snip assessments in 85 villages
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in order not to exclude potential onchocerciasis endemic villages because of 
the country’s long prior exposure to Ivermectin treatment. A total of 705 
villages (Table 9.1) were sampled.
Table 9.1: Sampled REMO Villages by region
Region REMO Villages Skin Snip Villages Proportion
Northern 120 10 8%
Ashanti 83 11 13%
Eastern 118 6 5%
Western 124 14 11%
Central 26 14 54%
Upper West 46 7 15%
Upper East 22 6 27%
Volta 68 9 13%
Brong Ahafo 86 6 7%
Greater Accra 12 2 17%
Total 705 85 12%
Sampling of REMO villages was based on WHO/APOC REMO manual 
(Ngoumou & Walsh, 1993) with due regard to adequate coverage of major 
potential vector breeding sites as revealed by available topographical maps. It 
seeks to stratify the country into the following; ecological behaviour of the 
vector, epidemiology of the disease and geography of the areas. The sampled 
villages were comprehensively selected with appropriate topographical maps. 
Selection of REMO villages is optimally biased towards those at high risk of 
infection implying that villages closest to black fly breeding sites normally had 
high disease infectivity levels as opposed to villages that are further away 
from the breeding spots. A clinical examination for Onchocerca nodules from 
a random sample of 30 - 50 resident adults more than 20 years of age in 
selected villages gives a clear epidemiological pattern of the disease. The
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survey also included case search for Buruli Ulcer and cases of blindness as 
part of assessing the burden and distribution of other NTDs.
A total of 27,635 persons, living in 705 communities, were surveyed (Table 
9.2). Even though participation in the survey was voluntary, field teams led by 
the research student spent time at each village to systematically examine the 
body following a standardized routine that gave attention to bony prominences 
particularly the iliac crest. Cervical and inguinal areas were excluded to avoid 
confusion with enlarged lymph nodes. Similarly in areas where skin snips 
were taken two skin snip biopsies were taken from the iliac crest, and after a 
drop of normal saline had been added it is examined under the microscope 
after thirty minutes of incubation. The GPS coordinates were obtained in each 
village using a hand-held Garmin Global Positioning System (GPS) unit from 
the centre of the surveyed village. Analysis of data was done using arc-GIS 
software. Demographic characteristics of villages and contacts of village 
heads were also collected.
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Figure 9.1: Nodule search during REMO surveys
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Table 9.2 Overall Summary Results for Nodule Examination and Skin Snipping for 
Microfiladermia
No. Examined for Nodules 27,635
Nodules Positive 1,091
Overall Nodule Positive Rate (%) 3.95
No. Skin Snipped 3,966
No. Positive for Skin Snip 365
Overall Crude Prevalence (%) 9.2
Table 9.3 Summary of Onchocerciasis Mapping Survey Results by Region
Region
Nodule Examination Skin Snippinng for Microfiladermia
Number of
Individuals
Examined
Number of
Nodule
Positive
Individuals
Nodule
Prevalence
(%)
Number of
Individuals
Examined
Number of
Microfiladermia
Positive
Individuals
Microodermia
Prevalence
Rate
Ashanti 3005 140 4.7 679 111 16.3
Brong Ahafo 3268 115 3.5 244 2 0.8
Central 1020 82 8.0 501 95 19.0
Eastern 4772 163 3.4 464 51 11.0
Greater Accra 341 1 0.3 106 0 0.0
Northern 4741 249 5.3 394 53 13.5
Upper East 718 16 2.2 233 0 0.0
Upper West 1869 47 2.5 307 14 4.6
Volta 2882 134 4.6 450 18 4.0
Western 4987 144 2.9 588 21 3.6
TOTAL 27603 1091 4.0 3966 365 9.2
322
Table 9.4: Results of Blindness and Buruli Ulcer Case Search
Region
BLINDNESS CASES BURULI ULCER CASES
NO.
Proportion of Total Number
Identified (%) NO.
Proportion of Total
Number Identified (%)
Ashanti 55 4.5 8 8.9
Brong Ahafo 87 7.1 7 7.8
Central 47 3.8 2 2.2
Eastern 89 7.2 14 15.6
Greater Accra 3 0.2 2 2.2
Northern 356 29.0 14 15.6
Upper East 364 29.6 0 0.0
Upper West 64 5.2 1 1.1
Volta 106 8.6 11 12.2
Western 58 4.7 31 34.4
TOTAL 1229 100 90 100
9.4 Discussions
Out of a total of 705 villages surveyed for REMO 85 of them forming 12% 
(Table 9.1) of communities surveyed also had the skin snip test conducted in 
them. Of the 27,603 individuals examined, 1091 (4%) were positive for skin 
nodules. This proportion varied from 0.3% in Greater Accra Region to 8.0% in 
Central Region (Table 9.4 and Figure 9.6). A total of 3966 individuals from 85 
villages were skin snipped. About 365 (9.2%) of them were positive for 
onchocerca! microfilariae and which varied from 0.0% in Greater Accra 
Region to 16.3% in Ashanti Region. Case search for blindness and Buruli 
ulcer disease discovered a total of 1229 cases of blind individuals and 90 
cases with Buruli ulcer. Northern and Upper East Regions had the highest 
number of blind cases, 29.0% and 29.6% respectively contributing a total of 
58.2% of all the cases. Greater Accra had the least of 0.2%. The greatest 
proportion of Buruli ulcer cases was found in the Western region (34.4%)
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while Upper West had the least (1.1%). Northern and Eastern regions had the 
second highest of Buruli ulcer cases of 15.6% each. Community nodule 
prevalence rates varied from 0.0% in many regions to 59.4% in one 
community in Ashanti region while community microfilaria! prevalence also 
varied from 0.0% in many communities across the country to 53.1% also in 
one community in Ashanti region (Table 9.4).
The total number of blind cases identified in the Northern and Upper East 
regions (58.6%) gives a possible indication of the severity of onchocerciasis 
and other blinding diseases in the northern parts of country. This might be 
evidence in support of early prevalence studies, which led the former OCR to 
focus the onchocerciasis in the northern parts of the country which was well 
known for blinding onchocerciasis. While onchocerciasis could be the 
contributory factor to old cases of blindness, trachoma might be the main 
contributory factor to new cases of preventable blindness in the northern parts 
of Ghana. The contribution of other non-infectious causes of blindness such 
as cataract, hypertensive eye disease and glaucoma among others should, 
however, be considered in this discussion.
The ecology of the Greater Accra region is not known to support the breeding 
of the black flies. None of the 64 skin snipped persons in the region was 
positive. Additionally, of the 12 selected villages examined for nodulesonly 
three (3) persons, one each from the three villages were positive with a 
nodule rate between 0 - 9%.
The results of these REMO surveys and previous epidemiological and 
entomological surveys were put together and applied to help delineate areas 
of onchocerciasis endemicity in Ghana. The main infected river basins were 
found to be the Pra, Pru, Offin, Afram, Bia, Bui-Black Volta, Daka and 
Majimaji river basins. Blackflies are known to be have a normal flight range of
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20 kins within their breeding sites, though with the aid of other climatic and 
physical conditions they are able to fly a distance of 400 kms. Selection of 
communities for treatment was therefore done along the infected rivers but 
within the normal flight range of the black fly. Within these identified infected 
river basins the programme went on to identify all communities within 20km 
radius and list them as communities endemic for onchocerciasis and for which 
biannual treatment with ivermectin was instituted.
This re-mapping of onchocerciasis has also resulted in the discovery of 
ivermectin naive treatment areas which have never been known to be 
onchocerciasis endemic in Ghana. These are the Afram Plains district of the 
Eastern region, Ho municipal in the Volta region, and Amansie Central district 
in the Ashanti region.
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Figure 9.3: Map Resulting from Mapping of Onchocerciasis in Ghana 
showing Identified Endemic Areas for Onchocerciasis Treatment (REMO Map 
2)
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Several challenges encountered during the re-mapping of onchocerciasis in 
Ghana included poor timing of the surveys which coincided with the rainy 
season which rendered many roads particularly to the rural areas where these 
surveys were undertaken not motorable. Some communities selected on the 
available topographical maps were non-existent on the ground and had to be 
replaced. Other communities were simply inaccessible to the field teams. 
Many of the GPS coordinates initially collected were displaced either from the 
districts in which they were supposed to be located or displaced into the sea 
or other neighbouring countries with Ghana requiring that retraining and 
retaking of all GPS coordinates had to be undertaken.
9.5 Conclusions
Re-mapping and re-launching of the onchocerciasis control activities in Ghana 
was successfully undertaken with confirmation of onchocerciasis endemicity 
with the development of onchocerciasis endemicity maps to guide the 
community-directed treatment with ivermectin for onchocerciasis endemic 
communities. Several new foci have also been discovered requiring 
ivermectin treatment. Onchocerciasis in Ghana is therefore endemic in 9 out 
of the 10 regions in Ghana (Figures 9.6 and 9.7), in 40 out of the 170 districts, 
involving 3200 hyper- and meso-endemic communities, which have been 
selected for ivermectin treatment.
The development of a new strategic plan for onchocerciasis control within the 
context of the NTD Strategic Plan has been developed to address control of 
onchocerciasis in Ghana. In order to improve on coverage, overcome possible 
ivermectin non-response as reported in certain parts of the country (Awadzi et 
al, 2004, Osei-Atweneboana et al, 2007) and progress towards possible 
elimination of onchocerciasis in Ghana, twice a year treatment with ivermectin 
is to be implemented while monitoring for recrudescence for selected sentinel
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sites will continue. Annual treatment of all historically endemic onchocerciasis 
treatment areas will also continue.
There are many inherent challenges associated with the re-launching of 
onchocerciasis control activities in the country. These include shortage and 
aging technical officers to undertake surveillance activities on the programme, 
recrudescence of onchocerciasis in certain endemic areas, competition with 
other health programmes and inadequate financial resources all of which 
hamper the successful re-launching of onchocerciasis control activities.
However, re-launching activities built into the plan include building the 
capacity of national, regional and district health officers to coordinate and 
undertake onchocerciasis control activities including surveillance and 
treatment with ivermectin. Production of community registers to replace old 
ones and for newly discovered treatment communities’ new registers to be 
produced will be undertaken. A 5-year onchocerciasis surveillance plan is also 
to be developed and incorporated into the general work plan for 
onchocerciasis control.
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10.1 Introduction
The goal of the GFEP has been the elimination of LF by the year 2010. This 
fell within the time frame of the GAELF, which targeted the year 2020 for 
elimination. The main strategies employed in order to achieve these goals 
involve the application of mass preventive chemotherapy using ivermectin and 
albendazole targeted at all endemic districts in countries like Ghana, which 
are co-endemic for LF and onchocerciasis.
Initial research to establish the endemicity of the LF in Ghana, mapping to 
delineate the extent of the problem, establishment of a programme to 
implement the identified strategies of MDA, morbidity control and health 
education, all of which should be well integrated into the health system have 
been pursued. During the period of implementation the LF programme has 
evolved from being a single disease entity programme to being merged with 
the onchocerciasis control programme into the integrated NTD Programme 
involving other neglected tropical diseases, which employ mass 
chemotherapy for their control. Several indicators have therefore been applied 
in measuring the impact of the GFEP. These include its impact on LF disease 
or programme specific indicators, impact on other NTDsand then its impact on 
the health system. This Chapter provides the opportunity to undertake this 
discussion in this context.
The main goal of this thesis is to determine the impact of MDA on the 
prevalence and transmission intensity of LF and investigate the suitability of 
the community directed approach as a vehicle for developing an integrated
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treatment strategy targeting other NTDs amenable to MDA within the context 
of the health system.
The LF elimination programme in Ghana has since its inception completed 
more than 10 annual rounds of MDA. Though the programme has missed its 
elimination target of 2010, it has made very significant impacts on many 
programme associated indicators. However, resource availability and its 
implications have to a large extent determined the impacts achieved under the 
programme.
LF specific indicators assessed include community antigen, microfilaria 
prevalence and intensity. Effect on morbidity determined by the change in 
quality and quantity of morbidity associated with elephantiasis/lymphoedema 
and hydrocoele cases. Most significant in this process is the capacity to 
determine the end point of MDA, which signifies the elimination of 
transmission of W.bancrofti. Achieving these impacts involve the process of 
ensuring the achievement of sustained adequate treatment coverage, which 
makes reported and surveyed treatment coverage important as process 
indicators.
These studies focused on the process from inception of the LF Elimination 
Programme, monitoring its implementation through surveys and determination 
of the impact of the programme both on parasitological and antigenic 
indicators of the infection and also its impact on the NTD control Programme. 
An attempt to determine the possible end points of the programme was 
undertaken. Some process, outcome and output indicators for the programme 
have been analyzed for discussion in this thesis.
The impacts of the LF elimination programme have been monitored through 
longitudinal and cross sectional surveys. The methods that have been
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employed applied parasitological and antigen test indicators and some 
indicators for programmatic assessment the LF Programme, the integrated 
NTD Programme and the health system at large. The determination of the 
possible end points of LF Elimination Programme has been undertaken in 5 
selected districts. Some process, output and outcome indicators have been 
employed by collecting both longitudinal and cross-sectional quantitative and 
qualitative data programme data have been employed to demonstrate the 
impacts of the LF Programme on these selected indicators and on the health 
system.
Ghana’s population of about 25 million is endemic for all the preventive 
chemotherapy diseases namely LF, onchocerciasis, soil transmitted 
helminthiasis, schistosomiasis and trachoma. The country has been mapped 
for all these diseases and the 10 regions have different mixes of these 
diseases with each region being endemic for a minimum of 3 of these 
preventive chemotherapy diseases. The LF Elimination Programme has made 
significant impacts on the epidemiology, implementation of LF in Ghana, the 
implementation of other NTDs the health system of Ghana. The prevention, 
control, elimination and even the eradication of the NTDs is on track via the 
platform of LF elimination.
After mapping LF was found to be endemic in the present 74 out of the 170 
districts in Ghana. The LF elimination programme was merged with 
onchocerciasis control programme in 2004 and have since undertaken 
activities leading improvements in the immune-parasitological indicators of LF.
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Table 10.1: Proportion of At-risk Population Covered by Mass Drug Administration by 
Preventive Chemotherapy Disease
PCI Diseases Total Endemic
Implementation Units
(Districts)
Total At-risk
Population (N)
Proportion of At-risk
Population undertaking
MDA (%)
Lymphatic Filariasis 74 12,265,335 (Total
Population)
100%
Schistosomiasis 141 6,859,637 (School-
Aged Children)
100%
Soil Transmitted
Helminthiasis
170 6,859,637 (School-
Aged Children)
100%
Onchocerciasis 40 2,075,542 (Total
Population)
100%
Trachoma 29 3,096,238 (Total
Population)
100%
Ghana is endemic for all the preventive chemotherapy diseases among the 
neglected tropical diseases. Onchocerciasis control activities started in Ghana 
under the former Onchocerciasis Control Programme of the World Health 
Organization in 1974. The programme at the time focused on black fly control 
using aerial larviciding. Ivermectin distribution started in 1987 with the use of 
mobile teams. The community-directed treatment with ivermectin strategy was 
introduced in 1998. Onchocerciasis control activities have since been 
undertaken under other onchocerciasis control initiatives such as Special 
Interventions Zones (SIZ) Programme and now the African Programme for 
Onchocerciasis Control (APOC).
The onchocerciasis control programme in Ghana was merged with the LF 
Elimination activities in 2004. The LF Programme has since provided the 
platform for implementation of onchocerciasis and other NTDs control 
activities which include MDA with ivermectin in all onchocerciasis endemic 
communities most of which overlap geographically with the LF endemic 
communities in Ghana. A single dose of ivermectin and albendazole
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administered to these co-endemic communities have had the benefit of having 
impacts on both LF and onchocerciasis transmission.
Subsequently the GFEP became the platform for implementing the integrated 
NTD Programme, which included implementing control activities for 
schistosomiasis, and the soil transmitted helminthiasis. Trachoma elimination 
activities were also planned for and implemented together with these other 
neglected tropical diseases, though it operated from within the Eye Care 
Department of the Institutional Care Division.
Activities aimed at the prevention, control, or elimination of these preventive 
chemotherapy diseases namely LF, onchocerciasis, schistosomiasis, soil 
transmitted helminthiasis and trachoma were co-implemented together and 
well integrated into the health system. This strengthened the health system 
through the provision of funds for capacity building of health workers and 
community drug distributors, drugs and other logistics, monitoring and 
supervision of community drug distribution and other community based health 
activities. The registers provided to the communities formed an excellent 
source of data for other community based health activities. It helped to identify 
the vulnerable populations within communities who include pregnant women 
and the children less than five years for Insecticide Treated Nets (ITN) 
distribution and other immunization programmes.
The World Health Assembly resolution (WHA 50.29) for the elimination of LF 
as a public health problem from endemic areas set in motion a series of 
global, regional and country activities aimed at ensuring the achievement of 
this final goal has been the guiding principle of Ghana’s Programme to 
eliminate LF. The benefits of this programme have been its impacts on LF 
elimination and the programme, other NTDs and the health system as a 
whole.
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Assessments of the programme implementation activities such as MDA with 
ivermectin and albendazole, morbidity control and monitoring and evaluation 
have provided the information relevant to making this determination. The 
achievements and challenges of the process have provided useful lessons to 
inform the recommendations and conclusions of this thesis.
The main goal of this study is to determine the impact of MDA on the 
prevalence and transmission intensity of LF and investigate the suitability of 
the community directed approach as a vehicle for developing an integrated 
treatment strategy targeting other NTDs amenable to MDA. The LF 
elimination programme was implemented as a single and specific disease 
control programme since the year 2000, merged with onchocerciasis control 
activities in 2004 and with schistosomiasis and soil transmitted helminths 
diseases control in 2006 while working very closely with trachoma elimination. 
This programme is now run as the NTD Programme with significant impacts 
on each other and the health system by being fully integrated into the National 
Flealth Care Plan.
This thesis setting out to test the hypothesis that with the current strategy of 
MDA and a minimum coverage of 65%, the programme has been able to 
achieve the interruption of LF within the period proposed by the WHO with 
significant impacts on W. bancrofti transmission and other NTDs employing 
preventive chemotherapy and transmission control activities.
The focus of this discussion is on the process from inception of the GFEP, 
monitoring its implementation through surveys and determination of the 
impact of the programme both on parasitological and antigenic indicators of 
the microfilaria worm and also its impact on the NTD Control Programme. 
Determining the possible end points of the programme has been undertaken.
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The process, outcome and output indicators for the programme have been 
analyzed and discussed in this thesis.
10.2 Impact of the Programme on Lymphatic Filariasis Elimination
LF is endemic in 8 of the 10 regions and in 74 of the 170 districts in Ghana 
with an estimated at risk population of about 12 million in 2011 (2010 
Demographic and Housing Census) which is about half of Ghana’s 
population. The programmes started implementation activities in 2000 and by 
2006 implementation activities including MDA were taking place all endemic 
districts. One of the objectives of the programme is alleviation of the suffering 
of individuals affected with disability. The programme therefore targets people 
with hydrocoeles and lymphoedema with free surgeries and hygiene 
management respectively.
The LF elimination programme has completed 10 annual rounds of MDA 
undertaken through a gradual up-scaling programme. Total geographic 
coverage was achieved by the 6th annual round of MDA in 2006. 
Achievements of coverage have ranged between 63.9% and 77.3% (Figure 
10.1 and Table 10.2) nationally and total treatments achieved under the 
programme are about 40,687,937 with ivermectin and albendazole. The total 
quantities of albendazole and ivermectin used are about 185,220,291 and 
53,993,541 tablets respectively.
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Figure 10.3: Trends in National Geographic and Total Population Coverage for Lymphatic
Filariasis Treatment
Table 10.2: School-Aged Children Dewormed through the LF Programme
Year Distr
ict
At-Risk
Pop
Ivermectin Albendazole No. of
Treatments
De-wormed
Sch-Aged
Children
Cov(%)
2001 5 333,686 1,001,000 333,596 246,743 67,361 73.9
2002 14 1,643,211 5,743,056 1,914,400 1,217,936 332,497 74.1
2003 30 3,696,893 9,100,000 3,522,000 2,622,722 716,003 70.9
2004 40 5,378,143 13,967,000 5,180,000 3,971,869 1,084,320 73.9
2005 60 6,907,375 25,000,000 8,598,900 5,141,482 1,403,625 74.4
2006 61 8,851,923 25,234,485 8,060,000 6,359,200 1,736,062 71.8
2007 61 9,278,935 24,080,000 5,932,174 1,619,484 63.9
2008 74 10,334,602 26,856,250 9,407,600 7,313,521 1,996,591 70.8
2009 74 10,331,867 25,575,000 8,035,100 7,913,735 2,160,450 77.3
2010 74 9963010 28,663,500 8,503,400 7491873 2,045,281 75.2
Total - 185,220,291 53,993,541 40,687,937 13,161,673 *
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Impact assessments undertaken involving the 5 start up districts and other 
districts that joined the programme at various stages in the up-scaling process 
have demonstrated significant impacts on both microfilarial prevalence and 
densities. There have been reductions in the microfilaria prevalence in the first 
5 start up districts at mid-term and end of term evaluation carried out, though 
none of the districts achieved a prevalence of less than 1% as required to 
enable the programme proceed to determine the end point of MDA since the 
sixth annual round of MDA. Further longitudinal assessments undertaken after 
two more rounds of MDA identified two districts, Awutu-Afutu-Senya and 
Agona districts which had since been separated into 4 districts to have 
microfilaria prevalence of less than 1% and could proceed to the end point 
determination applying the new WHO designed transmission assessment 
survey protocol. Longitudinal impact surveys undertaken among the second 
and third batch of districts indicated a greater reduction in the microfilarial 
prevalence rates as compared to the 5 start-up districts with many of these 
districts having achieved microfilaria prevalence levels less than 1%.
Selection of districts for these end point determination surveys was informed 
by the programmes exit plan (Table 10.3) and results of longitudinal 
microfilarial impact surveys. Determination of the end point of MDA in the 5 
start up districts was undertaken by applying the antigen Og3C4 and antibody 
Bm14 filter paper test methods. Using the TAS protocol the end point 
determination was also undertaken in 4 districts including Awutu-Efutu-Senya 
district which is one of the 5 start-up districts.
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Table 10.3: Exit Plan of the LF Programme Elimination
Year 2010 2011 2012 2013 2014 2015 Total
Number of Implementation
Unit (Districts) Involved
10 26 17 9 8 4 74
No. Evaluation Units Involved
4 7 6 4 4 1 26
Estimated Population Stopping
MDAs
887,267 2,678,563 2,371,448 1,428,831 2,036,597 3,164,736 12,567,441
Estimated Population
remaining
11,680,174 9,001,611 6,630,163 5,201,332 3,164,736 - -
Generally trends in immune-parasitologic indicators showed significant 
downward trends in all programme districts surveyed. The first 5 start up 
districts also demonstrated good progress in the reduction of microfilaria 
prevalence. In comparison lower prevalence and more reduction in 
microfilaria prevalence were recorded among the second and third batch of 
districts to begin undertaking MDA.
Application of the Og4C3 antigen tests in the 5 start up districts among 
children 5 years or less indicated ongoing transmission after round 6 of MDA 
in all these 5 districts requiring further annual rounds of MDA. The results of 
the TAS in Awutu-Efutu-Senya and Agona districts demonstrated a break in 
transmission of LF and therefore have proceeded to undertake a two-year 
post-MDA surveillance.
Higher baseline microfilaria prevalence in the 5 start up districts is likely to be 
responsible for the difficulty in suppressing transmission in these districts 
compared to the second third batch of districts that the joined the programme. 
Two more annual rounds of MDA made it possible to suppress transmission 
further in Awutu-Efutu-Senya district, one of the 5 start-up districts which did 
not qualify with earlier surveys done. Transmission assessment surveys
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conducted ultimately indicated a possible interruption of transmission in 
Awutu-Efutu-Senya and Agona districts.
The results of these surveys indicate that the 5-6 years recommended for 
elimination of transmission with MDA may not be adequate but also requires 
attainment of the adequate coverage and should also take into consideration 
coverage achieved, compliance with MDA (Ottesen et al, 2008; Talbot et al, 
2008; Cantey et al, 2010; Hodges et al, 2010), geographic coverage, 
characteristics of the vector and the drug regimen applied (Bockarie et al, 
2009).
Providing morbidity control on programme has involved registration of 
hydrocele and lymphoedema cases, which was considered and undertaken at 
the inception of programme activities. The programme has been able to 
register and provide morbidity management through hygiene education to 
lymphoedema and free surgeries to hydrocoele cases.
Several workshops to build the capacity of medical officers to undertake 
hydrocoelectomies using the WHO recommended method of total excision of 
the hydrocoele sac have been undertaken. Free hydrocoele surgeries have 
been provided during these surgical workshops and camps organised by the 
programme. About 3000 free hydrocoele surgeries have been provided by the 
programme although about 10,000 cases of hydrocoeles registered. About 
5,000 cases of lymphoedema have been registered and provided with 
education to enable them undertake hygiene management of the affected 
limb.
The free hydrocoele surgeries organized by the National LF Programme have 
made a major and positive impact on the physical, social and economic life of 
the people who have benefited from the service. Improved quality of life of the
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beneficiaries of the hydrocoele surgeries has been noted with the assessment 
of the morbidity management programme. Individuals indicated in the survey 
that mobility, self care, ability to undertake activities had improved while pain, 
discomfort, anxiety and depression associated with hydrocoele had reduced.
Apart from recording improvements in the socio-economic life, post-surgical 
recurrence had also been reduced to the barest minimum with the total 
excision method. The incidence of post surgical infection negatively impacted 
on the successful conduct and outcome of some surgeries since many 
patients with incompletely healed wounds mismanaged these wounds at 
home. The role of government facilities in the management of post-surgical 
complications was however significant.
The role of morbidity control in achieving the elimination targets of IF should 
not be underestimated since it builds the confidence of communities in the 
programme by playing an advocacy role in these endemic communities as 
well.
Observed trends in coverage in these 5 start-up districts indicated that 
coverage as reported has generally been adequate, though deviations 
between reported and surveyed coverage above 10% was observed in some 
districts for some years. However among the 5 start-up districts, reliability of 
the reported coverage had generally improved by year 4. Generally, coverage 
surveys are important in determining the reliability of reported coverage. 
Integrated coverage surveys are also possible and provided similar reliable 
results as those of the disease specific surveys.
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10.3 Impact on Other Preventive Chemotherapy NTDS
The impacts made by the LF Programme on the LF transmission, other NTDs 
that employ preventive chemotherapy and the health system have been made 
with support of several institutions, organisations and partners who have 
provided technical and financial support. They include USAID/NTDCP, 
CNTD, WHO, Ghana, AFRO, HQ, APOC, MDSC, Sightsavers and 
Government of Ghana working through the Ghana Health Service at the 
National, Regional, District and Sub-district health management teams. The 
role of the endemic communities cannot be over-emphasised.
Ghana is endemic for all the preventive chemotherapy diseases among the 
NTDs (Table 10.1). The LF elimination programme became the platform for 
the inception of some programmes, reviving of others and implementing the 
integrated NTDs Programme, which included implementing control activities 
for schistosomiasis, and the soil transmitted helminthiasis. Of the 170 districts 
in Ghana 74 are endemic for LF, 40 are hyper or meso endemic for 
onchocerciasis, 29 are endemic for trachoma, 141 have established 
endemicity for schistosomiasis though all 170 districts are endemic for soil 
transmitted helminthiasis prevalence is generally low (Table 10.1).
10.4 Impact on Onchocerciasis Control
The main goal of onchocerciasis programme is to reduce its transmission to 
levels at which they will no longer be of public health significance and 
preventing recrudescence of the disease. This involves ensuring a target 
therapeutic coverage of 85% and a geographic coverage of 100%, and 
maintaining black fly infectivity of less than 0.5/1000 parous flies and 
community microfilarial load of less than 0.5 per skin snip. The Ghana Oncho 
programme is part of the NTD control programme that ensures co-
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implementation of other products especially at co-endemic areas. Through 
the NTD programme there has been selection of priority areas for ivermectin 
distribution for onchocerciasis, mapping of breeding sites within the Black 
Volta Basin, several CDTI training workshops asides the annual refresher 
training programmes for distribution. Several entomological and 
epidemiological surveys for onchocerciasis have also been undertaken which 
results have shown marked improvement in the onchocerciasis situation in the 
country. Remapping of onchocerciasis has been undertaken and twice annual 
treatment of onchocerciasis using ivermectin is provided under the 
programme for onchocerciasis hyper- and meso endemic areas.
During this period trends in the transmission of onchocerciasis within many of 
the onchocerciasis endemic river basins have declined particularly in 
communities within Pru and Bui river basins, both in the Brong Ahafo region 
as part of the Special Intervention Zones (SIZ) of the Onchocerciasis Control 
Programme in Ghana. These were onchocerciasis hotspots, which were 
identified at the closure of the former Onchocerciasis Control Programme 
(OCP) in 2002 with devolution of the programme to the countries.
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Figure 10.2: NTDs Programme Data from Impact Surveys Conducted showing Reducing
Trends in Onchocerciasis Prevalence in the Pru River Basin
Trend of Oncho Prevalence in the Pru river basin, 
1987-2007
—— Asubende
— Fawomang
— Hiampe
The communities surveyed within the Pru River basin were Asubende, 
Fawomang and Hiampe where onchocerciasis prevalence obtained by skin 
snipping has reduced from 85.7%, 88.4% and 85.6% in 1987 to 6.8%, 8.8% 
and 5.1% in 2004 but increased to 5.9%, 10.8% and 3.8% respectively, while 
those surveyed in the Black Volta Basin were Baffour Akura and Bui Damn 
site showed declining trends from 52.9% and 38.2% in 1987 to 14.3% and 
13.6% in 2001 and showed rising trends to 33.8% and 18.8%. However from 
2004 to prevalence from 8.8% in Asubende to 5.9% since the programme was 
merged with the IF programme (Figures 10.2 and 10.4).
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Figure 10.3: NTD Programme Data from Impact Surveys Conducted showing Trends of
Onchocerciasis Prevalence in the Bui Black Volta Basin from 1987-2007
,Baffou
Akura
Bui
1987 1994 1997 2001 2007
Figure 10.4: NTD Programme Data from Impact Surveys Conducted showing the Reducing 
Trend of Onchocerciasis Prevalence at Asubende in the Pru River basin between 1980 and 
2007 in Ghana
346
The LF filariasis programme has also provided the platform for mapping of 
schistosomiasis and re-mapping of onchocerciasis in Ghana. These were 
carried out in 2008 and 2009 respectively with maps that have since been 
employed to guide MDA and impact monitoring of the two programmes.
10.5 Remapping of Onchocerciasis
Through the NTD programme there has been selection of priority areas for 
ivermectin distribution for onchocerciasis, mapping of breeding sites within the 
Black Volta Basin, several CDTI training workshops asides the annual 
refresher training programmes for distribution. Several entomological and 
epidemiological surveys for onchocerciasis have also been undertaken which 
results have shown marked improvement in the onchocerciasis situation in the 
country. Remapping of onchocerciasis has been undertaken and twice annual 
treatment of onchocerciasis using ivermectin is provided under the 
programme for onchocerciasis hyper- and meso endemic areas. Remapping 
of onchocerciasis results was combined with recent epidemiological and 
entomological survey results to establish the areas of hyper- and meso- 
endemicity for onchocerciasis treatment in the country (Figures 10.5 and 
10.6). Nine of the ten regions in Ghana are endemic for onchocerciasis. 
About 3115 communities from 40 districts have been identified for treatment 
under the onchocerciasis programme. The total population found in these 
communities is therefore 2,075,542, which is being offered biannual treatment 
with ivermectin. With the shift in onchocerciasis strategy from control to 
elimination, all communities historically known to be onchocerciasis endemic 
have been identified and are also under annual treatment with ivermectin.
Since the merging of the onchocerciasis programme with the LF programme 
treatment for onchocerciasis has been regular with major consistent 
improvements in both annual and biannual geographic and total
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population/therapeutic coverage. Coverage has improved from 65.4% in 2006 
to 76.8% in 2010. Geographic coverage has also improved from 82.8% in 
2007 to 100% in the first round in 2009. The treatment 2010 recorded a 
geographic coverage of 97.7% (Figures 10-7 and 10-8).
Figure 10.7: Treatment Coverage from 2006-2010 since the Merging of Onchocerciasis
Control and LF Elimination Programmes
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10.6 Impact on Soil Transmitted Helinthiasis and Schistosomiasis
The LF Elimination Programme has also provided a major platform for the 
control of schistosomiasis and soil transmitted helminths control with marked 
health process impacts. Prior to the inception of the integrated NTD control 
activities and through the LF programme an estimated number of about 
13,161,673 (Table 10.5) school-aged children had been de-wormed with 
albendazole through the community-based treatment for LF using ivermectin 
and albendazole over 10 annual rounds of MDAs. From 2007 to 2010, other 
de-worming activities have been carried out in collaboration with the School 
Health Education Programme of the Ghana Education Service. In 2007, 
4,326,621 school-aged children were de-wormed; in 2009, 802,561 school- 
aged children were de-wormed, and, 1,739,857 children in 2010 whilst 
1,355,189 children were de-wormed through the collaboration with 
GES/SHEP programme. A total of 21,385,801 treatments have been achieved 
through the school-aged de-worming programme, which has been mainly 
school-based.
Table 10.4: Treatments Achieved with Mass Drug Administration for Soil Transmitted 
Helminthiasis and Schistosomiasis under LF Elimination and the Integrated NTD Programme
Activity
Treatments
STH SCH
Under LF Programme (2001-2010) 13,161,573 -
2007 4,326,621 -
2009 802,561 802,561
2010 1,739,857 1,739,857
2011 1,355,189 1,517,963
Total Treatments 21,385,801 4,060,381
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Since 2009 mass treatment for schistosomiasis using praziquantel has also 
been carried out regularly also in collaboration with the Ghana Education 
Service (GES)/ School Health Education Programme (SHEP) programme. In 
2009, 802,561 school-aged children were treated for schistosomiasis, in 2010, 
1,739,857 children were again treated, and 1,355,189 school-aged children 
were also treated in 2011. Through the community-based approach high at- 
risk communities identified through the mapping and validation were also 
identified for treatment resulting in the treatment of 162,774 community 
members with praziquantel. In all 4,060,381 treatments (Table 10.5) have 
been conducted with praziquantel for schistosomiasis control.
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Table 10.5: School-Aged Children (SAC) De-wormed under the LF Elimination
Programme
Year Districts
Treated for
Lymphatic
Filariasis
(N)
At-Risk Pop
(N)
Ivermectin
used (N)
Albendazole
used (N)
Total
Number of
People
Treated (N)
Total Number
of Dewormed
Sch-Aged
Children (N)
MDA
Coverage
(%)
2001 5 333,686 1,001,000 333,596 246,743 67,361 73.9
2002 14 1,643,211 5,743,056 1,914,400 1,217,936 332,497 74.1
2003 30 3,696,893 9,100,000 3,522,000 2,622,722 716,003 70.9
2004 40 5,378,143 13,967,000 5,180,000 3,971,869 1,084,320 73.9
2005 60 6,907,375 25,000,000 8,598,900 5,141,482 1,403,625 74.4
2006 61 8,851,923 25,234,485 8,060,000 6,359,200 1,736,062 71.8
2007 61 9,278,935 24,080,000 5,932,174 1,619,484 63.9
2008 74 10,334,602 26,856,250 9,407,600 7,313,521 1,996,591 70.8
2009 74 10,331,867 25,575,000 8,035,100 7,913,735 2,160,450 77.3
2010 74 9963010 28,663,500 8,503,400 7491873 2,045,281 75.2
185,220,291 53,993,541 40,687,937 13,161,673
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Identification of schistosomiasis endemic districts and communities for 
treatment have been based on initial baseline data collected in 2006, mapping 
data collected in 2008 and then data collected to validate the mapping and 
also improve on the mapping results.
Figure 10.9: Aggregated Prevalence of Infection from Baseline Schistosomiasis Surveys
20 n------------------------------------------------------------------- 18
Parasites
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10.7 Impact on Trachoma Elimination
Trachoma mapping established its endemicity in 29 districts in 2 regions in 
Northern Ghana namely Upper West and Northern regions. Surgery for 
trachoma trichiasis, mass treatment with the antibiotic, azithromycin, has been 
undertaken annually, facial cleanliness with regularly washing with soap and 
clean water, and environmental improvement has been implemented as the 
SAFE strategy for trachoma elimination. The results have been near 
elimination of trachoma transmission from Ghana. There is also a backlog of 
trachoma trichiasis that requires surgery. All these achievements were 
realised through the integrated NTD programme. The programme has 
established an integrated community-based surveillance system and will 
require a re-evaluation of transmission after a three-year period of post­
elimination surveillance before possible certification of transmission 
elimination.
10.8 Impact on the Health System
The LF elimination programme through its contribution to improvements in the 
health system can be demonstrated at several levels of the system. These are 
illustrated at the national, regional, district/sub-district and community levels 
through its contribution to the health system’s policies, strategies and plans of 
work, resources and activities.
At the national level, the programme at its initiation made available equipment 
in the form of computers, vehicles and furniture by its partners to complement 
government’s efforts in making available human resource personnel in the 
form of the programme manager, a deputy and technical officers to coordinate 
and administer the Ghana Filariasis Elimination Programme (GFEP). 
Government also provided office space at the national level. Through the
354
programme and in an effort to ensure integration of the programme in the 
health system, each endemic region also appointed programme coordinators 
who helped to ensure the smooth running of the programme within all 
endemic regions. These LF regional programme coordinators also assumed 
the role of coordinating other preventive chemotherapy NTDs within the health 
system in addition to providing other services to the public health system. 
Training has been provided at regional, district and sub-district levels by the 
LF and then the NTD programme to ensure the availability of capacity within 
the health system to carry out the activities of the programme and other health 
systems activities in as integrated a manner as possible.
Endemic communities have been empowered through the provision of health 
education community-directed treatment approach to ensure distribution of 
the drugs with improvements in the health status. These are provided through 
training of the community distributors, meetings with community leaders and 
whole communities where they are given the opportunity to ask questions. 
This health education approach provided enabled communities to monitor the 
drug distributors and distributions process themselves. Apart from the benefit 
of providing communities with protection against LF various ancillary benefits 
of ivermectin and albendazole have been reported. This includes treatment for 
intestinal worms, head lice and improvements in sexual libido.
The LF Elimination Programme through its strategic documents has 
contributed to the health policy and strategies at the national level. These 
include inputs in terms of both human contribution and materials into the 
Ghana Poverty Reduction Strategies II, the MDG 6, and New Partnership for 
African Development Health Strategy, the African Union Health Strategy and 
the Ghana Health Sector Strategic Plan and the Integrated Disease 
Surveillance and Response (IDSR).
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International and local partnerships have also been employed by the 
programme to strengthen the health system through both technical 
contributions and resource allocation through the programme. The 
programme has also improved on its local partnership with organisations like 
GES (Ghana Education Service), central and local government, Food and 
Drugs Board who help to monitor the quality of drugs distributed and severe 
adverse reactions during MDAs, drug companies, multilaterals and bilateral 
organisations, international support institutions/centres, NGOs and endemic 
communities).
10.9 Challenges of Elimination of Lymphatic Filariasis
Major challenges encountered with the implementation of LF elimination 
activities have been in the area of monitoring and evaluation. Others include 
weak data management at all levels, ensuring a feedback for all programme 
activities, synchronizing funding from different partners under the NTD Control 
Programme, implementation of community-directed treatment in the context of 
NTD control programme and human resource constraints. Inadequate 
financial support for surveillance activities is one notable challenge, which has 
led to continuation of MDA inspite of many rounds of distribution activities. 
The evidence required to justify ending of the annual distribution process has 
not been available.
Other challenges have been timing of treatment cycle in the light of 
implementation of bi-annual treatment, competing competing health 
programmes at regional and district levels, apathy among regional and district 
staff, advocacy for political commitment at the highest level, cross-border 
issues (coordination of treatment and other cross-border activities such as 
supervision of MDA).
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10.10 Major Recommendations
Collaboration with partners to build capacities of regional and district staff for 
effective management of LF and other NTD surveillance activities and further 
collaboration with other agencies to deal with challenging epidemiological 
situations that arise on the programme is absolutely essential.
The need to acquire equipment for surveillance activities, provide training for 
more technicians for surveillance activities for most of the regions to lessen 
the work load and improve quality and volume of work and ensure that 
strategic plans to address all programme issues are available.
To improve on the impacts made so far the programme needs to strengthen 
advocacy with stakeholders and improve in-country fund-raising. Advocacy for 
inclusion of MDA coverage indicators into the Ghana Health Service set of 
indicators will improve on the attention given to the programme by the 
regional and district health officers and greatly reduce apathy to the 
programme.
10.11 Conclusions
Elimination of LF with mass chemotherapy is possible and has been 
demonstrated by the Ghana Filariasis Elimination Programme in 4 districts. 
The total population coverage of 80% required to ensure elimination of the 
disease within the timeframe of six years eluded the programme. Surveyed 
coverage has mainly been consistent with the reported coverage on the 
programme for most of the programme areas.
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The five start up districts, most of which had high prevalence of LF have 
shown that in such a situation more annual rounds of mass treatment are 
required to ensure elimination. In the meantime there is the need to consider 
the application of other strategies such as mosquito vector control to speed up 
the process of elimination.
Integration with other NTDs has been effective and cost-efficient with added 
improvements on the general health system including the endemic 
communities.
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Appendices
Appendix”I: Com&ined Knowlecige/ Attidute ancTPractices ~Coverage arid 
Non-Compliance Assessment Questionnaire
Name of Interviewer.......................................................Date of
Interview..................................................
Community.................................................................... Sub­
district............... ................................................
District
My name is....................................................... lam working for the Ghana
Health Service and want to have a discussion with you about the drugs that 
were distributed this year and for which the height of people were measured 
before the drugs were given. The purpose of this exercise is to help improve 
on future drug distribution programmes and also find out ways of helping 
people with elephantiasis or hydrocoele disease.
Interviewer
Please note that multiple correct answers are allowed where applicable. The 
codes for Yes is 1, No is 2, other, specify is 7, don’t know is 8 and not 
applicable (N/A) is 9.
Section A: Socio-demographic Data
1. Name of respondent
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2. Age [ ] [ ]
3. Sex 1. Male 2. Female
4. Marital Status 1. Married 2. Single 3. Divorced 4. Widowed
5. Number of people in this household [ ] [ ]
6. Occupation 1. Farmer 2. Fishermans. Teacher 4. Artisan
5. Trader 6.Other, specify....................................
7. Religion: 1. Christian 2. Moslem 3. Traditional Relig 4. None
5 Other, specify......................................
8. Number of completed years of education [ ] [ ]
Section B: Knowledge about the Disease
9. Have you heard about the disease filariasis? I.Yes 2. No
10. If yes, how does it present in an affected individual? (Multiple correct
answers are allowed)
1. Enlarged Legs 2. Enlarged Scrotum 3. Enlarged Arms
4. Enlarged Breasts 5. Fever and Chills 6. Painful swollen groin
7. Other, specify................................................................................
11. How is this disease acquired?
1. Through the bite of a mosquito 2. Breathing in the germs
3. Eating contaminated food 4. Drinking contaminated
water
5. Other, Specify...................................................................
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12. Which germs are responsible for the disease?
1. Tiny worms in the body 2. Bacteria 3. Viruses
7. Other, Specify................ ................. 8. Don’t Know
Section C: Management and Programme
13. How is lymphatic filariasis disease prevented? (Multiple correct 
answers are allowed)
1. By taking drugs 2. Sleeping in Insecticide treated
mosquito nets
3. Keeping a clean environment 7. Other, specify..............................
8. Don’t know
14. Are you aware of any drug distribution in this community this year for 
which people were measured?
1. Yes 2. No
15. How many different drugs are given during the exercise? [ ] [ ]
16. What categories of people should not take the drugs?
1. Children less than a certain height 2. Pregnant women 
3. Breastfeeding mothers 4. Seriously sick people
7. Others, specify.................... ...........................
17. Did everybody in your household take the drugs?
1. Yes 2. No 8. Don’t Know
18. What reasons do people give for refusing to take the drugs?
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19. Are you aware of any side effects of taking these drugs?
1. Yes 2. No
20. What are some of the side effects of taking these drugs?
(Multiple correct answers are allowed)
1. Itching 2. Rashes 3. Swelling of parts of the body 4. 
Headache
5. Fever 6. Chills 7. Other,
Specify.........................................................................
21. If the drugs were given again, would you want it to be distributed the 
same way?
I.Yes 2. No 3. Don’t Know 8. N/A
22. How many time have these drugs been distributed in this community?
[ ] [ ]
23. How many times have you taken these drugs yourself?
[ 3 [ ]
24. What suggestions do you have for improving mass drug distribution 
exercises?
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25. Do you know anynone with elephantiasis or a hydrocoele?
1. Yes 2. No
26. Is there anyone in this household with any of the two conditions?
1. Yes 2. No
27. Is any treatment available to people with these conditions in this 
community?
1. Yes 2. No 8. Don’t know
28. What help is available for people with hydrocoeles?
29. What help is available for people with elephantiasis?
Thank you for spending time to answer these questions for me, if you have 
any questions and difficulties concerning this exercise of the Filariasis 
Elimination Programme after we have left you contact personnel of the health 
centre for help or the research student in the person of;
Dr Nana Kwadwo Biritwum 
Health Research Unit 
Ghana Health Service 
P.O. Box GP-184 
Accra 
Ghana
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HOUSEHOLD NON-COMPLIANCE INTERVIEW
INTERVIEWER: ASK TO TALK WITH ALL THOSE WHO ARE PRESENT
IN THE HOUSEHOLD AT THE TIME OF INTERVIEW (Head of household will 
answer for those not present)
Name
(Number
Names)
Sex Age Currently
Present
Yes/No
Disease Status
Yes / No / NA
Indicate Yes or No for Taking of Drugs and Put
the code for side reactions experienced or
reason for not taking the drugs in brackets for 
any particular years’ treatment in the box.
El Hy Year
1
Year 2 Year
3
Year 4 Year
5
Year
6
El - Elephantiasis Hy-Hydrocoele
If answer for drug received is No put in one of the following codes
1. Less than 90cm 2. Pregnant 3. Severely ill 4. Absent during
treatment 5. Breast feeding 6. Other specify............................
*Did anybody have any problem within two days after taking the drug?
1. No problem 2. Fever 3. Headache 4. Vomiting 5. General Muscle 
Pains 6. Dizziness 7. Itching 8. Diarrhoea 
9. Other, specify........................ 10. NA
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Appendix II : Morbidity Control Programme Assessment Questionnaire
Name of Interviewer....................................... Date of
Interview........................
Community..................................................... Sub­
district.................................
District
My name is......................... ........................... ..lam doing this work for the
Ghana Health Service and want to have a discussion with you about the 
programme that is aimed at preventing and also providing help for people with 
lymphatic filariasis disease. The purpose of this exercise is to enable us 
determine if the programme is reaching out to the people with this disease 
and if those receiving this help are happy with the programme.
Interviewer
Please note that multiple correct answers are allowed where applicable. The 
codes for Yes is 1, No is 2, other, specify is 7, don’t know is 8 and not 
applicable (NA) is 9
Section A: Socio-Demographic Data
1. Name of respondent
2. Age [ ] E ]
3. Sex 1. Male 2. Female
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4. Marital Status 1. Married 2. Single 3. Divorced 4. 
Widowed
5. Number of people in this household [ ] [ ]
6. Occupation 1. Farmer 2. Fisherman 3. Teacher 4. Artisan
5. Trader 7.Other, specify.....................................
7. Religion 1. Christian 2. Moslem 3. Traditional Religion
4. None 7. Other, specify........................................
8. Number of completed years of education [ ] [ ]
Section B: Knowledge and Participation
9. Flave you heard about the disease filariasis? 1. Yes 2. No
10. If yes, how does it present in an affected individual?
(Multiple answers are allowed)
1. Enlarged Legs 2. Enlarged Scrotum 3. Enlarged
Arms
4. Enlarged Breasts 5. Fever and Chills 6. Painful and swollen groin
7. Other, Specify..............................
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11. How is this disease acquired?
1. Through the bite of a mosquito 2. Breathing in the germs
3. Eating contaminated food 4. Drinking contaminated
water
7. Other, Specify...................................................................
12. Which germs are responsible for the disease?
1. Tiny worms in the body 2. Bacteria 3. Viruses
7. Other, Specify..................... 8. Don’t know
13. How is lymphatic filariasis disease prevented?
(Multiple answers are allowed)
1 .By taking drugs 2. Sleeping in Insecticide treated mosquito nets 
3. Keeping a clean environment 7. Other,
Specify............................................. .
14. Are you aware of any drug distribution exercise in this community for 
which the heights of people were measured?
1. Yes 2. No
15. How many different drugs are given during the exercise? [ ] [ ]
16. Did you take and swallow some of the drugs during the distribution?
1. Yes 2. No
Interviewer:
For patients with elephantiasis complete section C;
For patients with hydrocoeles complete section D;
If patient has both conditions complete sections C and D;
Section C: Elephantiasis Patient
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17. For how long have you had elephantiasis? [ ] [ ]
18. Are you aware of the availability of help for patients with elephantiasis?
1 .Yes 2. No
19. What treatment is available for people with elephantiasis?
1. Medication 2, Surgery 3. Medication and Surgery
7. Other, specify.................. 8. Don’t know
20. Have you been given a copy of the small book, which teaches you how 
to care for your elephantiasis leg?
1. Yes 2. No
21. Have you been taught how to apply the instructions in this booklet?
I.Yes 2. No 9.N/A
22. How do you take care of your leg?
(Multiple correct answers are allowed)
1. Regular washing 2. Exercising 3. Limb elevation 4. Proper wound
care
7. Others, Specify....................................
23. What do you do when you get an acute attack?
(Multiple correct answers are allowed)
1. Immerse leg in cold water 2. Take painkillers 3. Go to the 
hospital
4. Go to the traditional healer 7. Other, specify
8. Don’t know
24. For how many years have you been undertaking limb washing?
[ ][ ]
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25. Have you seen any improvement in your condition since you started 
limb washing?
I.Yes 2. No 9. N/A
26. How many times did you have acute attacks each year before starting 
this treatment?
[ ][ ]
27. Have you noticed a change in the number of acute attacks you get 
each year since you started the limb washing?
1. No change 2. Yes, it is increasing 3. Yes, it is reducing 9. N/A
28. How many times have you had an acute attack this year? [ ] [ ]
Have you noticed a change in the size of your limb since you started the limb 
washing?
1. No change 2. Yes, it is getting bigger 3. Yes, it is getting smaller 
9. N/A
Section D: Hydrocoele Patient
30. For how many years have you had a hydrocoele? [ ] [ ]
31. Are you aware of the availability of treatment for people with 
hydrocoeles?
1. Yes 2. No
32. Have you made any attempt to seek treatment for your condition?
I.Yes 2. No If No,
why?...............................................................................
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33. What kind of treatment is available for people with hydrocoeles? 
1. Medication2. Surgery 3. Medication and Surgery?
7. Other, specify.................... 8. Don’t know
34. Have you had any treatment for your hydrocoele?
1. Yes 2. No
If No,
why?.............................................................................................................
35. If yes, what was the outcome of this treatment?
1. Good 2. Bad 7. Other, specify......
9. N/A
36. Is this treatment free?
1. Yes 2. No 9. N/A
If No, how much did you pay?
37. Are you happy with the results of this surgery?
1. Yes 2. No 3. Cannot tell 9. N/A
Appendix III: End Point Determination
Protocol for Bm14 lgG4 Antibody Assay
Sensitize a 96 well plate with 100ul Bm14-HIS per well (2ug Bm14-HIS per ml 
in carbonate buffer, pH 9.6) overnight 37°C. Sensitize another plate with 2 
ug/ml control Cat-HIS antigen in carbonate buffer.
Next morning shake out the antigen solution, wash 3 times with PBS/Tween, 
and block by adding 200 ul per well PBS/T/FCS (PBS/Tween with 5% v/v fetal
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calf serum) 30 minutes at 37°C.
Wash plate 3 times with PBS/Tween.
Dilute sera 1:100 in PBS/T/FCS (5 ul serum plus 495 ul diluent).
For serum sets expected to have many positives:
Test sera in duplicate wells on each of the plates (100ul of 1:100 dilution per 
well), incubate 2 hours 37°C. Include controls; 2 wells each of a positive 
filarial antibody serum pool and a nonendemic normal human serum pool. 
Each lab must produce and test its own positive and negative control 
samples. We dilute our positive pool so that it produces a net O.D. between 
2.0 and 3.0 (i.e., not “over” or starring out the reader).
For serum sets expected to have few positives:
Test one well per serum. Retest positives in another run with duplicate wells 
for conformation.
Wash plates 3 times with PBS/Tween.
Conjugate:
Add 100ul peroxidase labeled anti-human lgG4. Working dilution must be 
worked out by your lab.
Wash plate 3 times with PBS/Tween.
Substrate:
Add 100 ul OPD substrate solution per well, and incubate in the dark, 10min, 
room temperature. (Other substrates such as premixed ABTS or TMB can be 
used, but we have not used these extensively).
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Stop the OPD substrate reaction by adding 50ul of 4 M sulfuric acid to each 
well. (Be careful with acid! Add acid to water for dilution).
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Scoring results:
Read OD 490 and calculate mean OD values for each serum tested. (When 
duplicate values do not agree regarding positivity, the serum should be 
retested). (Note that it is desirable to use 490 with a second reference 
wavelength over 600 nm if possible to correct for imperfections in ELISA 
plates). (We keep aside wells G11 and G12 as blanks and blank the reader 
with water in those wells). Subtract mean OD values on the Cat-HlS plate 
from those on the Bm14-H!S plate to get the mean net OD. The cutoff net OD 
value is the mean plus 3 SD of the net OD values obtained with the pane! of 
negative sera. Cutoff values will vary from lab to lab, but they should be in the 
range of 0.100 to 0.200. Note that most sera will give very low OD values 
with the Cat-HIS control antigen. However, we like to test the sera in parallel 
to catch the unusual serum that reacts with Cat-HIS in the lgG4 assay. You 
may find that this is not necessary. Your positive control pool is your proof that 
the assay is working properly.
Note: Before you start testing your sera:
It is necessary to start with a technical run with 10 to 20 of your own non­
endemic (not exposed to filariasis) sera and a few of your own positive sera to 
make sure the reagents are working and to define the background cutoff for 
the assay in your laboratory. We use the mean plus 3 SD of the net OD 
obtained with the panel of negative sera to define the cutoff for a positive test. 
This tends to be approx 0.150 in our lab conditions. Control serum samples 
generally look water clear in the ELISA and wells in the CAT-his control 
antigen plate are also usually water clear. If a serum produces an O.D. value 
with the control antigen that is as high or higher than that produced on the 
Bm14 plate, the result is indeterminate/invalid.
Buffer Recipes
Carbonate buffer (0.06M, pH 9.6)(for sensitizing plates with antigen):
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Buffer A: 1.0M Sodium Bicarbonate (NaHCOS) 8.4g in 100 ml dH20. 
Buffer B: 1.0M Sodium Carbonate (Na2C03) 10.6g in 100 ml dH20. 
Combine 22.65 ml Buffer A, with 9.1 ml Buffer B, and dilute to 500 ml with 
dH20.
PBS Stock Solution to make PBS/Tween Wash
54,8g Sodium Phosphate Dibasic (Na2HP04) into 772 ml dH20.
15.75g Sodium Phosphate Monobasic (NaH2P04) into 228 ml dH20. 
Dilute to 2000ml with d dH20
PBS/Tween Wash (Tween concentration is 0.05%)
240ml PBS Stock Solution 
51g Sodium Chloride NaCI 
3.0 ml Tween 20 (Sigma)
Dilute to 6000 ml with dH20.
PBS/T/FCS (Blocking solution and diluent for sera)
PBS/Tween with 5% fetal calf serum (heat inactivated serum, 56 C for 34 hr)
Citrate Buffer (for OPD substrate):
Buffer A. 9.6g Citric Acid, 500ml dH20.
Buffer B. 26.87g Dibasic Sodium Phosphate (Na2HP04) in 500 ml dH20.
Add 486 ml of A. to 500 ml B. Adjust pH to 5.0
OPD substrate solution:
4mg OPD (O-phenylenediamine, Sigma Chem. Co., St. Louis, MO, USA) in 
10ml Citrate buffer, 2 ul of 30% H202. OPD is poorly soluble and must be 
added at least 20 minutes before you plan to use the substrate. Add H202 at 
the last minute. (Substrate must be made up daily. Keep substrate in the dark 
until you use it. Plates with substrate must be incubated in the dark).
ELISA PLATES:
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We have found that polyvinyl plates work best in this assay. These can be flat 
or round bottomed (for example, Vinyl U bottom plates, Part No. 
2401,ThermoLab Systems, 8 East Forge Parkway, Franklin, MA 02038. Tel 
800 522 7763). Immunlon 4 plates do not work well.
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Appendix IV : Methods for calculating indirect costs
Average daily wage used for the calculation of the indirect cost of surgery to 
both patient and caregiver was 016,500.00 (Minimum daily wage in Ghana - 
as at 24/10/06)
In calculating the hourly wage, 8 working hours per day was used.
Exchange rate of the Ghanaian Cedi to the US Dollar (April 2006) - $1.00: 
09,000.00
Appendix V: Verbal Consent Form
Knowledge, Attitude and Practice, Coverage and Non-Compliance Study 
Consent Form
My name is................................................................................lam doing this
work for the Ghana Health Service in order to help assess the effect of the 
drug distribution programme and also improve on the health services provided 
to the people of Ghana.
This discussion is about the two drugs that are distributed every year and for 
which the height of people are measured before the drugs are given.
You have been selected randomly and hope you will take a moment and 
volunteer answers to all the questions. We cannot give anything for answering 
the questions but please note that your answers will be important in helping 
improve the health status of the people in this community.
We will record your name but this will only help us to trace you if there is any 
problem, however your name will not be linked to any answers that you
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provide and will not be shared with anybody. No one will know that the 
answers are yours.
You may refuse to answer the questions and will not be penalised if you 
refuse to answer the questions. If you are uncomfortable with any question 
you may also decline to answer them or withdraw at any point in the interview.
The questions are about the drug distribution exercise and the participation of 
yourself and your household in the exercise.
The report from this study will be shared with your community after this work 
is complete without making any reference to any individual response.
Will you like to participate in the survey? Yes............
No.....................
If no thank the person and move on.
If you have any queries or difficulties after I have left you may contact the 
head of the local health centre for any clarification with regards to this study or 
contact the following person;
Dr. Nana Kwadwo Biritwum 
Health Research Unit 
Ghana Health Service 
P. O. Box GP-184 
Accra - Ghana
Signature/Thumbprint.........
Date.........................
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Appendix VI: Blood Survey Consent Form
This blood sampling exercise will help us determine the disease levels of 
lymphatic filariasis in this community after so many years of taking the drugs 
in this community annually.
We are selecting 500 people as they willingly come, take a tiny sample (about 
100 microlitres) of blood from your fingertip for later analysis. It will involve 
pricking the finger which may be a bit painful but do not worry as the pain 
associated will disappear soon afterwards. In order to prevent infection the 
site will be cleaned very well before and after the prick. We do not expect any 
bleeding after taking the blood sample.
Blood taken will be put on a slide and studied in the laboratory for the disease. 
People found to have the disease but missed the treatment will be followed up 
and offered the treatment.
We will also ask you a few questions about yourself and participation in this 
survey. You may or may not answer the questions or decline to allow your 
blood to be taken at any point. You will not be penalised in any way for 
withdrawing your participation.
Your blood test results will not be shared with anyone but kept strictly 
confidential. You will only be contacted if there is the need to give you some 
treatment. The results of the whole exercise will be shared with the 
community without making reference to individual results.
The consent of community leaders and then the parents of children less than 
5 years of age will both be sought before collecting finger prick blood for the 
antigen or antibody analysis.
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In case of any further queries or difficulties after we leave, you may contact 
the one in-charge of your local health centre for help.
Will you like to participate in the survey? Yes............
No.....................
If no thank the person and move on.
Would you allow your child’s finger prick blood sample to be taken?
Yes................................................. No........................................
If you have any problem you may contact the following person;
Dr. Nana Kwadwo Biritwum 
Health Research Unit 
P. O. Box GP-184 
Accra - Ghana
Signature/Thumbprint..............................................................................
Date.................................
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